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ABSTRACT
Saccharomyces cerevisiae: A Model Host for Antisense Gene Control?
S. cerevisiae was chosen as a host for the development of a model 
system, which tested the effectiveness of antisense as a mechanism of controlling 
gene expression. The reporter gene chosen for this study is the a-amylase gene 
from Bacillus licheniformis. S. cerevisiae has no endogenous a-amylase activity. 
The sense and antisense gene copies were introduced into the yeast cell in 
various combinations, initially with the primary objective of obtaining an excess 
of antisense to sense transcripts. In several of the yeast recombinant strains used 
in this study the a-amylase gene (sense or antisense) was integrated into one of 
the yeast chromosomes. Despite achieving a copy number difference of 9:2, and 
a reasonably favourable mRNA ratio (4:1), together with temporal coincidence 
of the two transcript populations, no down-regulation of a-amylase was 
observed.
In these initial experiments a complete copy of the a-amylase antiscript had been 
used. It was considered that the lack of any observable antisense effect may have 
partly been due to poor interactions between the two complementary a-amylase 
sequences. One of the critical requirements to achieving an antisense effect is 
that the two complementary RNA molecules be available to base pair with one 
another. This requirement would not be met if the antisense RNA molecule, 
when synthesised, was forming stable intramolecular structures. With this in 
mind, several truncated forms of the gene were tested for their ability to down- 
regulate a-amylase expression. Northern analysis of the mRNA population from 
these yeast recombinant strains yielded the expected sized RNA products. These 
truncated anti-mRNA molecules appeared to be reasonably stable (relative to the 
a-amylase mRNA itself), and present in an abundance similar to that found for 
the complete gene antisense transcript (3-4:1). However, none of these truncated 
antisense molecules were found to exert an antisense effect.
In an effort to improve the spatial coincidence of the two RNA 
populations, the two a-amylase genes (sense and antisense), were introduced on
I
separate episomal plasmids. Additionally, a more favourable ratio of antisense to 
sense transcripts was obtained (7.5:1) by placing the antisense gene under the 
control of the inducible GAL1 promoter, while the sense remained under the 
control of the AdHl promoter. This experimental system resulted in a 12% 
reduction in the levels of a-amylase activity.
The final set of experiments presented involved the construction of a 
chimeric sense-antisense fusion (referred to as the cis construct), in such a way 
that, upon transcription, a fusion RNA product would be produced consisting of 
the complete a-amylase message tagged to a-amylase antisense sequences. This 
construct was designed to maximise the co-localisation of the two RNAs (sense 
and antisense) by linking their transcription and cellular distribution. Upon 
introduction and subsequent transcription of this gene fusion in yeast cells, a 
complete inhibition of a-amylase enzyme activity was achieved. Interestingly, 
Northern analysis revealed a shorter, but discrete transcript than that predicted. 
The particular location of this construct, whether episomal or chromosomal, was 
found not to alter the outcome.
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NOMENCLATURE
Throughout this thesis this symbol (::) has been used to indicate the 
presence of an episomal plasmid in a particular yeast strain, for example, 
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the S. cerevisiae strain DBY746. S. cerevisiae yeast strains which have particular 
DNA sequences integrated into one of the chromosomes are individually named.
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CHAPTER 1 
Literature Review
1
1. LITERA TURE REVIEW
1.1 INTRODUCTION
Nowadays, it is possible to isolate virtually any gene from any desired 
organism and to establish its DNA sequence, however there are very few 
techniques available that allow one to determine these genes’ in vivo function. 
Antisense techniques are emerging as important tools in determining the in vivo 
function(s) o f these genes, since they provide a method o f preventing or reducing 
gene function by targeting the genetic material or its expression. These methods 
require only a knowledge of the DNA or RNA sequence o f the target gene. 
Realisation o f the genetic code is a multistep process which involves the flow of 
information from gene to protein. This flow depends at each stage on specific 
base pairing interactions between complementary nucleotides which ensure the 
accuracy of transmission of the information. This complementary nature of the 
two strands o f DNA in the double helix as proposed by Watson and Crick lead to 
the determination that both single stranded DNA and RNA can form homo and 
heterodimers of DNA:DNA, RNA:DNA and RNA:RNA hybrids. These 
complementary interactions are of basic importance to transcription, RNA 
processing and ultimately translation. Because o f the fundamental importance of 
these complementary base pair interactions to the function o f genes, interference 
with any o f these interactions by using a complementary or antisense sequence 
offers the possibility o f interfering with target gene expression in a highly 
selective manner. The antisense sequence may exert its’ effect by preventing 
these complementary interactions from occurring or by occluding a process that 
requires a single-stranded substrate (such as the binding o f ribosomes to the 
mRNA molecule for the initiation of translation); or by stimulating the action of 
nucleases specific for double-stranded regions of DNA:RNA or RNA:RNA 
hybrids, or finally the antisense sequence may inactivate the target directly by 
intercalation or cleavage. Therefore it should be obvious at this stage that 
antisense techniques can in principle be designed to modulate the information
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flow for any gene for which sequence information is available and in any system 
into which the antisense sequences can be introduced.
The ultimate objective of using antisense techniques is to use a sequence 
complementary to the target gene, to block or to downregulate its expression, 
thereby creating a mutant cell line or organism in which the level of a single 
chosen protein or in certain cases, the replication of a virus is selectively reduced 
or abolished. Blocking the expression o f a particular gene opens up the 
possibility of investigating the function of the gene in cellular or developmental 
processes. Antisense sequences may also be employed to reduce the expression 
of a gene causing an undesirable phenotype in transgenic plants or animals, or on 
a medical note, to interfere with oncogenic transformation or viral infection.
Despite the simplicity of the concept behind antisense RNA regulation, 
this technique does not always result in downregulation of gene expression and 
usually requires the construction of a number o f different antisense genes (van 
der Krol et al., 1988a). In addition to the numerous successes associated with 
antisense RNA mediated regulation there have also been a number of failures 
(Salmons et al., 1986; Kerr et al., 1988; Law and Devenish, 1988; Olsson et al.,
1997). Based on these observations a large research effort has been directed 
towards analysing the exact mechanism(s) underlying this technology with the 
ultimate goal o f enhancing the efficiency o f antisense RNA control. Now that the 
initial excitement and subsequent disappointment has given way to a greater 
pragmatism, it is clear that there is an important future for antisense approaches 
not only as a research tool but also in biotechnology for manipulating the 
characteristics o f  transgenic animal and plants and in pharmacology as 
therapeutic agents (Uhlmann and Peymann, 1990).
Within this chapter I will review natural and artificial antisense gene 
regulation in both prokaryotes and eukaryotes, with a particular emphasis on 
Saccharomyces cerevisiae. I will highlight the evidence for the mechanism(s) 
underlying antisense regulation, since one of the least satisfying aspects of 
antisense technology is the lack of information regarding its mode of action, 
which makes a rational design of antisense strategies difficult. This is partly due 
to the variety o f different model systems (with their inherent differences) being 
used, but is perhaps chiefly a reflection o f the large number of variables within 
the multistep process from gene to protein. Any one o f these steps may or may
3
not be a target depending on mRNA structure, accessibility, transport and other 
factors that can differ from gene to gene, cell type to cell type and organism to 
organism.
1.2 NATURAL GENE REGULATION B Y  ANTISENSE RNA IN  
PROKARYOTIC SYSTEM S
1.2.1 CLASSIFICATION OF NATURALLY OCCURRING 
PROKARYOTIC ANTISENSE RNA SYSTEMS
Over the last decade antisense RNA has emerged as a natural component 
of many regulatory circuits. The targets for this newly discovered mode of 
regulation seems to be any process which involves single-stranded RNA, namely 
RNA processing, transcription and translation. In many instances this antisense 
RNA gene is part o f a more complex regulatory system and in its natural role 
may not be the only or the main regulatory gene. From examples in the naturally 
occurring systems, it appears more likely that the antisense RNAs act as fine 
tuners of complex regulatory systems (Pines and Inouye, 1986). These natural 
prokaryotic antisense RNA systems exhibit a variety of modes of inhibiting gene 
expression under which they maybe classified (Table 1-1). These mechanisms 
include interference with transcription, (transcriptional attenuation), translation 
(sequestering o f the ribosomal binding site), indirect interference with translation 
by means of RNase cleavage and finally through interference with other RNA 
functions such as the inhibition o f primer formation in plasmid replication, as in 
the case of ColEl.
The genomic organisation of many of the natural prokaryotic antisense 
genes is one in which the antisense genes and the target gene overlap such that 
the antisense RNA and the target mRNA are transcribed from opposite template 
DNA strands. These antisense RNAs can be classed as being cis encoded. More 
recently, however trans-encoded antisense RNAs have come to light. These 
RNAs are encoded by genes that are located at genetic loci other than those of 
the target genes. Only a few of these unlinked antisense RNA genes have been 
detected and they like cis encoded RNAs are normally small, but they exhibit 
only partial complementarity to their target RNAs (Delihas, 1995). Naturally
4
occurring antisense RNAs could be further classified as to whether they are cis or 
trans encoded.
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Table 1-1 Classification of Naturally Occurring Antisense RNAs on the basis of 
Function.
Target Gene Antisense RNA
Name Function System Name Size (nt) Target
Interference with transcription (transcriptional attenuation)
LRNA*repC Replication pTl 81 RNAI 87
traJ Transfer F FinP 105 L-RNA
crp cAMP receptor E.coli tic 92 L-RNA
repR Replication pIP501 RNAIII L-RNA
Direct interference with translation (sequestering of ribosome binding site)
IS 10 Transposition TnlO RNAour 69 RNA1n
gvpABC Formation of Calothrix 7601 gvp 420 coding
operon gas vesicles Cyanobacterium region of 
gvpA, AE 
ABC
repB Replication pLSl RNAII L-RNA
repA Replication IncB RNAI 70 L-RNA
Q Antitermination X PaqRNA 220 L-RNA
sulA Division
Inhibition
E.coli is f 353 L-RNA
ompF Outer
membrane
E.coli micF 174 L-RNA
Indirect interference with translation (RNase cleavage)
cD/O inter- Replication X cWO 77 cII/O
genic region
repA Replication R1 CopA 89 CopT
Interference with other RNA functions
RNA II Replication ColEl RNAI 108 RNAII5’
end
Activation of translation
hla Activation of S. aureus RNAIII 500 L-RNA
alpha toxin 
* L-RNA, leader RNA
Finally, prokaryotic antisense RNAs can be classified according to 
function for example many are involved in plasmid replication and maintenance, 
others regulate either bacterial or phage gene expression while a further group of 
these antisense RNAs are involved with transposition and conjugal DNA 
transfer. In the following section the antisense RNAs listed in Table 1-1 will be 
discussed individually, features that will be highlighted include their mechanism 
of action, structure and function.
1.2.2 PLASMID REPLICATION AND MAINTENANCE
Many prokaryotic antisense RNAs are involved in the regulation of 
plasmid copy number and different mechanisms of regulation are exhibited
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between different organisms. In the ColEl plasmid family for example, the 
antisense RNA, RNA1 inhibits primer maturation, whereas in plasmids of the 
IncFII-like and IncIa/IncB families, antisense RNAs inhibit translation of a Rep 
(replication) protein either by inhibiting Rep protein synthesis through 
prevention o f leader peptide translation or by the inhibition of formation of an 
activator RNA pseudoknot, required for Rep protein synthesis respectively. On 
the other hand, antisense RNAs of plasmids, like pT181 and pIP501, found in 
Gram-positve hosts, function by inducing transcriptional attenuation of the Rep 
mRNA. In all these systems antisense RNAs act as efficient inhibitors of the 
functions o f their target RNAs. The inhibition is mainly post-transcriptional and 
involves antisense-target RNA base pairing (Hjalt and Wagner, 1995).
1.2.2.1 ColEl
The negative control of replication of the plasmid ColEl (which is a 6.4 
kb plasmid that encodes the colicin E l protein as well as immunity to the lethal 
effect o f this protein) is accomplished by an antisense RNA, RNAI which is 
transcribed in the opposite direction from the same DNA that encodes the primer 
RNA, RNAII, for DNA replication at the origin. Replication of ColEl initiates 
when the primer precursor, RNAII hybridises to its DNA template and is cleaved 
by ribonucleaseH at the origin. Using the cleaved RNA as a primer, DNA 
synthesis by DNA polymerase I can ensue. The antisense RNA (RNAI) has a 
short sequence o f 108 nucleotides, which functions by blocking processing of the 
primer precursor by hybridising with it, thus causing a conformational change, 
which then prevents formation of a suitable ribonuclease H substrate (i.e. a 
DNA:RNA hybrid; Green etal., 1986; Simons, 1988).
Maximal negative control of plasmid replication by RNA I is further 
enhanced by a plasmid encoded protein consisting o f 63 amino acid residues 
referred to as rop (repressor o f protein) or rom (RNA one modulator). This 
protein is capable of accelerating the association of RNA I with RNAII. The 
protein itself is a small rigid dimer o f exact two-fold symmetry. This lead to the 
proposal that each subunit binds to one RNA molecule and that if two molecules 
have complementary loops, these are then positioned correctly for the “kissing” 
interaction, (Cesarini and Banner, 1985).
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The actual pairing between RNA I and RNA II can be broken down to 
three steps. In the first step termed “kissing” RNA I and RNA 11 form reversible 
contacts between the free 5’ end of RNA I and essentially the 3 equivalent loops 
in RNA II. Next, stable complex formation begins between the free 5’ end of 
RNA I and its complementary in RNA II, as the kissing intermediate gives way. 
Mutations that delete the 5’ end of RNA I prevent stable complex formation. 
Finally pairing is propagated from the 5’ end of RNA I to the full extent of 
complementarity (Figure 1.1).
Figure 1.1 Schematic representation of the pairing reaction between RNA I and 
RNA II (Simons and Kleckner, 1988).
1.2.2.2 IncF
Another example o f this type o f organisation where the antisense and 
target genes overlap is involved with the control of the conjugative transmission 
of the IncF plasmids. Conjugative transmission in IncFI, IncFII and related 
plasmids involves a large number of transfer genes (tra) whose transcription 
requires the product o f a single gene traJ. Upon transfer to a new cell, the traJ 
gene is expressed and additional rounds o f conjugation occur. However, after 
residing in the cell for several generations traJ gene expression is inhibited and 
further transmission becomes rare (Simons, 1988; Simons and Kleckner, 1988).
The FinOP system mediates this plasmid DNA transfer between 
enterobacterial cells. This system consists of an antisense RNA,finP, and a 21.2 
kDa protein FinO which together inhibit traJ expression. finP  is a plasmid
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specific antisense RNA, whereas FinO encodes a proteic co-repressor which is 
not plasmid specific but exchangeable among F-like plasmids. The finP  gene 
product of plasmid R1 is encoded from the strand complementary to the traJ 
mRNA which results in a 72-base untranslated RNA transcript (finP) that is fully 
complementary to the 5’ non-translated sequence, the ribosome binding site and 
the first two codons o f the traJ mRNA. Hence it appears that the finP  product is 
the principal player in regulatory events due to its ability to bind the 5 ’ end of the 
traJ mRNA, including the RBS. This pairing presumably prevents the access of 
ribosomes and as a result inhibits traJ mRNA translation (Koraimann et al.,
1996).
In addition finP  exhibits a highly ordered secondary structure consisting 
of two stem-loop domains with a short single-stranded 5’ tail. The 5’ 
untranslated region of traJ mRNA adopts a conformation complementary to that 
offinP. Results presented by Koraimann et al. (1996) demonstrated that the 
specificity o f the finP  antisense RNA resides in loop II of the predicted finP  
RNA molecule (Figure 1.2), however further analysis o f an additionally created 
loop I mutant showed a reduced function offinP which strongly suggested that 
the central nucleotides in both loops offlnP  play a role in the initial interaction 
between an antisense RNA and its target, the traJ mRNA. A mutant located at 
the periphery of loop I in finP  did not lead to a loss o f function phenotype 
suggesting that not all o f the loop nucleotides are involved in the creation of the 
kissing complex. Hence, one could postulate that the primary interaction via 
‘kissing of the loops’ is sufficient for occlusion of the traJ RBS and the shutting- 
down o f traJ expression. TraJ sequence complementarity to the RBS lies 
partially in loop I o ffinP, a feature that is not found in other well-characterised 
antisense RNA systems (Koraimann et al., 1996).
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Figure 1.2 Structure o f the prokaryotic antisense RNA, finP (Simons, 1988).
1.2.23 R1162 and pT181
Other examples o f natural antisense RNAs, which are produced by the 
transcription o f their individual target regions in the opposite orientation to the 
target RNA transcription, include the control of plasmid replication o f the broad 
host range plasmid R1162 and also of the gram positive Staphylococcus aureus 
plasmid pT181. In contrast to ColEl, the antisense RNAs in these plasmids 
inhibit the expression of an essential plasmid encoded replication initiation 
protein.
In the case o f pT181, two overlapping antisense RNA species are made 
which are complementary to the mRNAs coding for the plasmid specific 
replication protein, RepC. The two leftward transcripts, RNA III and RNA IV are 
utilised as mRNAs for RepC and contain long, untranslated 5’ leaders of 190 and 
260 bases respectively. The translation of the RepC mRNAs can be inhibited by 
two countertranscripts, RNA I (80 bases) and RNA H (150 bases) which are 
complementary to the 5’ regions o f RNA III and RNA IV. (Takayama and 
Inouye, 1990). The original understanding was that these species function by 
repressing the translation o f the rep gene mRNA, however Highlander and 
Novick (1990), came to the conclusion that it appears more likely that they cause 
attenuation (i.e. premature termination of transcription). The attenuation is 
proposed to occur as a result o f the antisense RNA:mRNA duplex influencing the
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choice o f possible secondary structures and favouring the adoption of the one 
that includes a transcriptional terminator, (Thomas, 1992).
The copy number of the broad host range plasmid R1162 is regulated by 
a 75 nucleotide antisense RNA complementary to a region of the replA mRNA, 
including the RBS and first two codons of the repl A coding sequence. It is 
proposed that this antisense RNA competes with the ribosomes for binding at the 
ribosome binding site o f the repl A mRNA (Takayama and Inouye, 1990).
1.2.2.4 pIP501
Antisense RNA mediated transcriptional attenuation is also the 
mechanism of control for the streptococcal plasmid pIP501. This particular 
mechanism implies that the replication (repR) mRNAs must be capable of 
folding into two mutually exclusive structures. Formation o f one of these 
structures is induced by the binding o f the antisense RNA, RNA III to the 
nascent repR mRNA, RNA II, and this induces transcriptional termination at an 
inverted repeat structure located upstream of the RepR reading frame. As the fate 
of the nascent RNA transcript is dependent on the binding rate of this antisense 
RNA to its target, the control is kinetic. To simplify, despite the mechanism 
employed, all replication control circuits involve a branched pathway in relation 
to the fate o f the target RNA; binding o f the antisense RNA results in inhibition 
of translation, escape allows replication. As the relative rates of the competing 
mutually exclusive branches o f the pathway determine replication frequency, it 
becomes clear that the control is kinetic.
The synthesis o f  the replication rate-limiting protein, RepR is controlled 
transcriptionally by CopR and at the post-transcriptional level by the antisense 
RNA, RNA III (Figure 1.3). The secondary structure of this RNA molecule, 
RNA III, possesses two minor stem-loops (I + II), a relatively unstructured 
middle-region and two major stem-loops towards the 3 ’ end terminus (IE + IV).
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Figure 1.3 Structure o f  the antisense RNA, RNAIII (Brantl and Wagner, 1994).
1.2.2.5 p L S l
The control o f synthesis of the RepB initiator protein of the streptococcal 
plasmid pLSl was proposed to be carried out by two plasmid-encoded gene 
products; the CopG protein and an antisense RNA, RNA II. CopG represses 
transcription from the single promoter for the copG-repB operon, whereas it was 
predicted that the antisense RNA would act at the translational level, perhaps by 
blocking the accessibility o f the ribosomes to the RepB translation’s initiation 
signals. The pLS 1 region which is involved in the control of this initiator protein 
RepB, encompasses less than 300 base pairs and includes the genes CopG and 
mall, that read in opposite directions. The use o f plasmid mutants affected in the 
m a ll  gene characterised a plasmid DNA region involved in both transcription of 
m a ll  and translation o f RepB (del Solar et al., 1997).
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The replication of IncB’s mini-plasmid, pMU720, is dependent upon the 
expression o f the repA gene. This gene encodes the replication initiator protein 
RepA. The activation of rep A expression is negatively regulated by a small 
highly structured antisense RNA designated RNAI. This small antisense RNA 
binds to its complementary target, the stem-loop I (SLI) o f the repA mRNA and 
this occludes the participation o f SLI in the formation of a pseudoknot that is an 
enhancer of the translation of the rep A mRNA. Therefore RNAI regulates the 
frequency of replication of pMU720 by controlling the efficiency of translation 
of the repA mRNA. Interestingly, despite the fact that SLI and RNAI show 
complete complementarity the structures o f the two molecules are different 
(Figure 1.4). The m a l gene resides in the leader region o f repA and is transcribed 
in the direction opposite to that of SLI, so that RNAI is fully complementary to a 
70 base region o f SLI (Wilson et al., 1997).
1.2.2.6 IncB
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Figure 1.4 Secondary structures o f RNAI and SLI (Wilson et al., 1997).
1 .2 3  T R A N SL A T IO N A L  R E G U L A T IO N  (BA C T E R IA L  G ENE  
E X PR E SSIO N )
1 .2 3 .1  m icF
An example of a ?r<mv-encoded RNA involves control o f the genes OmpF 
and OmpC, which encode outer membrane proteins in E.coli. Regulation of these 
proteins is due partially to the micF (mRNA inhibitory complementary RNA) 
antisense RNA encoded by the micF gene. The micF locus is transcribed 
divergently from the OmpC promoter region (47 minutes on the E.coli 
chromosome) but acts on the distant OmpF locus (21 minutes on the E.coli 
chromosome) showing that inhibitor-target interactions do not require the 
antisense RNA to be transcribed from the complementary strand of the target 
gene itself (Thomas, 1992).
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Specifically, micF is involved in the post-transcriptional negative 
regulation o f OmpF. Two tandem promoters o f micF give rise to two species of 
RNA; an abundant 93 nucleotide 4.5S RNA and a less abundant 174 nucleotide 
6S RNA. Both RNAs contain sequences complementary to the Shine-Dalgamo 
and translational initiation sequences of OmpF mRNA. These sequences inhibit 
OmpF translation and they may also be involved with destabilising the mRNA as 
well (Pratt et al., 1996).
1.23.2 gvpABC operon
A higher level o f genomic complexity is exhibited by the naturally 
evolved RNA system described for the gvpABC operon of the cyanobacterium 
Calothrix 7601 (Csiszar et al., 1987). This operon encodes genes involved in the 
formation of gas vesicles, which provide buoyancy to its’ cells. Four different 
RNA species were found to be transcibed from the gvpABC operon in 
differentiated cells. Three of the transcripts (gvpA, gvpAB and gvpABC) initiate 
from the same nucleotide, 56 bases upstream from the gvpA AUG start codon 
and extend for various distances in the 5’ - 3’ direction. The resulting transcripts 
are 326 bases (covering only the gvpA gene), 773 bases (covering the gvpA and 
gvpB genes) and 1408 bases (covering all three genes, gvpA, gvpB and gvpC) in 
length. The fourth transcript originates from the opposite strand and is a 420 base 
pair long antisense RNA that is complementary to a portion of each of the three 
mRNAs o f the gvpABC operon. Unlike other prokaryotic naturally occurring 
antisense RNAs, the 420 base pair gvp antisense transcript is considerably larger 
and can hybridise along its entire length to each of the three mRNA species in 
the operon.
The gvp antisense RNA can form duplexes with the gvpABC RNAs 
which result in inhibition of translation due to the blockage of ribosome binding 
and/or ribosome migration during translation of the mRNAs (Csiszar et al.,
1987).
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1.2.4 PH A G E  G EN E E X PR E SSIO N
1.2.4.1 Phage A,
In phage X, choice between lytic and lysogenic pathways is critically 
dependent on the level o f ell protein. This protein activates the A,pre and Pi 
promoters which transcribe functions required for repression and integration, ell 
also delays X late gene expression, to allow sufficient time for establishment of 
lysogeny. This delay is thought to be mediated by an antisense RNA which 
reduces expression o f XQ protein, the activator of late gene expression. This 
antisense RNA is specified by a cll-dependent promoter PaQ which is located 
within and antisense to the Q gene. Reduction in the level of P3q RNA reduces 
the frequency of lysogeny.
The expression o f the ell protein itself is controlled at several levels, one 
of these being another antisense RNA, the oop RNA. This 77 base transcript oop 
RNA, does not contain any open reading frames but the 3’ terminal bases are 
complementary to the last 17 codons of ell mRNA (Takayama and Inouye, 
1990), when the oop RNA is expressed from a multicopy plasmid it inhibits ell 
expression. Many regulatory processes are involved in the determination of the 
course o f A, development. The ell protein plays a role in the lysis-lysogeny 
decision, while the antisense RNAs act in a specific way to prevent a particular 
target message from functioning. The inhibition of antiterminator Q expression 
by P3q RNA indirectly impels the phage to enter the lysogenic cycle, whereas 
oop RNA which targets ell mRNA functions in favour of the lytic mode.
1.2.5 TRANSPOSITION AND CONJUGAL DNA TRANSFER
1.2.5.1 TnlO
Another example of the overlapping genomic organisation o f prokaryotic 
antisense genes is illustrated by the bacterial transposon TnlO. Insertion 
sequence IS70, the mobile genetic element of transposon TnlO, encodes a single 
protein, transposase, which acts at the ends of IS 10 to bring about transposition. 
This sequences’ rate o f transposition is regulated by the action of an antisense 
RNA (RNA-OUT) on the transposase mRNA (RNA-IN). The ends of this
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composite, tetracycline-resistant transposon are inverted repeats of the insertion 
sequence IS/0. IS/0-right contains both the weak promoter Pin (that directs 
transcription o f the transposase mRNA) and the strong promoter P0ut (that 
initiates transcription o f RNA-OUT). These two promoters overlap each other by 
36 base pairs with transcription from Pin proceeding toward the internal region of 
the TnlO transposon and transcription from Pout proceeding in the opposite 
direction. Pout specifies the synthesis of an antisense RNA (RNA-OUT) that is 
complementary to the initial 36 nucleotides o f the Pin directed RNA-IN including 
the ribosome binding site and the translation start codon for transposase (Simons 
et al., 1983; Simons and Kleckner, 1983).
This small, 69 nucleotide untranslated antisense RNA, transcript is 
composed o f a simple secondary structure in which an approximately 20 base- 
pair stem is topped by a loosely paired loop domain. RNA-OUT is an unusually 
stable RNA having a half-life o f 60 minutes. More than likely the metabolic 
stabilities of antisense RNAs evolved to suit their individual regulatory roles. For 
example the plasmid ColEl antisense RNA, RNA I, which as mentioned earlier 
is involved in ColEl replication and hence copy number, is unstable and 
expressed from a strong promoter. This set-up allows RNA I levels to rapidly 
respond to the relatively fast changes in ColEl copy number. The IS10 antisense 
RNA in contrast is very stable and is expressed from a modest promoter. This 
set-up is ideal as the concentration o f RNA-OUT need respond only slowly to the 
very slow changes in IS10 copy number (Pepe et al., 1994).
Deshler et al., (1995), utilised this natural prokaryotic antisense RNA, 
RNA-OUT by replacing its’ loop domain with a hammerhead ribozyme (1.4.1.2) 
as a step towards developing a widely applicable system for expressing small 
ribozymes in a variety of cell types utilising T7 RNA polymerase. RNA-OUT 
was chosen because o f its unusually long half-life in E.coli due to the stem in its 
secondary structure. This should endow in vivo stability to small RNA sequences 
expressed within RNA-OUTs loop domain.
traJ (section 1.2.2.2)
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1.2.6 A C T IV A T IO N  O F T R A N SL A T IO N
1 .2 .6 .1  hla
All discussion o f naturally occurring prokaryotic antisense RNAs thus 
far, have shown these antisense RNAs as negative regulators of gene expression. 
One exception is the activation o f alpha-toxin {hla) translation in Staphylococcus 
aureus by the iram-encoded antisense RNA, RNA III. According to Morfeldt et 
al., (1995), this is one of the first examples of an antisense RNA that stimulates 
translation of the target RNA.
Staphylococcus aureus, a gram-positive bacteria is a major pathogen, 
causing abcess formation and severe tissue damage as well as toxin related 
diseases such as food poisoning and toxic shock syndrome. The virulence o f this 
bacterium has been attributed to a large number of extracellular toxins and 
enzymes (i.e. alpha-toxin, hemolysins, leucocidin, proteases, lipase, nuclease and 
staphylokinase) and to several cell-surface proteins including protein A, 
coagulase and fibronectin receptor. The synthesis of these virulence factors is 
controlled by a regulatory 0.5 kb RNA molecule RNA III, encoded by the agr 
(accessory gene regulator) locus. RNA III seems to act primarily on the initiation 
of transcription of virulence genes as demonstrated by transcriptional and 
translational fusion experiments localising the agr responsiveness to the 
promoter region of target genes.
In the report by Morfeldt et al., (1995), they have shown that in a S'. 
aureus mutant lacking the regulator RNA III, the steady-state levels of alpha- 
toxin mRNA was reduced 5 -1 0  fold, while the differential rate of alpha-toxin 
production was reduced 70 fold in comparison to the wild-type strain. These 
results indicate that RNA III activates hla gene expression both at the 
transcriptional and translational level. They suggest that translational activation 
is achieved by a direct interaction between RNA III and the target mRNA and 
transcriptionally indirectly by means o f intermediary protein factors. This 
complex of RNA III and hla mRNA was found in extracts o f total RNA isolated 
from the wild-type strain. A ribonuclease T1 digest revealed that the RBS of the 
hla transcript is blocked by intramolecular base-pairing. Hybridisation with RNA 
III prevents this intramolecular base-pairing and makes the hla mRNA accessible 
for the initiation o f translation. There is approximately 75% complementarity
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between the 5’ end o f RNA III and a stretch of approximately 80 base pairs 
within the Shine-Dalgamo region of the hla mRNA, which leads to the base 
pairing between the two molecules. As a result, in the absence of RNA III, the 
hla mRNA would be in a non-translatable form, subsequently when binding of 
RNA III does occur, this results in a conformational change that is amenable to 
translation. Thus RNA III appears to be an example o f an antisense RNA that 
stimulates translation of the target transcript, in contrast to the known antisense 
RNA species which block translation by interfering with the binding of 
ribosomes to the target mRNA.
A question likely to crop-up in relation to RNA III is why does alpha- 
toxin need to be regulated both at the level o f transcription and translation? A 
possible hypothesis may be that hla mRNA has a relatively long half-life of 10 - 
15 minutes, therefore in order to decrease the production of alpha-toxin quickly 
in response to environmental signals the bacterium may need to down-regulate 
translation of pre-formed mRNA although transcription has been silenced. 
Finally, in conclusion, this antisense RNA appears to be unique in many respects; 
it seems to regulate both transcription and translation by independent 
mechanisms; it appears to be the first regulatory RNA that activates transcription 
and it is also the first example o f an antisense RNA where interaction with the 
target RNA leads to stimulation o f translation rather than inhibition (Morfeldt, et 
al., 1995).
1.2.7 ST R U C T U R A L  FE A T U R E S A SSO C IA T E D  W IT H  N A T U R A L LY  
O C C U R R IN G  P R O K A R Y O T IC  A N T ISE N SE  R N A  SY STEM S
1.2.7.1 Stem s and L oops
The majority o f natural antisense RNAs analysed display a high degree of 
secondary structure and most o f these RNAs have the potential to form one or 
more stem-loop structures. In many cases these structures have been clearly 
established (e.g.Figure 1.5). Many of the loops are the most energetically 
favorable size, six to eight nucleotides. Many of the stems in these structures are 
extremely stable, others however contain weakly paired segments usually
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adjacent to their terminal loops. The antisense RNAs o f  ColE I plasmids also 
have an important 5 ’ tail.
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Figure 1.5 Structures o f various prokaryotic antisense RNAs (Simons, 1988).
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With all of these antisense reactions, critical contacts between the 
antisense RNA and its target occur in the loops of the antisense RNA. The loops 
which contain these critical sequences may represent a convenient way of 
ensuring that single-stranded sequences are available for pairing but are 
unavailable to cellular RNases. In the ColEl, Is 10 and IncFII RNAs mutations in 
the loop often changes pairing specificity; when such a mutation is present in 
both the antisense and target RNAs pairing is essentially normal, but when the 
mutation is present in only one of the two RNAs, pairing is prevented These 
effects arise in most cases from single DNA base pair changes that result in 
complementary changes at strategic positions in the two interacting RNA 
species. Furthermore the severity of these point mutations suggest that only a few 
Watson/Crick base pairs are involved in the initiation of pairing. Naturally 
occurring differences in loop sequences are thought to account for compatibilty 
among ColEl type plasmids and conjugational specificity among the IncF 
plasmids (Simons, 1988).
The stems of antisense RNAs on the other hand allow the formation of 
the appropriate loops and they also determine the stability/instability of the 
antisense molecules. Any point mutations which disrupt the pairing in the RNA- 
OUT stem reduced the RNA half-life in vivo and the appropriate second site 
mutations that restored the stems also restored stability. Similar mutations in the 
stems of the ColEl and IslO RNAs decrease RNA levels in vivo, presumably by 
shortening the half-life (Simons, 1988).
1.2.7.2 Bulges
Bulged out nucleotides (or internal loops within stem regions) have been 
found in the stem-loop structures o f many naturally occurring antisense RNAs. In 
the paper by Hjalt and Wagner (1995) they examined the antisense/target RNA 
system CopA/CopT that controls the copy number o f plasmid R lto examine the 
possible function of these bulged out nucleotides. The CopA antisense RNA 
contains two regions within the major stem-loop, which contain bulged-out 
nucleotides. The result o f their findings tentatively indicates that these bulges 
protect the CopA RNA from being a substrate for the double-strand specific
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enzyme RNase III, as in  vitro  cleavage rates were increased when either the 
lower or both bulges were absent (see Figure 1.6).
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Figure 1.6 CopA RNA secondary structure (Hjalt and Wagner, 1995).
As well as playing a role in the above process, bulged-out nucleotides 
may also serve other functions such as protein recognition sites on RNAs. In 
vitro these bulges in CopA are required for rapid duplex formation with CopT as 
well as for an effective inhibition o f target RNA function in vivo (Hjalt and 
Wagner, 1995).
In the majority o f cases (IS 70, micF and finP) involving prokaryotic 
natural antisense RNAs, the RNAs are complementary to the 5’ end o f their 
target RNAs and they usually base pair in such a way as to sequester the 
ribosome binding site and/or the translation initiation codon. When an antisense 
RNA is complementary to some other region o f the target message, cleavage 
may play a more essential role. Indeed Krinke and Wuff (1988) have shown that 
inhibition o f e ll gene expression by oop RNA, which is complementary to the 3 ’ 
portion o f the e ll coding region requires RNaselll. Hence these antisense RNAs 
are also involved with destabilisation of the target message.
Despite the differences in size of the naturally occurring antisense RNAs, 
it is generally observed that the region of complementarity with the associated
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target mRNA is equal to or shorter than the entire length of the antisense RNA. It 
has also been found that these naturally occurring antisense RNAs do not need to 
retain 100% complementarity with the target mRNA in order to exert an 
antisense effect (Mizuno et al., 1984). A case in point is the micF antisense RNA 
which is only 70% complementary to the 5’ end of the ompFmRNA, in the 
region of the RBS, the initiation codon and the codons of the first nine amino 
acids o f the ompF protein.
Antisense RNAs (R1162 RNA, pT181 RNA) that bind to non-coding 
regions o f the target mRNA, such as sequences upstream from the Shine- 
Dalgamo sequence, it has been proposed that duplex formation in this region 
results in the formation of an alternative secondary structure at or near the 
sequence which then blocks ribosome binding (Inouye, 1988). The tic RNA 
which functions at the level o f transcription is considered to bind to the extreme 
5’ end of the crp mRNA and forms an intermolecular structure that mimics the 
secondary structure normally recognised by RNA polymerase as a Rho- 
independent transcription termination signal. Finally, antisense RNAs also come 
into play at the level o f events preceding DNA replication as in the case of ColEl 
(Inouye, 1988).
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1.3 ARTIFICIAL GENE REGULATION BY ANTISENSE RNA IN
PROKARYOTIC SYSTEM S
Due to the presence of natural antisense genes in prokaryotes it was 
reasonable to consider that other cellular genes might be able to be specifically 
controlled using artificial antisense RNAs. The natural examples discussed in 
section 1.2.1 illustrate the many possible ways in which artificial RNAs can be 
designed in order to function effectively, and they provide food for thought on 
various parameters to be considered, before designing effective artificial 
antisense RNAs. Since most bacterial mRNAs are translated as soon as 
transcription has created a molecule long enough to be recognised by ribosomes, 
the degree of inhibition achieved by the antisense RNAs will depend on its rate 
o f interaction with the target. In turn, the rate will depend on the concentration of 
both RNA species and their reactivity towards one another.
Another feature observed from naturally occurring antisense molecules is 
that they are highly structured and maximum reactivity is achieved by strict 
adherence to relatively rigid single-stranded loops that are involved in the initial 
“kissing” between antisense RNA and target. Artificial regulators should try to 
mimic this set-up as much as possible although this is not easy to achieve. Since 
most antisense RNAs are relatively unreactive, it is normally necessary for them 
to be made in large quantities. Furthermore, it is apparent from the many studies 
of these natural systems that the effectiveness o f antisense RNAs is often 
modulated by other macromolecules in the cell, such as the Rop protein in the 
ColEl system and the FinO protein involved in the conjugative transfer of 
plasmids. These proteins facilitate RNA-RNA interactions. Lastly the 
susceptibility o f the double-stranded RNA molecules formed between the 
antisense RNA and its target to RNase activity can influence the fate of the 
products o f the interaction and the success o f the inhibition (Thomas, 1992).
1.3.1 ANTISENSE GENES
Artificial antisense RNAs can be synthesised by placing a DNA fragment 
o f a specific target gene under the control o f a promoter in reverse orientation. 
Several such antisense RNA genes have been constructed, and a few will be 
described in the following section.
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1.3.1.1 Lipoprotein (Ipp), ompC and ompA genes of E.coli
An artificial antisense RNA vector, pJDC402, was constructed by 
Coleman et al. (1984), to produce complementary RNAs against the lipoprotein 
(Ipp), ompA and ompC genes of E.coli. This vector contains the highly expressed 
lipoprotein (Ipp) promoter and the inducible lactose promoter-operator (lacpo) in 
tandem and the Ipp transcription terminator separated by a unique site into which 
a DNA fragment can be inserted. This arrangement ensures high-level 
transcription o f the DNA fragment in the presence o f lac inducers such as IPTG. 
The vector was designed after the natural micF RNA to give rise to a transcript 
flanked by stem-loop structures, one at the 5 ’ end derived from the lacp0 and one 
at the 3’ end derived from the Ipp transcription terminator. With the anti -Ipp 
gene, which includes the RBS and the start o f the open reading frame there was a 
16-fold reduction in lipoprotein synthesis. Interestingly, a duplication of the 
antisense Ipp RNA gene resulted in a 31 -fold reduction of lipoprotein synthesis 
upon IPTG induction, thus hinting at the presence of an antisense gene dosage 
effect. Northern analysis demonstrated that the Ipp mRNA was signifcantly less 
stable when the anti-//?/; was induced. This suggests that the effect on ipp was not 
simply due to inhibition of translation, but may also be the result of accelerated 
mRNA degradation due to cleavage by ribonucleases such as RNaselH (Coleman 
etal., 1984).
The pJDC402 system was also used to inhibit the expression of the outer 
membrane protein OmpC of E.coli. The antisense ompC RNA was 
complementary to the first 20 bases of the leader sequence including the RBS 
and 100 bases o f the coding sequence, induction o f this antisense RNA caused an 
approximately fivefold reduction in OmpC synthesis. Another anti-ompC RNA 
with longer complementarity to the leader region (72 bases) was four times more 
effective in inhibiting the production of OmpC than the shorter anti-ompC RNA, 
thus implying that 5’ leader region complementarity may be an influential factor 
in antisense RNA-mediated inhibition (Coleman et al, 1984).
Using the pJDC402 vector once again, several antisense genes were 
constructed from the ompA gene in order to ascertain which components 
contribute to the effectiveness o f an antisense RNA. This gene was chosen for 
this study, because the leader and the coding regions o f  the ompA mRNA have
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been extensively characterised. A total of five DNA fragments were individually 
cloned into pJDC402 in antisense orientation. The resulting antisense ompA 
fragments are shown in Figure 1.7. Each of the five constructs were capable of 
inhibiting ompA synthesis by 45%, 51 %, 54%, 18% and 45% for the 
constructions using fragments I through V respectively. The antisense ompA 
RNA targeting fragment IV in figure 1.7 is clearly much less effective than the 
other four antisense ompA constructs. Unlike, fragments I and V, which 
encompass the ompA translation initiation site, fragment I which includes the 
Shine-Dalgamo sequence or fragment HI which encompasses only structural 
gene sequences, fragment IV does not include any sequences likely to come in 
contact with ribosomes. This may possibly be the reason why this antisense 
ompA construct is a weaker down-regulator of ompA synthesis than the other four 
constructs. Finally, the antisense ompA gene spanning fragment in  is 
complementary only to the the portion o f ompA which spans the coding regions 
for amino acid residues 4 - 45 of pro-OmpA. This indicates that the antisense 
RNA does not necessarily need to hybridise to the translation initiation site 
and/or the 5 ’ leader region sequence in order to exert an effect (Coleman et al., 
1984).
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Figure 1.7 Fragments used to construct antisense ompA genes.
The upper line illustrates the structure of the E.coli ompA gene. The arrow represents the 
promoter and the open box represents the region encoding the 5’ leader region of the ompA 
mRNA. The shaded box and the slashed box represent the regions of the ompA gene encoding the 
signal sequence and the mature OmpA protein respectively. Restriction fragments I - V were
OmpA .
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inserted into the pJDC402 vector in the orientation opposite to that shown here (Colem an et al., 
1984).
1.3.1.2 lacZ  gene
Pestka et al., (1984), cloned an 831 base pair sequence coding for the 
NH2 terminus of p-galactosidase in reverse orientation under the control of the 
phage X PL promoter. The gene coding for a temperature sensitive repression of 
Pl , cITs, was carried on a compatible plasmid. Thus at 30°C, no anti-mRNA 
would be made, but at 42°C anti-mRNA would be synthesised extensively.
Under conditions in which no anti-/acZ mRNA is made, p-galactosidase, lactose 
permease and transacetylase were induced by IPTG, however when anti-/ocZ 
mRNA was produced, the syntheses of all three enzymes produced from the 
same polycistronic mRNA were inhibited by 97%, 80% and 55% respectively.
Daugherty et al., (1989), performed many detailed experiments which 
examined the effects o f various aati-lacZ RNAs of different lengths and 
representing the different parts of the lacZ coding region. Once again all the 
antisense genes were placed under the control o f the phage X P l promoter. These 
plasmids generate anti-lacZ mRNA which either possessed or did not possess a 
synthetic ribososme binding site (RBS) adjacent to the X Pl promoter and/or the 
lacZ RBS in reverse orientation. LacZ DNA from the 5 ’ and/or 3 ’ regions were 
used in these constructs. Maximal inhibition o f P-galactosidase synthesis 
occurred when a functional RBS was present near the 5’ end of the anti-mRNA, 
in conjunction with the anti-mRNA being complementary to the 5 ’ region of the 
mRNA corresponding to the lacZ RBS and/or the 5’ coding sequence. 
Furthermore when the molar ratio o f anti -lacZ mRNA:normal lacZ was greater 
than 100:1 maximal inhibition o f P-galactosidase activity was achieved. 
According to other reports in eukaryotic cells (Izant and Weintraub, 1984; 
Melton, 1985) the ratio sufficient to produce significant inhibition can vary from 
1:1 to 600:1 (Daugherty et al., 1989).
1 .3 .1 3  Streptavid in  gen e
An exciting application o f artificial prokaryotic antisense control is 
involved with the containment o f microorganisms, by dual control o f streptavidin
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expression by an antisense RNA and the T7 transcription system, (Szafranski et 
al., 1997). The authors in this paper describe a potentially universal lethal system 
based on the derepression of the tightly regulated streptavidin gene from the 
actinobacterium, Streptomyces avidinii. The toxicity of streptavidin results from 
its high binding affinity for the essential prosthetic group, D-biotin. Cell death 
occurs as a result o f the depletion of free biotin and by the direct inhibition of 
biotin dependent carboxylases, decarboxylases and transcarboxylases.
The system was tested on the Gram-negative soil-rod Pseudomonas 
putida, a useful microbe for the bioremediation of areas polluted with aromatic 
hydrocarbon-based organic solvents and petroleum. The system was coupled to 
regulatory elements from the P.putida TOL catabolic plasmid to condition 
survival o f the bacteria only in the presence of an aromatic carboxylic acid that 
they can degrade. There is a problem however with cell suicide systems 
involving incomplete repression (leakiness) o f regulatory promoters. The authors 
sought to overcome this problem by the combination of the bacteriophage T7 
RNA polymerase-lysozyme system with the inducible synthesis of antisense 
RNA and the E.coli LacI repressor, to ensure very tight control of the 
derepression o f cell death.
To achieve control of the induction of a lethal phenotype, a heterologous 
RNA polymerase and its inhibitors were generated by coupling expression of the 
streptavidin gene to the bacteriophage T7 transcription system (see Figure 1.8). 
The streptavidin gene was transcribed in this case from the T7 gene 10 promoter 
(<(>10) by T7 RNA polymerase. The T7 gene 1, encoding the RNA polymerase 
was fused to the trp-lac (tac) promoter o f E.coli, and this was negatively 
regulated by the LacI repressor. The leakiness o f the PtaC promoter was 
compensated by an inhibitor o f T7 polymerase, T7 lysozyme. The function of 
lysozyme is that it binds to T7 RNA polymerase and blocks its transcription 
activity. The lacl gene was transcribed from the Pm promoter, which was induced 
by XylS protein aromatic carboxylic acid complexes. Streptavidin should be 
synthesised upon inactivation o f LacI with IPTG or by interception o f LacI 
synthesis in response to depletion o f  a benzoic acid effector o f the XylS protein. 
As mentioned previously, the problem with cell suicide systems is leakiness of 
the regulatory promoters, so in this system an additional level o f regulation of the
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streptavidin gene expression was achieved by placing the t|)::stv fusion 
immediately downstream of the la d  gene but in the opposite orientation. This it 
was hoped would further decrease uninduced expression of the streptavidin gene 
by generating an antisense RNA complementary to the streptavidin transcript.
Figure 1.8 Schematic representation o f the tightly regulated containment system 
to control survival o f bacteria by availibilty of 3 MB or other hydrocarbon 
effectors of the XylS protein. (A) Survival. (B) Induction of a lethal phenotype 
(Szafranski et al., 1997).
The rate of inactivation which is a basic determinant of the efficiency of 
suicide designs, in this streptavidin based system was 10'7 - 10"8 per cell per 
generation, this value is far lower than those reported for constructs based on 
single toxic functions (10'2 - 10'6). This result reflects the very low basal level of 
streptavidin in cells. Although the coupled T7 transcription/LacI-Oiac system is 
less leaky than the lac system alone an additional explanation of the better 
protection of cells against uninduced expression of the streptavidin gene is 
synthesis of the antisense RNA originating from the Pm promoter, (Szafranski et 
al., 1997).
[A]
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1.3.1.4 galKgene o f  E.coli and the N gene o f  co lip hage lam bda
On the down side o f things not all attempts to use artificial antisense 
RNA in prokaryotic systems have been successful. Hasan et al., (1988), studied 
the effect o f artificial antisense RNA on the expression of the E.coli galK  and X 
N genes. These antisense RNA target genes were either present in the E.coli 
chromosome as single copies or were cloned on plasmid vectors. The entire galK 
or N  gene or only their N-proximal regions were cloned in antisense orientation 
downstream from the strong PL, P r or lacZp promoters on multicopy vectors.
The authors performed many experiments with the galK and N  sense and 
antisense genes, in both cis and trans configurations, but they did not find any 
significant downregulation of these genes, even though there was a 50-fold 
excess of antisense RNA.
1.3.2 PEPTID E N U C LE IC  A C ID S
Peptide nucleic acids (PNAs) are another means by which gene 
expression can be downregulated by antisense mechanisms. A PNA is a DNA 
mimic with attractive properties for developing improved gene-targeted antisense 
agents. A PNA is a molecule of synthetic origin that binds to single-stranded 
nucleic acids. Instead of possessing a repeating sugar-phosphate backbone a 
PNA has a repeating polyamide structure to which the purine and pyrimidine 
bases are attached in a fashion that confers the ability to bind RNA by Watson- 
Crick hybridisation, (Figure 1.9). The unnatural chemical structure of PNA 
provides stability in cells because neither peptidases nor nucleases will cleave it 
(Ecker and Freier, 1998).
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Figure 1.9 Chemical structure of a PNA and DNA oligomer (Good and Nielsen,
1998).
To study the antisense potential o f PNAs in a prokaryotic system Good 
and Nielsen (1998) designed PNAs to target the start codon regions o f the p- 
galactosidase and p-lactamase genes in E.coli. Dose-dependent and specific gene 
inhibition was observed in vitro using low nanomolar PNA concentrations and in 
vivo using low micromolar concentrations. Specificity o f inhibition was 
demonstrated by the fact that the potency of the anti-p-lactamase PNAs was 
abolished by a six base substitution but was re-established using a PNA with 
complementary base changes. Antisense inhibition o f the P-lactamase gene was 
sufficient to sensitise resistant cells to ampicillin. The results demonstrate gene 
and sequence specific antisense inhibition in E.coli and open up the possibilities 
for antisense bacterial drugs (Good and Nielsen, 1998).
Recently, it has been demonstrated that certain peptide-PNA conjugates 
are taken up very efficiently by at least some eukaryotic cells and that antisense 
downregulation o f target genes in nerve cells in culture is attainable using such 
PNA conjugates. Perhaps, even more exciting is that antisense compatible effects 
have been reported using PNAs injected into the brain o f rats (Nielsen, 1999).
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1.4 ANTISENSE GENE REGULATION IN  EUKARYOTIC SYSTEMS
1.4.1 E V ID E N C E  FO R  N A T U R A L  A N T ISE N SE  G ENES
An abundance of antisense transcripts have also been found to occur 
naturally in eukaryotes but in contrast to prokaryotes where the mechanism of 
action is well understood, there are relatively few examples of gene regulation 
mediated by antisense RNA in eukaryotic systems. Although it is possible that 
many of these abundant RNA species may be involved in antisense RNA 
regulation, their regulatory role(s), if any, remain yet to be defined. These 
antisense transcripts derive either from transcription of both strands of a DNA 
fragment (overlapping transcripts) or from transcription o f complementary DNA 
strands located at different genomic positions (Rogers, 1988). Overlapping 
transcripts have been identified for many eukaryotic genes including the human 
ERCC-1 encoded DNA excision repair gene (van Duin et al., 1989); the barley 
a-amylase gene (Rogers, 1988); mouse polyoma virus (Kumar and Carmichael, 
1997) and in yeast numerous overlapping transcripts been identified including 
overlap within the RHOl and MRP2 genes (Peterson and Myers, 1993); SP012 
and SP016  genes (Malavasic and Elder, 1990) and the PET 122 locus (Ohmen et 
al., 1990; Marathe and McEwen, 1999) to name but a few. Once again in very 
few instances have actual functions been assigned to these overlaps.
1.4.1.1 snoR N A s
Further evidence for the existence of naturally occurring antisense RNAs 
has been the discovery o f small nucleolar RNAs (snoRNAs) within vertebrates, 
Drosophila and yeasts. These snoRNAs contain long stretches o f sequence 
complementarity to conserved sequences in mature ribosomal RNA and 
Bachellerie et al. (1995) propose that these antisense snoRNAs may be involved 
with pre-rRNA folding, base modification and ribosomal ribonucleoprotein 
assembly. Evidence to suggest that these snoRNAs are involved in ribosome 
production comes firstly from their cellular location which is nucleolar, secondly 
nearly all snoRNAs are associated with the nucleolar protein fibrillarin which 
itself is required for normal processing and methylation of rRNA and finally
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some o f  the snoRNAs are encoded within the introns o f  genes coding for proteins 
involved in ribosome synthesis.
The complementarities of snoRNAs to rRNAs map to both single and 
double-stranded regions. The thermodynamic stability predicted for each 
snoRNA-rRNA interaction in double-stranded regions largely exceeds that of the 
intramolecular stem in the mature rRNA. This indicates that the snoRNAs could 
compete favourably in intermolecular versus intramolecular rRNA-pairing 
reactions. Additionally the presence o f methylated nucleotides in antisense rRNA 
elements raise the question that possibly snoRNAs may play a role in post- 
transcriptional modification. Although the function behind méthylation of rRNA 
is mainly unknown some types of méthylation (particularly base méthylations as 
opposed to ribose méthylations) may affect conformation (Bachellerie et al., 
1995).
1.4.1.2 Ribozymes
Another type of naturally occurring antisense molecule is a catalytically 
active RNA species called a ribozyme. These molecules are responsible for the 
cleavage and ligation o f certain specific phosphodiester bonds within RNA 
molecules. In 1981 Cech discovered ribozyme activity in Tetrahymena 
thermophila, following this ribozyme activity has been detected in many other 
organisms including E.coli, B.subtilis, Salmonella typhimurium, plants and other 
eukaryotes which suggests that ribozymes occur universally (Uhlmann and 
Peyman, 1990). The attractive aspect of these molecules in contrast to 
“conventional” antisense RNAs is that they are not required in stoichiometric 
amounts, as a ribozyme possesses catalytic activity whereby it can cleave the 
target mRNA resulting in its inactivation without affecting the antisense 
“ribozyme” molecule which is then free to dissociate and attack other substrate 
molecules. The conventional antisense RNAs, in contrast must remain hybridised 
to block the mRNA function or to target the sense:antisense hybrid for 
degradation, in which case the antisense molecule is destroyed along with its 
substrate. Therefore the potential attraction o f catalytic RNA systems for gene 
regulation or antiviral strategies is that a lower concentration of antisense 
molecules may be necessary for effective regulation.
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Linked to the catalytic centre of a ribozyme molecule are RNA sequences 
which are complementary to, and thus serve to target the ribozyme to a unique 
RNA sequence (Rossi and Sarver, 1990; Figure 1.10). The cleavage reactions 
have a requirement for divalent metal ions and a neutral or higher pH, that results 
in the production of an RNA molecule with termini possessing 5’ hydroxyl and 
2’,3’ cyclic phosphate groups. The cleavage reactions presumably result from 
RNA conformation bringing reactive groups into close proximity. The sites of 
cleavage are specific and associated with domains o f conserved sequence and 
secondary structure (Haseloff and Gerlach, 1988).
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Figure 1.10 Schematic representaion of a ribozyme.
Three structural domains are boxed. [A] Contains conserved sequences in the RNA substrate, 
immediately adjacent to the site of cleavage. [B] Comprises the highly conserved sequences 
maintained in the ribozyme, and the regions [C] consist of flanking helices, with base pairing 
between the substrate and ribozyme RNAs (Haseloff and Gerlach, 1988).
Different types o f ribozymes have been reported; Tetrahymena Group 1, 
hammerhead and hairpin ribozymes. These ribozymes are classified according to 
their biological origin and catalytic motif (the 3D structure of the catalytic 
section o f the molecule). The 3D structure o f ribozymes is very important to their 
function, disruption o f the catalytic motif can easily render a ribozyme inactive 
(Putnam, 1996).
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Although ribozymes are naturally occurring they can be adapted to cleave 
other substrates (such as targeted mRNAs). Work has been carried out on 
exploiting the use o f engineered Tetrahymena derived ribozymes after it had 
been shown that the reaction can also proceed when the target and catalytic 
sequences are present on two different RNA molecules. The minimal recognition 
site requirement for the wild-type ribozyme has been shown to be CUCU. 
However various research groups have shown that by altering the guide sequence 
and conditions almost any substrate can be recognised (Murray and Crockett, 
1992).
1.4.1.3 O verlapping transcription  units w ith in  the m ouse genom e
One of the first reports documenting overlapping transcription in 
eukaryotes was presented by Williams and Fried (1986). They identified a region 
in the mouse genome containing two adjacent convergent transcription units 
which overlap by 133 base pairs at their 3’-untranslated ends. This finding 
implies a complex sequence organisation in this region as the poly(A) addition 
signal for one transcript is contained in the exon sequence of the other and vice 
versa. Furthermore, for these vertebrate genes transcription does not terminate at 
the poly(A) addition site but continues for some distance downstream. This 
implies that the sequences which may be involved in transcriptional termination 
or in the processing o f one transcript are also probably encoded in the sequence 
giving rise to the transcript from the opposite locus and vice versa. Therefore it 
may be significant that the overlap is in the 3 ’ untranslated region of both 
mRNAs.
Although no function has been assigned to this overlap, the authors 
postulate that these overlapping transcripts may display some novel mechanism 
of control o f mammalian gene expression. These being, if the overlapping 
transcripts were expressed at the same time, it might be expected that the RNA 
polymerase duplexes travelling in opposite directions along a DNA duplex might 
encounter a considerable degree of steric hindrance, especially as transcription 
probably continues past the poly(A) addition site. Also, although the abundance 
of the mRNAs is fairly low for each of the two species of mRNA, the local 
concentration o f the two opposite strand transcripts in the vicinity of the 3’ ends 
of the transcription units might favour RNA duplex formation with resultant
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inhibition of RNA processing and/or transport from the nucleus. Perhaps either 
the two strands are only rarely transcribed and their mRNAs very stable or there 
may be some spatial and/or temporal control of expression such that their 
transcription occurs at different times in the cell cycle or from different alleles 
(Williams and Fried, 1986).
1.4.1.4 a -A m ylase gen e o f  barley a leurone cells
As a model system for the investigation of developmental and hormonal 
controls of plant gene expression barley aleurone cells have been used. These 
cells possess a tough outer layer of tissue that surrounds the starchy endosperm 
of the grain. During germination the embryo secretes a hormone gibberellic acid 
(GA3) which in turn directs the aleurone layer to produce and secrete hydrolytic 
enzymes which digest the storage contents of the endosperm for use by the 
seedling. The most abundant hydrolases are the a-amylases and mechanisms 
controlling their expression have been studied extensively. Consequently this has 
led to the discovery of a naturally occurring antisense a-amylase RNA. This 
antisense a-amylase RNA may prevent unwanted expression of the a-amylase 
genes A and B (Rogers, 1988).
RNA complementary to the a-amylase mRNAs o f either isozyme were 
found to be present in developing endosperm tissue and in mature aleurone 
tissue, but not in shoot or root tissue. The abundance o f this antisense RNA was 
greatest (relative to the abundance o f a-amylase mRNA) in mature aleurone 
tissue following treatment with abscisic acid (ABA). ABA produces an effect 
which antagonises GA3-mediated changes in a-amylase expression, essentially 
ABA prevents the GA3-induced increase in a-amylase mRNA abundance. It was 
found that the antisense RNA was not perfectly complementary to any of the 3 ’ 
a-amylase genes known to be expressed, this leads to the conclusion that the 
antisense RNA must be derived from another uncharacterised amylase-like 
sequence. Northern blots o f total RNA isolated from different barley tissues 
using single-stranded probes to detect antisense RNAs and under conditions of 
moderate stringency resulted in three distinct hybridising species o f 1.6, 1.4 and 
1.0 kb isolated from mature aleurone RNAs. It was postulated that these 
antisense RNAs could function to alter the stability o f the a-amylase mRNA
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precursors and/or to interfere with their translation even at steady-state levels that 
are substantially lower (relative to the mRNA target) than those required in the 
previously described artificial systems (Rogers, 1988).
1.4.1.5 Mouse polyoma virus
Kumar and Carmichael (1997) used the mouse polyoma virus as a model 
system to examine naturally occurring mammalian antisense-induced regulation 
of transcript levels. This is a small virus, whose double-stranded, circular, 
polyoma genome is divided into early and late transcription units that are 
expressed from opposite strands o f the viral genome. The life cycle of this virus 
is divided into two phases; the early phase which occurs immediately after 
infection and before DNA replication and the late phase which begins after the 
onset o f DNA replication. During the early phase o f productive infection, early 
strand transcripts accumulate preferentially over late-strand transcripts, late 
strand transcripts are also synthesised during this period, but are degraded rapidly 
in the nucleus. Before DNA replication occurs, the ratio of late-strand to early- 
strand RNAs is less than 1:10. Subsequently, after the onset of DNA replication 
during the late phase of infection the late strand transcripts become more 
plentiful than the early strand transcripts. During this period transcription 
termination becomes inefficient and this allows RNA polymerase II to encircle 
the genome many times. The resulting multigenomic transcripts possess 
sequences which are complementary to the early-strand transcripts and thus have 
the potential to act as natural antisense regulators within the nucleus.
Furthermore the region o f the late strands that can form antisense hybrids with 
early-strand RNAs are found within intron sequences that do not appear in the 
late strand messages.
In their paper Kumar and Carmichael (1997) have examined the fate of 
these hypothetical sense-antisense hybrids in the nucleus, by asking whether the 
reduced levels of early-strand RNAs at late times o f infection are as a result of 
antisense-induced RNA degradation or are early-strand transcripts as a result of 
base modifications merely non-comp lementary to the probes used in RNase 
protection assays? This last possibility was considered because mammalian 
nuclei contain an enzymatic activity capable o f modifying double-stranded RNA 
(dsRNA) molecules. The enzyme double stranded RNA specific adenosine
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deaminase (dsRAD; 1.5.4.2) was originally discovered in the nucleus o fXenopus 
laevis. Its’ activity is mainly confined to the nucleus and it functions by 
catalysing the conversion of adenosines to inosines within dsRNA by means of 
hydrolytic deamination. The RNA produced contains I-U base pairs and this may 
lead to partial unwinding o f the RNA duplex.
Using RT-PCR to specifically amplify early-strand transcripts, the 
products were subsequently analysed to determine whether or not they were 
subject to RNA editing by dsRAD. The RT-PCR amplified fragments were 
shown to be resistant to a particular restriction enzyme in about 50% of the early- 
strand RNAs, thus indicating modification. Sequence analysis of these resistant 
fragments showed that 40-60% of the adenosines within the early-strand RNAs 
had been changed to guanosines. A-G changes in the cDNAs are suggestive of 
A-I changes within the dsRNAs, this result is consistant with modifications 
induced by dsRAD. The authors therefore considered it most probable that this 
enzyme was responsible for the antisense-induced base modifications in the 
polyoma system. As the modifications caused by dsRAD can be detected only in 
dsRNA it was postulated that the sense-antisense transcripts almost certainly do 
form duplexes within the nucleus. Results using probes that specifically detect 
modified RNAs indicate that extensive antisense-induced base modification 
results in nuclear accumulation o f the altered transcripts. More than likely the 
modified messages are trapped in the nucleus due to their base compositions, 
altered secondary structures or possibly because partial duplex structures 
resulting from the incomplete dissociation of the two RNA strands may form. On 
the other hand, these modified messages may be transported to the cytoplasm, 
where they are rapidly degraded. Either way these messages appear to be inert 
for gene expression (Kumar and Carmichael, 1997).
1.4.2 E V ID E N C E  F O R  N A T U R A L  A N T ISE N SE  G E N ES IN  
SACCHAROMYCES CEREVISIAE
As with most other eukaryotic cells, several examples o f complementary 
transcription units have been identified within the genomic DNA of yeast. These 
naturally occurring antisense RNAs of yeast can be categorised into examples 
where the two RNAs can be either in cis or in trans, with transcripts derived
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from DNA templates that overlap or are distantly positioned respectively. The cis 
acting RNAs can be further subdivided as being overlapped at the 3’ or 5’ 
termini, which is the case with convergent (section 1.4.2.1 to 1.4.2.2) and 
divergent (section 1.4.2.3 to 1.4.2.5) genes respectively, or it could be where one 
transcript is fully complementary (section 1.4.2.6) when it is encoded within the 
complementary strand o f a longer transcription template. Most o f the examples 
described thus far for Saccharomyces cerevisiae have been the cis acting type, 
(Atkins et al., 1994).
1.4.2.1 RADIO
The homologous Saccharomyces cerevisiae RADIO gene and the human 
ERCC-1 DNA excision repair gene, contain overlapping antisense transcription 
units in their 3 ’ regions (van Duin et al., 1989). Transcription of the RADIO gene 
results in the production of three transcripts of 1.0, 1.5 and 1.8 kilobases that 
vary in sequence at their 3 ’ end and an antisense transcript of 1.9 kilobases. The 
antisense RNA designated ASR10 (ontisense RADIO) overlaps with all the 
mRNAs with up to 600 bases o f complementarity to the 1.8 kilobase transcript 
(Figure 1.11). Similarly, the human ERCC1 DNA gene has a 2.6 kilobase 
antisense RNA that has an overlap o f 170 bases with the ERCC1 transcription 
unit, yielding the major 1.1 kilobase mRNA, whereas it is completely 
complementary to the 3.4 kilobase ERCC1 transcript for at least 1 kilobase. The 
antisense function of these overlapping transcripts is still only speculation, 
however the fact that the transcription pattern between humans and yeast is 
conserved may indicate a functional relationship rather than a coincidental gene 
arrangement (Atkins et al., 1994).
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Figure 1.11 Transcript map o f the RADIO gene and antisense gene region.
The positions of the RADIO and ASR10 ORFs are indicated by the open boxes. The arrows above 
the RADIO ORF and below the antisense ORF represent the directions and approximate sizes of 
RADIO transcripts and the antisense transcript respectively (van Duin et al., 1989).
1.4.2.2 RH O l and MRP2
A study by Peterson and Myers (1993), characterised transcription of a 
281 base pair region located between the convergently transcribed yeast genes, 
RHOl and MRP2. Their results showed that this intercoding region contains two 
adjacent, functionally independent 3 ’ end formation signals, each o f which 
contains a sequence motif implicated as a yeast polyadenylation signal. On 
occasion when transcription o f these genes has continued through their respective 
termination signal the two transcripts overlap at their 3’ ends by up to 111 base 
pairs.
The 3’ ends o f the RHOl and MRP2 mRNAs are natural antisense RNAs 
complementary to each other. In order to ascertain the significance if any o f this 
overlap, a third 3’ termination signal was inserted within the intercoding region 
in both orientations. This extra termination signal resulted in no overlap between 
the two sequences and this lead to no detectable effect on the expression of either 
gene suggesting that the complementary RNA domain was apparently 
dispensable. Insertion o f a strong promoter into the intercoding sequence of the 
RHOl and MRP2 genes resulted in transcription beyond the normal 
polyadenylation sites and this inactivated the gene located downstream. This may
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suggest that the intercoding region functions not only to specify polyadenylation 
sites, but also to terminate transcription (Peterson and Myers, 1993).
Gene inactivation by convergent transcription could be either a cis or 
trans acting effect. To investigate this heterozygote diploid yeast cells were 
prepared in which one allele o f  the gene w as wild type and the other possessed  
the artificial antisense gene. The apparent lack o f  an effect on the wild-type gene 
suggested that the antisense transcription unit was recessive and cw-acting.
Hence the gene suppression seen in this system was due to promoter interference, 
rather than true antisense RNA function (Peterson and Myers, 1993).
1.4.2.3 SP012 and SP016
Similarly, Malavasic and Elder, (1990), found that preventing 
overlapping transcription between the SP012 and SP016  genes did not block 
expression o f  either gene. The S P 0 1 2  protein has an open reading frame o f  173 
codons and is required for m eiosis I chrom osom e division during sporulation o f  
the yeast Saccharomyces cerevisiae. SP016, a second sporulation-specific gene 
was found adjacent to SP012. These two genes are encoded on opposite D N A  
strands and there are only 103 base pairs between their termination codons. The 
SP012 and SP016  transcripts overlap by 700 bases and the 3 ’ untranslated 
region o f  the longest SPOl 6 transcript is complementary to nearly all o f  the 
SP012 mRNA. Rem oval o f  the regions o f  complementarity does not affect the 
efficiency o f  sporulation or spore viability. The complementarity therefore has 
either no function or only a subtle function in m eiosis and sporulation (Malavasic 
and Elder, 1990).
1.4.2.4 ACT1 and ASR1
The Saccharomyces cerevisiae ACT1 intron contains the promoter and 
transcription start sites for an ACT1 antisense RNA, designated ASR1 (antLsense 
i?NA 1 in Saccharomyces cerevisiae). Preliminary co-culture results with an 
ACT1 intron containing and an ACT1 intronless strain where the growth rates o f  
the tw o yeast strains were compared, ruled out any drastic effects o f  the ARS1 
transcript on the expression o f ACT 1 in the vegetative stage. A s ACT1 is essential 
for growth a strong effect on its expression should be reflected in terms o f  
growth rate. However, subtle effects not evident in the growth rate phenotype
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cannot be ruled out. The ,457?/ transcript was found to be at very low 
concentration in the cell, from Northern blot analysis, whereas theACTl 
transcripts were present in high abundance, (Thompson-Jager and Domdey,
1990).
Theories suggested for the function of this antisense transcript include 
RNA-RNA double strand formation between ACT1 and A RSI may hinder 
splicing or translation of ACT1 mRNA, or indeed it may effect transport of the 
mature ACT1 mRNA to the cytoplasm. If such regulation does exist to help 
regulate the amount o f this important protein, it must operate within a small 
range, because S.cerevisiae does not have a mechanism which allows it to 
survive the presence of an additional ACT1 gene on a high copy vector 
(Thompson-Jager and Domdey, 1990).
1.4.2.5 PET122, ORF2 and ORF3
Divergent overlapping transcripts have been found at the PET122 locus in 
S.cerevisiae. PET122 is one of three nuclear genes required for translation of the 
mitochondrial mRNA for cytochrome c oxidase subunit IE. The nucleotide 
sequence o f2,862 bases encoding the PET122 locus demonstrates very close 
spacing between the PET122 gene (254 codons) and two unidentified open 
reading frames, designated ORF2 and ORF3. ORF2 is encoded by the same 
strand of DNA as PET122 and is located 53 bases downstream of PET122, while 
ORF3 is encoded on the opposite strand and is located 215 bases upstream of 
PET122.
From this locus five different transcripts are produced, with sizes of 2.9, 
2.3, 2.1, 1.5 and 1.4 kilobases (Figure 1.12). The 2.1 and 1.4 kilobase transcripts 
encode ORF3, the 1.5 kilobase transcript encodes ORF2 and the 2.9 and 2.3 
kilobase transcripts encode PET122. Interestingly, the ORF3-PET122-ORF2 
transcription unit shows a 535 base overlap between the 2.3 kilobase PET122 
transcript produced from one strand and the 2.1 kilobase ORF3 transcript 
produced from the opposite strand. Also the 2.9 kilobase PET122 transcript 
overlaps the 2.1 kilobase transcript ORF3 transcript by more than 900 bases and 
it overlaps the 1.5 kilobase ORF2 transcript by at least 200 bases. These pairs of 
transcripts are antisense to each other and may have the potential to regulate the 
posttranscriptional expression of ORF3 and PET122.
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F igure 1.12 Transcription map o f  the ORF3-PET122-ORF2 region (Ohmen et 
al., 1990).
Both o f  the intergenic regions o f  ORF3-PET122 and PET122-ORF2 are 
involved in promoting divergent transcripts. DED1-HIS3, MAT and GAL1- 
GAL10 are three w ell characterised pairs o f  divergently transcribed genes in 
yeast cells. The MAT and GAL 1-GAL 10 promoters co-regulate expression o f  
these divergent transcripts, while the HIS3-DED1 intergenic regions appear to 
regulate the tw o genes independently. A t this point it is not known whether the 
divergent transcript from PET122 (1 .4  kilobase transcript) is coregulated with the
2.3 kilobase PET 122 transcript or i f  the 1.5 and 2.1 kilobase transcripts are 
coregulated.
1.4.2.6 O verlapping transcripts in G enes cod ing fo r  G lycolytic Enzym es
M ore recently, B oles and Zimmerman (1994), discovered open reading 
frames in the antisense strands o f  genes coding for glycolytic enzymes in 
Saccharomyces cerevisiae. The glycolytic enzymes with open reading frames in 
their antisense strands include phosphoglucose isomerase, phosphoglycerate 
mutase, pyruvate kinase and alcohol dehyrogenase I. Proteins coded in codon  
register by complementary D N A  strands, it has been proposed, can interact with 
each other owing to a molecular complementarity o f  amino acids represented by 
complementary nucleic acid codons. Hence B oles and Zimmerman decided to 
investigate whether the open reading frames in the antisense strands o f  glycolytic 
enzymes are functional. To do this they introduced pairs o f  closely spaced base 
substitutions into the PGI1 (phosphoglucose isomerase 1) gene, which resulted in
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stop codons in one strand and only silent replacements in the other by means of 
oligonucleotide-directed mutagenesis. The introduction of the two stop codons 
into the sense strand caused the same physiological, defects as already observed 
for pgil deletion mutants. On the other hand no detectable effects were caused by 
the two stop codons in the antisense strand. Northern analysis using double­
stranded probes detected only one transcript for the PGI1 gene indicating that the 
antisense reading frames are not functional.
In the case of these naturally occurring complementary RNAs discussed 
over the last few paragraphs, it is important to realise that these RNAs do not 
necessarily interact by hybridisation and duplex formation, but rather 
transcription o f convergent genes may result in polymerase interference as 
transcription complexes on opposite DNA strands collide. Or indeed when genes 
have overlapping promoters in a divergent arrangement, the overlapping 
sequences may ensure the occlusion of RNA polymerase assembly and transit 
(Atkins et al., 1994).
If however the two RNAs do indeed interact by hybridisation at some 
point along their molecules, the functions o f these partially complementary 
transcripts derived from overlapping genes may involve a tail-tail duplex 
configuration o f the two mRNAs and this could result in their transport to a 
common location in the cytoplasm. Additionally, the stability o f such a tandem 
transcript could be affected by the duplex state and this may serve to protect 
against degradation. As regards translation, this could be slowed down or 
inhibited by the hybridised 3’ tail. Conversely, unwinding of the 3’ termini could 
offer the possibility of induction o f gene expression at the translational level. At 
the protein level, as regards to low expression genes, tail-tail association of the 
sense-antisense transcripts could provide an oppurtunity for complex formation 
between the two nascent proteins that are in close proximity to one another when 
the ribosomes on the opposite transcripts encounter one another, (van Duin et al., 
1989).
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1.5 AR TIFICIAL GENE REGULA TION B Y ANTISENSE
TECHNOL OG Y IN  EUKAR YOTIC SYSTEM S
1.5.1 ENGINEERED ANTISENSE GENES
One o f the most usual ways o f supplying antisense RNA sequences to 
eukaryotic cells involves the use of engineered antisense genes. This can be 
achieved in vivo by the introduction and expression of an antisense gene 
sequence, that is one in which part or all of the normal gene sequence is placed 
under the control o f a promoter in reverse orientation so that the “incorrect” 
(complementary) DNA strand is transcribed into a non-coding antisense RNA 
that can then hybridise with the target mRNA and interfere with its expression. 
The antisense expression vector can be introduced into cells by any of the usual 
ways o f transferring DNA such as transfection, electroporation, microinjection or 
in the case o f viral vectors by infection. Clearly the type of transformation and 
choice o f vector will influence whether expression is transient or stable, while 
the promoter chosen will decide the level, timing, inducibility or tissue 
specificity o f the antisense inhibition (Murray and Crockett, 1992).
1.5.2 CE L L  C U L T U R E  EX PE R IM E N T S
Many o f the early studies investigating the utility o f antisense genes for 
the ablation o f specific gene expression involved the use o f reporter genes such 
as the bacterial chloramphenicol acetyl transferase (CAT) gene and the herpes 
simplex virus (HSV) thymidine kinase (TK) gene. The latter gene was in fact the 
first gene targeted by artificial antisense RNA in eukaryotes (Izant and 
Weintraub, 1984). Artificial antisense genes were constructed by placing the TK 
structural gene in an inverted orientation relative to the HSV-TK promoter and a 
SV40 polyadenylation signal. The coinjection o f the antisense gene constructs 
with a plasmid carrying the wild-type TK gene at a ratio of 100:1 respectively, 
resulted in a significant reduction of transient TK expression in mouse TK' cells. 
TK activity was detected at four to five-fold lower levels when compared with 
cells coinjected with a control plasmid and wild-type TK.
The authors also demonstrated in this study the sequence specificity of 
the transcribed antisense HSV-TK RNA by showing that this antisense RNA had
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no effect on the expression of a chicken TK gene present in mouse L cells. In a 
further experiment, designed to answer whether the activity of a chromosomal 
gene could be inhibited by antisense RNA the authors integrated the antisense 
TK plasmids into the mouse L cell genome. This was done to pre-flood the cells 
with antisense TK RNA before the subsequent introduction of HSV-TK gene 
containing plasmids. Indeed the presence o f antisense HSV-TK RNA reduced the 
capacity o f the cells to express HSV-TK.
Evidence that endogenous genes can be inhibited was provided by the 
author’s attempts to inhibit the synthesis of cellular (3-actin. If actin synthesis 
was reduced significantly the cells would exhibit a lethal phenotype. Co- 
transformation of the LTK' cells with HSV-TK and an antisense |3-actin 
construction resulted in a decrease between 1 0 -2 0  fold of the production of TK+ 
colonies. Normally cells which took up the TK gene would form TK+ colonies 
but because o f the presence of the antisense P-actin the number of TK+ colonies 
was drastically reduced, thus indicating successful inhibition of an endogenous 
gene.
It was the goal of Takacs and Banerjee (1997) to determine whether 
replication of vesicular stomatitis virus (VSV) could be inhibited by expression 
of a virus-specific antisense RNA in mammalian cells. VSV is a rhabdovirus, 
which packages within the virus an RNA-dependent RNA polymerase that 
transcribes the negative sense genome RNA into five mRNAs in the cytoplasm 
of infected cells. The active polymerase complex consists of the large RNA 
polymerase (L) protein tightly associated with an activator phosphoprotein P.
The authors chose to target the L mRNA with an antisense RNA because it is the 
message transcribed in the least molar amounts and secondly because the RNA 
polymerase protein is essential for both virus transcription and replication.
The first 550 bases o f the VSV L gene were cloned in antisense 
orientation into an eukaryotic expression vector. The vector chosen contained a 
human cytomegalovirus (HCMV) promoter for expression of the inverted 
sequence and a mutant dihydrofolate reductase transcription unit with an 
increased Km for methotrexate. The data showed that the HeLa cell line 
transfected with the antisense vector did produce high levels o f antisense L RNA 
which substantially inhibited the transcription and replication o f VSV but only
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for a limited time after infection. A complete inhibition o f VSV infection was not 
obtained due to the increasing levels of virus L mRNA as the infection 
progressed. Because VSV replicates so fast, the concentration of target RNA will 
eventually become too high for inhibition by antisense RNA (Takacs and 
Banerjee, 1997).
1.5.2.1 PLA N TS
1.5.2.2 Inhib ition  o f  the T om ato Y ellow  L ea f C url V irus (TY LCV )
Engineered antisense genes have also been successful in downregulating 
gene expression in whole organisms in addition to the cell culture experiments 
just mentioned. Bendahmane and Gronenbom, (1997) designed antisense RNAs 
to interfere with a disease in plants caused by the Tomato Yellow Leaf Curl 
Virus (TYLCV). This disease is caused by a geminivirus and it is transmitted by 
the whitefly, Bemisia tabaci. Geminiviruses are single-stranded DNA plant 
pathogens with a wide spectrum of hosts and some can cause substantial crop 
losses. The authors chose the rare messenger RNA o f the Rep protein encoded by 
the Cl gene as the target for antisense RNA inhibition, as this gene is 
indispensable for the DNA replication of the geminivirus. Furthermore the Rep 
protein is multifunctional, hence it would serve as an attractive target.
The antisense gene cloned contained 351 nucleotides and was 
complementary to the full 5 ’ leader sequence o f the 1.45 kb Cl sense transcript 
and the first 288 nucleotides o f the Cl gene. The sequence o f the last 71 
nucleotides of the antisense RNA are very conserved within all o f the TYLCV 
genomes sequenced to date. These nucleotides encode a small protein of 11.4 
kDa (C4) whose expression is required for the systemic movement o f the virus in 
tomato. If this protein is expressed via a separate mRNA, this could then possibly 
represent an additional target for the antisense RNA. Finally this antisense gene 
was placed under the control of the cauliflower mosaic virus (CaMV) 35 S 
promoter.
Transgenic Nicotiana benthamiana plants were derived following leaf- 
disc transformation using Agrobacterium (LBA 4404) harbouring the respective 
Cl antisense or sense gene cassettes on binary plasmids. The authors found that 
they were unable to regenerate plants that expressed a sense copy of the complete 
Cl gene, due to the deleterious effects that the constitutive synthesis of the active
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Rep protein probably had on the cell. However, the transgenic plants which 
expressed the Cl antisense RNA were shown to resist infection by TYLCV and 
this resistance was found to be effective for at least two generations of progeny.
Northern blot analysis was used to analyse the steady-state levels of RNA 
expression in selected TYLCV tolerant and resistant first generation lines of 
Nicotiana benthamiana. A 400 base pair single transcript lit up when using a 
single strand probe. This transcript was not found in non-transgenic plants. The 
steady-state level o f this antisense transcript varied between different plant lines, 
however plants which exhibited an elevated transcript level consistently 
exhibited a higher degree o f virus resistance (Bendahmane and Gronenborn,
1997).
1 .5 .2 3  Petunias - Inhib ition  o f  th e expression  o f  the C halcone Synthase 
(C H S) gene dem onstrates the variab le effects o f  an antisense gen e in 
eukaryotes
van der Krol and colleagues (1988b) were the first to report the inhibition 
of an endogenous gene in plants using antisense RNA. The gene for chalcone 
synthase (CHS), a key enzyme in flavonoid biosynthesis, was placed in antisense 
orientation under the control o f the CaMV 35S promoter. The constitutive 
expression o f this antisense gene in transgenic petunia and tobacco plants 
resulted in decreased amounts of CHS protein and steady state mRNA.
Phenotypically, these reduced levels were found to correlate with alterations of 
flower pigmentation. The differences in pigmentation pattern which were 
observed among the flowers in both the trasgenic petunia and tobacco plants, did 
not appear to correspond necessarily to variances in antisense RNA steady-state 
levels but may be more likely to be as a result o f the fact that DNA sequences 
adjacent to the insertion site of the antisense gene may have influenced its 
activity in both a quantitative and qualitative manner. Finally, Southern analysis 
o f progeny plants demonstrated the stable inheritance and co-segregation of the 
antisense phenotype (van der Krol et al., 1988b).
1.5.2.4 G ranule-B ound Starch Synthase (G BSS) gene
Kuipers et al., (1995) used the granule-bound starch synthase (GBSS) 
gene, a key enzyme in starch biosynthesis as a model system for the investigation
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of antisense RNA inhibition. They constructed eleven antisense constructs 
derived either from the full-length GBSS cDNA, the genomic coding region 
(gDNA) or fragments o f each of these sequences. Each construct was analysed 
with respect to their inhibitory effect. As regards the efficacy of antisense 
inhibition, very little is known about the influence of the composition of the 
antisense gene construct. Effective inhibition in many systems has been achieved 
using cDNA-derived antisense RNAs covering either the complete target mRNA 
or a 5’ portion of varying size. In petunias, chalcone synthase gene expression 
was shown to be effectively inhibited by antisense genes containing the full- 
length cDNA or a 3’ cDNA fragment (van der Krol et al., 1990). Genomic 
antisense genes are also suitable for effective reduction o f gene expression as 
demonstrated by the almost complete inhibition o f expression of the tomato 
pectin methylesterase (PME) gene by the introduction o f an antisense gene based 
on the nearly full-length PME genomic DNA (Tieman et al., 1992).
In this study the authors found that the origin o f the GBSS sequence was 
an important factor in determining the efficacy of antisense inhibition. The full- 
length GBSS cDNA and gDNA constructs were all found to be capable of 
complete inhibition o f GBSS gene expression but it was observed that the 
antisense GBSS cDNA constructs resulted in complete inhibition o f GBSS gene 
expression in a higher percentage of transgenic potato clones. The presence of 
intron sequences in the genomic constructs might contribute to the observed 
differences in antisense inhibition. The full-length GBSS gene contains 12 
introns. These introns will not be processed in the antisense orientation. The 
duplex formed with the antisense RNA based on the genomic GBSS DNA is, 
therefore, expected to be most stable with the non-processed GBSS pre-mRNA, 
whereas the duplex formed with the GBSS cDNA-based antisense RNA will be 
most stable with mature GBSS mRNA. The higher inhibitory capacity o f the 
GBSS cDNA-based antisense constructs suggests that RNA duplex formation is 
most effective with mature GBSS mRNA or that the cDNA-based antisense 
RNA interferes with RNA processing more effectively.
In this system, A.tumefaciens mediated introduction o f the antisense 
genes driven by the GBSS promoter resulted in a higher percentage of transgenic 
clones with completely inhibited GBSS gene expression in contrast to when 
these constructs were driven by the CaMV promoter. This is most likely due to
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the observation from promoter-GUS fusion experiments that expression from the 
GBSS promoter is three-tenfold higher than the expression of the 35S CaMV 
promoter. This implies that similar amounts of antisense RNA and GBSS mRNA 
are transcribed in the case o f a GBSS promoter-driven antisense gene. The 
occurrence of antisense inhibition with comparable amounts o f antisense RNA 
and target mRNA has been demonstrated in several other studies (van der Krol et 
al., 1990). For naturally occurring antisense RNAs in plants, which are thought to 
be involved in gene regulation, the steady-state levels of antisense RNA and 
mRNA do not differ greatly (Rogers, 1988). This might indicate that, in contrast 
to what has often been hypothesised, the formation o f an excess of antisense 
RNA relative to sense mRNA may not be a prerequisite for successful inhibition 
(Kuipers et al., 1995).
1.5.2.5 T om atoes - Inh ib ition  o f  the activity o f  tw o enzym es, 
P olygalactu ron ase (PG ) and  Pectinm ethylesterase (PM E) w hich  cause fruit 
softening
Growers of fresh-market tomatoes harvest their crop while the tomatoes 
are still firm and green, so they can be washed, sorted, packed and shipped 
without undergoing extensive and costly bruising. Just before the tomatoes are 
shipped they are bathed in ethylene gas for many days to bring about ripening. 
The problem with this process is that prematurely plucked and artificially ripened 
tomatoes do not possess the flavour that homegrown tomatoes have. Ideally, 
growers would like to be able to leave mass-production tomatoes on the vine for 
a longer period of time in order to build up the sugars and acids needed for a 
fresh taste and aroma, yet remaining firm enough to handle without damage 
(Pendick, 1992). Pectin is a polysaccharide which functions as an intercellular 
adhesive in the middle lamella of plant cells. When the tomato fruit softens 
during the course o f ripening, this intercellular pectin becomes both 
depolymerised and solubilised which subsequently leads to a loss of cell -to-cell 
cohesion and fruit integrity. Polygalacturonase (PG) and pectinmethylesterase 
(PME) are the two enzymes involved in the degradation process o f pectin. It is 
thought that this degradation process occurs in two steps, where pectin is first 
demethylated by PME and then depolymerised by PG (Pear et al., 1993).
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Antisense RNA has provided a solution to these problems by the 
introduction of an engineered antisense polygalacturonase (PG) gene into 
tomatoes. This antisense gene prevents the tomato from making its normal 
amount o f PG and as a result of this, the tomato can remain longer on the vine 
without getting too soft for handling. It also posesses a longer shelf-life. The 
commercial implications for these transgenic tomatoes are immense because 
in i992 the worlds first genetically engineered tomato, the “Flavr Savr” made its 
way onto supermarket shelves in the US after the US Food and Drug 
Administration cleared the way for sale o f the tomato by declaring it “as safe as 
tomatoes bred by conventional means”.
Further work carried out involved the introduction o f the full-length 
antisense PME gene construct and a chimaeric antisense PG gene into tomato 
plants via Agro bacterium-mediated transformation. This transformation resulted 
in a significant reduction in both the mRNA and protein levels in ripe fruit, of 
these normally highly abundant cell wall hydrolases. This result indicates that 
antisense gene constructs in plants can be used to block multiple steps in 
metabolic pathways simultaneously.
However, some variability in chimeric gene expression and consequently 
in the degree o f enzyme reduction was observed during this particular study, 
possibly due to the site of insertion o f the T-DNA into the plant genome. 
Conversely, some of the transformed plants had reduced levels of PG but a much 
less effective reduction o f PME mRNA and protein. From this, one cannot 
assume that effective expression of one chimeric antisense gene construct 
forecasts similar effectiveness o f an accompanying antisense gene construct in 
transgenic plants. Finally, the authors are implementing this technique to 
transcribe multiple antisense RNA species in transgenic plants as a way of 
attenuating other biochemical pathways (Pear et al., 1993).
1.5.2.6 D eterm ination  o f  the function  o f  a gene in tom ato p lants using  
antisense R N A
In 1990, Hamilton et al. generated transgenic plants expressing antisense RNA to 
a gene o f unknown function, pTOM13. This clone was isolated from a ripe 
tomato fruit cDNA library and it was believed that this gene was involved in the 
synthesis o f ethylene during fruit ripening and wounding of leaves. To
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investigate this hypothesis, transgenic tomato plants expressing antisense genes 
against pTOM 13 were constructed. Indeed, biochemical analysis showed that in 
these plants ethylene synthesis was reduced in a dose dependent manner. Plants 
containing one antisense gene synthesised only 13% of the normal amount of 
ethylene, whereas in plants homozygous for the pTOM13 antisense gene the 
production of ethylene was only 3% of that found in normal fruits. This 
particular set of experiments demonstrates that antisense RNA techniques can be 
used to determine the biochemical function and biological role o f genes (Schuch,
1991).
1.53 YEAST
An examination of the field o f artificial antisense RNA technology in 
Saccharomyces cerevisiae has revealed the absence of many successful antisense 
gene suppression experiments. This is in contrast to its very successful 
application in a wide range of other host systems including other yeasts, such as 
Schizosaccharomyces pombe and Candida albicans. However the failure o f these 
experiments is not due to any lack o f attempts but rather it may indicate 
particular features o f Saccharomyces cerevisiae biology that make this organism 
refractory to antisense RNA technology (Atkins et al., 1994). Another interesting 
finding when researching this field is that many o f the published findings on 
artificial antisense or ribozyme gene function in Saccharomyces cerevisiae are 
concerned with establishing this yeast as a model host in contrast to the few 
studies where the aim is to generate a yeast mutant by antisense technology.
Within Saccharomyces cerevisiae the silencing of genes is usually 
accomplished by disruption o f the target gene with a selectable marker 
introduced by homologous recombination. The shortfall in reports of 
experimental attempts to inhibit the expression o f genes in Saccharomyces 
cerevisiae by antisense RNA may be as a result that homologous recombination 
is such a powerful technique for the creation of yeast mutants. In principle, even 
a small amount of sequence information and a selectable gene can be used to 
disrupt a target gene and create a null mutation. However, a major potential 
advantage for using antisense RNA expression in Saccharomyces cerevisiae as 
opposed to homologous recombination is that multiple disruptions would not be 
required to suppress expression of a gene in a polyploid strain.
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1.5.3.1 R egulation  o f  the Sulfom eturon M ethyl R esistant (SMR1) Gene?
Xiao and Rank (1988) reported for the first time or so they thought on the 
regulation of gene expression in Saccharomyces cerevisiae by antisense RNA. 
Their work involved construction of chimaeric genes containing the 5’ upstream 
and partial coding sequnce of a sulfometuron methyl resistant allele (SMR1) of 
the ILV2 locus. These fragments were placed 5’ to 3 ’ and 3’ to 5’ under the 
control o f the powerful GAL 10 promoter and CYC1 terminator in a high copy 
YEp plasmid. They found following galactose induction that it was only 
transformants containing antisense RNA exhibited biological activity against 
SMR1 gene expression. Synthesis o f the gene product acetolactate synthase was 
inhibited by the antisense RNA and this lead to the repression of cell growth 
which lead to a bradytrophic auxotroph revertable by addition of isoleucine and 
valine. However a few short years later, the results from these experiments were 
retracted, as a re-examination of their findings indicated that the reported YEp 
antisense plasmid containing transformants also harboured the corresponding 
sense control plasmid.
Further examination of the transformants harbouring the 5’ sense ILV2 
RNA alone, revealed that these transformants produced an increased percentage 
of petite colonies following induction o f 5’ sense ILV2 RNA transcription. The 
published DNA sequences for the GAL1-GAL10 promoter, the CYC1 
transcription terminator and the ILV2 DNA insert suggests that the 5’ ILV2 sense 
RNAs produced, retained the potential for translation into non-functional fusion 
proteins. At their 5’ ends these putative proteins would contain the acetolactate 
synthase mitochondrial targeting signal. An overexpression of these proteins may 
have lead to a disruption of mitochondrial structure and/or function, hence the 
repression of growth observed. Finally, Arndt et al., (1994) concluded that the 
observed isoleucine-valine bradytrophic phenocopy was not, unfortunately the 
result o f antisense ILV2 RNA regulation.
1 .5 3 .2  C an A ntisense R N A  regulate the expression  o f  the endogenous ADE1 
gen e in Saccharomyces cerevisiae?
Also in the late eighties, Law and Devenish, (1988), examined the utility 
o f antisense RNA as a means o f regulating gene expression in Saccharomyces
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cerevisiae. They chose to inhibit the endogenous ADE1 gene. This gene is only 
one of many in the adenine biosynthesis pathway. A mutation in any one of the 
genes results in a red colony phenotype. This phenotype arises from the 
accumulation and eventual polymerisation of the substrate phosphoribosyl-5- 
aminoimidazole to form an insoluble red pigment. This would provide a very 
convenient system for screening for adel cells created by antisense RNA 
inhibition of the ADE1 mRNA function.
Their initial experiments involved cloning a 570 base pair fragment of the 
ADE1 gene (comprising 161 base pairs o f coding region and 409 base pairs of 5’ 
flanking region) in antisense orientation into a YEp vector, between the PGK 
promoter and terminator. They found however that this clone was also producing 
sense ADE1 even though cloned in antisense orientation. This they concluded 
was due to the presence of the genes own promoter. To overcome this problem 
they removed the promoter and this time they cloned an ADE1 gene fragment of 
179 base pairs (comprising 18 base pairs of the 5’ untranslated region and the 
first 161 base pairs o f the coding region) in antisense orientation and transformed 
into yeast. This clone failed to produce an adel mutant phenotype.
Northern blot analysis of total cellular RNA extracted from transformed 
yeast cells confirmed the presence o f high levels of antisense RNA to natural 
ADE1 mRNA within cells. This result would appear to indicate that the failure of 
the antisense RNA to inhibit ADE1 gene expression was not as a result of an 
insufficient amount o f  antisense RNA being produced. Possible reasons 
suggested by the authors for the failure to create phenotypic adel mutants 
included self-annealing of the antisense RNA or formation of significant 
secondary structure within the 5’ non-coding region o f thcAD El gene. To 
investigate this hypothesis the sequences were analysed by an RNA folding 
computer algorithim which determines the optimal secondary configuration of an 
RNA molecule by minimising its conformation energy. The results indicated that 
the formation of significant secondary structure within the ADE1 related 
sequences o f the antisense transcripts or the equivalent region o f the ADE1 
mRNA was unlikely, therefore hybridisation o f the antisense RNA and mRNA 
could not be ruled out on this basis.
Other reasons for failure include the escape o f a small amount of natural 
ADE1 mRNA from antisense RNA inhibition, which maybe sufficient to direct
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synthesis of enough enzyme to maintain an ADE1 phenotype. Lastly, may be the 
fragment of DNA chosen directs the synthesis o f an antisense RNA which cannot 
efficiently block the translation of the ADE1 mRNA even after hybridisation 
with the ADE1 mRNA has occurred. This may be due to, at least in part, the 
presence of a tail of PGK coding sequences and poly(A) in the antisense RNA 
that arises from the presence of PGK terminator sequences in the expression 
vector, (Law and Devenish, 1988).
1.5.3.3 Does Antisense RNA in close proximity to the target gene enhance 
Antisense RNA control in Saccharomyces cerevisiae?
Arndt carried out a study in 1993 with its primary objective being to 
utilise the highly efficient system of homologous recombination in 
Saccharomyces cerevisiae to determine whether antisense RNA synthesis in 
close proximity to the target gene enhanced antisense RNA control. The ILV2 
gene, more specifically the SMR1-410 allele, encodes the enzyme acetolactate 
synthase (ALS) which catalyses the first step in the biosynthetic pathway for the 
amino acids isoleucine and valine. Two strategies were adopted to examine the 
effect o f localised antisense ILV2 RNA synthesis on SMR1 -410 gene expression. 
The first approach involved positioning 5’ and 3’ antisense ILV2 RNA 
expression casettes either 5’ or 3’ to the SMR1-410 gene at its endogenous 
chromosomal location. The second approach was designed to copy the genomic 
organisation of both natural prokaryotic antisense genes and overlapping 
transcription units in eukaryotes. To do this the GAL1-GAL10 promoter was 
integrated 3’ to the SMR1-410 gene such that transcription from the GAL1 start 
site was oriented in a direction opposite to that o f the SMR1-410 promoter. As 
with Xiao and Rank (1988), the criterion for a successful antisense RNA down- 
regulation o f gene expression was a change in cellular phenotype. Induction of 
the antisense ILV2-CYC1 RNA synthesis, in these integrants did not produce an 
isoleucine-valine bradytrophic or auxotrophic phenocopy in these cells. Northern 
blot analysis o f the relevant integrants indicated that the 5’ antisense ILV2-CYC1 
RNA was undetectable but the 3’ antisense ILV2-CYC1 RNA was expressed. The 
reasons for the lack of down-regulation o f gene expression in these integrants is 
unknown (Arndt, 1993).
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1.5.3.4 Is the bacterial C hloram phenicol A cetyltransferase (CAT) gene  
susceptib le to antisense regulation  in Saccharomyces cerevisiae?
In an attempt to identify a target gene susceptible to antisense regulation 
in Saccharomyces cerevisiae Arndt (1993) tested the effectiveness o f  an 
antisense RNA expressed against the bacterial chloramphenicol acetyltransferase 
(CAT) gene. To do this a chloramphenicol sensitive (Cms) yeast strain was 
transformed with a CAT gene expression cassette to produce isogenic 
chloramphenicol resistant (CmR) derivatives. YEp plasmids containing the 
antisense CAT RNA expression cassettes were then used to transform these cells. 
Following galactose induction o f  antisense CAT RN A  transcription, there was no 
difference in this strains sensitivity to chloramphenicol. A  similar result was 
obtained using antisense CAT RNA expression cassettes containing the 5 ’ or the 
3 ’ end o f  the CAT coding region. Interestingly this gene has been shown to be 
susceptible to antisense control in other host systems. Using the full-length 
antisense C 4T R N A , Izant and Weintraub (1985) were able to reduce CAT 
activity in m ouse L cells by 5 - 20  fold. Similarly, Delauney et al., (1988) were 
able to reduce CAT activity to undetectable levels in transgenic tobacco plants.
Atkins and Gerlach (1994) have combined a number o f  strategies to 
investigate the effect o f  antisense gene function and hammerhead ribozymes 
directed once again towards the bacterial chloramphenicol acetyltransferase 
(CAT) gene, in Saccharomyces cerevisiae. The authors chose this gene as 
sensitive assays exist to detect quantitative changes in its expression and 
secondly this gene had been shown previously to express a functional product in 
this yeast. The system was designed to examine the activity o f  both the antisense 
and ribozyme genes in both a cis and trans conformation, relative to the target. 
They found that when the target and ribozyme or antisense genes were 
transcribed in the same m RNA from an expression vector, CAT expression was 
reduced by up to 90%. The steady state levels o f  the chimaeric transcripts were 
increased several fold relative to control mRNAs, this observation indicates a 
mechanism o f  suppression o f  CAT gene expression other than duplex-dependent 
degradation o f  mRNA. In contrast, when the ribozyme or antisense genes were 
expressed in trans from a plasmid-based expression vector, expression o f  the 
CAT gene which w as chromosomally located was unaffected (Atkins and 
Gerlach, 1994).
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1.5.3.5 Silencing of the MIG1 gene of Saccharomyces cerevisiae
Olsson et al., (1997), attempted to silence the MIG1 gene. This gene 
encodes a transcription factor which imposes carbon catabolite repression on 
invertase. In an attempt to maximise the amount of antisense transcript, the 
antisense sequences were driven by the constitutive PGK promoter. As it is 
difficult to predict the best region of a gene to choose as a target for antisense 
RNA, three regions were chosen comprising the coding region of MIG1 alone or 
in combination with parts of the 5’ untranslated region. The expression cassettes 
were introduced into a haploid Saccharomyces cerevisiae strain as high copy 
number plasmids in one configuration and in another they were integrated into 
the ILV2 locus. To assess the effects of antisense gene expression on MIG1, the 
physiological characteristics of the antisense M1G1 strains were compared with 
those of the wild-type strain. The invertase level in the antisense MIG1 strains 
under repressive conditions was found to be 53 to 61U/g (dry weight) regardless 
of the copy number or the length of the antisense fragment. As these invertase 
levels equal the level in the wild-type strain (61U/g) the antisense constructs did 
not appear to have affected translation, even though Northern analysis showed 
that the antisense MIG1 RNA was sufficiently stable to be detected. The authors 
conclude the failure was possibly due to the fact that the constructs were 
designed to produce large RNAs which may in turn have lead to an oppurtunity 
for secondary structure formation. Therefore, these RNAs may not bind to MIG1 
mRNA with a high enough efficiency to prevent translation (Olsson et al., 1997).
1.5.3.6 Control of exogenous lacZ gene expression in Schizosaccharomyces 
pombe
Arndt et al. (1995), designed experiments to test the suitability of the 
fission yeast Schizosaccharomyces pombe as a model for the study of antisense 
RNA mechanisms. A lacZ gene expressing yeast strain was constructed and used 
as a host for the expression o f a series of antisense RNAs complementary to 
various parts o f the target lacZ mRNA. A long lacZ antisense gene was designed 
to produce an antisense RNA complementary to 56 bases o f the 5’ UTR, the 
entire coding region and 288 bases o f the 3’ UTR. Short antisense genes were
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designed to produce RNA complementary to either the 5’ or 3’ ends of the lacZ 
mRNA. The antisense genes were all placed under the control of the 
Schizosaccharomyces pombe thiamine repressible nmtl promoter and expressed 
from episomal plasmids. A corresponding sense control plasmid was constructed 
for each antisense plasmid. Each o f the lacZ antisense genes were shown to 
express antisense RNAs of the expected size at equivalent steady state levels. In 
the transformed cells expressing the long, short 5’ or short 3 ’ lacZ antisense 
RNAs (3-galactosidase activity was shown to be down-regulated by 45, 20 and 
10% respectively, relative to the control transformants. The antisense regulation 
in this system was both conditional and reversible with the reduction of P- 
galactosidase activity being dependent on the transcription of the lacZ antisense 
RNA (Arndt et al.,1995).
To validate the use of S. pombe as a host for identifying antisense genes 
for use in human cells Clarke et al., (2000) wanted to determine if sequences 
identified in yeast were as equally effective in a human cell line. Their report 
describes the comparison of a range o f lacZ antisense RNAs targeting a lacZ 
gene expressed in HeLa cells in a comparable manner to its expression in S. 
pombe cells in earlier studies (Arndt et al., 1995). In both cell types, the same 
lacZ gene target was expressed using the same promoter. The antisense genes 
were expressed episomally in both experimental systems and the levels of 
suppression were determined. In all cases, the relative level o f suppression of the 
lacZ gene was similar in the mammalian and yeast cells. The authors postulate 
that this result, (at least for the lacZ antisense RNAs), obtained in the fission 
yeast may be predictive o f the behaviour o f antisense RNAs in mammalian 
cellular environment (Clarke et al., 2000).
1 .5 3 .7  YBR1012 gen e o f  Saccharomyces cerevisiae - D eterm ination  o f  
function  using A ntisense R N A
During sequencing of chromosome II o f Saccharomyces cerevisiae the 
gene YBR1012 was identified. Nasr et al., (1994), inactivated this gene using 
antisense RNA and found that it was essential for cellular viability. The deduced 
ybrl012p  sequence was compared with the data banks and the analysis revealed 
the presence o f a putative phosphatidylinositol kinase domain and a strong
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homology to the Schizosaccharomycespombe rad3p. These results indicate that 
ybrl012p may be a gene involved in signal transduction, possibly related to 
replication control and/or DNA damage repair. The evidence for a link with 
DNA damage repair was strengthened by the isolation of the DUN1 gene as a 
multicopy suppressor o f the YBR1012 deletion.
To ascertain the function of the YBR1012 gene, the authors constructed a 
conditional allele, using an antisense fragment o f YBR1012 DNA to regulate the 
expression of the gene. To do this a 235 base pair fragment from the 5’ region of 
the gene was cloned between an inducible GAL10-CYC1 promoter and the PGK1 
terminator. Induction of transcription by galactose should produce a small 
polyadenylated antisense YBR1012 RNA. A haploid yeast strain was transformed 
either by control or antisense constructions, after growth on raffinose individual 
transformants were plated on glucose and galactose. Transformants harbouring 
the antisense construction were unable to grow on galactose, this result suggests 
that the presence o f the antisense YBR1012 RNA inhibited growth. The growth 
kinetics and YBR1012 RNA levels of both the control and antisense strains were 
investigated following a shift to galactose medium. The control strain began to 
grow after a lag phase of 5 hours while the antisense strains’ growth remained 
inhibited for a further 12 hours. Eventually the antisense strain showed slow 
growth indicating that suppression of the YBR1012 gene was not complete. 
However, the antisense strain did stop growing at a reduced cell density when 
compared with the control strain.
Northern blot analysis was performed on total RNA extracted from both 
the control and antisense strains grown initially on raffinose, then on galactose 
for between 1 -2 4  hours. The northern blot was hybridised with a YBR1012 
mRNA probe and an antisense YBR1012 probe. The results showed that in the 
presence of galactose the YBR1012 antisense RNA was induced and this led to a 
reduction in the level of YBR1012 transcripts. After phosphoimager analysis it 
was observed that the YBR1012 mRNA level in the antisense strain was 50% that 
found in the control.
In a continuation o f this work Nasr et al., (1995), made several more 
antisense constructions and tested their activity. They concluded that the 
response of the system appeared to be very delicate as either the presence or 
absence of 13 nucleotides in the polylinker of the 300 nucleotide antisense
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transcript could severely alter its’ effectiveness. Again the authors were utilising 
antisense RNA to study the biological function o f YBR1012. The results showed 
that some 80% of the antisense-RNA blocked cells accumulate with their DNA 
unreplicated, thus demonstrating that YBR1012 has an important role in G1 
and/or early S phase.
1.5.4 MICROINJECTION OF IN VITRO SYNTHESISED ANTISENSE 
RNA
In situations where there is a lack of availability o f suitable vectors and 
promoters, microinjection of in vitro synthesised RNA represents an option. 
Indeed in some instances this mode of introduction of antisense sequences into 
cells is necessary due to the fact that the cells in question may be 
transcriptionally inactive. Another advantage with this approach is that a large 
excess of antisense RNA over target RNA can be injected. The drawbacks with 
this mode o f transfer is that in multicellular organisms addition of transcripts is 
often difficult and in certain organisms such as Drosophila addition is restricted 
to the period of embryogenesis, before cellularisation occurs. Certainly systems 
like Drosophila, mouse embryos and Xenopus are more tractable to this approach 
than other systems because o f the difficulty of accessing certain cells. Another 
feature o f this approach which could be viewed either as an advantage or 
disadvantage is that the effect of the injection will be transient due to the 
antisense RNAs being degraded or diluted during growth. On the other hand by 
injecting antisense RNA at a specific time and thereby switching off gene 
expression it may be possible to demonstrate that the gene in question plays a 
role within a particular window of development.
1.5.4.1 Inhibition of exogenously microinjected p-globin mRNA in Xenopus 
oocytes
In 1985 Melton decided to test the feasibility o f microinjection for 
blocking translation of an exogenously microinjected p-globin mRNA. Globin 
mRNA was chosen for these studies because it is efficiently translated in oocytes 
and its’ protein product is easily detected. To prepare large quantities of pure 
antisense RNA, cDNA clones corresponding to the p-globin mRNA were cloned
into transcription vectors that contained a SP6 promoter. Xenopus oocytes were 
injected with antisense p-globin RNA and incubated for 5 hours before receiving 
an injection of (3-globin mRNA. A 50-fold excess of antisense RNA was injected 
and all injections were targeted to the oocyte cytoplasm. This resulted in a 
complete block in translation. Further experiments indicated that this 
translational inhibition is due to antisense-sense hybridisation in vivo. Also the 
most effective target region in the mRNA appeared to be the RBS (Melton, 
1985). Additionally the translation of an endogenous oocyte mRNA, ribosomal 
protein LI mRNA has also been inhibited by the injection o f antisense RNA 
(Wormington, 1986). With the success of microinjected antisense RNAs in 
oocytes Melton (1985) reasoned that this approach could be adopted to study 
embryonic determination in frog development.
1.5.4.2 Frog Embryos - The Discovery of Unwindase
In contrast to the success o f microinjected antisense RNAs in regulating 
gene expression in Xenopus oocytes, cognate experiments in frog embryos were 
found to have no inhibitory effect on target gene expression (Rebagliati and 
Melton, 1987). Endogenous maternal mRNAs (Anl, Vgl, An2, An3) could not 
form RNA:RNA hybrids with their respective antisense RNAs in fertilised frog 
eggs, even when there was a 200 - 400 fold molar excess of antisense Anl 
mRNA. Further studies revealed that a developmentally regulated double­
stranded RNA-specific unwindase activity was present in Xenopus oocytes, that 
catalysed the unwinding of antisensersense RNA hybrids (Rebagliati and Melton, 
1987).
The enzyme double-stranded RNA adenosine deaminase (dsRAD) 
requires a double-stranded RNA substrate and it acts to convert adenosine (A) 
residues within its substrate to inosine (I) residues. Due to the fact that IU base 
pairs are less stable than AU base pairs the dsRNA substrate becomes 
increasingly single-stranded during the reaction. Since antisense techniques are 
dependent on the formation o f a stable duplex the presence o f this enzymes 
activity in Xenopus early embryos was thought to explain why antisense RNA 
techniques were unsuccessful in these cells. However the discovery that 
adenosines are modified to inosines during the reaction makes this interpretation
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questionable. It is known that inosines are read as guanosines during translation 
therefore this modification would be expected to change the coding capacity of 
the DNA drastically, this would lead to the production of a non-functional 
protein. Thus it seems that this is more likely to contribute to the success of 
antisense RNA techniques (Bass, 1992).
Inhibition of target mRNA function by injected antisense transcripts is 
believed to occur in the cytoplasm, whereas antisense RNAS transcribed from a 
stably integrated gene or episomal plasmid may render its effect in either the 
nucleus or cytoplasm, thus with injected antisense RNAs, any potential points of 
regulation in the nucleus are bypassed (Murray and Crockett, 1992).
1.5.5 OLIGONUCLEOTIDES
Synthetic oligonucleotides (hereafter referred to as oligos) are widely 
used as another means for regulating gene expression artificially in cultured cells. 
An oligo is a short sequence of single-stranded DNA which is chemically 
synthesised and designed to be complementary to a specific intracellular target. 
Ideally an antisense oligo should possess a long half-life under physiological 
conditions, be resistant to nuclease degradation, exhibit efficient cellular uptake 
and affinity to its target nucleic acid and finally it is also highly desirable that the 
effect o f the oligo is catalytic rather than stoichiometric. Most o f the common 
oligo derivatives available today lack one or more of the aforementioned 
properties required for specific inhibition of gene expression (Lonnberg and 
Vuorio, 1996).
Oligos show great promise as therapeutic agents, however technical 
difficulties have slowed down their use as drugs, as structural modifications are 
needed to increase the stability and potency o f synthetic oligos, specific delivery 
systems are required to facilitate their entry into target cells and more 
information is needed on their mechanism of action. Zamenik and Stephenson 
(1978) were the first to suggest the use o f synthetic antisense oligos for 
therapeutic purposes. They were able to inhibit the growth of the Rous sarcoma 
virus with a 13-mer oligo targeted to a region of the viruses’ RNA. From then on 
many papers have highlighted the great potential of antisense oligos as 
therapeutic agents in several human viral diseases, malignancies and dominant
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Keriditary diseases. In fact clinical trials are now in process to evaluate their 
therapeutic potential (see Table 1-2 and 1-3).
Table 1-2 Antisense Oligonucleotides - Cancer targets in Clinical Develpoment 
(Ho and Parkinson, 1997).
Gene Target Oligonucleotide Sponsor Backbone-Size Disease
p53 exon 10 OL(I)p53 .1.Armitage & Lynx' PS-20 mer AML-MDS/Phase I
c-m yb LR-3001 A.Gerwitz &  Lynx' PS-24 mer CM L-Phase I
PK C a CGP64128A 
(ISIS 3521)
ISIS/Ciba PS-20 mer Solid tumours-Phasc 
I
c -r a f kinase CGP69846A 
(ISIS 5132)
ISIS/Ciba PS-20 mer Solid tumours-Phase 
I
bcl-2 G3139 Genta & F.Cotter PS-18 mer Lymphona-Phasc I
A bbreviation: PS, phosphorothioate.
‘ Trials conducted under an investigator IND. Oligonucleotide supplied by Lynx.
Table 1-3 Antisense Oligonucleotides: Viral and Inflammatory Targets in 
Clinical Development (Ho and Parkinson, 1997).
Gene Target O ligonucleotide Sponsor Backbone-Size Disease
HIV gag GEM91 Hybridon PS-25 m er m V -Phase n
HPV ISIS 2105 ISIS PS-20 m er Genital warts-Phase 
II*
CM V ISIS 2922 ISIS PS-21 mer CMV retinitis- 
Phase ni
HIV GPs0193 Chugai PS-26 m er HTV-Phase I
HTV integrase AR177 Aronex PO-17 mer! HIV-Phase I
ICAM-I ISIS 2302 ISIS PS-20 m er GVHD, RA, BD, 
psoriasis-Phase 11
c-myc LR-3280 Lynx PS-15 mer CAD-Phase I  (+ 
balloon angioplasty)
A bbreviations: PS, phosphorothioate; PO, phosphodiester; GVHD, graft versus host disease, RA, rheumatoid arthritis; 
IBD, inflanm atoiy  bowel disease; CAD, coronary artery disease 
! Lipid formation 
* Discontinued in 1995
In theory any disease state with a gene expression component has the 
potential to be treated with these antisense agents. To date viral (HIV, Herpes 
simplex, Epstein-Barr, Papillomavirus) infections and cancer (proto-oncogenes 
targeted include the myc family (including c-myc and N-myc) c-myb, c-fos, the 
ras family ( including N-ras and C-H-ras), BCl-2, c-raf-l, cdc-2 and c-mos) have
6 4
been the primary disease states under investigation for treatment with these 
oligos. However, other less obvious potential uses, such as restenosis, 
rheumatoid arthritis and allergies have also been studied (Putnam, 1996).
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CHAPTER 2 
M aterials and M ethods
6 6
2. Materials and methods
2.1 STRAINS
Strain and relevant Phenotype/Genotype
S. cerevisiae 
DBY746
Mat«, i7£>l-289a, his-Al, leu2-3-\ 12, uraS-52.
MT235
Mat«, ai/e2-1, trp-1, leu2-3, his3-\ 1, urcii, G4Z1.
12
DBY746 harbouring the integrating plasmid pFAMY 
Mata, frpl-289a, his-Al, leu2-3,-\\2, URA3.
SI
DBY746 harbouring the integrating plasmid pFAMY 
Mat«, frpl-289a, his-Al, /e«2-3,-112, URA3.
sn
DBY746 harbouring the integrating plasmid pFAMY 
Mato, frj>l-289a, his-Al, leu2-3,-\\2, URA3.
S1V
DBY746 harbouring the integrating plasmid pFAMY 
Mat«, ftp 1-289a, /iis-Al, leul-3-\ 12, URA3.
MI
DBY746 harbouring the ribosomal DNA integrating 
plasmid, pMJSOC
Mat«, frpl-289a, his-Al,LEU2, wra3-52.
E. coli 
DH5a
F’/e«JAl fei/R17(rk-mk+) SupE44 thi-1 recAl gyrA(Nalr) 
re/Al A(/acZYA-argF)U169 (<j>80dlac A(/at'Z)ml 5)
Berkeley Stock 
Centre
D.C.U. Stocks 
D.C.U Stocks
D.C.U Stocks
D.C.U Stocks
D.C.U Stocks
D.C.U Stocks
D.C.U Stocks
Source or Reference
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2.2 PLASMIDS
pSL52
pKSL52
pPSL52
pSL52i
pAAH5
pAAMY-01
pAAMY-02
pS600
pS1300
pUC 8 with Bacillus licheniformis a-amylase 
gene on a Hind HI - Hind ID fragment. 
pSL52 with a Hind III 8mer linker 
(CAAGCTTG), inserted in the Kpn I site of the 
a-amylase gene.
pSL52 with a Hind III 8mer linker 
(CAAGCTTG) inserted in the Pst I site o f the a- 
amylase gene.
pSL52 with the BamH I site o f the a-amylase 
gene removed.
Yeast shuttle vector, contains unique Hind III 
cloning site, between the constitutive AdHI 
promoter and terminator, LEU marker. 
pA AH5 containing the 1.9kb a-amylase Hind 
III fragment from pSL52 inserted in the sense 
orientation relative to the AdHI promoter 
and terminator.
pAAMY-01 with the internal BamH I site of the 
a-amylase gene removed. 
pAAH5 with the 0.6kb Hind III fragment of 
pKSL52 inserted into the Hind III site in its sense 
orientation relative to the AdHI promoter and 
AdHI terminator.
pAAH5 with the 1.3 kb Hind III fragment of 
pKSL52 inserted in the Hind HI site in its sense 
orientation relative to the AdHI promoter and 
terminator.
McMahon, 
(1995). 
This study.
This study.
This study.
Ammerer,
(1983).
McMahon,
(1995).
This study. 
This study.
This study.
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pSOC-02
pAS600
pAS1300
pM 02
pM03
pFL34
pFAMY
pSOC-O I pAAH5 containing the 1,9kb a-amylase gene
Hind III fragment from pAAMY-01 inserted in
the antisense orientation relative to the AdHI
promoter and terminator.
pSOC-Ol with the internal BamH I site o f the a-
amylase gene removed.
pAAH5 with the 0.6 kb Hind III fragment of
pKSL52 inserted into the Hind III site in
antisense orientation relative to the AdHI
promoter and terminator.
pAAH5 with the 1.3 kb Hind III fragment of
pKSL52 inserted into the Hind III site in
antisense orientation relative to the AdHI
promoter and terminator.
pAAH5 with the 1.6kb Hind III a-amylase gene
cloned in sense orientation relative to the AdHI
promoter and terminator, this fragment lacks the
genes transcriptional stop site.
pAAH5 with the 1.6 kb Hind III a-amylase gene
cloned in antisense orientation relative to the
AdHI promoter and terminator, this fragment
lacks the genes transcriptional stop site.
Yeast integrating vector, URA3 marker, unique 
BamH I site for cloning and a unique Stu I site 
for linearisation prior to integration.
Integration vector pFL34 with BamH I partial 
fragment from pAAMY-01 containing the entire 
AdHI promoter - a-amylase - AdHI terminator 
cassette. This vector has a URA3 marker, unique 
BamH I site for cloning and a unique Stu I site 
for linearisation prior to integration.
This study.
This study. 
This study.
This study.
Olsen,
(1995).
Olsen,
(1995).
Bonneaud et 
al., (1991).
McMahon,
(1995).
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pFL38-AMY
pMIRY
pMISOC
pYES2
pYES2-AMY
pYES2.SOC
pFL38 ARS-CEN vector, URA3 marker, unique BamH I 
site for cloning.
pFL38 with the 4.0kb partial BamH I fragment 
o f pAAMY-01 containing the AdHI promoter 
sense a-amylase gene - AdHI terminator cloned 
into the unique BamH I site.
Ribosomal DNA integrating vector, LEU2d 
marker, unique BamH I cloning site, and a 
unique Sma I or Hpa I site for linearisation of the 
plasmid for direction of integration into 
the yeasts ribosomal RNA. 
pMIRY with the BamH I fragment from pSOC- 
02 containing the entire antisense a-amylase 
gene between the AdHI promoter and terminator. 
Yeast expression vector containing the GALI 
promoter for inducible expression, CYCI 
terminator, a versatile MCS, 2\i origin of 
replication and a URA3 marker. 
pYES2 with the 1.9 kb Hind HI fragment 
containing the a-amylase gene cloned in sense 
orientation with respect to the GALI promoter 
and CYCI terminator into the unique Hind El site 
o f the MCS.
pYES2 with the 1.9 kb Hind in  fragment 
containing the a-amylase gene cloned in 
antisense orientation with respect to the GALI 
promoter and CYCI terminator into the unique 
Hind III site o f the MCS.
Bonneaud et 
al., (1991). 
This study.
Lopes et al., 
(1989).
This study. 
Invitrogen.
This study.
This study
7 0
pMAS-H5
pFL34-MAS
pGEM-7Zf
p M A S
pT7AMY
pSP6AMY
ppACTSP6
pUC-19 which contains the 1.6 kb BamR l-Hind 
IE a-amylase fragment of pM 02 ligated in sense 
orientation to the 0.6 kb antisense Hind III- 
BamR I fragment of pAS600, all ligated into the 
unique pUC-19 BamR I site.
2.2 kb BamR I fragment of pMAS blunt-ended 
into the unique Hind IE site of pAAH5 in the 
desired orientation.
4.2 kb BamR I fragment of pMAS-H5 cloned 
into the unique BamR I site of pFL34
3.0 kb vector containing T7/SP6 polymerase 
transcription initiation sites for use in in vitro 
transcription assays. This vector also contains a 
versatile multiple cloning site, an ampicillin 
resistance marker gene and the presence o f the 
lacZ a-peptide allows recombinants to be 
positively selected for. 
pGEM-7Zf with the 1.9 kb Bacillus 
licheniformis a-amylase gene cloned into the 
unique Hind IH site. The gene is in sense 
orientation relative to the T7 polymerase 
promoter.
pGEM-7Zf with the 1.9 kb Bacillus 
licheniformis a-amylase gene cloned into the 
unique Hind IH site. The gene is in sense 
orientation relative to the SP6 polymerase 
promoter.
pGEM-7Zf with the 3.8 kb p-actin gene from 
pRB149 cloned into the unique EcoR I site. The 
gene is in sense orientation relative to the SP6 
polymerase promoter.
T his study.
This study.
This study. 
Promega.
This study.
This study.
This study.
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pRB149 Yip 5 with a 3.8 kb yeast chromosomal (3-actin 
gene (Ng and Abelson, 1980) cloned into a 
unique EcoR I site. Yip 5 contains a 1.1 kb 
URA3 gene, an ampicillin resistance gene and a 
tetracycline resistance gene.
(1994).
Canavan,
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2.3 MICROBIOLOGICAL MEDIA
All media was sterilised by autoclaving at 121°C (15 psi) for 20 minutes.
2.3.1 LB
Luria Bertani (LB) medium contains the following components:
per litre
Tryptone 10.0 g
NaCl 10.0 g
Yeast extract 5.0 g
13.5 g Oxoid bacteriological agar no. 1 was added to the above for solid medium 
preparation.
2.3.2 SOC
(used for the growth o f E. coli following electroporation)
Tryptone 2% (w/v)
Yeast extract 0.5% (w/v)
NaCl 10 mM
KC1 2.5 mM
MgCl2 10 mM
MgS04 10 mM
Glucose 20 mM
2.3.3 AMPICILLIN
For selective growth o f E. coli strains, ampicillin was added after the media had 
been autoclaved and cooled to 55°C. The ampicillin stock solution (50 mg/ml) was 
made up freshly in sterile water and used at a concentration o f 50 ng/ml for solid 
media and 40 jj.g/ml for broth.
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2.3.4 X-GAL
A stock solution of X-gal (5-bromo-4-chloro-3-indolyl-P-D-galactopyranoside) 
was prepared by dissolving in dimethylformamide to make a 20 mg/ml solution. 
The tube containing the solution was wrapped in aluminium foil to prevent damage, 
by light and stored at -20°C. It was not necessary to sterilise the X-gal solution by 
filtration.
2.3.5 IPTG
Isopropylthio-p-D-galactoside (IPTG) is an inducer of the p-galactosidase gene in 
bacteria. It was prepared by dissolving 2 g IPTG in 10 ml of water and sterilised by 
filtration through a 0.22 (j,m disposable filter. The solution was then dispensed into 
1 ml aliquots and stored at -20°C.
2.3.6 YEAST MINIMAL MEDIUM
This media is used for the selective growth of yeast auxotrophic strains carrying 
plasmids and it contained the following component per litre:
Yeast nitrogen base (Difco #0392-15-9) 6.7 g
In addition the following components were added;
(i) For a broth media, the pH was adjusted by adding 10 g o f succinic acid and 6.0 g 
of NaOH. Solid media is buffered using 0.1 M sodium phosphate buffer, pH 6.9.
(ii) Glucose (galactose or raffinose) was added to the media after autoclaving, from 
a sterilised stock solution of 40% to give a final working concentration of 2%.
(iii) The appropriate amino acid(s) was added to the media from the sterilised stock 
solutions shown below, after autoclaving.
7 4
Amino acid/Base Supplement per litre Final concentration me/ml
Uracil 8.0 ml of 0.25% soln. 20
Leucine 2.0 ml of 1.5% soln. 30
Adenine 8.0 ml of 0.25% soln. 20
(iv) 2% Lintners’ starch was added, prior to autoclaving to the solid media for the 
routine screening of a-amylase activity.
(v) For integrative transformation it was necessaiy to supplement the above media 
with 0.75 g of the mix listed below:
Adenine 1.0 g
Uracil 1.0 g
Tryptophan 1.0 g
Histidine 1.0 g
Arginine 1.0 g
Methionine 1.0 g
Tyrosine 1.5 g
Leucine 3.0 g
Lysine 1.5 g
Phenylalanine 2.5 g
Threonine 10.0 g
Aspartic acid 5.0 g
Compounds were omitted as required, i.e. for selection on uracil - minus media 
uracil was omitted from this mix.
2.3.7 YEPD
YEPD is a complex medium used for routine yeast culturing and it contained the 
following components:
per litre
Yeast extract 10.0 g
Bacteriological peptone 20.0 g
Glucose 20.0 g
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2 0 .0  g  o f  O xoid  bacteriological agar n o .l w as added to the above for solid  m edium  
preparation.
2.4 BUFFERS AND SOL UTIONS
2.4.1 TE buffer
Tris.HCl, pH 8.0 
Na2-EDTA
10 m M
1 mM
2.4.2 0.5 M EDTA
Disodium ethylene diamine tetraacetate (EDTA) was added to 800 ml of water and 
stirred vigorously. The pH was adjusted to 8.0 with NaOH and the volume made up 
to one litre with distilled water.
2.4.3 DNS
(3,5 - Dinitrosalicyclic acid) (for measuring a  -amylase activity).
per 5 OOmls
The above were dissolved in 250 ml o f 2% NaOH and made up to 500 ml with 
distilled water. The solution was stored in the dark at 4°C.
3,5 - Dinitrosalicylic acid 
Phenol
Sodium sulphite 
Sodium potassium tartrate
5.00 g
1.00 g
0.25 g
100.00 g
7 6
2.4.4 PBS
(Phosphate buffered saline)
KM 2PO 4
Na2HP04 
NaCI
2.4.5 BUFFERS AND SOLUTIONS FOR AGAROSE GEL 
ELECTROPHORESIS
per litre 
1-09 g 
1.705 g 
9.0 g
2.4.5.I 50X TAE
per litre working conc
Tris-HCL 242 g
Glacial acetic acid 57.1ml 0.04 M Tris-acetate
0.5 M EDTA, pH 8.0 100 ml 0.001 M EDTA
2.4.5.2 10X TBE
per litre working conc.
Tris-borale 108 g 0.089 M
Boric acid 55 g 0.089 M
EDTA, pH 8.0 40 ml 0.002 M
2.4.53 6x Bromophenol blue
Bromophenol blue 0.25% (w/v)
Sucrose in H20  40% (w/v)
DNA samples were mixed in a ratio of 5:1 with bromophenol blue prior to loading 
on agarose gels.
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(for running R N A  sam p les).
MOPS, pH 7.0 0.1 M
Sodium acetate 40 mM
EDTA 5 mM
Made up in DEPC treated H20.
2.4.5.5 6x Formaldehyde Loading buffer
(RNA samples)
Na2EDTA (pH 8.0)
Bromophenol blue 
Xylene cyanol 
Glycerol
Made up in DEPC treated H20.
2.4.5.6 10X MOPS
(stored in the dark)
To 800 ml of DEPC (see section 2.4.10.2) treated H2O, 41.8 g o f 3-[-N-Morphilino] 
propanesulfonic acid was added and the pH adjusted to 7.0 with NaOH or acetic 
acid. 16.6 ml of 3 M sodium acetate (DEPC treated) and 20 ml of 0.5 M EDTA, pH 
8.0, (DEPC treated) were then added and the solution was brought up to a volume 
of 1 litre with DEPC treated H20  and sterilised through a 0.22 (xm filter. This buffer 
oxidises with age, if autoclaved or exposed to the light. Straw coloured buffer 
works well but darker buffer does not.
2A.5.4  5 X  F o r m a ld e h y d e  R u n n in g  b u ffe r
1.0 mM 
0.25% (w/v) 
0.25% (w/v) 
50% (v/v)
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One gram of ethidium bromide (warning, a mutagen) was added to 100 ml H2O and 
stirred for several hours to ensure that the dye was dissolved. The container was 
wrapped in aluminium foil and stored at 4°C. Gloves were worn at all times when 
handling EtBr containing solutions. EtBr waste was collected, treated with activated 
charcoal and filtered through 3MM Whatman filter paper. The clear liquid was 
disposed normally and the solids contained on the filter paper were incinerated. 
After electrophoresis to visualise DNA the agarose gel was immersed in distilled 
water containing EtBr at a concentration o f 1 )ig/m 1.
2 .4 .S .7  E th id iu in  b r o m id e  (E tB r )  (1 0  m g /m l)
2.4.6 SOLUTIONS FOR MINI-PREPARATIONS OF PLASMID DNA
(small scale isolation o f plasmid DNA from E. coli.)
2.4.6.1 Solution 1 per 10ml final conc
0.5 M Glucose 1.0 ml 50 mM
0.1MEDTA 1.0 ml 10 mM
1.0 M Tris.HCl (pH 8.0) 0.25 ml 25 mM
2.4.6.2 Solution 2
(Made up freshly every fortnight and stored at room temperature)
per 10 ml final conc
INNaOH 2.0 ml 0.2 N
10 % SDS 1.0 ml 1% SDS
2.4.63 Solution 3
To 60 ml of 5 M potassium acetate, 11.5 ml o f glacial acetic acid and 28.5 ml of 
H2O were added. The resulting solution was 3 M with respect to potassium and 5 M 
with respect to acetate.
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2 .4 .6 .4  S T E T  b u ffe r
8% (w/v) sucrose 
5% (v/v) T riton-X-100 
50 mM Na2EDTA 
50 mM Tris.HCl (pH 8.0)
2.4.6.5 Phenol/Chloroform mix: (Kirby mix)
100 g of AnalaR grade phenol was dissolved in 100 ml of chloroform. The phenol 
was then equilibrated with 100 mM Tris.HCl pH 7.5 until a pH of 7.5 was obtained 
(assessed by measuring the pH of the aqueous layer) then 4 ml of isoamylalcohol 
and 0.8 g of 8-hydroxyquinoline were added and the mixture was stored under 100 
mM Tris.HCl pH 7.5 in a dark bottle at 4°C.
2.4.7 SOLUTIONS FOR MIDI-PREPARATIONS OF PLASMID DNA 
(QIAGEN)
(large scale isolation of plasmid DNA from E. coli, buffers were supplied with the
kit)
2.4.7.1 Resuspension Buffer 
(Buffer PI)
Tris-HCl,
EDTApH 8.0 
RNase A (2.4.13.6)
Store at 4°C.
2.4.7.2 Lysis Buffer 
(Buffer P2)
NaOH 200 mM
SDS 1% (w/v)
Store at room temperature.
50 mM 
10 mM 
100 (J.g/ml
8 0
(Buffer P3)
2 A 7 .3  N e u tr a lis a t io n  B u ffe r
KAc.pl 15.5 
Store at 4"C.
3,0 M
2.4.7.4 Equilibration Buffer
(Buffer QBT)
NaCl
MOPS, pH 7.0 
Ethanol 
Triton X-100
750 mM 
50 mM 
15% 
0.15%
Store at room temperature.
2.4.7.S Wash Buffer
(Buffer QC)
NaCl
MOPS, pH 7.0 
Ethanol
1.0 M 
50 mM
15%
Store at room temperature.
2.4.7.6 Elution Buffer
(Buffer QF)
NaCl 1.25 M
Tris-HCl, pH 8.5 50 mM
Ethanol 15%
Store at room temperature.
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2.4.8 SOLUTIONS FOR THE ISOLATION OF TOTAL GENOMIC DNA 
FROM YEAST
2.4.8.1 S P M
Sorbitol 0.9 M
Sodium phosphate buffer (pH 7.5) 0.05 M
2-mercaptoethanol (freshly added) 0.14 M
2.4.8.2 Lyticase
Lyticase enzyme (Sigma) was resuspended in 
0.05 M potassium phosphate buffer (pH 7.5) to 
a final concentration of 8,000 U/ml.
2.4.8 J  Proteinase K
10 mg/ml Proteinase K was resuspended in 
freshly prepared 150 mM NaCl.
2.4.9 S O L U T I O N S  F O R  T H E  I S O L A T I O N  O F  Y E A S T  
C H R O M O S O M A L  D N A  F O R  P U L S E  FIELD G E L  E L E C T R O P H O R E S I S
2.4.9.1 S C E  buffer
Sorbitol 1,0 M
Sodium citrate 0.1 M
EDTA, pH 7.5 10.0 mM
8 2
2A.9.2  S o lu t io n  I
SCE buffer (2.4.9.1) 
2-mercaptoethanol 
Zymolyase 60,000
10 ml
0.5% (v/v)
10 mg
2.4.9.3 Solution II
EDTA, pH 9.0 
Tris-HCl, pH 8.0 
2-mercaptoethanol
0.45 M 
10.0 mM 
7.5 % (v/v)
2.4.9.4 Solution ni
EDTA, pH 9.0 0.45 M
Tris-HCl, pH 8.0 10.0 mM
Sodium N-lauroylsarcosinate 1.0% 
Proteinase K 1 mg/ml
2.4.10 S O L U T I O N S  F O R  T H E  I S O L A T I O N  O F  R N A  F R O M  Y E A S T
2.4.10.1 Letts buffer
LiCl 0.1 M
EDTA 0.1 M
Tris.HCl (pH 7.4) 0.01 M
SDS 0.02%
2.4.10.2 D E P C  treatment
Diethylpyrocarbonate (toxic) was used to inhibit RNases in the preparation of 
solutions for RNA manipulations. DEPC (0.1%) was added to the solution, shaken 
vigorously, left at room temperature for at least 20 minutes and then autoclaved to 
inactivate the DEPC. DEPC was not added directly to solutions containing Tris as it
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is highly unstable in these solutions decomposing rapidly into ethanol and carbon 
dioxide (Maniatis et al., 1982). Gloves were worn at all times in the preparation of 
solutions for the manipulation of RNA to avoid the introduction of RNases.
2.4.11 S O L U T I O N S  F O R  L I T H I U M  A C E T A T E  Y E A S T  
T R A N S F O R M A T I O N
2.4.11.1 Lithium acetate stock solution (1.0 M  )
10.2 g of lithium acetate was dissolved in 100 ml of distilled water, the pH was then 
checked and should be between 8.4 - 8.9. The solution was then autoclaved and 
stored at room temperature.
2.4.11.2 P E G  3350 stock solution, 5 0 %  (w/v)
50 g of PEG was weighed into a graduated 150 ml beaker, water was added slowly 
until the level was just below the 100 ml mark. A stirring bar was placed in the 
beaker and mixed on a magnetic stirrer until the PEG had dissolved, this takes 
approximately 30 minutes at room temperature. The viscous solution was then 
decanted into a 100 ml measuring cylinder and water was added to the 100 ml 
mark, sealed with parafilm and mixed thoroughly by inversion. The solution was 
then autoclaved. An important point to note was that the solution was stored in a 
tightly sealed container to prevent evaporation because if the solution was stored in 
a loosely capped bottle, the concentration of PEG steadily increases, causing a slow 
but noticeable decline in transformation efficiency with time.
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2.4.12 SOLUTIONS FOR ISOLATION OF DNA FROM AGAROSE 
(GeneClean)
2.4.12.1 Sodium Iodide solution
90.8 g Nal was dissolved in 100 ml H2O. 
The solution was filtered through Whatman 
No.l filter paper. 15 g ofNa2S04 was added 
and the solution stored at 4°C in the dark.
2.4.12.2 Ethanol Wash solution
(New Wash)
Ethanol 50%
NaCl 100 mM
Tris.HCl (pH 7.5) 100 mM
EDTA 1 mM
This solution was stored at -20°C.
2.4.13 B U F F E R S  A N D  S O L U T I O N S  F O R  D N A  MANIPULATIONS.
2.4.13.1 Restriction buffers
Buffers were supplied with the restriction 
enzymes and used according to the 
manufacturers instructions.
2.4.13.2 Ligation buffer
Supplied and used according to the 
manufacturer’s instructions.
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2 .4 .1 3 .3 Klenow buffer
Supplied and used according to the 
manufacturer’s instructions.
2.4.13.4 Dithioflireitol (1M DTT)
DTT (3.09 g) was dissolved in 0.01 M 
sodium acetate (pH5.2) and filter 
sterilised. A1 iquoted and stored at -20°C.
2.4.13.5 ATP (0.1M)
ATP (60 mg) was dissolved in 800 of
sterile H20  and the pH adjusted to 7.0 
with 0.1 M NaOH. The volume was 
adjusted to I ml with sterile hfeO, 
aliquoted and stored at -20°C
2.4.13.6 RNase (DNase free)
10 mg/ml RNase A (Sigma) was 
dissolved in 10 mM Tris.HCl (pH 7.5), 
15 mM NaCl; heated to 100°C for 15 
minutes, allowed to cool slowly to room 
temperature and stored at -20°C.
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(radioactive hybridisation)
2 .4 .1 4  S O L U T I O N S  F O R  S O U T H E R N  H Y B R I D I S A T I O N
2.4.14.1 Depurination solution
HC1 0.25 M
2.4.14.2 Denaturing solution
per litre working conc.
NaCI 87.66 g 1.5 M
NaOH 20.0 g 0.5 M
2.4.14.3 Neutralising solution
Tris-HCl
NaCI
per litre
121.1 g
87.66 g
working conc. 
1 M
1.5 M
Dissolved in 800 ml o f distilled H20 , the pH was adjusted to 8.0 and the 
volume to 1 litre.
2.4.14.4
(2 OX SSC)
Transfer buffer
NaCI 175.3 §
Trisodium acetate 88.2 g
Dissolved in 800 ml o f distilled H2O, the pH was adjusted to 7.0 and the 
volume brought up to 1 litre.
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2.4.14.5 50X Denhardts solution
per 500 ml 
Ficoll 5.0 g
Polyvinylpyrolidone 5.0 g 
B.S.A 5.0 g
H20  to 500 ml
This solution was stored at -20°C.
2.4.14.6 Prehybridisation solution
6X SSC
5X Denhardts solution 
0.5% SDS
100 |ig/ml denatured salmon sperm 
DNA (section 2.4.14.8).
2.4.14.7 Hybridisation solution
as for prehybridisation solution except 
it contains in addition EDTA (0.1 M) 
and the 32P labelled probe.
2.4.14.8 Preparation of salmon sperm D N A  (10 mg/ml)
Salmon sperm DNA was used in hybridisations with radiolabelled probes and was 
prepared as follows; 500 mg of salmon sperm DNA (Sigma, type IV) was dissolved 
in 50 ml distilled H20  for at least 4 hours. The DNA was sheared by passing it 
through a syringe with a microlance at the top (21G Becton Dickenson, Dublin), 
aliquoted and stored at -20°C. The DNA was denatured before use, by placing it in 
a boiling water bath for 5 minutes and then placing immediately on ice.
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(radioactive hybridisation)
2 .4 .1 5  S O L U T I O N S  F O R  N O R T H E R N  H Y B R ID IS A T IO N
2.4.15.1 Prehybridisation
6X SSC 
2X Denhardts 
0.1 %SDS
100 jig/ml denatured salmon sperm 
DNA (section 2.4.14.8).
2.4.15.2 Hybridisation
as for prehybridisation solution except 
it contains the 32P labelled probe.
2.4.16 S O L U T I O N S  F O R  D I G  - D N A
(non-radioactive hybridisation, kit supplied by Boehringer Mannheim)
2.4.16.1 Prehybridisation solution
(Southern) at 68°C
5X SSC
1% Blocking reagent (2.4.16.4) 
0.1% N-Laurolysarcosine 
0.02% SDS
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2.4.16.2 Prehybridisation solution
(Northern) at 42°C
5XSSC
50% Formamide 
2.0% Blocking reagent (2.4.16.4)
0.1 % N-Lauroylsarcosine 
0.02% SDS
2.4.16.3 Buffer I
Tris-HCI, pH 7.5 
NaCI
2.4.16.4 Blocking stock solution (10%)
Blocking reagent was dissolved in Buffer I to a final concentration of 10% (w/v) 
with shaking and heating on a heating block, pH had to be exactly 7.5 for the 
reagent to dissolve. After autoclaving the solution turns pink and was stored at 4°C.
2.4.16.5 Buffer II (1% Blocking reagent)
Blocking stock solution diluted 1:10 in Buffer I.
2.4.16.6 Washing Buffer
Buffer I and 0.3% (w/v) Tween-20.
2.4.16.7 Buffer HI (Detection buffer)
Tris-HCI, pH 9.5 0.1 M
NaCI 0.1 M
MgCla 0.05 M
0.1 M 
0.15 M
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2 .4 .1 6 .8 Buffer IV
Tris-H C l, pH 8 
EDTA
0.01 M
0.001 M
All the above solutions were made up in ultrapure FLO and autoclaved at 121°C 
(15psi) for 20 minutes.
2.5 GROWTH AND STORAGE OF STRAINS
All E. coli strains were grown overnight at 37°C in LB medium. All S. cerevisiae 
strains were grown overnight at 30°C in complex media or for 36 hours in minimal 
medium. Both yeast and bacterial strains were stored as glycerol stocks. An equal 
volume of 80% glycerol was added to a late log phase culture and stored at -70°C. 
Working stocks were stored on plates at 4°C.
2.6 RECOMBINANTDNA TECHNIQUES
2.6.1 T R A N S F O R M A T I O N  O F  E. COLI
(based on a method by Mandel and Higa, 1970).
2.6.1.1 Preparation of competent E. coli D H 5 a  cells for transformation.
100 ml of LB was inoculated with 2 ml o f an overnight culture of E. coli and 
incubated in a shaking waterbath at 37°C to an OD600 o f 0.3 - 0.4. The cells were 
cooled on ice and subsequently centrifuged at 4°C, 3,000 rpm for 10 minutes. The 
media was poured off and the pellet resuspended gently in 25 ml cold 50 mM 
CaCl2, then it was left on ice for 20 minutes. The cells were harvested by 
centrifugation as before, then resuspended in a total volume of 2.5 ml 50 mM 
CaCh. The cells were then left on ice for between 1 hour and overnight. Cells are 
competent at this stage.
91
200 fil of competent cells were added to the ligation reaction/plasmid, vortexed 
briefly and left on ice for 30 minutes. The cells were then heat shocked at 43°C for 
exactly 2 minutes, 1 ml of LB without the selection antibiotic was added and the 
microfiige tubes incubated at 37°C for 1 hour to allow the cells to recover. The cells 
were collected by centrifugation in a microcentrifuge for 1 minute, the supernatant 
was poured off and the cell pellet was resuspended in 100 jxl of sterile H20 . 
Appropriate volumes of the cells were spread on to selective media and incubated at 
37°C overnight. The transformants were picked off, purified and plasmid DNA was 
isolated using one of the methods described in section 2.6.5. pUC 18/19 based 
transformations were carried out in DH5a to exploit the lacZ phenotype. Selection 
of the transformants included inoculation onto ampicillin plates containing 5- 
bromo-4-chloro-3-indolyl-B-D-galactopyranoside (X-gal) and isopropylthio-B-D- 
galactoside (IPTG). This was achieved by adding 40 fil of a stock solution of X-gal 
(20 mg/ml in dimethyiformamide, section 2.3.4) and 4 p.1 of a solution of IPTG 
(200 mg/ml in H20 , section 2.3.5) to a premade LB agar plate containing the 
appropriate antibiotic and spreading over the entire surface of the plate. The plate 
was incubated at 37°C until all of the fluid had disappeared, this can take up to 3 
hours if the plate is freshly made due to the low volatility of dimethyiformamide. 
Colonies with inserts in the plasmid remained white, while those without inserts 
remained blue.
2.6.13 Transformation of in-gel ligation.
Competent cells were prepared as in section 2.6.1.1. The ligation reaction mixture 
was heated to 68°C for 5 - 1 0  minutes to remelt the agarose. The ligation reaction 
was diluted with sterile distilled water such that 1 p.1 of diluted ligation mix 
contained 1 - 10 ng o f DNA. 1 jj.1 of diluted ligation was then added to 200 |_il of 
competent cells. The mixture was incubated on ice for 30 minutes, heat shocked at 
42°C for 3 minutes, then incubated at 37°C for 1 hour and plated on selective 
media.
2 .6 .1 .2  T r a n s fo r m a t io n  o f  c o m p e te n t  E. coli D H 5 a  ce lls .
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2 .6 .2  E L E C T R O P O R A T IO N  O F  E. COLI
2.6.2.1 Preparation of electrocompetent E. coli DH5a cells.
1 litre of LB was inoculated with 1% (v/v) of an overnight E. coli culture and 
shaken vigorously at 37°C to an O D 6oo of 0.5 - 0.8. The flask was chilled on ice for 
1 5 -3 0  minutes and the cells were centrifuged at 4000 rpm for 15 minutes at 4°C. 
The cell pellet was resuspended by gently shaking in an ice water bath, in 1 litre of 
ice cold distilled H20. The suspension was centrifuged as before and resuspended 
in 0.5 litres of ice cold distilled H20. Following resuspension the cells were 
centrifuged as before and resuspended in 20 ml of 10% (v/v) ice-cold glycerol. 
Once again, the cells were centrifuged and resuspended finally in 2-3 mis of 10% 
glycerol. The cells were dispensed into 100 jo.1 aliquots and stored at -80°C for up to 
six months.
2.6.2.2 Electroporation of competent E. coli DH5a cells.
The apparatus used was a BioRad Gene Pulser™, set at 25 mF capacitance, 2.49 
kV and 200 ohms to deliver a single exponentially decaying pulse. The 
electroporation cuvettes were chilled on ice for 5 minutes, the cells thawed on ice 
and 1 - 5 pi of plasmid DNA/ligation mix was added and left for 1 minute before 
electroporating. The DNA must be cleaned of excess protein and salts to minimise 
arcing. The mixture of cells and DNA was then transferred to an electroporation 
cuvette, the outside of which was dried, then tapped sharply off the bench to get rid 
of air bubbles which can also cause arcing. The cuvette was placed in the sliding 
holder and the pulse applied by pressing the two red buttons simultaneously. 
Immediately after a high pitched beep is heard, (indicating that the pulse has been 
delivered) 1 ml of SOC or LB medium was added to the cuvette and the cell 
suspension placed at 37°C for 1 hour. Dilutions of the cells were plated onto 
selective medium and incubated at 37°C overnight.
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2 .6 .3  L I T H I U M  A C E T A T E  Y E A S T  T R A N S F O R M A T I O N
2.6.3.1 Preparation of yeast competent cells.
100 mis of YEPD was inoculated with 20 jj.1 of an overnight culture of S. cerevisiae 
and grown at 30°C with agitation to an OD600 of 0.7. The cells were harvested at 
room temperature by centrifugation at 5000 rpm. After two washes in half the 
original volume of TE pH 7.5, the cells were resuspended in one tenth the original 
culture volume o f 100 mM LiAc and incubated at 30°C with agitation for 60 
minutes. The cells were harvested as before and resuspended in the same volume of 
100 mM LiAc. Routinely 10 ml samples of culture were used yielding 1.0 ml of 
competent cells.
2.63.2 Transformation of yeast competent cells.
Plasmid DNA (0.1 pg - 10 pg) was added to 300 pi of competent cells. 0.7 ml of 
40% PEG3350/ 0.1 M LiAc was added, mixed gently by inversion and incubated at 
30°C for 60 minutes. The cells were then placed at 42°C for 5 minutes and plated 
directly onto selective media
2.6.4 TRANSFORMATION OF S. CEREVISIAE BY 
ELECTROPORATION
2.6.4.1 Preparation of cells.
The yeast strain was grown in YEPD to late log phase or early stationary phase. 
The cells were harvested by centrifugation at 5,000 rpm for 5 minutes then washed 
three times with sterile distilled water. The cells were finally resuspended in water 
to 10% of the original volume and cooled to 0°C. The electroporation cuvettes (0.2 
cm electrode gap) were also cooled to 0°C. To 100 pi of cells approximately 1 pg 
of DNA and 50 pi o f 40% PEG 3000 were added.
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2.6.4.2 Electroporation of electrocompetcnt S. cerevisiae cells.
Electroporation of cells was accomplished using a BioRad Gene Pulser™, set at a 
resistance of a 1,000 ohms, a capacitance of 25 uF and a voltage of 0.8 kV, to 
deliver a single exponentially decaying pulse. The cells were pulsed, then 0.5 ml of, 
20% sucrose was added, mixed and the mixture transferred to a microcentriliige 
tube, a range of concentrations were then plated onto selective media plates.
2.6.5 SMALLSCALE ISOLATION OF PLASMID DNA FROM E. COLI
2.6.5.1 STET prep
(Described by Holmes and Quigley, 1981).
An overnight culture (2 ml) or a toothpick colony was resuspended in 300 fil of 
STET (section 2.4.6.4) by vigorous vortexing then 20 jo.1 of 10 mg/ml lysozyme was 
added to the microcentrifuge tubes, the tubes were then left at room temperature for 
10 minutes. Following this, the samples were denatured in a boiling water bath for 
exactly 60 seconds, then spun immediately at 13,000 rpm for 10 minutes. The 
supernatant was removed and precipitated with an equal volume o f isopropanol. 
After incubation at -20°C for 30 minutes, the samples were spun at 13,000 rpm for 
5 minutes. The resulting plasmid DNA pellet was washed with 500 |al of ether, 
dried at room temperature for 5 minutes and resuspended in 50 p.1 o f TE containing 
DNase free RNase (50 |ag/ml). This was incubated for 10 minutes at 37°C to 
degrade RNA that may mask small fragments o f DNA in an agarose gel.
2.6.5.2 Solution 1,2,3 prep
(Described byBimboim and Doly, 1979).
1 ml of an overnight broth culture was pelleted at 13,000 rpm and resuspended by 
vortexing in 100 fil o f Solution 1 (section 2.4.6.1) and incubated at room 
temperature for 5 minutes. 200 fil o f Solution 2 (section 2.4.6.2) was added and the 
microfuge tubes were left on ice for a further 5 minutes. To this, 150 jo.1 of Solution 
3 (section 2.4.6.3) was added, the samples were left on ice for 10 minutes and then 
centrifuged at 13,000 rpm for 5 minutes. The supernatant was removed and 400 jil
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of phenol-chloroform mix (section 2.4.6.5) added. After thorough mixing, the 
samples were spun at 13,000 rpm, the aqueous layer removed and precipitated with 
0.8 ml ice-cold ethanol. Following 10 minutes at room temperature, the plasmid 
DNA was pelleted by centrifugation at 13,000 rpm. The pellet was washed twice in 
70% (v/v) ethanol, dessicated and resuspended in 50 pi TE.
2.6.6 LARGE SCALE ISOLATION OF PLASMID DNA FROM E. COLI 
(QIAGEN COLUMN-PLASMID MIDI-KIT)
For large-scale isolation of plasmid DNA from E. coli, the Qiagen method was 
employed, (Qiagen Inc., USA), in which an affinity resin column and the 
appropriate buffers are supplied. A single colony was used to inoculate 5 ml of LB 
(containing the appropriate antibiotic) which was grown overnight, then used to 
inoculate a further 100 ml of the same medium. This was again grown overnight, 
and harvested by centrifugation in a Beckman J2-21 (JA-14 rotor) at 6,000 rpm for 
15 minutes at 4°C. The pellet was resuspended in 4 ml o f resuspension buffer 
(section 2.4.7.1), and transferred to a glass “corex” tube. Lysis buffer (4 ml, section
2.4.7.2) was added, mixed, and the tube incubated at room temperature for 5 
minutes. Then 4 ml of neutralisation buffer (chilled, section 2 .4.7.3) was added, 
mixed gently, and further incubated, on ice for 15 minutes. This was then spun (JA- 
20 rotor) at 12,000 rpm for 30 minutes at 4°C, but if the resulting supernatant was 
not fully clear, the step was repeated for a further 15 minutes, and the clear 
supernatant then promptly removed. A Qiagen-tip 100 column was equilibrated 
with 4 ml equilibration buffer (section 2.4.7.4) just before use, then the supernatant 
applied and allowed to flow through. The column was then washed with 2 x 10 ml 
of wash buffer, (section 2.4.7.5) and eluted with 5 ml elution buffer (section 
2.4.7.6). The eluent was collected into a “corex” glass tube, 0.7 volumes 
isopropanol added, and immediately centrifuged at 12,000 rpm and 4°C for 30 
minutes. This served to precipitate the DNA, which was visible as a faint glassy 
pellet. The pellet was then washed with 70% ethanol, spun again, and air dried, 
before being resuspended in 100 - 300 pi TE, and stored at -20°C.
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2.6.7 ISOLATION OF PLASMID DNA FROM S. CEREVISIAE
5 ml of cells from a late exponential phase culture were harvested by centrifugation,
5,000 rpm for 5 minutes, and then resuspended in 0.5 ml 1M sorbitol/0.1 M EDTA. 
50 pi of lyticase (8,000 units/ml) was then added and the cells were incubated for 
60 minutes at 37°C. The cells were then spun at 1,000 rpm for 1 minute and 
resuspended in 0.5 ml 50 mM Tris-HCl, pH 7.4/ 20 mM EDTA. 50 pi of 10% SDS 
was then added and the mixture was incubated for 30 minutes at 65°C. 200 pi of 5 
M potassium acetate was added and the mix was left on ice for 60 minutes, spun for 
5 minutes at 5000 rpm after which the supernatant was removed and precipitated 
with an equal volume of isopropanol. After 5 minutes at room temperature the 
DNA was pelleted by spinning for 10 seconds. The pellet was then dried at 55°C 
and resuspended in 300 fj.1 of TE pH 7.4. 15 pi of RNase (1 mg/ml) was added to 
the resuspended DNA and incubated for 30 minutes at 37°C after which the DNA 
was precipitated by the addition of 30 pi of 3 M sodium acetate and 300 pi cold 
isopropanol. The DNA was pelleted by centrifugation (5 minutes/5,000 rpm) and 
resuspended in 50 pi TE. This volume of DNA was then used for transformation of 
E. coli.
2.6.8 ISOLATION OF GENOMIC DNA FROM S. CEREVISIAE
2.6.8.1 Long Method
(This method is a modification of that o f Cryer et al., 1975).
5 ml of a YEPD culture was inoculated with the appropriate strain and the culture 
was grown to stationary phase. If the cells were grown in minimal media a 25 ml 
culture volume was inoculated and the cells were once again grown to stationary 
phase. The cells were harvested by centrifugation. The pellet was washed once with 
10 ml distilled water and once with 2 ml SPM (section 2.4.8.1). The cells were 
resuspended in 0.5 ml SPM. A 20 pi sample was taken and diluted in 5 ml distilled 
H20  and the OD6oo measured. This value represented time zero OD value for 
evaluation of protoplasting efficiency. 100 pi o f lyticase enzyme (section 2.4.8.2) 
was added and mixed. The sample was incubated at 30°C for 1 - 2 hours, or until a 
reduction of OD«)o to 10 - 30% of the original OD600, when a 20 pi sample was
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diluted in 5 ml distilled HjO. 100 (il Proteinase K (section 2.4.8.3), 50 (j.1 of 1 mM 
EDTA:0.25 M sodium phosphate (pH 8.0) and 70 jj.1 of 25% SDS were added to the 
yeast spheroplasts. This lysis mixture was incubated for 30 minutes at 37°C. On 
completion of incubation, 500 p.I of phenol/chloroform was added and mixed by 
inversion. The sample was left on ice for 10 minutes, before centrifugation at
12.000 rpm for 5 minutes. The upper aqueous phase was carefully removed using a 
wide bore pipette (cut-off 1 ml tip) to a fresh tube. The lower phase (including the 
interphase) was back extracted with 200 jj.1 of TE buffer, centrifuged as before and 
the supernatant pooled with the aqueous phase of the previous extraction. Two 
further phenol/chloroform extractions were performed as above except with no 
back extraction of the interphase to ensure complete deproteinisation and extraction 
of lipids. The aqueous phase was extracted once with 700 |il chloroform at room 
temperature. 1 ml of ethanol (-20°C) was added and the sample mixed by inversion 
and incubated at -20°C for at least 2 hours. The total DNA was pelleted by 
centrifugation at 12,000 rpm for 10 minutes. The DNA pellet was dried at 50°C 
washed twice with 70% ethanol and carefully dissolved overnight in 300 p.1 TE 
buffer. 15 (4.1 of RNase (10 mg/ml) was added to the dissolved DNA, and incubated 
for 30 minutes at 37°C. The DNA solution was again deproteinised, precipitated 
with ethanol and washed in 70% ethanol as before. Finally, the DNA pellet was 
carefully dissolved in 100 jil TE buffer.
2.6.8.2 Quick Method for Preparation of S. cerevisiae genomic DNA.
The yeast was inoculated into 10 ml of YEPD medium in a 250 ml flask. The 
cultures were grown overnight at 30°C with shaking. The cells were harvested at
4.000 rpm for 5 minutes and the supernatant was discarded. The cell pellet was 
resuspended in 0.5 ml o f 1 M sorbitol solution, this suspension was transferred to a 
microcentrifuge tube and 25 p.1 of lyticase solution (5 mg/ml) was added. The tube 
was incubated at 37°C for 30 minutes. After this incubation, the microcentrifuge 
tube was spun for 1 minute at 13,000 rpm and the supernatant was discarded. The 
cells were resuspended in 0.5 ml of TE buffer by pippetting up and down. 25 p,l of 
20% SDS was then added and the tube was inverted 10 times to mix. The tube was 
then incubated at 65°C for 20 minutes. Following this, 0.4 ml o f 5 M KAc was
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added, the tube was inverted 10 times to mix, then it was left on ice for half an hour. 
The microcentrifuge tube was then spun at 13,000 rpm for 5 minutes. The 
supernatant was transferred to a fresh microcentrifuge tube and 0.75 ml of 
isopropanol was added at room temperature. The tube was inverted 10 times to mix, 
then allowed to sit at room temperature for less than 5 minutes. The tube was then 
spun for 5 minutes at 13,000 rpm, the supernatant was poured off, then the tube was 
respun. This time the remainder o f the supernatant was removed by pipette and the 
pellet was air-dried for 5 minutes. The DNA was resuspended in 300 p.1 of TE by 
finger-flicking. 30 j_il of 3M NaAc and 200 p.1 of isopropanol were then added, the 
tube was inverted 5 times to mix. The tube was then spun for 5 minutes, the 
supernatant was discarded, the tube was respun and once again the remainder of the 
supernatant was removed by pipette. The DNA was air-dried for 5 minutes then 
finally resuspended in 150 p.1 ofTE buffer.
2.6.9 S. CEREVISIAE CHROMOSOMAL DNA ISOLATION FOR 
PULSE-FIELD GEL ELECTROPHORESIS
(Carle and Olson, 1985).
2.6.9.1 Standard DNA plug preparation for Pulsed Field Gel 
Electrophoresis.
Cells were grown to late logarithmic phase in 100 ml of YEPD medium and then 
harvested and washed twice with 50 mM EDTA, pH 7.5 at 0°C; the final cell pellet 
was suspended in 3.25 ml o f 50 mM EDTA pH 7.5; 3 ml o f the cell suspension 
was mixed at 37°C with 5 ml of 1% low melting point agarose (which was prepared 
in 0.125 M EDTA pH 7.5, and cooled to 42°C) and 1 ml of solution I (section
2.4.9.2); the mixture of agarose, cells and cell-wall-removing enzyme was then 
quickly pippetted into the wells o f a plastic mould suited for running on a CHEF 
Mapper and placed in a refrigerator to accelerate gelling; after setting, the plugs 
were removed from the mould (with a narrow piece of x-ray film) into a petri dish 
(6mm diameter) containing 5 ml of solution II (section 2.4.9.3), and incubated 
overnight at 37°C in a plastic bag with gentle shaking; solution II was then replaced 
by 5 ml of solution III (section 2.4.9.4), the plastic bag was resealed, and the plates 
were then incubated overnight at 50°C. Plugs should look clear after proteinase K
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treatment. Finally the plugs were washed twice with 0.5 M EDTA pH 9.0. Plugs 
were now ready for use or they could be stored in 0.5 M EDTA pH 9.0 at 4°C. For 
electrophoresis conditions see section 2.10.3.
2.6.10 ISOLATION OF RNA FROM .V. CEREVISIAE
Total RNA was isolated from yeast using a method adapted from Sherman et al., 
(1986). In order to minimize RNase activity during the isolation of RNA the 
following precautions were taken. All solutions (section 2.4.10) used in this 
procedure were made up in DEPC treated H20  and autoclaved at 15 psi for 20 
minutes. Glassware and glass beads were washed in 3 M HC1 and baked at 180°C 
for 8 hours before use. Plasticware was rinsed in chloroform and autoclaved before 
use.
Cells were grown in appropriate media to an OD6oomn of approximately 0.8. 100 ml 
of cells were harvested by centrifugation at 5,000 rpm for 10 minutes at 4°C and 
resuspended in 2 mis Letts buffer. The cell suspension was transferred to a 15 ml 
corex tube containing 8 g glass beads (40 mesh for GLC, BDH) and 2 ml 
phenol/chloroform that had been equilibrated with Letts buffer. The cells were 
lysed by vortexing for 3 minutes (6 x 30 second bursts with 30 seconds intervals on 
ice between each burst). 2 ml Letts buffer was added, the sample mixed by 
vortexing and spun for 5 minutes at 8,000 rpm at 4°C. The aqueous layer was 
removed and the sample extracted 3 times with phenol/chloroform. The RNA was 
precipitated in 0.1% 5 M LiCl and 2 volumes ice cold absolute ethanol and 
incubated at -20°C for at least 3 hours. Total RNA was harvested by centrifugation 
at 10,000 rpm for 10 minutes at 4°C. The pellet was washed in 80% ethanol, air 
dried and resuspended in 1.0 - 1.5 ml DEPC treated H2O.
2.6.11 GENERAL DNA MANIPULATIONS
2.6.11.1 Restriction digestion.
Restriction buffers were supplied by the manufacturers and used under the 
recommended conditions. When restricted DNA was required for further 
manipulations it was cleaned up either by extraction with phenol/chloroform and 
ethanol precipitations (section 2.6.11.7), or by Spin Column (section 2.6.11.8) or
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finally by GeneClean (section 2.6.11.9). For restriction of 20 (0.1 of total yeast DNA 
for a Southern blot, the DNA was restricted in a volume of 200 (0.1, using 4 (J of 
restriction enzyme(lunit/fig) and incubated at 37°C for 12 hours.
2.6.11.2 Klenow reaction.
After restriction digestion and prior to recircularisation or the addition of linkers to 
plasmids, the Klenow reaction was used to fill-in cohesive termini generated by 
certain restriction enzymes. Following restriction digestion, the DNA was cleaned 
using the GeneClean (section 2.6.11.9) procedure and the Klenow fill-in reaction 
was carried out as follows. To a 1.5ml microcentrifUge tube on ice the following 
were added:
10X React 2 buffer 3 jal
0.5 mM dATP 1 fj.1
0.5 mM dTTP 1(11
0.5 mM dGTP 1 (xl
0.5 mM dCTP 1 (¿1
DNA 0.5-1 jxg
Large fragment of DNA polymerase I 1 unit 
Sterile distilled water to 30 p.1.
The above reaction was mixed gently, then centrifuged briefly to bring the contents 
to the bottom of the tube. Incubation was at room temperature for 30 minutes, and 
the reaction was terminated by phenol extraction. Alternatively, for restriction 
digestions which left 3 ’overhangs the exonuclease activity of Klenow was exploited 
and the above reaction was carried out minus the nucleotides.
2.6.11.3 Dephosphorylation of digested DNA.
0.5 fil of Calf-Intestinal Phosphatase (CIP, lunit/(j.l) and 1.5 (J.1 o f CIP buffer (5X) 
were added to 13 pi (0.25 ^g -1.0 (jg) of linearised plasmid DNA and incubated at
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37°C for 20 minutes. The reaction was stopped by heat inactivation of the enzyme 
at 65°C for 10 minutes, followed by phenol extraction and ethanol precipitation.
2.6.11.4 DNA ligations.
Ligations were carried out in the presence o f 0.1 unit of T4 DNA ligase for cohesive 
end ligations and 1.0 unit of T4 DNA ligase for blunt end ligations. Vector (CIP 
treated, section 2.6.11.3) and insert fragments were routinely ligated in a ratio of 
1:10. Ligations were incubated at 4°C overnight.
2.6.11.5 In-gel ligation.
The DNA to be used as insert was digested with restriction enzyme, the DNA was 
then electrophoresed in the appropriate concentration of NuSieve GTG agarose (see 
Table 2-1 below). The gel was stained with ethidium bromide, destained and the 
gel band containing the insert was excised and placed in a sterile preweighed tube. 
Exposure of DNA to UV irradiation was minimised to less than 1 minute. The 
excised band could be stored at 4°C until ready for use.
Table 2-1.Determination of the optimal agrose concentration.
Size range in bp % Agarose conc. (TAE)
500 -1000 2.5
150 - 700 3.0
100 - 450 3.5
70 - 300 4.0
10 - 1 0 0 4.5
8 -5 0 5.0
1 0 2
2.6.11.6 Ligation of vector and insert in remelted agarose.
The ligation reaction mixture was set up such that the final ligation reaction volume 
was approximately 50 |_U, and the amount of agarose in the final reaction mixture 
did not exceed 1.5%. The agarose slice containing the insert was remelted by 
heating to 68°C for 10 minutes, the sample was then maintained at 37°C to prevent 
gelling. A volume of melted agarose containing the required quantity of insert was 
transferred to a preheated (37°C) microcentriiiige tube and the following were 
added to a 50 (il final volume:
T4 ligase buffer (1 OX) 5 fj.1
Vector 0.1 jig
Deionised water
T4 ligase enzyme (1 unit/fj) 5 fj.1
The above were mixed gently, transferred to a ligation temperature of 14°C for a 
minimum of two hours or overnight.
2.6.11.7 Ethanol precipitations.
This procedure was derived from Bethesda Research Laboratories protocol Focus 
(1985) 7(4): 1 -2.
Precipitation of DNA was achieved by the addition of 1/10 th the volume o f 3.3 M 
sodium acetate and two volumes of ice-cold (-20°C) 95% ethanol. The contents of 
the tube was mixed and stored at -20°C for at least 30 minutes or overnight. The 
mixture was then centrifuged for 30 minutes at 13,000 rpm, the supernatant was 
carefully poured off and the DNA pellet washed with 2 volumes of 80% ethanol (- 
20°C). The contents of the tube were mixed by inverting the tube several times, the 
mixture was stored at -70°C for 15 minutes, then centrifuged once again for 30 
minutes at 13,000 rpm. The supernatant was poured off and the pellet dried under 
vacuum. The DNA was reconstituted in TE buffer.
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2.6.11.8 Spin Columns
(Hunter, 1991).
Spin columns were used for removing impurities from DNA preparations and for 
changing buffer conditions. Fifty jj.1 of glass beads (40 mesh for GLC, BDH) were, 
placed at the bottom of a 0.5 ml microfuge tube which had been pierced with a hot 
lance. To this 0.5 ml of 70% sepharose CL6B (cross-linked 6% beaded agarose, 
Sigma) was added and the column was equilibrated 3 times with sterile distilled 
water. To do this, a volume of water equal to the sample volume was added to the 
column and centrifuged at 1,500 rpm for exactly 2 minutes into an empty microfuge 
tube. Once the column was equilibrated and eluting the exact sample volume, the 
sample was added and the column spun at 1,500 for 2 minutes into a clean sterile 
microfuge tube.
2.6.11.9 Isolation of DNA fragments from agarose 
(GeneClean).
This method for the recovery of DNA fragments from agarose gels was based on 
Vogelstein and Gillespie, (1979). This method was also used to clean up DNA 
preparations, change buffer conditions and clean ligations prior to electroporation. 
The DNA was separated by agarose gel (TAE) electrophoresis. The fragment of 
interest was cut from the gel using a clean blade. The gel slice was chopped into 
small pieces, weighed and sodium iodide solution was added (2 ml/g agarose). The 
sample was mixed and incubated at 55°C for 5 minutes or until the agarose had 
dissolved. 1 - 2 |xl of glass bead sluny (prepared as in section 2.6.11.10) was added, 
the sample was mixed by pippetting up and down and left at room temperature for 5 
minutes. The sample was spun at high speed for 5 seconds the supernatant was 
removed and the pellet was washed 3 times with 100 of New Wash (section
2.4.12.2), spinning for 5 seconds between each wash. The pellet was resuspended in 
10 - 20 fo.1 of TE, pH 8.0, and the DNA allowed to elute from the beads for 3 
minutes at 55°C. The beads were then spun and the eluate (DNA) removed into a 
sterile microfuge tube. This elution step was repeated to ensure maximum recovery 
of the DNA.
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2.6.11.10 Preparation of Silica 325 Mesh Glass Beads for GeneClean 
Procedure.
250 ml o f silica powder was suspended in distilled water and the volume made up 
to 500 ml in a 600 ml beaker. The suspension was stirred for 1 hour and then 
allowed to settle for a further hour. The supernatant was then removed to two 
centrifuge tubes and spun at 5,000 rpm for 5 minutes. The pellet was resuspended 
in 100 ml of distilled water and transferred to a 600 ml beaker and the volume 
adjusted to approximately 140 ml. 350 ml of 70% HNO3 was then added to give a 
final concentration of 50% HNO3 . The suspension was then heated to near boiling 
on a hot plate with continuous stirring. The suspension was then transferred to 2 
centrifuge tubes and spun at 5,000 rpm for 5 minutes. Each pellet was then 
resuspended in 100 ml of distilled water and spun down at 5,000 rpm for 5 minutes. 
This process was repeated 3 times. The volume of the final pellet was then 
estimated and resuspended in an equal volume of distilled water and the suspension 
stored at 4°C.
2.6.11.11 Determination of DNA concentration.
Method I:
Serial 1:1 dilutions were prepared by mixing 5 jj.1 o f DNA sample with 5 pi o f TE 
buffer. After addition of 1 pi of bromophenol blue dye, 5 pi o f each dilution was 
loaded onto a 0.7% agarose gel. In the same way dilutions of DNA (of known 
concentration and similar size) were prepared and loaded onto the same gel. 
Electrophoresis was performed at 100 V for 20 minutes. The gel was then stained 
with ethidium bromide and destained in H20 . The concentration o f the sample 
DNA was estimated by comparing the intensity o f fluorescence of the samples with 
that of the standard DNA samples.
Method II:
Alternatively, the concentration of DNA in any given preparation was measured by 
absorbance spectrophotometry. A 5 pi aliquot was taken diluted in 1 ml of TE, 
decanted into a quartz cuvette and the absorbance read on a UV spectrophotometer 
(Unicam 8625, UVWis Spectrometer). The absorbance of a DNA solution was
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determined at 260 and 280 nm using an absorption coefficient of 50 (.ig/ml = 1 
OD260 unit for double-stranded DNA and 40 p-g/tnl for single-stranded DNA. The 
method is subject to interference by RNA and protein and an assessment of the 
purity of the sample can be gauged from the OD26o / OD28o ratios.
2.6.12 SOUTHERN BLOTTING - TRANSFER OF DNA TO 
NITROCELLULOSE FILTERS
This procedure described by Southern (1975) results in the transfer of 
electrophoresed DNA from an agarose gel to a nitrocellulose filter, thereby 
allowing the long term storage of the DNA and its subsequent analysis using 
hybridisation to a labelled probe. After electrophoresis, the gel was visualised and 
photographed. When the fragments o f interest were larger than 10 kb, the gel was 
placed in depurination solution (0.25 M HC1) and gently agitated at room 
temperature for 10 minutes or until the bromophenol blue turned yellow. The gel 
was then rinsed well with distilled H20  and incubated in several volumes of 
denaturing solution (section 2.4.14.2) with agitation for 1 hour. The denaturing 
solution was decanted and the gel was soaked for 1 hour in neutralising solution 
(section 2.4.14.3), with constant shaking. At this stage the pH of the gel was below 
8.5. The transfer took place using either the standard procedure or a modified 
bidirectional method involving two nitrocellulose filters.
For the standard Southern blot, a piece of nitrocellulose (Schliecher and Schnell) 
slightly larger than the gel was floated on the surface of 2X SSC for 5 minutes and 
then submerged for a further five minutes. This ensures even wetting o f the 
nitrocellulose, eliminating air bubbles. The gel was placed on a 3 MM Whatman 
filter paper wick, the ends of which were in contact with 20X SSC (section 
2.4.14.4). The wet nitrocellulose was laid carefully on the gel and the air bubbles 
removed by rolling a glass test tube over the surface. Two pieces of filter paper 
soaked in 2X SSC were placed on top of the nitrocellulose and the stack (5-8 cm 
high) built up with paper towels. A weight was placed on top to aid the transfer. 
Parafilm was used to prevent the towels coming in contact with the gel or 20X SSC, 
thereby preventing the liquid bypassing the nitrocellulose.
The bidirectional blotting procedure was essentially the same except the gel was 
sandwiched between two nitrocellulose filters and four 3MM Whatman filter papers
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soaked in 20X SSC with towels on either side. There was no need for a wick or 
reservoir of 20X SSC in this method. During the first 2 hours of transfer, the gel 
stack was inverted every 30 minutes to ensure even transfer. The wet towels were 
also removed and replaced with dry ones.
After the overnight transfer of DNA to nitrocellulose with either procedure, the 
towels and filter paper were removed and the position of the wells were marked on 
the nitrocellulose. The nitrocellulose filters were then washed in 6X SSC to remove 
any fragments of agarose, air dried for 1 hour and baked between two pieces of 
filter paper for 2 hours at 80°C. Routinely the filters were stored at room 
temperature sealed in plastic.
2.6.13 SOUTHERN TRANSFER OF PULSE-FIELD GEL 
ELECTROPHORESIS GELS
2.6.13.1 Alkaline transfer protocol.
Alkaline transfer was not recommended for use with Schliecher & Schnell 
nitrocellulose membrane as this membrane is not suitable. Instead BioTrace PVDF 
(GelmanSciences) was used. This is a hydrophobic microporous polyvinylidene 
fluoride membrane that binds biomolecules with high affinity. This membrane has 
high resistance to discoloration upon exposure to basic solutions and it possesses 
high mechanical strength. Due to the hydrophobic nature of PVDF, the membrane 
does not wet out in aqueous solutions, therefore the membrane was wet out by 
lowering into a container of 80 - 100% ethanol. The membrane should change from 
white to translucent almost immediately. The membrane was agitated in the alcohol 
solution for a few minutes to ensure complete wetting. The alcohol was rinsed from 
the membrane with several changes of distilled water prior to equilibrating in 
transfer buffer.
The pulse-field gel was stained with 1 fjg/ml EtBr for 20 minutes and destained in 
distilled water for a further 20 minutes. While photographing the gel, minimising 
the exposure to UV light was essential. The gel was then immersed in 0.25 M HC1 
at 30°C for 5 minutes. Neutralisation of the gel took place in 0.5 M Tris, pH 7.0 for
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30 minutes at room temperature, with gentle shaking. Transfer of DNA onto the 
PVDF membrane took place using 0.4 N NaOH, 1.5 M NaCl as transfer buffer. The 
blot was set up as for a Southern, and transfer was allowed to take place for 24 
hours. After transfer the membrane was neutralised in 0.5 M Tris, pH 7.0 for 5 
minutes, followed by rinsing briefly in 2 X SSC. The membrane was blotted dry 
and baked at 80°C for 1 hour.
2.6.14 NORTHERN BLOTTING - TRANSFER OF RNA TO 
NITROCELLULOSE FILTERS
This procedure differs slightly to the Southern blot procedure for DNA transfer. 
Electrophoresis was carried out as described (section 2.10.2) Electrophoresis and 
transfer to nitrocellulose were carried out sequentially, as it is not recommended to 
leave a time interval between carrying out these procedures. Being single-stranded, 
native RNA molecules are capable of binding to nitrocellulose filters. However, in 
order to transfer efficiently from agarose, a denaturing step is recommended. 
Following electrophoresis the gel was washed several times in DEPC treated 
H 2O (section 2.4.10.2) then soaked in 0.05 N NaOH to partially hydrolyse the 
RNA for 20 minutes. The gel was then rinsed in DEPC treated H2O and soaked in 
20X SSC (section 2.4.14.4) for 45 minutes. The nitrocellulose was placed in DEPC 
treated H20  for 1 minute and then in20X SSC for 5-10 minutes. The gel was 
blotted either one way or bidirectionally as described for Southern blotting. The 
following day, the wells were marked and the filters were baked at 80°C for 2 
hours. The blots were stored dry at room temperature.
2.6.15 RNA TRANSCRIPTION IN  VITRO; PREPARATION OF 
RIBOPROBES
(Promegas ’ RiboprobeR in vitro transcription system)
2.6.15.1 DNA template preparation.
The vector (pGEM-7Zf with insert) was linearised with a suitable restriction 
endonuclease (i.e. any restriction endonuclease which does not generate a 3 ’ 
overhang, if restriction endonuclease does leave a 3’ overhang it must be converted
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to a blunt end using the 3’ - 5’ exonuclease activity of DNA polymerase 1 Large 
(Klenow fragment, see section 2.6.11.2). Following restriction digestion, the 
linearised plasmid was extracted with phenolxhloroform before using the DNA for 
in vitro transcription reactions.
2.6.15.2 Synthesis of high specific activity radio labelled RNA probes.
NOTE: Throughout these procedures precautions should be taken to protect 
against ribonuclease contamination.
Standard transcription protocol 
Transcription Optimised 5X Buffer
(contains 10 mM spermidine,supplied with kit) 4 )il
DTT (100 mM) 2 pi
Recombinant RNasin Ribonuclease inhibitor (supplied in kit) 20 units 
ATP, GTP and UTP (2.5 mM each)
(prepared by mixing 1 volume deionised water with 1 volume 
of each of the 10 mM ATP, GTP and UTP stocks supplied) 4 pi
100 pM C IP (diluted from stock) 2.4 pi
linearised template DNA
(0.2 - 20 mg/ml in water or TE buffer) 1 pi
r 32P]CIP (50 pCi at 10 faCi/fj.1) 5pl
SP6, T7 or T3 polymerase 15-20 units
20 pi
Note: The mixture was kept at room temperature during the addition of each 
successive component. Since DNA can precipitate in the presence of spermidine if 
kept at 4°C.
The above reaction was then incubated at 37 - 40°C for 1 hour.
2.6.15.3 Removal of the DNA template following transcription.
RNase free DNase (supplied with Promegas ’ RiboprobeR in vitro transcription 
system kit) was added to a give a final concentration of lunit /pg. The reaction was 
allowed to proceed for 15 minutes at 37°C. After this the reaction was extracted
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with 1 volume of TE saturated phenol:chloroform (pH 4.5), then vortexed for I 
minute and centrifuged at 12,000 rpm for 2 minutes. The upper aqueous phase was 
transferred to a fresh tube and 1 volume of chloroform:isoamylacohol (24:1) was 
added. The contents o f the tube were once again vortexed for 1 minute followed by 
centrifugation at 12,000 rpm for 2 minutes. The upper aqueous phase was 
transferred to a fresh tube and 0.5 volumes of 7.5 M ammonium acetate and 2.5 
volumes of 100% ethanol were added. The contents of the tube were mixed and 
placed at -70°C for 30 minutes or at -20°C for a minimum of 2 hours. Following 
centrifugation (20 minutes), the supernatant was carefully removed and the pellet 
washed with 70% ethanol. The pellet was dried and resuspended in 10-20 |il of TE 
buffer or water.
2.6.16 PREPARATION OF RADIOACTIVE LABELLED DNA PROBE
Random primer labelling of probe DNA was performed using the Promega “Prime 
a gene” kit, based on the method developed byFeinberg and Vogelstein (1983). 25 
ng o f DNA was linearised and denatured by heating to 100°C for 5 minutes, then 
immediately transferred to ice. The reaction (50 jal, total volume) included the 
following:
5X Klenow buffer 10 |il
Mixture o f 3 unlabelled dNTPs (500 |oM) 2 jj.1
Denatured linear DNA template 25 ng
Acetjdated BSA (1 mg/ml) 2 jal
[32P] dATP (3,000 Ci/mM) 5 jil
Klenow polymerase 5 units
The components were mixed gently and the reaction tube incubated at room 
temperature for 1 hour. The reaction was terminated by heating to 100°C for 2 
minutes, then chilled on ice. 2 (j.1 of 0.5 M EDTA was added and the labelled, 
denatured probe DNA was used directly for hybridisation to nitrocellulose filters.
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2.6.17 PREPARATION OF NON-RADIOACTIVE LABELLED DNA 
PROBES DIG DNA labelling
(Boehringer Mannheim Biochemica).
This procedure involved the labelling of DNA by random primed incorporation of 
digoxygenin labelled deoxyuridine triphosphate. The steroid hapten digoxygenin is 
linked to the dUTP molecule via a spacer arm. Following hybridisation, the target 
DNA hybrids were detected with colourimetric or chemiluminescent alkaline 
phosphatase substrates by an enzyme linked immunoassay. If a colourimetric 
substrate was used, the signal develops directly on the membrane. The colour 
precipitate starts to form within a few minutes and the reaction is usually complete 
after 12 hours. The signal was detected on X-ray film (as with 32P) when a 
chemiluminescent substrate was used. Exposure times in this case are typically in 
the range of 15-30 minutes. This procedure allows the efficient labelling of small 
(10 ng) and large (up to 3 pg) amounts of DNA. Linearised DNA labels more 
efficiently than circular. The DNA must be thoroughly heat denatured prior to 
labelling.
100 ng of DNA was routinely linearised and denatured and the following 
components were added to a sterile microcentrifuge tube;
The components were mixed gently and incubated at 37°C for at least 1 hour. The 
reaction was quenched by addition of 2 pi EDTA (0.2 mol/1) and the labelled DNA 
precipitated by addition o f 2.5 pi LiCl (4 mol/1) and 75 pi ethanol (-20°C). The 
mixture was left to stand at -20°C for 2 hours or 30 minutes at -70°C. The DNA was 
pelleted by centrifugation at 12,000 rpm for 10 minutes, washed with 70% ethanol,
freshly denatured probe DNA 
hexanucleotide mixture 
dNTP labelling mix
(containing dATP,dCTP,dGTP,(l mMol/L);dTTP 
(0.65 mMol/L); DIG-dUTP (0.35 mMol/L) 
Klenow polymerase (2 units/ pi)
2 pi 
2 pi
100 ng
lpl
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dried under vacuum  and dissolved in 50 p.1 T E  buffer. Labelled D N A  could be 
stored at -20°C  or used directly for hybridisation to nitrocellulose filters.
2.6.18 HYBRIDISATION USING THE HYBAID HYBRIDISATION
OVEN
The hybaid roller bottles (200 ml) were placed in an Hybaid hybridisation oven and 
allowed to warm up (approximately 1 hour). A piece of support mesh appropriate 
for the size of the membrane was then selected. The mesh and nitrocellulose filter 
were pre-wetted in a suitable tray containing 2 X SSC. After ensuring that the 
hybridisation membrane exactly overlaid the mesh, both were rolled up into a tight 
roll. The roll was inserted into a hybridisation bottle in a way such that the leading 
edge (inside the roll) and the trailing edge are positioned relative to each other. The 
bottle was placed on a flat surface and the mesh and membrane were slowly 
unwound around the inside of the bottle by rocking and gently rolling the bottle 
along the surface of the bench. No air bubbles should be visible between the 
membrane and the bottle. If bubbles were found to be present, the membrane was 
removed and re-rolled. The mesh ensured that the probe had access to all parts of 
the hybridisation membrane, including those parts of the membrane which overlap.
2.6.18.1 Pre-hybridisation.
Once the membrane was placed in the bottle the 2X SSC was discarded and 
replaced with pre-hybridisation fluid (0.2 ml/cm2 o f nitrocellulose filter) or 10 - 20 
ml of solution was recommended for the 200 ml bottle size used. Higher volumes 
were required when there was more than one membrane in the bottle. The bottle 
was placed in the hybridisation oven, the rotisserie switched on and 
prehybridisation was allowed to proceed for between 1 -4  hours at 68°C (or at 42°C 
for Northern blots when the hybridisation solution contained formamide).
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2.6.18.2 Hybridisation and washing conditions when using a 
radioactively labelled probe.
After pre-hybridisation, the fluid was replaced with hybridisation solution (50 
(il/cm2 filter) containing the 32P-labelled denatured probe. The bottle was again 
incubated at 68°C with constant rolling for 16 - 20 hours. Following hybridisation, 
the radiolabelled probe was poured into a radioactive waste container and the blot 
was then washed according to the blot type.
For a Southern blot probed with homologous DNA the washes were as follows;
2X SSC/0.5 % SDS at room temperature for 5 minutes,
2X SSC/0.1% SDS at room temperature for 15 minutes,
0.1X SSC/0.5% SDS at 68°C for 2 hours,
0.1X SSC/0.5% SDS at 68°C for 30 minutes
For a Northern blot probed with a radioactively labelled probe, the washing 
conditions were;
IX SSC/0.1% SDS, twice at room temperature for 15 minutes each,
0.2X SSC/0.1% SDS, three times at 68°C for 15 minutes each time.
The wash solutions were pre-warmed and the bottles were half-filled 
(approximately 100 mis) with these solutions. Note that washing with solutions 
which are not pre-warmed may result in background problems. The blots were air 
dried after washing and those probed with a radioactively labelled probe were 
placed into heat sealable bags. Exposure to autoradiography film was carried out in 
light proof cassettes for between 24 hours and one month, depending on the 
strength of the signal, after which the film was developed as described in section 
2 . 12.
2.6.18.3 Hybridisation and washing conditions using a non- 
radioactively labelled probe.
3.5 ml o f hybridisation solution was required for a blot of 10 x 10 cm containing a 
probe concentration o f 5 - 25 ng/ml which had to be denatured prior to addition.
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Hybridisation was allowed to proceed for 16 - 20 hours at 68°C or at 42°C for 
hybridisation solutions containing formamide. Following hybridisation the solution 
was poured off and washed. For either a Southern and Northern blot probed with a 
DIGoxygenin -labelled probe, the washing conditions were as follows;
2X SSC/0.1% SDS, twice at room temperature for 5 minutes each,
0.5X SSC/0.1% SDS twice at 68°C, for 15 minutes each
2.6.18.4 Detection of non-radioactively labelled probe.
The filters were washed briefly in buffer I (section 2.4.16.3) before incubating for 
30 minutes in buffer II (blocking solution, section 2.4.16.5). The filter was 
incubated for a further 30 minutes in buffer n. The filter was then incubated for a 
further 30 minutes in 20 ml of diluted antibody i.e. 1/5000 dilution or 150 mU/ml of 
anti-digoxygenin AP conjugate. Unbound antibody conjugate was removed by 
washing for 2 x 15 minutes with 100 ml buffer I. The filter was equilibrated for 2 
minutes in 20 ml of buffer HI (section 2.4.16.7). For colour development, the filter 
was incubated in 10 ml colour solution in the dark until band formation one hour to 
twenty-four hours later. The reaction was stopped by washing the filter in buffer IV 
(section 2.4.16.8) for 5 minutes.
2.6.18.5 Chemiluminescent detection of non-radioactively labelled 
probe.
After hybridisation and post-hybridisation washes, the membrane was equilibrated 
in washing buffer (section 2.4.16.6) for 1 minute. The chemiluminescent substrate 
was allowed to come to room temperature. Using a freshly washed dish the 
membrane was blocked by gently agitating it in blocking solution (section 2.4.16.4) 
for 30 - 60 minutes. The antibody conjugate was then diluted 1:10,000 in blocking 
solution. The blocking solution was poured off and the membrane was incubated 
for 30 minutes in the antibody containing solution. After this, the membrane was 
washed gently twice, 15 minutes per wash in washing buffer (section 2.4.16.6). The 
washing buffer was then poured off and the membrane was equilibrated in detection 
buffer (Buffer HI, section 2.4.16.7) for 2 minutes. The chemiluminescent substrate
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CSPD1 M was diluted 1:100 in detection buffer. It is important that the filter is kept 
wet before the chemiluminescent substrate is added to avoid high backgrounds. The 
membrane was placed between two sheets of acetate (plastic page protectors). The 
top sheet of plastic was lifted gently, and with a sterile pipette, approximately 0.5 
ml (per 100 cm2) of the chemiluminescent substrate was added to the top of the 
membrane by scattering drops all over the surface o f the membrane. The top sheet 
of plastic was then lowered and with a damp lab tissue the top sheet was wiped to 
remove any bubbles present under the sheet and to create a liquid seal around the 
membrane. The blot was then incubated at 37°C for 15 minutes before exposure to 
X-ray film. (Note - it is advisable to use a nylon membrane when using a 
chemiluminescent substrate).
2.6.19 POLYMERASE CHAIN REACTION (PCR)
A Hybaid Omnigene Thermal cycler, fitted with a 48 well heating block taking 0.5 
ml tubes was used for all PCR reactions. The reactions were set up in the laminar 
air flow, under sterile conditions, and the target DNA was added last to each 
microcentrifuge tube to prevent cross contamination. The oligos and dNTPs were 
kept on ice at all times. A typical PCR reaction was set up as follows:
Primers (50 |oM stock) 1 filX 2
dNTPs (500 (4M stock) 2 (4.1
10X buffer 5 (jl
MgCk (25 mM stock) 3(41
Target DNA 1 (il
h 2o 36 nl
Taq Polymerase 5 units
The tube contents were mixed, centrifuged briefly and overlaid with 60 j_il of sterile 
mineral oil. Following the PCR reaction a 5 p.1 sample was examined on an agarose 
gel (usually 0.7%) and the tubes stored at 4°C.
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2.7 CURING S. CEREVIS1AE OF PLASMID DNA
In order to cure yeast cells of plasmid DNA the strains were grown up in YEPD for 
2 days and then replica plated onto YEPD and selective media. The colonies which 
grew on YEPD and not on selective media were considered cured.
2.8 CELL ENUMERATION
Total yeast cell counts were performed using a Neubauer haemocytometer. All 
counts were performed in duplicate. Standard curves of cell number versus ODsoo 
were constructed for cells in YEPD and selective medium. Theses standard curves 
were used to estimate the number of cells per ml in a culture by simply reading the 
ODgoo-
2.9 PLASMID STABILITY STUDIES
Strains were inoculated into 5 ml selective media lacking the amino acid used for 
selection and grown to stationary phase. The cell number was determined by direct 
cell counting and 106 cells were inoculated into 100 ml YEPD. After overnight 
incubation at 30°C the cell counting and inoculation were repeated, this procedure 
was followed for up to 7 days. The number of generations per day was between 9 
and 11. Each day after the cell count had been determined suitable dilutions were 
plated onto YEPD plates in duplicate. After 2 days at 30°C 100 colonies from the 
YEPD plates were replica plated onto YEPD and selective media. The percentage 
of colonies retaining plasmid (percentage plasmid stability) was determined from 
the ratio of the number o f colonies growing on the minimal media plate, compared 
to the YEPD plate.
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2.10 ELECTROPHORESIS
2.10.1 ELECTROPHORESIS AND VISUALISATION OF DNA
Agarose (0.7% w/v) in TAE was routinely used for the analysis of plasmid and 
chromosomal DNA. Mini-gels, used for analysis of plasmid DNA preparations, were 
run at 100V in IX TAE buffer on a gel box system for approximately 1 hour, while 
total (genomic) DNA digests were run at 40V on a gel box for 14-16 hours. A 
concentration of 6X bromophenol blue dye (see section 2.4.5.3) was added to samples 
before loading. Gels were stained in EtBr (5 fig/ml) for 20 minutes, destained in H20  
for 5 minutes and the DNA was visualised using UV transillumination with the aid of a 
UVP UV transilluminator.
2.10.2 FORMALDEHYDE GEL ELECTROPHORESIS AND 
VISUALISATION OF RNA
RNA molecules were separated on formaldehyde gels before blotting onto 
nitrocellulose. All manipulations o f agarose gels containing formaldehyde were 
carried out in the fume cupboard.
2.10.2.1 Preparation of Formaldehyde gel.
For a 200 ml gel (1.2%), 2.4g of agarose was boiled in 144 ml DEPC treated H2O 
and allowed to cool to 60°C. 40 ml 5X formaldehyde buffer (section 2.4.5.4) and 36 
ml 37% formaldehyde were added and the gel allowed to set at room temperature.
2.10.2.2 Preparation of RNA samples for loading.
For a total sample volume of 20 pi, 4 pi 5X formaldehyde buffer, 5 pi deionised 
formamide, 2 pi 37% formaldehyde and 1 pi ethidium bromide (1 mg/ml) were 
mixed in a microcentrifuge tube. Up to 8 pg o f RNA was added. A separate sample 
containing 4 pi 5X bromophenol blue and 4 pi H20  and no RNA was also prepared 
as a marker for running the gel. The samples were heated to 65°C for 10 minutes
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before loading. Before running the gel, the electrophoresis tank was thoroughly 
rinsed w ith D EPC  treated H2 O. dried w ith ethanol and then filled with IX 
Form aldehyde running buffer. T he gel was run  at 3V /cm 2 in IX  form aldehyde 
buffer for 4 -6  hours until the dye had reached halfw ay dow n the gel. The gel w as 
rinsed several tim es in D E PC  treated  H 2 O  to  rem ove the form aldehyde and the 
rem ainder o f  the p rocedure  w as carried o u t on  the  bench.
2.10.3 GEL PREPARATION AND ELECTROPHORESIS CONDITIONS 
FOR PULSE-FIELD
The 1% gel was prepared using BioRad Ultra-pure DNA Grade certified agarose 
(catalogue no. 162-0133, Molecular Biology certified agarose) dissolved in 0.5X 
TBE. The running conditions consisted o f a 60 second pulse for 15 hours followed 
by a 90 second pulse for 9 hours at 6V/cm, a temperature of 14°C and a pulse angle 
of 120°
2.11 PHOTOGRAPHY
Photographs were taken using an Olympus OM-20 camera and T-Max 100 black 
and white film (Kodak). An A003 red filter (Corkin, France) was used to block UV 
light when necessary, and also close-up lenses (Vivitar) were fitted when required. 
Negatives were developed using a 35 mm Film Tank (Photax), the reel of film 
being loaded onto the spool and placed in the tank in darkness, 250 ml of D76 
(Kodak) developer was added. Air bubbles were removed by tapping a few times 
off the bench. After the required development time (temperature dependent), the 
developer was poured out, the tank rinsed with tap water and 250 ml Unifix (1/3 in 
H2O, Kodak) were added. When completely fixed, usually after 10 minutes, the 
negatives were rinsed for at least one hour in tap water and then air dried. Prints 
were later made onto Kodak Kodabrome II RC F4 high contrast paper using an 
enlarger (darkroom), developed with Polymax (Kodak) and fixed also with Unifix 
fixer. After rinsing thoroughly in tap water, the prints were dried.
Photographs were also taken using an image analyser, UVP ImageStore 7,500. The 
photographs were then printed on a Sony Video Graphic printer UP-860CE.
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2.12 X-RA Y FILM DEVELOPMENT
In the darkroom with a red filter (GBX-2 safelight, Kodak), the film was marked by 
inserting a few holes in the blots and film to aid orientation. The film was placed in 
Kodak developer LX24 (1:4) for 5 minutes, washed in water briefly and fixed in 
Kodak Fixer LX20 (1:4) for 5 minutes until clearing occurred. The film was 
washed in tap water and dried. Kodak Min-RE film (blue, 18x24cm) was used 
routinely for radioactive blots.
2.13 ASSAYS FOR MEASUREMENT OF a-AMYLASE ACTIVITY
2.13.1 PLATE ASSAYS FOR DETECTING a-AMYLASE ACTIVITY
In order to visualise a-amylase activity on plates, amylase secreting strains of E. 
coli and S. cerevisiae were grown up on either LB, YEPD or minimal medium, 
whichever was appropriate, supplemented with 2% Lintners starch. The amylase 
activity was visualised by incubating the plates at 4°C for 24 hours, after which the 
undegraded starch had precipitated leaving clear haloes corresponding to areas of 
amylase activity.
Alternatively, the plates were inverted over iodine crystals for 60 seconds. Areas 
where the starch had been hydrolysed appeared as clear haloes on a dark blue 
background.
2.13.2 DNS ASSAY FOR MEASURING a-AMYLASE ACTIVITY
In order to ensure accurate quantitation of enzyme activity in cell supernatants, it is 
necessary to remove all remaining glucose in the growth media, prior to assaying. 
This was achieved by dialysis. Dialysis removes the sugars effectively without loss 
of enzyme. Samples o f supernatant (2.0-5.0 ml volumes) were placed in the 
preprepared dialysis tubing (section 2.13.2.1) and sealed with dialysis tubing clips, 
to ensure minimal volume increase during dialysis, the samples were pressurised 
into the smallest amount o f tubing then dialysed against IX PBS at 4°C for 12 - 16 
hours. The buffer was changed at least 3 times during that period.
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T he fo llow in g  reaction m ix  w as set up in a test tube:
0.1 M Sodium phosphate buffer, pH 6.9 
1 % Lintners starch 
0.5 M NaCl 0.2 ml
1.0 ml
1.0 ml
The reaction mix was preincubated at 93°C for 10 minutes. 0.5 ml of culture 
supernatant (diluted as necessary) was then added to the reaction mix and mixed 
thoroughly by vortexing. The reaction was incubated for 30 minutes at 93°C. 1 ml 
of DNS solution (section 2.4.3) was then added to the tube and the reaction was 
boiled for 15 minutes, allowed to cool, and the OD measured at 640 nm. One unit 
of enzyme activity was defined as that amount o f enzyme producing 0.15 jimol of 
reducing sugar in 30 minutes in the standard assay.
2.13.2.1 Preparation of dialysis tubing.
The dialysis tubing was boiled in 10 mM EDTA for 10 minutes, to regulate the pore 
size, then boiled in distilled water for a further 10 minutes. The tubing can be stored 
in distilled water at 4°C. Gloves must be worn when handling.
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CH APTER  3
Introduction to Results
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3. Introduction to results
Since 1953, much effort has gone into unravelling the complexities of
how genetic information is expressed - in particular, how gene expression is 
controlled. Initially the focus was on simpler organisms, with the long term goal 
of being able to understand all the complexities o f the human body. Ultimately, 
equipped with such knowledge, together with the aid of current molecular 
genetic techniques it should be within our reach to control or correct things when 
they go wrong. Although it might be a long way off from understanding the 
complexities o f an organ like the human brain, this simple single-celled 
eukaryote, Saccharomyces cerevisiae, has been invaluable in the understanding 
of many complex pathways, such as cell cycle control. With the development of 
a method for transforming S. cerevisiae cells in 1979, a range of techniques were 
developed which have enabled us to dissect many of the complexities o f this 
simple organism. By the early eighties, this had opened a whole new approach to 
regulating individual genes - namely antisense technology, and more specific to 
this project, “antisense RNA technology”.
The basis o f this technology is the production o f an RNA strand with a 
nucleotide sequence that is complementary to a particular mRNA. The regulation 
of gene expression by this nucleic acid sequence is thought to depend on the 
formation o f a hybrid duplex between the sense mRNA sequence - the one that 
bears the genetic information - and the complementary one, the so-called 
antisense sequence. The formation of this sense-antisense duplex is thought to 
interfere with protein synthesis at the ribosome. This type of inhibition o f gene 
expression seems to be highly specific. Therefore this mode of regulation may be 
considered for any gene whose sequence is known. The simplicity, specificity 
and elegance o f this technique make it an extremely attractive one.
The work presented in the following chapters describes the development 
and use o f  a reporter system to explore the possibility of using antisense 
technology as a general mechanism for controlling gene expression in the yeast 
S. cerevisiae. It was hoped that the results o f such a study might be useful if one 
was to consider applying such an approach to control the growth o f pathogenic 
yeasts such as Candida. S. cerevisiae serves as an attractive host for the 
development of this model system as it is well characterised genetically and is
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amenable to sophisticated molecular genetic manipulations such as precise gene 
replacement/exchange within individual specified chromosomes (Botstein and 
Fink, 1988). In addition to having the advantage associated with being 
unicellular and having a rapid cell division cycle, it is a eukaryote and has been 
clearly shown to regulate cellular processes (such as cell cycle, signal recognition 
from the environment and intracellular protein targeting) in a manner similar to 
that of higher eukaryotes. Lastly, with the complete sequence data now available 
for S. cerevisiae, this can only serve to shed more light both on the variety of 
mechanisms this organism uses naturally to regulate its’ own genetic 
information, and in turn on what possibilities are likely to be realistic approaches 
to regulating gene expression from without.
The experiments described in this thesis were designed to test whether 
antisense could be used to regulate gene expression in S. cerevisiae, as has been 
shown to operate in a range of plant and animal cells. The a-amylase gene was 
chosen as the reporter gene. Although S. cerevisiae has no endogenous a- 
amylase activity, this gene has been successfully cloned from Bacillus 
licheniformis (Yukki et al., 1985) into S. cerevisiae and all detectable a-amylase 
activity is found in the supernatant; a feature which simplifies the analysis o f  the 
product produced. Several convenient assays are available for monitoring a- 
amylase activity, including a simple plate assay which can be used for screening 
a large number o f samples.
When this work began there were surprisingly very few reported cases of 
this type o f control in S. cerevisiae compared with other cell systems (Atkins et 
al., 1994). Since S. cerevisiae was fast being developed as the model eukaryote 
expected to shed light on a great variety o f other cellular processes, it seemed 
important and worthwhile to investigate this further. When starting this work, my 
initial goal was to create hybrid yeast cells which contained the a-amylase gene 
on an expression cassette together with this gene (or part of) in an antisense 
construct, in such a way so that when the two cassettes were being expressed 
simultaneously, a much higher proportion o f antisense transcripts would be 
produced.
The work presented can be divided into two sections; the first describes 
what I have chosen to call trans expression systems, the second, cis expression
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systems. A trans experimental system is one in which the sense and antisense 
genes are transcribed from different transcriptional units. In this thesis the trans 
expression systems are divided into 7>a«.v-Experiment t and II, /ram--Experiment 
I being further subdivided into (a), (b) and (c). In contrast to the trans expression 
systems, in the cis experimental systems, both genes are transcribed from the 
same transcriptional unit, resulting in a single fusion transcript. These expression 
cassettes are located either episomally (cw-Experiment (a)) or chromosomally 
(cis-Experiment (b)).
7><mv-Experiment I (a) involved the construction of a yeast strain in 
which the a-amylase gene, under the transcriptional control of the AdHl 
promoter, was integrated into the yeast genome in low copy number. The 
dihybrid strain was obtained by the introduction of a full-length episomal 
antisense gene in higher copy number than the integrated a-amylase gene (Figure 
3.1). This antisense fragment was required to work in trans to reduce a-amylase 
gene expression. Although both RNAs were being made by the cell, and there 
was an excess of anti-mRNA to mRNA, no downregulation of a-amylase gene 
expression was observed.
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Figure 3.1 Schematic representation o f Trans-Experiment I (a) with the sense a- 
amylase gene being chromosomally transcribed and the antisense gene being 
episomally transcribed.
The result obtained from trans I (a), lead to the design of trans- 
Experiment I (b), (Figure 3.2), where the aim was to improve the ratio of 
antisense to sense mRNA. This design sought to integrate the entire antisense a- 
amylase gene in multiple copies into the yeasts’ ribosomal RNA (rRNA). This 
region o f the genome was chosen as it contains 140 tandem repeats of a 9.1 kb 
rDNA unit. According to Lopes et al., (1989) who designed a vector for 
integrating DNA fragments into the rDNA locus of S. cerevisiae, it is possible to 
integrate up to 140 copies o f the vector which are stably maintained over long 
periods of growth under non-selective conditions. It was hoped therefore, that by 
integrating the entire antisense a-amylase gene under the control of the 
constitutive AdHI promoter, that the copy number and hence the amount o f anti­
message being made, would be in far greater excess than the mRNA being 
produced from the sense a-amylase gene, which was cloned into an ARS-CEN 
vector. ARS-CEN vectors are present in only 1 - 2 copies per cell and once again 
the sense a-amylase gene was under the control of the AdHI promoter to ensure
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temporal coincidence of the two RNAs. Activity assays however, demonstrated 
no downregulation or ablation o f a-amylase gene expression. Northern blot 
analysis revealed that no anti-mRNA was being produced in these constructs; 
only sense a-amylase mRNA was detected. In some systems where antisense 
RNA is successful in downregulating or ablating the expression o f a particular 
gene it has sometimes been the case that no anti-mRNA could be detected in the 
cell.
Figure 3.2 Schematic representation o f 7ram-Experiment I (b) with integration 
o f the antisense gene into the rDNA o f chromosome XII, the sense gene being 
expressed episomally.
Perhaps the absence o f antisense activity in trans I (a) and (b) was caused 
by a poor interaction o f the antisense RNA with the sense RNA. This poor 
interaction may be due to either different locations of the antisense and sense 
transcripts within the cell, and/or intramolecular secondary structures, present 
within one or both of the interacting RNAs, which may have precluded efficient 
interactions. According to Nellen and Lichtenstein (1997), the difficulty with 
intramolecular secondary structures can sometimes be overcome by using a
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different part of the target gene for the antisense construct. This idea lead to the 
design of trans I (c) (Figure 3.3), where antisense genes targeting certain regions 
of the a-amylase gene were constructed. These antisense a-amylase sequences 
were directed to the 5’ binding site o f the a-amylase gene, to the coding regions, 
and the 3 ’ end of the gene. Each of these constructs was introduced on a higher 
copy number plasmid, into an integrated sense a-amylase yeast strain (which 
was constructed in trans I (a)). Similarly, to tram I (a), although both sense and 
antisense transcripts were being made by the cell, and there was a slight excess 
of antisense to sense RNA, no effect on a-amylase activity was noted.
Figure 3.3 Schematic representation o f 7ram’-Experiment I (c) with the sense ex- 
amylase gene being chromosomally transcribed and the antisense genes targeting 
different regions of the sense a-amylase gene being episomally transcribed.
Trans-Experimental system n, designed and described in chapter 5 
(Figure 3.4) sought to once again improve the ratios of anti-mRNA to mRNA, in 
addition to improving the spatial coincidence o f the two RNAs. For two RNAs to 
interact they must be both temporally and spatially coincident. In trans
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experimental systems I, the sense and antisense genes were under the control of 
the same promoter which should ensure temporal coincidence, as indeed it did in 
trans experimental system I (a) and (c) as both sense and antisense RNAs were 
visualised on Northern blots. Spatial coincidence however may have been a 
different matter as the sense and antisense genes were transcribed from different 
locations within the cell i.e. from either a chromosomal or episomal location.
Work carried out by Xing et al., (1993) has postulated that the spatial fate 
o f a mRNA can be correlated with gene location, hence in /nms-experiment II it 
was decided to introduce both the sense and antisense genes into the yeast cell on 
episomes, thereby hoping to ensure spatial coincidence. Once again generation of 
excess antisense RNA to mRNA was an issue. The full-length antisense a- 
amylase gene was cloned into a high copy episomal vector under the control of 
the very powerful and inducible GALl promoter. The sense gene was introduced 
on a 2(4, based episomal plasmid under the control o f the constitutive AdHI 
promoter. A prerequisite for the introduction of both plasmids into the cell was 
that each carry a different selection marker. Temporal coincidence could be 
ensured in this experimental system by the fact that the sense a-amylase gene is 
being constitutively expressed. Following the addition of galactose to the media 
the GALl promoter is switched on with subsequent expression of the antisense 
a-amylase gene. An excess of anti-mRNA to mRNA was achieved in this 
experimental system and activity assays showed a small but significant reduction 
in a-amylase activity.
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Figure 3.4 Schematic representation of 7ra«.s-Experiment n  where both sense 
and antisense genes are episomally transcribed.
Finally, temporal and spatial coincidence were the major consideration in 
the design o f the cw-Experimental systems (a) and (b) (Figure 3.5). The approach 
adopted in these systems involved the cloning into a single expression unit part 
of the a-amylase gene - in antisense orientation - fused to the 3' end o f the 
complete gene. This sense-antisense a-amylase gene sequence was placed under 
the control o f the AdHl promoter. This expression cassette was cloned into both a 
yeast episomal (cw-Experiment (a)) and yeast integrating vector (c/'s-Experiment 
(b)) to examine whether the location of the transcriptional unit would alter the 
outcome. In contrast to all of the tram systems described, where little or no 
effect on a-amylase activity was observed, using this cis configuration 100% 
inhibition was achieved - irrespective of the location of the transcriptional unit.
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Figure 3.5 Schematic representation o f the c/.s-Experimental systems (a) and (b) 
where the sense and antisense gene were transcribed from either the same 
episomal (cis (a)) or chromosomal (cis (b)) location.
The reasoning behind each o f these experimental systems and their 
outcomes will now be discussed in more detail in chapters 4 to 6. An overall 
discussion and conclusion will be provided in chapter 7.
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CHAPTER 4 
7>a«A-Experiment I (a), (b) and (c)
CjrtopUtm
NucWo»'
I Sense amylase sequences 
I Antisense amylase sequences
P; Plasmid
Chr; Chromosomal location
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4. Introduction
In each of the trans experiments discussed in this thesis the envisaged 
mechanism of action is the interaction of sense and antisense a-amylase RNA 
strands, resulting in the formation of a double-stranded structure. Although the 
sequences o f the sense and antisense RNAs are complementary, the interaction of 
these two molecules is dependent upon the accessibility of these two molecules 
to each other. Taking into consideration that each o f the respective molecules has 
its’ own inherent intramolecular structure and also, each RNA may have its’ own 
collection of bound proteins. Both of these factors will affect the strength of the 
interaction between the sense and antisense RNAs. Therefore, for an interaction 
to take place, the respective intramolecular structures o f the sense and antisense 
RNAs need to be disrupted to allow formation o f this double-stranded 
bimolecular complex, from this, it follows that for conversion o f the target RNA 
molecules into this complexed form, the antisense RNA must be present in 
excess molar concentration (Riesner, 1997). 7raM.s-Experiments I (a) and (b) 
were designed in such a way so as to provide this excess of antisense:sense RNA.
A further consideration concerning the intramolecular structures is that it 
is possible that only certain regions o f the sense RNA will be sufficiently free of 
secondary structure so as to be amenable to hybridization with the antisense 
RNA. Possibly, the lack of an effect on a-amylase activity in trans I (a) was 
caused by poor interaction o f the full-length antisense a-amylase RNA with the 
sense RNA. If indeed intramolecular secondary structures prevented an efficient 
interaction of the sense and antisense RNAs, this problem, it has been 
documented, can sometimes be solved by using a different region of the target 
gene for the antisense construct (Nellen and Lichtenstein, 1997). Trans- 
Experiment I (c) examined this hypothesis by constructing antisense genes to 
target different regions o f the a-amylase gene.
7><mv-Experiments I (a), (b) and (c), were grouped together in this 
chapter because conceptually, all 3 experimental systems possess a similar type 
of trans configuration i.e. if the antisense genes were transcribed from episomes, 
then the sense genes were transcribed from a chromosomal location, or vice 
versa. Furthermore, temporal coincidence was ensured the same way in all of 
these trans experimental systems, by utilizing the same promoter to control
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expression  o f  both  the antisense and sense genes. Finally, underlying each o f  
these experim en ta l  systems was the desire  to crea te  a favourable  ratio o f  
antisense:sense R N A .
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4.1 TRANS-EXPERIM ENT I  (a) - INTRODUCTION
Sometimes it is desirable to achieve a very high plasmid copy number for 
optimal expression o f the cloned gene. In other cases it is important that the 
plasmid copy number is kept low, because either the gene product is deleterious 
to the host organism at elevated intracellular concentrations or as in my case, to 
achieve an optimal antisense:sense mRNA ratio. Ultimately in rraw.?-Experiment 
I (a) the aim was to construct a Saccharomyces cerevisiae strain containing both 
sense and antisense a-amylase sequences under the control of the same 
promoter, AdHI, but on separate transcriptional units. Therefore, assuming a 
similar level o f transcription from each copy o f these a-amylase sequences, one 
might expect an optimum suppression o f translation of the sense transcripts when 
the antisense:sense ratio is high. To achieve this objective the sense a-amylase 
gene was integrated in low copy number into the ura3-52 locus of the yeast strain 
DBY746. The experiment was completed by the introduction of a full-length 
antisense a-amylase gene on a 2p, based yeast episomal vector which has a copy 
number of at least 10 plasmids per cell.
The first half o f tram I (a) describes how the gene was integrated into the 
yeast chromosome, followed by the characterisation of this integration event. The 
integrant most appropriate for the introduction o f the antisense genes had to fulfil 
the following criteria: (I) It must have a reasonably low copy number relative to 
the antisense genes to be introduced into the integrated strain, but (II) it must not 
possess too low a copy number so as to result in an insensitive assay. The 
remainder o f  trans I (a) focuses on the construction and analysis of an antisense 
gene complementary to the entire Bacillus licheniformis a-amylase gene.
4.1.1 CONSTRUCTION OF THE SACCHAROMYCES CEREVISIAE 
STRAIN W ITH  THE SENSE a-AMYLASE GENE LOCATED ON 
CHROMOSOME V
The yeast chosen for this study was Saccharomyces cerevisiae strain 
DBY746. A number o f features associated with this strains’ genetic background 
were important for the successful expression of antisense a-amylase RNA and
135
sense a-amylase RNA. The leu 2-3, leu 2-112 mutations in these cells could be 
complemented by the LEU2 selectable marker located on the YEp-antisense 
plasmids. The ura3-52 mutation served as a region for targeting homologous 
integration of a URA3 gene from an integrating plasmid thus converting the 
strain from uracil auxotrophy to uracil prototrophy. Finally, strain DBY746 is 
[cir+], which means that this strain contains endogenous 2(j. plasmid DNA which 
is essential as this plasmid supplies trans-acting factors required for the 
maintenance and amplification of YEp shuttle vectors in yeast cells and it is 
important for maintaining their episomal state.
Ultimately, I wanted to create a yeast cell expressing both sense and 
antisense a-amylase genes, ideally with the sense gene in lower copy number. 
Therefore I set about to integrate the sense copy of the gene into one of the 
yeasts’ chromosomes. This was achieved by transformation of S. cerevisiae with 
a plasmid, containing the a-amylase gene on an expression vector, that lacks an 
origin o f replication. Integration occurs by recombination between homologous 
regions on the plasmid and the S. cerevisiae genome, producing an integrated 
plasmid. When yeast cells are transformed with a plasmid containing a double­
strand break within sequences homologous to the S. cerevisiae genome, the 
following three consequences have been observed: (1) The plasmid transforms at 
higher frequency, (2) the double-strand ends target the plasmid to integrate at the 
homologous locus in the genome and (3) the gap is repaired from chromosomal 
information during plasmid integration (Orr-Weaver and Szostak, 1983).
It was decided to target integration of the sense a-amylase gene into the 
ura3-52 locus o f  S. cerevisiae yeast strain DBY746 using a low-copy integrative
S. cerevisiae/E. coli shuttle vector. The vector chosen, pFL34 (Appendix I) is 
based on the pUC-19 plasmid, its properties include an origin o f replication for 
E. coli, the ampicillin resistance gene and a large polycloning site, this vector is 
also amenable to P-galactosidase a-complementation which allowed for the fast 
screening of plasmids with a-amylase gene inserts, and most importantly this 
vector contains the yeast selectable marker URA3. See Figure 4.1 for a schematic 
representation o f the probable integration event.
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Figure 4.1 Schematic diagram of the probable integration event.
A partial BamH I fragment (3.9 kb), containing the AdHI promoter, the 
entire a-amylase gene and the AdHI terminator, was cloned into the integrating 
vector pFL34 to yield the plasmid pFAMY (McMahon, 1995; Figure 4.1). The 
URA3 marker on this vector contained a unique Stu I site for linearisation o f the 
plasmid and for directing integration o f the plasmid to the ura3-52 locus o f 
DBY746. This ura3-52 mutation is a non-reverting URA3 mutation which 
resulted from a Ty insertion mutation within the coding region of the URA3 gene, 
(Rose and Winston, 1984). Integration leads to a duplication of the URA3 gene 
and conversion of the strain to uracil prototrophy and it also ensures an identical 
target copy number of a-amylase genes within all test cells.
Before integration of the plasmid pFAMY (McMahon, 1995) into the 
ura3-52 locus o f DBY746, this plasmids’ construction was confirmed by 
restriction enzyme analysis (Figure 4.2). The diagnostic restriction enzymes 
chosen were Hind HI (chosen to prove the presence o f the 1.9 kb a-amylase 
gene) and BamH I (chosen to release the parental vector, pFL34 fragment of 3.8 
kb, a band of 2.35 kb which contains the a-amylase gene and the AdHI 
terminator and a band of 1.55 kb containing the AdHI promoter). The restriction
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enzym es Stu I and E coR I w ere  chosen  to  linearise the plasmid to yield a band
size o f  7 .7 kb.
— 5 0 9 0
— 1018
Figure 4.2 Restriction digests o f the integrating plasmid, pFAMY.
The sizes o f the fragments are shown in base pairs (bp) below.
Lane 1: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072; 3,054;
2,036; 1,636; 1,018; 506 bp)
Lane 2: pFAMY undigested
Lane 3: pFAMY digested with Hind III (5,350; 1,900; 450 bp)
Lane 4: pFAMY digested with BamH I (3,800; 2,350; 1,550 bp)
Lane 5: pFAMY digested with Stu I (7,700 bp)
Lane 6: pFAMY digested with EcoR I (7,700 bp)
Lane 7: pFAMY digested with Sal I (6,480; 1,220 bp)
Lane 8: pFAMY digested with Kpn I (5,560; 2,140 bp)
Lane 9: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072; 3,054; 
2,036; 1,636; 1,018; 506 bp)
Figure 4.2 does indeed confirm the construction of the integrating plasmid 
pFAMY. The Hind III digest (lane 3, Figure 4.2) produced the expected fragment 
sizes o f  5.35, 1.9 and 0.45 kb. The BamH I digest (lane 4, Figure 4.2) also 
produced fragments o f the expected size, these being 3.8, 2.35 and 1.55 kb 
respectively. The Stu I and EcoR I restriction digests (lanes 5 and 6, Figure 4.2)
linearised the plasmid to produce a 7.7 kb fragment. The Sal I and Kpn I digests
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(lanes 7 and 8, Figure 4 .2 )  also p ro d u ced  the expec ted  restriction fragm ents and 
are a further confirm ation  o f  this p la sm ids  construc tion .
Following transformation of S. cerevisiae DBY746 cells with pFAMY 
DNA, integrants were selected for, by plating on selective media supplemented 
with all the amino acids (see section 2.3.6) minus uracil.
4.1.1.1 Characterisation of the integration event.
4.1.1.1.1 Growth on selective plates
Only the transformants which received the URA3 gene from the plasmid 
pFAMY would be capable of growth on uracil minus minimal media. As the 
plasmid, pFAMY does not contain an origin o f replication, growth of 
transformants on media lacking uracil would strongly suggest the presence o f the 
integrated plasmid. As DBY746 is auxotrophic for both uracil and leucine, the 
transformants were plated on minimal media containing only leucine. All ura 
transformants were tested for a-amylase activity by plating on selective media 
containing 2% starch. According to the predicted mechanism o f integration, if 
the ura gene is integrated, one would expect the a-amylase gene also to be 
inserted into the chromosome. As expected all the transformants tested exhibited 
a-amylase activity, as demonstrated by formation o f a clear halo around the 
colonies as a result o f starch degradation (Figure 4.3).
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Figure 4.3 Minimal media plate containing 2% starch showing haloes 
surrounding a-amylase positive clones after flooding the plate with iodine 
vapour.
4.1.1.1.2 Stability o f the Integrated Strains
To examine the mitotic stability o f the ura3-52 integrated exogenous 
DNA sequences, the yeast transformants were grown initially in minimal 
medium. Following this, they were transferred to YEPD media where they were 
kept growing for over 200 generations by repeatedly transferring them into fresh 
YEPD medium. The percentage o f cells with the ura+ marker was then 
determined by plating single colonies on YEPD and checking for the loss of the 
plasmid associated marker by replica plating onto selective medium. The 
episomal plasmid pAAMY-01 was used as a control. The number of leu cells 
harbouring the YEp-type plasmid pAAMY-01 which contains the a-amylase 
gene, showed a decrease over the first few generations and dropped to 
approximately 10.0% after 50 generations. In contrast, no decrease in the number 
of urct cells was observed among the ura3-52 integrants even after 150 
generations. These results indicated that the ura3-52 integrated sequences were
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maintained very stably during mitotic growth in rich medium. The high stability 
of the ura phenotype was also another indication that integration into the yeast 
genome had occurred. A number o f these stable integrants that will appear in 
subsequent experiments have been given the following names; h, SI, SII and 
SIV.
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Figure 4.4 Graph o f the stability of one of the pFAMY transformants, SI, 
together with that o f the episomal plasmid pAAMY-01.
4.1.1.1.3 Development o f a semi-quantitative well assay for measuring a-
amylase activity.
The a-amylase plate assay was developed for detecting a-amylase 
activity in the supernatants o f transformants. This involved making up plates 
consisting o f 2% starch and 2% agar made up to volume in 0.1 M sodium 
phosphate buffer, pH 6.9. Wells were then removed from the firm agar using 
sterile pipette tips (Sarstedt 70.760/002,10-100p,l). Following growth, aliquots of 
growth medium (supernatant) were then loaded into the wells and the plates were 
incubated at 37°C for 16 hours. To estimate the amount o f a-amylase produced 
the halo size was compared to a standard curve produced for a-amylase over the 
concentration range 0.00625 units to 100 units of amylase activity (Figure 4.5). 
The amylase used was from a commercial source ( Sigma B. licheniformis
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amylase Type X I1 A). One unit of amylase activity is defined as the amount 
necessary to liberate lmg of maltose from starch in 3 minutes at pH 6.9 and 
20°C. Figures 4.6 and 4.7 show the well assays used for the construction of the 
calibration curve which is shown in figure 4.5.
Halo diameter (mm)
Figure 4.5 Standard Curve for Well Assay.
The plate assay was used as a semi-quantitative tool for the measurement 
of a-amylase activity. The haloes were visualised by either iodine vapour (Figure 
4.6) or starch precipitation (Figure 4.7). In the former the plates were exposed to 
iodine vapour for 30 - 60 seconds and with the latter the plates were incubated at 
4°C overnight in order to precipitate any undegraded starch, the a-amylase 
producing supernatants were surrounded by distinct clear haloes, while non- 
amylolytic supernatants stained dark blue with the iodine vapour. Both assay 
procedures had similar sensitivity, but the definition of the haloes was superior 
with the iodine assay.
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Figure 4.6 Well Assay plates after flooding with iodine vapour.
Figure 4.7 Well Assay plates after overnight incubation at 4°C.
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Another advantage of this plate assay is that unlike the DNS method 
(section 2.13.2) for measuring a-amylase activity, the samples do not need to be 
dialysed prior to analysis.
4.1.1.1.4 Southern Blot Analysis I  - Proof o f integration
This particular experiment was designed to demonstrate that integration 
into the yeasts’ chromosomal DNA had taken place. Genomic DNA extracted 
from several independently isolated integrants I2, SI, SII and SIV was digested 
with a restriction endonuclease which cuts outside the plasmid DNA. This should 
yield a single band of high molecular weight on the gel when Southern blotted 
and probed with j2P-labelled EcoR I linearised pFAMY if integration has been 
successful. If, although unlikely, integration into the genome had not occurred 
one would expect to see bands identical in size to undigested pFAMY plasmid.
To ascertain what restriction enzymes do not cut within the plasmid 
pFAMY, firstly the sequence o f the parental plasmid pFL34 was obtained 
(accession no. X70479) from GenBank Then this sequence and the sequence of 
the B. licheniformis a-amylase gene were analysed using SeqAid which provided 
information on restriction endonucleases which do not cut within these 
sequences. From the data retrieved, the restriction endonucleases Mlu I and Xho I 
neither o f which cut within t|ie plasmid wçre chosen.
The Mlu I data indicated integration had occurred by the appearance o f a 
single band which was o f high molecular weight for each of the four integrants 
digested with Mlu I (lanes 10 to 13, Figure 4.9). Lane 8 of the gel shown in 
Figure 4.8 clearly shows that the restriction enzyme chosen did not cut within the 
plasmid pFAMY, the banding pattern is identical to lane 2 which contains 
undigested pFAMY plasmid DNA. A further point which confirms the Mlu I data 
is the observation that in the undigested lanes, (lanes 4 to 7, Figure 4.9), where 
no restriction enzyme was used, there appeared a high molecular weight band 
comigrating with the genomic DNA. If integration had not occurred one would 
expect a banding pattern as for pFAMY undigested DNA (lane 2, Figure 4.8).
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Similar analysis was carried out using the enzyme Xho I which confirmed the 
above results (data not shown).
Figure 4.8 Agarose gel of genomic DNA from DBY746, the integrants I2, SI, SII 
and SIV and the plasmid pFAMY unrestricted and restricted with M u  I.
Lane 1: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072; 
3,054; 2,036; 1,636; 1,018; 506 bp)
L a n d : pFAMY undigested
Lane 3: DBY746 undigested
Lane 4: I2 undigested
Lane 5: SI undigested
Lane 6: SII undigested
Lane 7: SIV undigested
Lane 8: pFAMY digested with Mlu I
Lane 9: DBY746 digested with Mlu I
Lane 10: I2 digested with Mlu I
Lane 11: SI digested with Mlu I
Lane 12: SII digested with Mlu I
Lane 13: SIV digested with Mlu I
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Figure 4.9 Southern Blot o f genomic DNA from DBY746, the integrants h, SI, 
SII and SIV and the plasmid pFAMY unrestricted and restricted with Mlu I and 
probed with 32P-labelled EcoR 1 linearised pFAMY.
Lane 1: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072; 
3,054; 2,036; 1,636; 1,018; 506 bp)
Lane 2: pFAMY undigested
Lane 3: DBY746 undigested
Lane 4: I2 undigested
Lane 5: SI undigested
Lane 6: SII undigested
Lane 7: SIV undigested
Lane 8: pFAMY digested with Mlu I
Lane 9: DBY746 digested with Mlu I
Lane 10: I2 digested with Mlu I
Lane 11: SI digested with Mlu I
Lane 12: SII digested with Mlu I
Lane 13: SIV digested with Mlu I
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To examine further the fate o f pFAMY in the S. cerevisiae transformants, 
with respect to whether integration had occurred as a single or multiple 
integration event, genomic DNA was extracted, digested with various enzymes, 
electrophoresed, Southern blotted and probed with EcoR I linearised 32P-Iabelled 
pFAMY. Initially the restriction enzymes chosen were Hind III, EcoR I and Sal I 
as these enzymes cut within both the plasmid and Ty element. Since some 
sequence data for the 5’ end o f the Ty element was available at the time that 
these experiments were being designed it was possible to predict the expected 
sizes o f the Hind III, Sal I and EcoR I 5 ’ flanking fragments. Kpn I was chosen 
as it cuts within the plasmid but not within the Ty element. The presence of 
junction fragments o f the predicted size would provide proof of the integration of 
the plasmid at the ura3-52 locus. If integration had occurred by a single cross­
over event as outlined in Figure 4.10 the following fragment sizes (in base pairs) 
would be observed (Table 4-1 below). Some of the junction fragments are of 
unknown size as the sequence 3 ’ to the integration site had not been determined 
when these experiments were being carried out.
Table 4-1 Expected fragment sizes (in base pairs, bp) following restriction if 
integration had occurred by a single cross-over event.
4.1.1.1.5 Southern blot analysis II -A  single or tandem integration?
Restriction enzyme Plasmid fragments (bp) Junction fragments 
(bp)
Hind m 1,900; 450 2,750; ND*
EcoR I ******* 6,600; ND*
Sal I 1,220 2,740; ND*
Kpn I 2,150 ND*
*ND: not determined.
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Figure 4.10 Schematic representation of a single integration event with 
restriction fragments highlighted. (Restriction site Hind III is indicated as HUI.)
Furthermore, due to the fact that about 50% of the resulting transformants 
in integration experiments can result in double or multiple tandem integrations 
(Orr-Weaver and Szostak, 1983) the expected band sizes for a tandem integration 
event shown diagrammatically in Figure 4.11 were also calculated. The 
following fragment sizes (in base pairs, Table 4-2) would be expected:
Table 4-2 Expected fragment sizes (in base pairs, bp) following restriction if a 
tandem integration event had occurred.
Restriction enzyme Plasmid fragments (bp) Junction fragments 
(bp)
Hind m 5,300; 1,900; 450 2,750; ND*
EcoR I 7,700 6,600; ND*
Sail 6,480; 1,220 2,740; ND*
Kpn I 5,560; 2,140 ND*
*ND: not determined.
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Figure 4.11 Schematic representation of a multiple (tandem) integration event 
with restriction fragments highlighted. (Restriction site Hind IQ is indicated as 
f f l l l .)
Finally, the occurrence of the integration event alone, irrespective of 
single or tandem integration events could once again be confirmed in this 
experiment by the presence of a single high molecular weight band comigrating 
with the genomic DNA on a Southern blot o f undigested DNA probed with 32P- 
labelled EcoR I linearised pFAMY. In contrast, if the a-amylase gene had 
remained episomally, bands characteristic o f pFAMY should be detected.
The results of the Southern blotting experiment can be seen in Figure 
4.13. Possibly the best choice of enzyme to demonstrate the type of integration 
event was EcoR I. It appears that a multiple integration event was the most likely 
event for SI, SII and SIV, as both plasmid and junction fragments were seen on 
the Southern blot (lane 13, 16 and 19, Figure 4.13) corresponding to band sizes 
of 7.7 kb, (a plasmid band indicating multiple integration), 6.6 kb (a junction 
fragment) and a much larger band oTindeterminate size (which may be the 
second junction fragment).
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Figure 4.12 Agarose gel o f genomic DNA from DBY746 and the integrants I2, 
SI, SII and SIV, electrophoresed unrestricted and restricted with Hind HI and
EcoR I.
Lime I :
Lane 2: 
Lane 3: 
Lane 4: 
LaneS: 
Lane 6: 
Lane 7: 
Lane 8: 
Lane 9: 
Lane 10: 
Lane 11: 
Lane 12: 
Lane 13: 
Lane 14: 
Lane 15:
1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072; 
3,054; 2,036; 1,636; 1,018; 506 bp) 
pFAMY undigested
pFAMY digested with Hind HI (5,350; 1,900; 450 bp) 
pFAMY digested with EcoR I (7,700 bp)
DBY746 undigested
DB Y746 digested with Hind in
DBY746 digested with EcoR I
I2 undigested
I2 digested with Hind in
I2 digested with EcoR I
SI undigested
SI digested with Hind m
SI digested with EcoR I
SII undigested
SII digested with Hind HI
Lane 16: SII digested with EcoR I
Lane 17: SIV undigested
Lane 18: SIV digested with Hind HI
Lane 19: SIV digested with EcoR I
Lane 20: X DNA Hind IIlAEcoR I digested (21,226; 5,148; 4,973; 4,277; 2,027; 1904;
1,584; 1,330; 983; 831; 564 bp)
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Figure 4.13 Southern blot of genomic DNA from DBY746 and the integrants I2, 
SI, SII and SIV, electrophoresed unrestricted and restricted with Hind III and 
EcoR I, and probed with 32P-labelled EcoR 1 linearised pFAMY.
Lane 1: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072; 
3,054; 2,036; 1,636; 1,018; 506 bp)
Lane 2: pFAMY undigested
Lane 3: pFAMY digested with Hind ID (5,350; 1,900; 450 bp)
Lane 4: pFAMY digested with EcoR I (7,700 bp)
Lane 5: DBY746 undigested
Lane 6: DBY746 digested with Hind III
Lane 7: DBY746 digested with EcoR I
Lane 8: I2 undigested
Lane 9: I2 digested with Hind III
Lane 10: I2 digested with EcoR I
Lane 11: SI undigested
Lane 12: SI digested with Hind HI
Lane 13: SI digested with EcoR I
Lane 14: SII undigested
Lane 15: SO digested with Hind in
Lane 16: SII digested with EcoR I
Lane 17: SIV undigested
152
Lane 18: SIV digested with Hind IH
Lane 19: SIV digested with EcoR I
Lane 20: X DNA Hind mi EcoR I digested (21,226; 5,148; 4,973; 4,277; 2,027; 1904;
1,584; 1,330; 983; 831; 564 bp)
The lane containing DBY746 DNA restricted with EcoR I (lane 7, Figure
4.13) highlighted two faint bands o f 10.0 kb and 8.0 kb respectively, (seen on the 
autoradiograph but not on the photograph, Figure 4.13). The presence of these 
bands was most likely due to the uracil portion of the plasmid hybridising with 
the uracil gene in the yeast genomic DNA. This result was in accordance with the 
findings of Canavan (1994), when the same DNA was restricted with EcoR I but 
probed with a 32P-labelled uracil probe. Also because integration was directed to 
the ura3-52 locus of DBY746 and because the band o f 10 kb appears to have 
shifted in the integrated strains one could take this to be a further proof of 
integration.
The Hind IH digest data of the four integrants were somewhat 
incomplete. If multiple integration had occurred one would expect to see all of 
the plasmid bands (5.3 kb, 1.9 kb and 0.48 kb) lighting up plus two junction 
fragments. What was observed however was the 5.3 kb plasmid fragment 
lighting up for all four integrants (lanes 9, 12, 15 and 18, Figure 4.13). This band 
should only light up if a tandem integration event had occurred (see Figure 4.11). 
With SI, SII and SIV (lanes 12, 15 and 18, Figure 4.13) one can also see the 1.9 
kb plasmid fragment and in the case o f SIV (lane 18, Figure 4.13) can also make 
out the 0.45 kb plasmid fragment although it was very faint and it did not 
photograph well. The fact that this small band o f 0.45 kb was not visualised for 
all the integrants may be due to the fact that not enough genomic DNA had been 
loaded on the gel. A band at 8.0 kb was seen clearly for SIV (lane 18, Figure
4.13) and this possibly represents one o f the junction fragments and the same 
band but of lower intensity was also seen in the case of SI (lane 12, Figure 4.13) 
as expected. Also the junction fragment of 2.7 kb could be seen for SIV (lane 18, 
Figure 4.13). Once again the fact that this fragment (which would be present 
only once) was not visualised for all of the integrants could be due to not enough 
genomic DNA being loaded. However conclusive proof o f multiple (tandem)
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integration for all 4 integrants from this Hind 111 data was the presence of the 5.3 
kb band which would only light up in the case of a multiple integration event.
The Sal I digests further indicate tandem integration for all four integrants 
by the presence of the 6.5 kb plasmid bands (see Figure 4.11), which should only 
be visualised if a tandem integration event had occurred (lanes 9, 12, 15, and 18, 
Figure 4.14). The 1.2 kb band was also there its intensity being weak in the case 
of h, SI and SII, (lanes 9, 12 and 15, Figure 4.14), but clearly visible for SIV 
(lane 18, Figure 4.14). In all four integrants there was a high molecular weight 
band observed upon digestion with Sal I. This band also occurred when DBY746 
was digested with Sal I which suggests that the uracil portion of the plasmid 
probe pFAMY is hybridising to uracil genomic DNA. This band may represent 
the junction fragment which is of indeterminate size because of its high 
molecular weight >23 kb (lanes 6, 9, 12 and 15, Figure 4.14).
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Figure 4.14 Southern blot o f genomic DNA from DBY746 and the integrants I2, 
SI, SII and SIV, electrophoresed unrestricted and restricted with Sal I and Kpn I, 
and probed with 32P-labelled EcoK 1 linearised pFAMY.
L anel: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8*144; 7,126; 6,108; 5,090; 4,072; 
3,054; 2,036; 1,636; 1,018; 506 bp)
Lane 2: pFAMY undigested
Lane 3: pFAMY digested with Sal I (6,480; 1,220 bp) .
Lane 4: pFAMY digested with Kpn I (5,560; 2,140 bp)
Lane 5: DBY746 undigested
Lane 6: DBY746 digested with Sal I
Lane 7: DBY746 digested with Kpn I
Lane 8: I2 undigested
Lane 9: I2 digested with Sal I
Lane 10: I2 digested with Kpn I
Lane 11: SI undigested
Lane 12: SI digested with Sal I
Lane 13: SI digested with Kpn I
Lane 14: SII undigested
Lane 15: SII digested with Sal I
Lane 16: SII digested with Kpn I
Lane 17: SIV undigested
Lane 18: SIV digested with Sal I
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Lane 19: SIV digested with Kpn I
Lane 20: X DNA Hind WFxoR I digested (21,226; 5,148; 4,973; 4,277; 2,027; 1904;
1,584; 1,330; 983; 831; 564 bp)
Finally the Kpn I digests also indicate tandem integration, as the plasmid 
bands of 5.56 kb and 2.14 kb are clearly visible for all four integrants along with 
a very strong band at approximately 2.6 kb (which was also present in the 
unintegrated DBY746, lane 7 Figure 4.14) and another band at 9.0 kb once again 
this may possibly represent a junction fragment (lanes 10, 13, 16 and 19, Figure
4.14).
From the results of the above experiment one can conclude that in all 
cases a tandem integration event was the outcome of all four transformations 
with the integrating vector pFAMY.
4.1.1.1.5.1 Analysis o f the Restriction Spectra o f genomic DNA extracted
from Saccharomyces cerevisiae and restricted with Hind III and EcoR I (Figure 
4.12).
Strong characteristic bands can be readily identified within the genomic 
DNA of S. cerevisiae on an agarose gel after restriction digestion with certain 
restriction enzymes. The proper evaluation of these restriction spectra is 
important for many experiments, if only to see that restriction digestion went to 
completion. In particular, correct interpretation o f the Southern blotting data for 
integrated genomic DNA samples is dependent on adequate restriction digestion 
of the original samples. However complete digestion of the sample is ideal.
In many instances the bands which stand out following restriction 
digestion are due to repeated sequences. In fact, up to 15% of the nuclear DNA 
consists of repeated sequences, some of which can be seen as weak or strong 
bands after cleavage of the DNA with restriction endonucleases and separation of 
the fragments in agarose gels. There are four classes of repeated DNA (rDNA, 
2(j.m plasmid, Ty elements, telomeric Y’ sequences) within the genome of S. 
cerevisiae which are the origin o f most of the bands seen in the restriction spectra 
after electrophoresis on a 0.7% agarose gel stained with ethidium bromide. The 
ribosomal DNA consists of a cluster of usually 100 to 140 tandem copies of a
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9.08 kb repeat unit. The 2-(j.m plasmid is present in 50 to 100 copies in many but 
not all S. cerevisiae strains. The mobile elements Tyl and Ty2 are usually 
present in 30 - 35 copies dispersed throughout the genome. Ty3 and Ty4 are 
present in only 1 - 4 copies. These Ty elements can be lost from the 
chromosome by homologous recombination between their 0.34 kb terminal direct 
repeats. Single copies o f the terminal repeats remain at the previous location of 
the Ty element. This explains the many copies o f solo 8 sequences (50 - 100), 
solo a sequences (20 -30), and solo t  sequences (15 - 25) found in all strains 
even those with low Ty copy number. The fourth class of repeated DNA visible 
in restriction spectra consists of the 6.7 kb telomeric Y’ sequences. These are 
present as single copies or short clusters of 2 - 4 copies at the ends o f almost all 
16 chromosomes, with about 45 copies per haploid genome. Approximately 85% 
of the sequences in yeast chromosomes are unique. Some genes exist in pairs, for 
example genes for histones, a-tubulin, translation elongation factor la , mating 
pheromones, several ribosomal proteins and some glycolytic enzymes 
(Philippsen et al., 1991).
The EcoR I restriction spectra of DBY746 (lane 7, Figure 4.12) and the 
four integrants (lanes 10, 13, 16 and 19, figure 4.12) are dominated by ribosomal 
DNA and 2-(om bands. Six bands are clearly distinguishable, four o f these bands 
represent the 2-p.m plasmid the other two arise from cleavage o f the ribosomal 
DNA. The 4.2 kb, 3.9 kb, 2.5 kb and 2.1 kb fragments arise from the 2-pm 
plasmid DNA. The 2.5 kb band is in fact a doublet which comigrates with a 
rDNA fragment. The bands at 2.9 kb and 1.9 kb represent 25s rRNA and 18s 
rRNA bands respectively.
The Hind III digests (lanes 6, 9, 12, 15 and 18, Figure 4.12) contain a 
strong band at 6.9 kb which originates from the rDNA, as does the band at 2.6 
kb. The remaining four bands represent the 2-jj.m plasmid at 4.2 kb, 2.7 kb, 2.1 
kb and 1.3 kb respectively. In the undigested lanes (lanes 5, 8, 11, 14 and 17, 
Figure 4.12) one band stands out clearly, at approximately 3.6 kb this band most 
likely represents the covalently closed circular forms o f the 2-p.m plasmid DNA. 
From viewing the banding patterns on the agarose gel after restriction digestion 
with both EcoR I and Hind HI it is clear that the restriction digestion went to 
completion.
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Genomic DNA from the four integrated strains I2, SI, SII and SIV was 
once again digested with Sal I but this time the probe used was the plasmid 
pRB149 (Appendix II) which contains the URA3 gene and p-actin gene from S. 
cerevisiae. The probe was radiolabelled with 32P. Analysis o f Figure 4.16 shows 
DBY746 (lane 9) hybridising to the probe at a position o f approximately 23.0 kb 
(the uracil specific portion of the probe) and a band at approximately 9.4 kb 
which according to Canavan (1994), is the p-actin band. In the integrated strains 
(lanes 10, 11, 12 and 13, Figure 4.16) there is a shift in size of the 23.0 kb band 
for all four integrants offering further proof o f an integration event. This band 
cannot be accurately sized as it is o f high molecular weight. Also the 6.5 kb 
plasmid band, which incidentally contains the uracil gene is present in the lanes 
o f the integrants only, (lanes 10, 11,12 and 13, Figure 4.16), as expected.
4.1.1.1.6 Southern Blot analysis III - Further proof of integration
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Figure 4.15 Agarose gel o f genomic DNA from DBY746 and the integrants h, 
SI, SO and SIV, electrophoresed unrestricted and restricted with Sal I.
Lane 1: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072; 
3,054; 2,036; 1,636; 1,018; 506 bp)
Lane 2: pFAMY undigested
Lane 3: DBY746 undigested
Lane 4: I2 undigested
Lane 5: SI undigested
Lane 6: SD undigested
Lane 7: SIV undigested
Lane 8: pFAMY digested with Sal I (6,480; 1,220 bp)
Lane 9: DBY746 digested with Sal I
Lane 10: I2 digested with Sal I
Lane 11: SI digested with Sal I
Lane 12: SII digested with Sal I
Lane 13: SIV digested with Sal I
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Figure 4.16 Southern Blot o f genomic DNA from DBY746 and the integrants I2, 
SI, SII and SIV, electrophoresed unrestricted and restricted with Sal I and probed 
with a uracil and p-actin probe.
Lane 1: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072; 
3,054; 2,036; 1,636; 1,018; 506 bp)
Lane 2: pFAMY undigested
Lane 3: DBY746 undigested
Lane 4: I2 undigested
Lane 5: SI undigested
Lane 6: SII undigested
Lane 7: SIV undigested
Lane 8: pFAMY digested with Sal I (6,480; 1,220 bp)
Lane 9: DBY746 digested with Sal I
Lane 10: I2 digested with Sal I
Lane 11: SI digested with Sal I
Lane 12:. SII digested with Sal I
Lane 13: SIV digested with Sal I
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4.1.1.1.7 Pulse-field gel electrophoresis o f DBY746 and the integrated
strains I2, SI, SII and SIV
The purpose of this experiment was to confirm that integration had 
occurred at a single site in the genome, this being the ura3-52 locus on 
chromosome V. The chromosomal site of integration of the pFAMY plasmid was 
confirmed for the four transformants, I2, SI, SII and SIV by Southern blotting of 
intact chromosomes separated by Pulse-field gel electrophoresis. This method is 
capable of separating out the 16 chromosomes o f S. cerevisiae into clearly 
resolved bands on an agarose gel with band sizes ranging from 200 kb to 2,200 
kb, which cannot be resolved by conventional agarose gel electrophoresis.
The gel was prepared and the running conditions were as described in 
section 2.10.3. The apparatus used was a BioRad CHEF Mapper. After 
electrophoresis the gel was stained with ethidium bromide, destained and 
photographed. Following this the gel was blotted and probed with a non­
radioactive DIGoxygenin a-amylase labelled probe. Figure 4.17 shows S. 
cerevisiae chromosomal DNA markers, (BioRad 170-3605, lane 1), DBY746 as 
the negative control (lane 2) and the 4 integrated strains, I2, SI, SII and SIV 
(lanes 3 to 6). Southern blot analysis (Figure 4.18) shows hybridisation to a 
single chromosome corresponding to the chromosome V on the gel. Interestingly, 
in the integrated strains I2, SII and SIV a size increase in chromosome V was 
noted in comparison to the control strain DBY746, suggesting that these three 
integrants contain multiple copies of the plasmid. This increase in size was not so 
obvious for the integrant SI. This result correlates well with the data from copy 
number analysis (section 4.1.1.1.9) which predict that the integrants I2, SII and 
SIV contain 5, 4 and 5 copies respectively of the plasmid. A tandem integration 
o f 5 copies o f this plasmid would result in an increase in chromosome size of 
approximately 38.5 kb, which is in keeping with the observed band shift. In 
contrast, SI is the result of a double integration event (corresponding to a size 
increase of 15.4 kb which is not very noticeable on a pulse-field gel).
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Figure 4.17 Pulse-field Gel showing the individual chromosomes of 
Saccharomyces cerevisiae strain DBY746 and the four integrated strains I2, SI, 
SH and SIV.
Lane 1: CHEF Saccharomyces cerevisiae DNA size markers (Biorad, 170-3605)
225; 285; 365; 450; 565; 610; 680; 750; 785; 825; 945; 1,020; 1,125; 1,600; 2,200 kb 
Lane 2: DBY746 
Lane 3: I2 
Lane 4: SI 
Lane 5: SII 
Lane 6: SIV
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Figure 4.18 Southern blot o f  the Pulse-field Gel shown in figure 4.17.
Lane Is CHEF Saccharomyces cerevisiae ISSA W &fttarkers (Biorad, 170-3605)
225; 285; 365; 450; 565; 610; 680; 750; 785; 825; 945; 1,020; 1,125; 1,600; 2,200 kb 
Lane 2: DBY746 
Lane 3: I2 
Lane 4s SI 
Lane 5: SU 
Lane 6s SIV
4.1.1.1.8 Activity Analysis o f Integrated Strains, I2, SI, S lI  and SIV.
To
1960). This assay measures the levels o f  reducing sugars produced as a result o f  
the digestion o f starch by a-amylase. In order to ensure accurate quantitation o f 
activity in cell supernatants, glucose in the growth medium had to be removed 
before assaying by dialysis (2.13.2.1). Figure 4.19 shows atypical standard curve 
used for the determination ofa-amylase activity. One unit o f enzyme activity
was
carbohydrates with a reduction power corresponding to 0.1 Ipmoles D-glucose in 
30 minutes in the standard assay.
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mg glucose
Figure 4.19 Standard Curve for DNS Assay.
The units o f a-amylase activity were calculated as follows:
Units of enzyme activity: mg glucose/ml per 30 minutes x D x RV
180.2 x 10'6
where D = Dilution factor
RV = Reaction Volume
180.2 = Molecular weight of glucose
The optimum assay conditions for the B. licheniformis a-amylase gene 
are a pH of 6.9 and a temperature of 93°C (Ortlepp et al., 1983). The optimum 
pH and temperature conditions of the S. cerevisiae recombinant a-amylase 
strain, DBY746::pAAMY-01 were also determined and the findings were in 
agreement with those of Ortlepp (see figures 4.20 and 4.21 below). The a- 
amylase activity was once again quantified using the DNS assay. Culture 
supernatants o f stationary phase (36 hours) DBY746::pAAMY-01 were dialysed 
against 1 x PBS prior to assaying. The pH profile was determined over the range 
pH 2 to 10 and the temperature profile over the range 30 to 100°C. All assays 
were carried out in duplicate and the mean values are expressed as the relative 
percentage activity with the optimal conditions giving 100% activity.
164
pH
Figure 4.20 pH profile o f the B. licheniformis ’ a-amylase gene activity in S. 
cerevisiae DBY746::pAAMY-01.
Temperature °C
Figure 4.21 Temperature profile ofthe B. licheniformis’ a-amylase gene activity 
in S. cerevisiae DBY746::pAAMY-01.
The level o f extracellular a-amylase produced by the 4 integrated strains I2, SI, 
SII and SIV are shown in table 4-3 below. DBY746 was used as a negative 
control in this experiment.
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Table 4-3 Levels of a-amylase expressed by the Integrants.
Strain Units o f secreted 
amylase
Cell no. Units/cell
h 569.37 3.35 x 107 1.69 x 10'5
SI 329.6 3.3 x 107 1.0 x 10'5
s n 494.5 3.4 x 107 1.36 x 10‘5
SIV 464.48 3.4 x 107 1.45 x 10 3
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Figure 4.22 Bar Chart depicting the levels o f extracellular a-amylase activity as 
displayed by the integrants.
4.1.1.1.9 Determination of the copy number o f integrated a-amylase 
genes
The method chosen for determining plasmid copy number (PCN) was 
based on Southern hybridisation and it depended on an appropriate probe 
containing sequences which would be capable of binding to both the plasmid
f
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DNA and at the same time to some endogenous chromosomally located sequence 
(reference DNA) whose copy number is known. PCN can then be calculated 
from the intensity o f hybridisation to the plasmid specific fragment, relative to 
the intensity of hybridisation to the reference DNA. To estimate the copy number 
of an integrated plasmid it was decided to let one of the junction fragments 
represent the reference DNA as these sequences should only occur once. pUC-19 
was chosen as the probe since both pUC-19 and the integrating plasmid pFAMY 
contain homologous pBR322 sequences (in the cases of these plasmids the 
homologous region is the ampicillin resistance gene). When the integrated strains 
are digested with EcoR I one would expect hybridisation o f the 32P-radio labelled 
pUC-19 probe to hybridise to a 7.7 kb band, which represents the number of 
integrated copies o f the plasmid (EcoR I cuts once within the plasmid pFAMY) 
and to a junction fragment 3’ to the site of integration of unknown size as the 
region had not been sequenced prior to the design o f this experiment. There 
should be only one junction fragment to which this probe will hybridise as the 
ampicillin resistance gene is after the EcoR I site in the plasmid (see Figure
4.23).
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Figure 4.23 Schematic representation of where the pUC-19 probe is expected to 
bind if [A] a single copy or [B] if multiple copies o f the plasmid pFAMY 
integrate into the ura3-52 locus o f DBY746.
Genomic DNA was extracted from DBY746 and the 4 integrants, I2, SI, 
SH and SIV. Following extraction, the DNA was restricted (section 2.6.11.1) 
with EcoR I and the samples were electrophoresed on a 0.8% agarose gel (Figure
4.24). This gel was blotted and probed with a 32P-labelled pUC 19 probe (Figure
4.25).
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Figure 4.24 Agarose Gel o f genomic DNA digested with EcoR I.
Lane 1: X DNA Hind WEcoR I digested (21,227; 5,148; 4,973; 4,268; 3,530; 2,027;
1,904; 1,584; 1,375; 974; 831; 564; 125 bp)
Lane 2: pRB 149 digested with EcoR I (5,500; 3,800 bp)
Lane 3: DBY746 undigested
Lane 4: DBY746 digested with EcoR I
Lane 5: I2 digested with EcoR I
Lane 6: SI digested with EcoR I
Lane 7: SII digested with EcoR I
Lane 8: SIV digested with EcoR I
Lane 9: -------------------
Lane 10: -------------------------
Lane 11: pFAMY digested with Hind III (5,350; 1,900; 450 bp)
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Figure 4.25 Southern blot of genomic DNA digested with EcoR I, 
electrophoresed and probed with a 32P-labelled pUC 19 probe.
Lane 1: X DNA Hind WEcoR I digested (21,227; 5,148; 4,973; 4,268; 3,530; 2,027;
1,904; 1,584; 1,375; 974; 831; 564; 125 bp)
Lane 2: pRB 149 digested with EcoR I (5,500; 3,800 bp)
Lane 3: DBY746 undigested
Lane 4: DBY746 digested with EcoR I
Lane 5: I2 digested with EcoR I
Lane 6: SI digested with EcoR I
Lane 7: SII digested with EcoR I
Lane 8: SIV digested with EcoR I
Lane 9: ------------------
Lane 10: -------------- ---------
Lane 11: pFAMY digested with Hind IE (5,350; 1,900; 450 bp)
The intensities o f the bands were analysed using a Leica Q 500MC Image 
Processing and Analysis System (Cambridge, England). The areas under the 
curve were integrated using Sigma Plot (Jendal Scientific). The ratio of the 
intensity o f the plasmid DNA to the reference was tabulated (table 4-4). The 
copy number of the integrants h, SI, SII and SIV was estimated to be 5, 2, 4 and 
5 respectively according to the method employed. SI was the integrant chosen as 
it possessed the lowest copy number, but more importantly if there was a 
reduction in the activity of SI this could still be measured.
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Table 4-4 C o m p a r iso n  o f  the intensity o f  the p lasm id bands to the reference band 
in o rd e r  to de te rm ine  the  c o p y  n u m b er  o f  integration.
Integrant Plasmid DNA Reference DNA Copy Number
h 1392 264 5
SI 241 148 2
SII 1487 423 4
SIV 2201 415 5
As a further step to confirm this result, the copy number of each o f the integrants 
and an episomal plasmid, pAAMY-01 (which contains a functional a-amylase 
gene) were plotted against their relative a-amylase activities. As expected the 
graph (Figure 4.26) indicates that the integrant with the least copy number of a- 
amylase genes gave the lowest activity (SI). Although it might be expected that 
an integrant with 4 copies o f the a-amylase gene should have twice the activity 
of an integrant with 2 copies, this was not found to be the case although the 
activity was higher.
The integrants SII, SIV and I2 which possess 4, 5 and 5 copies o f the a- 
amylase gene respectively, do not vary significantly in the levels o f a-amylase 
produced. On the other hand the episomal plasmid, pAAMY-01, which has a 
copy number of 9 exhibits twice the activity of SII possessing 4 copies of the a- 
amylase gene.
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Figure 4.26 Copy number o f the integrants and the episomal plasmid pAAMY- 
0 1 versus their respective amylase activities.
The a-amylase gene copy number of the integrant SI (which is the chosen 
strain for the introduction o f the various antisense constructs in this section and 
in trans I (c)) was further proven to be present at 2 copies per cell by Northern 
blot analysis (Figure 4.27). When a total RNA sample o f SI was probed with 
both an a-amylase probe and a (3-actin probe (which is present in one copy per 
cell) the calculated ratio o f a-amylase to p-actin transcripts was 2: l .
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Figure 4.27 Northern blot of total RNA extracted from SI and probed with a 32P- 
labelled a-amylase and P-actin fragment.
4.1.2 CONSTRUCTION OF A YEAST EPISOMAL VECTOR 
CONTAINING THE BACILLUS LICHENIFORMIS a-AMYLASE GENE 
CLONED IN  ANTISENSE ORIENTATION
Plasmid pAAH5 was used to construct a YEp plasmid carrying 
expression cassettes capable o f producing either antisense a-amylase mRNA 
(pSOC-Ol) or sense a-amylase mRNA (pAAMY-01, McMahon, 1995). The 
plasmid pAAH5 contains 2\x sequences, a LEU2 selectable marker and an 
expression cassette composed o f the AdHI promoter, a unique Hind m  site for 
cloning and an ^ ¿////terminator. The 2[i fragment includes the 2fx origin of 
replication which permits this plasmid and its derivatives to exist in high copy 
number in [cir+] yeast cells. YEp based shuttle vectors have been reported to 
exist at 10 - 40 copies per cell in yeast transformants (Armstrong et al., 1989).
With the expression cassette located on plasmid pAAH5, the AdHI 
promoter was used to direct transcription of antisense RNA sequences. This is a 
constitutive promoter. The AdHI transcription terminator downstream o f the 
AdHI promoter provided the signals for precise termination o f transcription and 
polyadenylation o f the resulting transcripts. Any transcripts produced from this 
expression cassette or its derivatives were predicted to contain both a 5’cap and a 
3’ poly-A tail.
SI
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The construction and ana lysis o f  the e fleet of the antisensc transcript 
produced from pSOC-01 on a-amylase gene expression from the yeast strain SI 
are discussed in this section. The plasmid pSOC-O I is represented schematically 
in Figure 4.28 and the details of construction are Included in the legend to the 
figure.
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Figure 4.28 Construction o f a yeast episomal vector (pSOC-Ol) containing the 
B. licheniformis a-amylase gene in its antisense orientation.
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The plasmid pAAMY-01 was digested w ith Hind III to release a 1.9 kb fragment corresponding 
to the a-am ylase gene. The restriction digest was then column cleaned to remove any remaining 
restriction enzyme and buffer. Following this the mixture was ligated at 4°C overnight, then 
transform ed into D H 5a cells, plated on LB amp starch plates and screened.
Normally, expression o f a-amylase in E. coli would not be expected with 
a yeast expression vector construct (such as pAAH5) as it lacks a prokaryotic 
promoter at the cloning site. However it had already been observed in our 
laboratory that this Hind III a-amylase containing fragment when introduced into 
E. coli cells, resulted in a-amylase activity irrespective of either the plasmid into 
which it was cloned or orientation o f the fragment, suggesting the sequences on 
the fragment itself contained promoter activity (Figure 4.29). For this reason, one 
could take advantage o f this finding, and screen potential pAAH5-based 
transformants for a-amylase activity, thereby indicating the presence/absence of 
the insert in the transformants under investigation.
Figure 4.29 Plasmids pAAMY-01 and pSOC-Ol displaying a-amylase activity 
after transformation into E. coli DH5a cells.
Restriction analysis (Figure 4.30) o f the transformants displaying a- 
amylase activity was carried out to check for transformants carrying single
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copies o f the gene. The orientation of the gene was confirmed using Sal I 
restriction analysis (Appendix HI, VIII). Digestion with this enzyme gave 
fragment sizes o f 6.75kb, 5.52kb and 1.86kb (lane 10, Figure 4.30) in the 
antisense orientation and fragment sizes o f 6.75kb, 5.88kb and 1.5kb (lane 9, 
figure 4.30) in the sense orientation (plasmid pAAMY-01). The antisense 
construct will be referred to as pSOC-Ol from now on, and it is important to note 
that the a-amylase gene was antisense in relation to the constitutively expressed 
yeast AdHI promoter and terminator.
The restriction enzyme Hind. HI was chosen to show that the a-amylase 
gene insert was the desired 1.9 kb (lane 14, Figure 4.30). BamR I was chosen as 
a further enzyme to demonstrate the orientation of the insert. pAAH5 was also 
restricted with the same enzymes as pSOC-Ol and pAAMY-01 in order to 
highlight bands corresponding to vector sequences.
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Figure 4.30 Restriction analysis of plasmids pAAH5, pAAMY-01 and pSOC-Ol.
The approximate sizes o f each of the restriction fragments are shown in kilobases 
in brackets below. The relevant sizes o f the 1 kb ladder are as indicated.
Lane 1: 1 kb ladder (12.216; 11.198; 10.180; 9.162; 8.144; 7.126; 6.108; 5.090; 4.072;
3.054; 2.036; 1.636; 1.018; 0.506 kb)
Lane 2: pAAH5 undigested
Lane 3: pAAMY-01 undigested
Lane 4: pSOC-Ol undigested
Lane 5: pAAH5 digested with BamH I (10.23 kb; 2.0 kb)
Lane 6: pAAMY-01 digested with BamH I (10.23 kb; 2.35 kb; 1.55 kb)
Lane 7: pSOC-Ol digested with BamH I (10.23 kb; 3.45 kb; 0.45 kb)
Lane 8: pAAH5 digested with Sal I (6.75 kb; 5.48 kb; high molecular weight partial)
Lane 9: pAAMY-01 digested with Sal I (6.75 kb; 5.88 kb; 1.5 kb)
Lane 10: pSOC-Ol digested with Sal I (6.75 kb; 5.52 kb; 1.86 kb)
Lane 11: 1 kb ladder (12.216; 11.198; 10.180; 9.162; 8.144; 7.126; 6.108; 5.090; 4.072;
3.054; 2.036; 1.636; 1.018; 0.506 kb)
Lane 12: pAAH5 digested with Hind IE (12.23 kb)
Lane 13: pAAMY-01 digested with Hind IH (10.23 kb; 1.9 kb)
Lane 14: pSOC-Ol digested with Hind III (10.23 kb; 1.9 kb)
Lane 15: pAAH5 digested with EcoR I (9.63 kb; 2.6 kb)
Lane 16: pAAMY-01 digested with EcoR I (11.53 kb; 2.6 kb)
Lane 17: pSOC-01 digested with EcoR I (11.53 kb; 2.6 kb)
Lane 18: 1 kb ladder (12.216; 11.198; 10.180; 9.162; 8.144; 7.126; 6.108; 5.090; 4.072;
3.054; 2.036; 1.636; 1.018; 0.506 kb)
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The restriction data (Figure 4.30) confirms the construction of the 
antisense plasmid pSOC-Ol in which the oc-amylase gene was cloned in antisense 
orientation relative to the AdHI promoter and terminator. The orientation was 
confirmed by the sizes o f the BamH I and Sal I fragments obtained (lanes 7 and 
10, Figure 4.30). In the case of BamH I, there are BamH I sites at either end of 
the AdHI promoter, terminator cassette, in addition to an internal BamH I site at 
the beginning of the a-amylase gene sequence. The distance from the promoter 
to the BamH I site in the a-amylase gene in antisense orientation is 3.45 kb. The 
distance from the BamH I site in the antisense a-amylase gene to the BamH I site 
of the AdHI terminator is 0.45 kb. These bands corresponded to the band sizes 
observed in lane 7 (Figure 4.30). If the gene had been cloned in sense orientation 
(pAAMY-01) relative to the AdHI promoter and terminator, a BamH 1 restriction 
digest should yield fragment sizes of 10.23, 2.35 and 1.55 kb respectively (lane 
6, Figure 4.30).
From the restriction data it is apparent that the a-amylase fragment has 
been successfully cloned in antisense orientation.
4.1.2.1 Transformation of pSOC-Ol into the yeast strain DBY746
The plasmid pSOC-Ol was transformed into S. cerevisiae strain DBY746 
and transformants were plated onto buffered minimal media containing 2% 
Lintners starch to screen for lack o f a-amylase activity. The media was buffered 
with 0.1 M sodium phosphate buffer, pH 6.9. Previous work, carried out by 
McMahon (1995), showed that growth o f S. cerevisiae for 48 hours at 30°C in 
unbuffered minimal media broth resulted in a drop in pH from 6.2 to 2.3. This 
lowering of the pH of the medium was found to result in undetectable a-amylase 
activity. Buffering of the media to pH 6.9 with 0.1 M sodium phosphate buffer 
overcame this problem and amylolytic activity was demonstrated by clear haloes 
around amylase positive clones. DBY746 transformed with pSOC-Ol displayed 
no amylolytic activity on the starch supplemented minimal media plates. 
pAAMY-01 was also transformed into DBY746 as a positive control to 
demonstrate the effect o f amylase activity.
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4.1.2.2 C onfirm ation o f  the presence o f  the plasmid pSOC-Ol in DBY746
4.1.2.2.1 Growth on selective media
The yeast strain DBY746 is auxotrophic for uracil and leucine. 
Transformants were plated onto minimal medium supplemented with uracil only 
as the plasmid pSOC-Ol has a LEU2 marker and the strain will only grow if the 
plasmid has been successfully transformed thus converting the strain to leucine 
prototrophy. Figure 4.31 shows a minimal media plate divided into 3 sections, 
section 1 contains uracil spread onto this region of the plate, which was then 
allowed to dry, similarly section 2 contains leucine and section 3 was minimal 
media alone unsupplemented with any amino acids. DBY746::pSC)C-01 was then 
patched onto each o f these sections of the plate. As can be seen DBY746::pSOC- 
01 grew only on the section o f the plate supplemented with uracil. In Figure 4.32 
starch was added to the media and the same application o f amino acids was 
carried out, once again the same result was observed and this plate also 
demonstrated the lack o f a-amylase activity when the plates were flooded with 
iodine vapour. DBY746::pAAMY-01 Figure 4.33 was used as a positive control 
for demonstrating a-amylase activity in this experiment.
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Figure 4.31 DBY746::pSOC-01 plated on each of the 3 sections o f the minimal 
media plate containing on section 1 uracil, section 2 leucine and no amino acid 
supplementation on section 3.
Figure 4.32 DBY746::pSOC-01 plated on the minimal media plate with the 
same amino acid composition as Figure 4.31, except the media also contains 2% 
starch.
Figure 4.33 DBY746::pAAMY-01 plated on the minimal media plate with the 
same amino acid composition as Figure 4.31, except the media also contains 2% 
starch.
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4.1.2.2.2 The use of the Polymerase Chain reaction (PCR) to confirm the 
presence of the plasmid pSOC-Ol in DBY746.
PCR was chosen firstly to directly confirm the presence of the antisense 
gene in DBY746 and secondly because it is difficult to obtain good yields of 
plasmid DNA for restriction analysis starting from yeast cells. The experiment 
was designed so that one set of primers would amplify the sense a-amylase gene 
to give a band size of 0.98 kb and the second set of primers would give a 2 kb 
band if the antisense a-amylase gene was amplified (see Figure 4.34). One 
primer was common to both reactions and it contained sequences complementary 
to the pBR322 sequences present in the plasmid pAAH5. The other primers were 
sequences designed to hybridise to the sense or antisense a-amylase gene, shown 
schematically in Figure 4.34 (and Appendix III).
Sense primer pBR322 primer
■  Antisense primer Ampicillin gene
Figure 4.34 Schematic diagram to illustrate where the primers bind.
The primers selected for use in the PCR reaction are shown below:
pBR322: 5’ GTG ATG TCG GCG ATA TAG 3’
Amylase sense: 5’ GTG AGACAT GGC ATG AC A 3’
Amylase antisense: 5’ TGT GAT GCC ATG TCT GAC 3’
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The annealing temperature was calculated to be 49°C.
The template DNA used in the PCR reactions was obtained after genomic 
DNA was extracted from DBY746::pAAH5 (used as a negative control), 
DBY746::pAAMY-01 and DBY746::pSC)C-01. The annealing reactions were 
performed at 49°C. 5(il from the PCR reaction was run on a 0.7% agarose gel.
Figure 4.35 Result o f the PCR reactions.
Lane 1: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072;
3,054; 2,036; 1,636; 1,018; 506 bp)
Lane 2: Negative control (pAAH5 with pBR322 primer and antisense amylase)
Lane 3: DBY746::pAAMY-01 (pBR322 primer and sense amylase primer) (0.98 kb)
Lane 4: DBY746::pSOC-01 (pBR322 primer and antisense amylase primer) (2.0 kb)
Lane 5: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072;
3,054; 2,036; 1,636; 1,018; 506 bp)
As expected there was no amplification observed in the lane containing 
DBY746::pAAH5 (lane 2, Figure 4.35). A band o f the expected size of 0.98 kb 
was observed in lane 3, thus indicating the presence o f the a-amylase gene in 
sense orientation in DB Y746::pAAMY-01. Finally a band o f the expected size o f 
2 kb was observed in the lane containing DBY746::pSOC-01 (lane 4, Figure
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4.35) thus indicating the successful transformation of' the plasmid pSOC-O I into
5. cerevisiae.
4.1.2.2.3 Southern blot analysis
Genomic DNA was extracted from DBY746 and DBY746::pSC>C-01, 
both were electrophoresed undigested on a 0.7% agarose gel, then blotted and 
probed with a non-radioactively labelled DIGoxygenin a-amylase probe. The 
presence o f the plasmid was confirmed by multiple bands o f the various forms of 
undigested DNA lighting up, there was no hybridisation o f the probe to the lane 
containing DBY746, (see Figure 4.67, section 4.3.1.5.2).
4.1.2.2.4 Northern analysis
To determine whether there was in vivo production of antisense cx- 
amylase RNA from DBY746::pSOC-01, the transformant was examined using 
Northern hybridisation. Total RNA was isolated under the conditions described 
in section 2.6.10. RNA was separated on an agarose - formaldehyde gel and 
bidirectionally transferred to a nitrocellulose membrane. The first blot was 
hybridised with a 32P-labelled 1.9 kb a-amylase probe. The second blot was 
probed with a p-actin probe in order to be able to [1] standardise loadings and [2] 
to show that the RNA was not degraded.
As expected, control strain DBY746 generated no signal on the 
autoradiograph when probed with the a-amylase probe (lane 2, Figure 4.36). The 
positive control, DBY746::pAAMY-01 (lane 3) expressed the full-length a- 
amylase transcript o f the expected size o f 1.9 kb and DBY746::pSOC-01 (lane 
4) produced an antisense transcript which was discrete and of the same length. It 
should be noted that the vector contains a transcriptional stop site; the RNA 
transcript obtained was o f a length consistent with that expected if transcription 
was initiated close to the AdHI promoter and terminated at the AdHI transcript 
terminator.
A band of 1.3 kb, which corresponds to the P-actin gene is clearly visible 
in the lanes containing pAAMY-01 and pSOC-Ol (lanes 3 and 4, Figure 4.37). 
This indicates that the RNA was not degraded. A weaker p-actin band was
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visualised in the lane containing DBY746 (lane 2, Figure 4.37), this was due to 
poor loading of this sample onto the agarose gel (data not shown).
The intensities of the bands from both blots were analysed using a Bio- 
Rad Imaging Densitometer (Model GS670). The areas under the curve were 
integrated using Sigma Plot (Jendal Scientific). The ratio o f the intensity of the 
sense a-amylase mRNA transcripts produced by pAAMY-01 to the antisense a- 
amylase transcripts produced by pSOC-01 (after standardising the loadings with 
P-actin) was 1:1. This result demonstrates that the insertion of a full-length 
antisense a-amylase gene (to produce pSOC-01) into the vector pAAH5 
produces a significant amount o f antimessage of similar size to its’ sense 
counterpart (pAAMY-01). The sharpness o f the mRNA band on the blot also 
demonstrates the stability o f the anti-message.
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Figure 4.36 Northern blot o f total RNA extracted from DBY746, 
DBY746::pAAMY-01 and DBY746::pSC)C-01 probed with a 32P-labelled a- 
amylase fragment.
Figure 4.37 Northern blot o f total RNA extracted from DBY746,
DBY746::pAAMY-01 and DBY746::pSC)C-01 probed with a 32P-labelled p-
actin fragment.
Lane 1: RNA markers (6,583; 4,981; 3,638; 2,604; 1,908; 1,383; 955; 623; 281 bp)
Lane 2: DBY746
Lane 3: DBY746::pAAMY-01
Lane 4: DBY746::pSOC-01
4.1.2.2.5 Growth Curves
DBY746 and DBY746::pSC)C-01 were grown in minimal media over 
time to examine whether or not the presence o f this antisense construct had any 
adverse effects on growth. DBY746::pAAMY-01 was also included in this study 
as a further control for comparison purposes. As can be seen from the growth
186
profiles in Figure 4.38, there were no significant growth effects on the S. 
cerevisiae strain DBY746 transformed with the antisense plasmid pSOC-Ol.
time (hour»)
Figure 4.38 Growth Curves o f yeast strains; DBY746, DBY746::pAAMY-01 
and DBY746::pSC)C-01.
4.1.2.3 Analysis of the effect of the YEp-antisense plasmid pSOC-Ol when 
transformed into the integrated sense a-amylase strain SI.
To assess the effect of the antisense a-amylase ENA transcript produced 
from the plasmid pSOC-Ol on the levels of a-amylase activity exhibited by the 
integrated strain SI, pSOC-Ol was transformed into SI. Transformants were 
plated on minimal media containing 2% starch but lacking the amino acids 
leucine and uracil, as the integrating plasmid converts DBY746 to uracil 
prototrophy while the YEp-antisense plasmid pSOC-Ol bears a. L E W  marker. 
Hence a successful transformation event exhibited colonies growing on minimal 
media minus uracil and leucine.
In this study, an inhibitory effect (if any) on the expression of the target 
gene was assessed initially by plating o f transformants (containing both the sense 
and antisense a-amylase gene) onto minimal media containing 2% Lintners’ 
starch. The plates were then normally flooded with iodine vapour. The lack o f a
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halo surrounding a transformant would be indicative o f a lack o f a-amylase 
activity. Since all transformants displayed some level o f activity, approximately 
100 transformants were taken and patched onto more minimal starch containing 
media plates to examine more clearly the sizes of the halos produced. A selection 
of these transformants were then chosen for further analysis by means o f DNS 
assay and/or Northern blot analysis.
Initial visualisation of starch containing minimal media plates after 
transformation of SI with pSOC-Ol showed that all the transformants were 
capable o f breaking down starch, thus indicative of a-amylase activity.
Eventually, four different transformants (A, B, C and D) were chosen, because of 
slight variations in halo size, for analysis to determine whether or not there was 
any downregulation of amylase activity. The DNS assay was used to measure the 
amount o f amylase produced in relation to the control strain SI. All samples were 
assayed in triplicate and the entire assay was repeated 3 times. The cumulative 
results of this experiment are represented by the bar chart shown below (Figure 
4.39). Results are reported as the % amylase activity relative to the control strain 
SI (100%).
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Figure 4.39 Bar chart depicting the effect of the antisense plasmid pSOC-Ol on 
the levels of a-amylase produced by the integrated strain SI.
From the barchart shown in Figure 4.39 one can see that the presence of 
the antisense RNA construct in SI did not significantly downregulate or ablate 
the expression o f the a-amylase gene. Indeed as can be seen from transformant C 
there was a slight increase in the level of a-amylase activity being produced as 
compared to the control strain SI. These results raises the following questions 
assuming that both sense and antisense transcripts are being made (which shall 
be determined in section 4.1.2.4):
1. Is the sense mRNA accessible to the antisense RNA?
2. What is the degree o f secondary folding within the a-amylase transcript?
3. Is the antisense mRNA stable?
4. Is there spatial and temporal coincidence of the two RNAs?
5. Is it possible that there is an unfavourable ratio o f antisense:sense mRNA?
The Northern blot analysis performed in section 4.1.2.4 should help to 
address the question of antisense mRNA stability (or instability), the temporal 
coincidence of the two RNAs and finally the ratio of antisense:sense RNA.
■ si
■  A
□  B
■  C
□  D
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In order to confirm the presence of antisense transcript in the 
transformants, RNA was extracted for analysis. Assuming the antisense 
transcript is present it should then be possible to estimate the ratio of 
sense:antisense mRNA. Due to the fact that both sense and antisense transcripts 
will be o f equal size a probing system which could discriminate between a sense 
and antisense transcript was necessary. The system chosen was Promegas’ 
Riboprobe. This system is designed for the in vitro preparation of high specific 
activity single-stranded RNA probes from cloned DNA inserts (Figure 4.40) in 
the vector pGEM7Zf. This vector has a versatile multiple cloning site (MCS) 
cloned between the T7 and SP6 promoters. Hence depending on the way that the 
DNA of interest is cloned into this MCS either a T7 or SP6 polymerase may be 
used to generate a probe which will bind specifically to a sense or antisense 
sequence on a Northern blot.
4.1.2.4 Northern Analysis
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Figure 4.40 Schematic representation o f how RNA transcripts are generated 
using Promegas’ Riboprobe system.
A bi-directional Northern blot was performed with one blot being probed 
with an antisense probe which should detect all sense a-amylase transcripts and a
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P-actin probe. Conversely the second blot was probed with the sense probe to 
detect all the a-amylase antisense gene sequences. For preparation of the 
recombinant pGEM7Zf vector a 1.9 kb Hind III a-amylase gene fragment was 
gene cleaned from a 0.7% agarose gel and ligated into Hind ID restricted 
pGEM7Zf. The transformants were plated on LB amp plates which also 
contained 2% Lintners starch and X-gal for exploitation of the lacZ phenotype. If 
the ligation and subsequent transformation resulted in the a-amylase gene 
sequence being cloned in one orientation only with respect to the T7 and SP6 
promoters, then both polymerases would be necessary to generate the sense and 
antisense probes. However as the cloning resulted in the a-amylase gene being 
cloned in both orientations (pSP6-AMY and pT7-AMY, Figure 4.41) it was only 
necessary to use one of the polymerases.
<   ►
Figure 4.41 Schematic representation of the plasmids pSP6-AMY and pT7- 
AMY which were used for the generation of riboprobes. (BHI represents the 
restriction enzyme Bam H I).
Additionally to standardise the loadings on gels it was necessary to have a 
probe capable o f binding to P-actin sequences. A 3.8 kb fragment containing the 
p-actin gene was removed from the plasmid pRB149 (Appendix II) after 
restriction digestion with EcoR I. This fragment was gene cleaned and ligated 
into EcoR I restricted pGEM7Zf. This plasmid was named ppACTSP6 as the
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insert was in sense orientation relative to the SP6 promoter (Figure 4.42). 
Restriction analysis of each of these 3 plasmids is shown in Figure 4.43.
i --------------------------
Figure 4.42 Schematic representation o f the plasmid pPACTSP6 used for the 
generation of a riboprobe.
To confirm the construction of pSP6-AMY, pT7-AMY and pPACTSP6, 
plasmid DNA was extracted from DH5a cells and analysed by restriction 
enzyme digestion. The plasmids pSP6-AMY and pT7-AMY were restricted with 
Hind in  (to prove an insert o f 1.9 kb corresponding to the a-amylase gene) and 
BamH I was chosen for the purposes o f orientation, i.e. whether the a-amylase 
gene was cloned in the sense orientation relative to the T7 or SP6 promoter. The 
restriction enzyme EcoR I was chosen as this enzyme should linearise the 
plasmid. The plasmid pPACTSP6 was restricted with EcoR I (to confirm an 
insert of 3.8 kb) and BamH I was chosen for purposes o f orientation i.e was the 
P-actin gene sequence cloned in sense orientation relative to the SP6 or T7 
promoter. Bgl II was chosen as this restriction enzyme should linearise the 
plasmid as there is a Bgl II restriction site in the cloned p-actin fragment but not 
within the pGEM vector.
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Figure 4.43 Restriction analysis of pSP6-AMY, pT7-AMY and ppACTSP6.
Lane 1: 1 kb ladder (12.216; 11.198; 10.180; 9.162; 8.144; 7.126; 6.108; 5.090; 
4.072; 3.054; 2.036; 1.636; 1.018; 0.506 kb)
Lane 2: pSP6-AM Y undigested
Lane 3: pSP6-A M Y  digested w ith  H ind  IE (3.0; 1.9 kb)
Lane 4: pSP6-AM Y digested w ith  BamW  I (4.9 kb)
Lane 5: pSP6-A M Y  digested w ith E co R  I (4.9 kb)
Lane 6: pT7-AM Y undigested
Lane 7: pT7-AM Y digested w ith H ind  111(3.0; 1.9 kb)
Lane 8: pT7-AM Y digested w ith  Bam] 11 (3.0; 1.9 kb)
Lane 9: pT7-AM Y digested w ith  EcoR  I (4 .9  kb)
Lane 10: pPACT-SP6 undigested
Lane 11: pPACT-SP6 digested w ith  E coR  I (3.8; 3.0 kb)
Lane 12: pPACT-SP6 digested w ith  BamW  1 (6.0; 0.8 kb)
Lane 13: pPACT-SP6 digested w ith  B gl D (6.8 kb)
Lane 14: 1 kb ladder (12.216; 11.198; 10.180; 9.162; 8.144; 7.126; 6.108; 5.090; 
4.072; 3.054; 2.036; 1.636; 1.018; 0.506 kb)
From Figure 4.43 it can be seen that the Hind HI digests of pSP6-AMY 
and T7-AMY (lanes 3 and 7) confirm an insert of 1.9 kb. The BamW I digest of 
pSP6-AMY (lane 4, Figure 4.43) yielding a fragment size of 4.9 kb indicates that
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the a-amylase gene was cloned in sense orientation relative to the SP6 promoter, 
whereas the BamH I digest of pT7-AMY (lane 8, Figure 4.43) yielded the 
expected 2 bands o f 3.0 and 1.9 kb bands to prove that the a-amylase gene was 
cloned in sense orientation relative to the T7 promoter. Restriction digestion of 
these two plasmids with EcoR I (lanes 5 and 9) yielded the expected single band 
of 4.9 kb.
Restriction digestion of pPACT-SP6 with EcoR I demonstrates an insert 
of the expected size o f 3.8 kb (lane 11, Figure 4.43). The BamH I digest yielding 
bands o f 6.0 and 0.8 kb respectively (lane 12, Figure 4.43) indicates that the P- 
actin gene sequences had cloned in sense orientation relative to the SP6 
promoter. If this gene had cloned in sense orientation relative to the T7 promoter 
band sizes of 3.8 and 3.0 kb would have been expected. The Bgl n  restriction 
data (lane 13, Figure 4.43) linearised the plasmid to give a fragment size of 6.8 
kb. In conclusion, the restriction data obtained (Figure 4.43) confirms the 
construction o f the plasmids pSP6-AMY, pT7-AMY and pPACT-SP6.
Total RNA was isolated from DBY746, DBY746::pSOC-01, SI and 
SI::pSOC-01 under the conditions described in section 2.6.10. The RNA was 
separated on an agarose - formaldehyde gel and bidirectionally transferred to a 
nitrocellulose membrane. The first blot (Figure 4.45) was probed with a 32P- 
labelled sense a-amylase riboprobe and the second blot with both a 32P-labelled 
antisense a-amylase riboprobe and a P-actin riboprobe.
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Figure 4.44 Formaldehyde agarose gel o f total RNAs.
Lane 1: DBY 746
Lane 2: SI
Lane 3: D BY 746::pSOC-01
Lane 4: SI::pSC)C-01 (B)
Lane 5: RNA m arkers (6,583; 4,981; 3,638; 2 ,604; 1,908; 1,383; 955; 623; 281 bp)
2*11
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Figure 4.45 Bi-directional Northern blot of total RNAs probed with a 32P-
labelled sense a-amylase riboprobe.
Figure 4.4«
riboprobe.
.46 probed with a 32P-labelled antisense a-amylase and P-actin
Lane 1: D BY 746
Lane 2: SI
Lane 3 : DBY746::pSOC-01
Lane 4: SI::pSOC-01 (B)
Lane 5: R N A  markers (6,583; 4,981; 3,638; 2,604; 1,908; 1,383; 955; 623; 281 bp)
The Northern blot analysis was performed as previously mentioned to 
answer the following questions;
1. Is there anti-message being made?
2. Is there temporal coincidence o f the two transcripts?
3. Are both RNAs stable? And finally,
4. What are the relative ratios of antisense:sense RNA?
After hybridisation with the sense probe (Figure 4.45) the following observations 
were made. Firstly, and most importantly a band of the expected size for the 
antisense a-amylase transcript (1.9 kb) can be seen in the lane containing the
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integrated yeast strain SI::pSC)C-01(B) (lane 4, equivalent in size to that seen in 
lane 3 containing DBY746::pSC>C-01). However for some unexplained reason 
there appears to be far less antisense a-amylase transcripts in SI::pSC)C-01 
compared with DBY746::pSOC-OL As expected, DBY746 and SI strains alone 
(lanes 1 and 2, Figure 4.45) do not have the 1.9 kb antisense a-amylase 
transcript. It should be noted that 2 non-specific bands of sizes (2.25 and 1.15 kb) 
appear in lane 2 (Figure 4.45). These 2 bands have appeared on other Northern 
blots in samples extracted from yeast samples containing plasmid DNA.
When the blot was probed with an antisense a-amylase probe, a band of 
the expected size for the sense transcript (i.e. 1.9 kb) is visible in lanes 2 and 4 
(SI, SI::pSC)C-01, figure 4.46), but is not present in lanes 1 and 3, (Figure 4.46 
DBY746 strains rather than SI), however a non-specific band of 2.1 kb does 
appear in lane 3. The presence of the (3-actin band is visible in lanes 1 to 3 
(Figure 4.46), but has not hybridised to the sample in lane 4 (Figure 4.46). It 
might be possible to explain the absence of this band simply in terms of poor 
hybridisation overall of the RNA in this lane to all probes used. In summary the 
following overall conclusions can be made;
1. anti-message is being made,
2. there was temporal coincidence of the two transcripts,
3. both the sense and antisense transcripts are discrete bands of the expected sizes 
of 1.9 kb respectively.
Finally, although the p-actin probe did not bind strongly in lane 4 (Figure 
4.46), on measuring the band intensities of the sense and antisense transcripts 
produced from SI::pSC)C-01 on a Pharmacia-Biotech (ImageMaster ID) Imaging 
densitometer (taking into account the backgrounds) an estimation of the ratio of 
sense : antisense transcripts was obtained and calculated to be 1:4. Based on the 
known copy number o f pSOC-Ol and the integrated sense gene number in SI 
(10:2), this observed transcript ratio of 4:1 does reflect the copy number data.
Copy number analysis has been performed on the plasmid pSOC-Ol 
based on Southern hybridisation (data not shown) and the result obtained showed 
that the plasmid pSOC-Ol was present in DBY746 between 9 -1 1  copies per 
cell. In agreement with this result was the result obtained from copy number 
analysis o f a similar plasmid, pJG317, (which has a p-glucanase gene inserted
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into the vector pAAH5) it was found to be present in DBY746 at 10 - 11 copies 
per cell (Canavan, 1994). Also Korpela et al., (1987) measured the plasmid copy 
number of pAAH5 as 10 copies per cell. Although the plasmid copy number was 
lower than expected there is still an excess of antimessage to message being 
produced. However the amount of antimessage being produced is not as high as 
that recommended for studies o f this kind (Izant and Weintraub, 1984, Melton, 
1985). In order to try and increase the levels o f antisense transcript, two 
alternative approaches were taken. These are described in iram-Experiment I (b) 
(this chapter) and /ram-Experiment II (chapter 5).
4.1.3 DISCUSSION
The first half o f /ram-Experiment I (a) dealt with the construction of a 
yeast strain containing an integrated sense a-amylase gene in as low a copy 
number as possible. This was achieved successfully and the integrated copy 
number of the a-amylase gene was 2. A full-length antisense a-amylase gene 
was introduced into the integrated strain on the plasmid pSOC-Ol, this plasmid 
being based on the yeast shuttle vector pAAH5. pAAH5 was chosen initially as 
Armstrong et al., (1989) reported that yeast-shuttle vectors which contain a 2fi 
origin o f replication can exist in high copy numbers (from 10 -40  copies per 
cell) in [cir+] yeast cells. It was hoped therefore to that by using this system we 
would be able to produce antisense RNA in 10 - 20 times excess of the sense 
message assuming that no transcription factors are limiting. However copy 
number analysis of pSOC-Ol in yeast strain DBY746 revealed a copy number of 
between 9 -1 1  plasmids per cell. This number was lower than what was 
anticipated and even though there was an excess o f antisense mRNA to mRNA 
(4:1) perhaps the excess was inadequate to mop up all the sense transcripts and 
hence this is one o f the possible explanations for the lack o f inhibition of a- 
amylase gene activity.
In many cases, the lack of inhibition by antisense genes has been 
attributed to the instability of the transcribed antisense RNA (Kim and Wold, 
1985; Nishikura and Murray, 1987; Delauney et al., 1988; van der Krol et al., 
1988b). In /ram-Experiment I (a), Northern blot analysis was used to examine 
the steady state level o f antisense a-amylase RNA and sense mRNA in the
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appropriate yeast transformants. This analysis suggested that the antisense RNAs 
were stable but possibly the excess of antimessage to message was inadequate to 
produce a regulatory effect on a-amylase gene expression.
Temporal coincidence o f the antisense and sense a-amylase gene 
transcripts was monitored directly in this experimental system. This was 
achieved by northern analysis as a coincident hybridisation signal for both 
antisense and target RNA on a northern blot was assumed to indicate temporal 
coincidence. Following on from this point it was essential that liquid cultures 
were sampled appropriately and that growth and comparison between individual 
samples was carefully controlled. For analysis o f all transformants each sample 
was taken at mid-log phase (an OD 0.8 - 1.0, usually after 36 hours) to ensure 
that all strains were at the same level o f growth before comparisons were made. 
Time course analysis (both DNS and Northern) was also performed (data not 
shown) to assess the best time point to take samples for DNS and Northern 
analysis.
The results obtained from /rara-Experiment I (a) led to the design of 
/ram-Experiment I (b) where the main concern was to increase the amount of 
antisense RNA relative to sense RNA. From the early studies o f Izant and 
Weintraub (1984) and Melton (1985) to more recent studies based on 
oligonucleotides, the emphasis has been on creating a situation in the cell where 
there is an excess of antisense to sense RNA. Izant and Weintraub (1984) co­
injected an antisense thymidine kinase (TK) gene with a wildtype TK gene- 
containing plasmid into mouse TK' L cell nuclei at a ratio o f 100 to 200:1, 
respectively. Under these conditions there was a 4- to 5- fold reduction in the 
TK+ cell transformants compared to controls. Melton (1985) showed that 
injection of Xenopus oocytes with a 50-fold greater amount of antisense p-globin 
RNA resulted in complete blockage o f P-globin mRNA translation. Therefore in 
this study, by increasing the antisense: sense message ratio it was hoped that a 
critical threshold would be reached after which a-amylase activity would begin 
to be down-regulated.
2 0 0
Tìra/fs-Experiment I (b)
I Sense amylase sequences 
lAntisense amyl.ase sequences
P; Plasmid
Chr; Chromosomal location
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4.2 TRANS-EXPERIMENT I (b) - INTRODUCTION
Like the trans I (a) experimental system, the irons I (b) system also 
sought to generate a favourable anti-mRNA:mRNA ratio, as the importance of 
having excess antimessage to message has been stressed in many review articles 
(Daugherty et al., 1989). Although an excess o f anti-mRNA was being produced 
in trans Experiment I (a), this ratio of 4:1, of anti-mRNA:mRNA was not 
sufficient to down-regulate expression o f the a-amylase gene. It was decided to 
increase the amount o f anti-mRNA being produced by the integration of the a- 
amylase antisense gene into the ribosomal DNA (rDNA) cluster of the S. 
cerevisiae strain DBY746. This region of the genome was chosen as it contains 
140 tandem repeats of a 9.1 kb rDNA unit on chromosome XII. According to 
Lopes et al., (1989) who designed a vector that can integrate into the rDNA locus 
of S. cerevisiae, it is possible to integrate up to 140 copies o f the vector which 
are stably maintained over long periods of growth and non-selective conditions. 
Furthermore by introducing the sense a-amylase gene on a low-copy number 
plasmid bearing an ARS-CEN origin o f replication (ARS-CEN vectors are 
present in only 1 -2  copies per cell) it was hoped that the amount of antimessage 
being made would be in far greater excess than the sense mRNA being produced 
from this plasmid. Once again the sense and antisense a-amylase genes were 
under the control o f the same promoter to ensure temporal coincidence of the two 
RNAs.
Various different approaches based upon integration into reiterated 
chromosomal DNA have been adopted to generate stable multi-copy integrants. 
These strategies include integration into TY elements, delta elements and 
reiterated ribosomal DNA (rDNA) sequences. Sakai et al., (1991), developed a 8- 
integration system which utilises the 8 sequences o f the TY element on yeast 
chromosomes as a homologous recombination site. No less than 80 copies of 8- 
sequences are estimated to be present on the yeast chromosomes and integration 
o f multiple copies o f a heterologous gene enabled a stable overproduction o f the 
encoded protein in rich medium, these integrations being mitotically stable.
Unlike the 2fj.-based, YEp-type multi-copy plasmid used to introduce
2 0 2
heterologous DNA into yeast which are not mitotically stable and tend to be lost 
during cultivation in rich media without a selective force. Using the 8-integration 
system Sakai et al., (1991), succeeded in overproducing human nerve growth 
factor at a level 3-4 times higher than that achieved by a 2(i-based plasmid 
(Mochizuki et al., 1994).
The multiple integration vector chosen was pMIRY (for Multiple 
Integration in the_Ribosomal DNA of Yeast) developed by Lopes et al., (1989). 
Lopes et al., integrated genes encoding PGK (phosphoglycerate kinase), SOD 
(superoxide dismutase) and thaumatin into a non-transcribed spacer region of the 
reiterated rDNA. These integrative transformations resulted in LE i f  
transformants carrying 100-200 copies o f the aforementioned genes.
Yeast vectors suitable for high level expression of heterologous proteins 
should combine a high copy number with a high mitotic stability under non- 
selective conditions. High stability can be ensured by integration of the vector 
into chromosomal DNA and the high copy number is ensured by targeting the 
vector to the reiterated rDNA yeast sequence. The ribosomal yeast DNA 
sequences present in the pMIRY2 vector are composed of part o f the 26S rRNA 
gene, NTS1 (non-transcribed spacer), 5S RNA gene and NTS2 (see Figure 4.47 
[rDNA alone]). Additionally, in order for amplification to occur, a strong 
selection pressure is required, which was created in the pMIRY vector (Appendix 
VI), by using as a selection marker an expression deficient gene (LEU2d) 
involved in the production of the basic nutrient leucine. The pMIRY vector 
chosen for this part o f the study, fulfils all o f the above criteria. Additionally, this 
vector can also be linearised at the unique Kpn I site present in its leucine 
deficient gene, to direct integration to the LEU2 locus present on chromosome 
III. This would result in a lower copy number of plasmid integrations.
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Figure 4.47 Genetic organisation of an rDNA unit from Saccharomyces 
cerevisiae (Lopes et al.,1996).
The first half of /rans-Experiment I (b) describes the cloning of the 
Bacillus licheniformis a-amylase gene into the ARS-CEN vector pFL38 with 
subsequent analysis of its’ cc-amylase activity in comparison to the sense a- 
amylase integrants and the 2\x based sense a-amylase plasmid pAAMY-01 (from 
/ram-Experiment I (a)). The second half of this section will deal with the 
construction of the multiple integrating plasmid pMISOC, which contains the 
entire a-amylase gene cloned in antisense orientation relative to the AdHI 
promoter and terminator. Following this, will be a description o f how this 
plasmid was integrated into DBY746 to produce the integrated strain MI, ensued 
by a characterisation of this integration event. The important results as with 
/ram-Experiment I (a) come in this section with the introduction of the pFL38- 
AMY plasmid into this integrated yeast strain, MI. 7><ms-Experiment I (b) will 
conclude with a brief discussion on the results obtained.
4.2.1 CLONING OF THE BACILLUS LICHENIFORMIS a-AMYLASE 
GENE INTO A LOW COPY VECTOR
Once again the objective in this experimental system as with trans- 
Experimental system I (a), was to keep the sense a-amylase gene copy number 
low, (low relative to the antisense genes), but not too low so as to result in an 
insensitive assay. This objective was achieved by cloning the sense a-amylase 
gene into a low-copy vector (by virtue of its’ ARS-CEN origin of replication, 
these plasmids are present in only 1 - 2 copies per cell), the assumption here 
being that the level of message will be reflected in the copy number. The vector 
chosen was pFL38 (Bonneaud et al., 1991, Appendix VII), as in addition to the
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ARS-CEN origin o f replication, this vector also possesses a different selection 
marker to the multiple integration vector. pMISOC. L1RA3 being the marker 
present on pFL38. T he a-amylase gene was cloned into the unique BamH  I site 
o f pFL38 on an AclHI promoter - sense a-amylase gene - AdH I terminator 
cassette. By virtue o f  the fact that both the sense and antisense genes were under 
the control o f  the same promoter this should ensure temporal coincidence o f both 
RNAs. The construction o f this plasmid, which w ill be referred to as pFL38- 
AM Y from now on, was constructed as outlined in the legend to Figure 4.48.
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Figure 4.48 Construction o f  pFL38-AMY.
A 4.0 kb B anM  1 partial containing the A dH I promoter - sense a-am ylase gene - AdH I 
term inator from the plasmid pAAMY-01 was gene cleaned from a 0.7%  agarose gel and ligated 
into the B am ti I d igested pFL38 vector. The ligation mix was transform ed into D H 5a E. coli 
cells and plated on LB am p plates containing 2%  starch. W ith this clone orientation does not 
m atter as the gene is in th e  correct orientation w ith respect to  the A d H I  promoter and terminator, 
This plasmid was named pFL38-A M Y  and is 8.51 kb in size.
Plasmid DNA was extracted from DH5a E. coli transformants, which 
exhibited a-amylase activity. Restriction enzyme analysis was then carried out 
(Figure 4.49). Restriction of pFL38-AMY with the enzyme BamH I should 
produce 3 bands, corresponding to the parental vector pFL38 (4.61 kb), the a- 
amylase gene and AdHI terminator (2.35 kb) and the AdHI promoter (1.55 kb). 
The DNA was also restricted with Hind III and Sal I to further confirm the 
construction of the plasmid pFL38-AMY.
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The approximate sizes o f each of the restriction fragments is shown in base pairs 
in brackets below. The relevant sizes o f the 1 kb ladder are as indicated.
Figure 4.49 R estriction analysis o f  pFL38 and pFL 38-A M Y .
Lane 1: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072; 
3,054; 2,036; 1,636;1,018; 506 bp).
Lane 2: pFL38 undigested
Lane 3: pFL38-A M Y  undigested
Lane 4: pFL38 digested w ith  BamH  I (4 ,610 bp)
Lane 5: pFL38-A M Y  digested w ith  B am H  I (4,610; 2,350; 1,550 bp)
Lane 6: pFL38 digested w ith  H ind  HI (4 ,610 bp)
Lane 7: pFL38-A M Y  digested w ith H ind  III (5,060; 1,900; 1,550 bp)
Lane 8: pFL38 digested w ith  Sa l I (4 ,610 bp)
Lane 9: pFL38-A M Y  digested w ith  S a l I (5,830; 2 ,680 bp)
Lane 10: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072; 
3,054; 2,036; 1,636; 1,018; 506 bp).
The BamH I restriction digest of pFL38-AMY (lane 5, Figure 4.49) produced the 
expected bands of 4.61, 2.35 and 1.55 kb respectively. The Hind III digest (lane 
7, Figure 4.49) released the expected 1.9 kb a-amylase gene fragment. The Sal I
restriction digest (lane 9, Figure 4.49) produced 2 bands o f 5.83 and 2.68 kb 
consistent with the cloning o f the 3.9 kb AdHl promoter -sense a-amylase gene - 
AdHI terminator cassette into pFL38.
4.2.1.1 Activity analysis of pFL38-AMY
This plasmid was transformed into DBY746 to estimate the level o f a- 
amylase activity. Transformants were plated on minimal media supplemented 
with 2% Lintners starch. Visualisation of the plates after exposure to iodine 
vapour demonstrated that this plasmid does indeed express a functional product 
in S. cerevisiae strain DBY746. The actual level o f amylolytic activity was 
assessed for 3 o f  these transformants by performing a DNS assay. The level 
expressed by these transformants, DBY746::pFL38-AMYl, 2 and 3 was 
compared to the levels expressed in the recombinant pAAMY-01 which carries 
the a-amylase gene on a higher copy number 2\x episomally based vector. A 
comparison was also made with the integrated strains h, SI, SII and SIV 
(constructed in section 4.1.1) the copy numbers of which, in particular SI, should 
be similar to that of pFL38-AMY. DBY746 was used as a negative control. The 
results o f this assay are tabulated in Table 4-5.
Table 4-5 Levels o f a-amylase activity as produced by different plasmids and 
from various integrated strains.
Strain Activity
U/ml
Cell Number Activity/Cell
DBY746 0 0 0
DBY746::pAAMY01 985.2 3.3 x 107 2.98 x 10 5
DBY746::pFL38-AMYl 345.2 3.4 x 107 1.02 x 10 5
DBY746::pFL38-AMY2 321.8 3.45 x 107 0.93 x 10 5
DBY746::pFL38-AMY3 307.9 3.3 x 107 0.93 x 10'5
h 547.3 3.3 x 107 1.65 x 10 5
SI 304.9 3.2 x 107 0.95 x 10 5
sn 503.7 3 .3 .x 107 1.50 x 10 5
SIV 578.6 3.5 x 107 1.65 x 10 s
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4.2.2 CONSTRUCTION AND ANALYSIS OF A MULTIPLE 
INTEGRATING PLASMID PRODUCING ANTISENSE RNA 
COMPLEMENTARY TO THE ENTIRE a-AMYLASE GENE
A pMIRY plasmid containing an expression cassette capable of 
expressing antisense a-amylase was constructed and named pMISOC. The 
plasmid is represented schematically in figure Figure 4.50 and the details of 
construction are included in the legend to the Figure 4.51. The plasmid 
construction was confirmed using diagnostic restriction enzyme analysis (Figure 
4.53). Orientation of the 4.0 kb BamH I insert into the parental vector pMIRY 
did not matter as the insert was a cassette consisting o f the AdHI promoter - 
antisense a-amylase gene - AdHI terminator. The important factor being that the 
a-amylase gene was in antisense orientation relative to the AdHI promoter and 
terminator.
Figure 4.50 Schematic representation of the multiple integrating plasmid 
pMISOC which contains the a-amylase gene in antisense orientation relative to 
the AdHI promoter and terminator.
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Figure 4.51 Steps involved in constructing the multiple integrating vector 
pMISOC.
The A d H I  prom oter - term inator cassette o f  pAAH5 (A ppendix VIII) is on a  2 .0  kb B am H  I 
fragment, how ever because there is an  internal B am H  I site at the start o f  the a-am ylase gene 
before the transcription start site, it m eant partially digesting pSOC-Ol to  obtain a  4 .0  kb Bam H  I 
fragment containing th e  A d H I  prom oter - antisense gene - A d H I  term inator, w hich could then  be 
cloned into the unique B am H  I site o f  pM IRY. The partial digest proved to  be somewhat 
refractory, therefore another approach w as adopted.
212
Step  I: Involved the removal o f  the internal B am H  I site from the a-am ylase gene cloned into 
pSL52 by in  vitro  m utagenesis. This was achieved by digesting pSL52 w ith Bam H  I, the ends 
w ere filled-in using the K lenow enzyme. A fter th is the  m ixture was phenol extracted twice, 
chloroform w ashed once, ethanol precipitated and w ashed. Follow ing this the contents o f  the 
microfuge tube w ere religated w ith T4DNA ligase. The m ixture was transform ed into E. coli 
D H 5 a  cells. C lones w ere screened by digesting w ith  Bam H  I to  confirm  the removal o f  this site, 
follow ed by digestion w ith  H ind  III to  release the 1.9 kb a-am ylase gene. This plasmid now  
being called pSL52i- S tep  I I  involved subcloning the H ind  IU a-am ylasc gene from pSL52i into 
the unique H ind  III site  o f  pAAH5. The ligation m ixture was transform ed into E. coli D H 5 a cells 
and resulting transform ants w ere screened. P lasm ids w hich contained the a-am ylase gene in 
sense orientation w ere designated pA AM Y -02; plasm ids w hich contained the gene in the 
antisense orientation w ere designated pSC)C-02. O rientation w as confirmed using K pn  I as the 
diagnostic enzyme. pA A M Y -02 giving fragm ent sizes o f  7.49, 4 .14 and 2.5 kb. pSO C-02 giving 
fragment sizes o f  6.77, 4.86 and 2.5 kb (figure 4.52). Finally, in  S tep  I I I  the 3.9 kb Bam H  I 
A d H I  prom oter - antisense a-am ylase gene - A d H I  term inator cassette was cloned after gene 
cleaning the fragment from a  0.7%  agarose gel in to  th e  unique Bam H  I site o f  the m ultiple 
integrating vector pM IRY to  yield pM ISOC. W ith  th is clone orientation obviously does no t 
m atter as the gene is in correct orientation w ith  respect to  the A d H I  promoter and terminator.
The construction o f pSC)C-02 and pAAMY-02 (step [II], Figure 4.51) was 
verified by restriction enzyme analysis. The restriction enzyme Kpn I was chosen 
to demonstrate the antisense (pSC)C-02) and sense (pAAMY-02) orientation of 
the a-amylase gene insert into pAAH5, whereas BamH I was used to 
demonstrate the successful removal of the internal BamH I site of the a-amylase 
gene.
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Figure 4.52 Restriction analysis o f plasmids pSOC-02 and pAAMY-02.
The approximate sizes of each of the restriction fragments is shown in base pairs 
in brackets below. The relevant sizes o f the 1 kb ladder are as indicated.
Lane 1: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072;
3,054; 2,036; 1,636; 1,018; 506 bp).
Lane 2: pSOC-Ol undigested
Lane 3: pAAMY-01 undigested
Lane 4: pSOC-02 undigested
Lane 5: pAAMY-02 undigested
Lane 6: pSOC-Ol digested with Kpn I (6,770; 4,860; 2,500 bp)
Lane 7: pAAMY-01 digested with Kpn I (7,490; 4,140; 2,500 bp)
Lane 8: pSOC-02 digested with Kpn I (6,770; 4,860; 2,500 bp)
Lane 9: pAAMY-02 digested with Kpn I (7,490; 4,140; 2,500 bp)
Lane 10: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072;
3,054; 2,036; 1,636; 1,018; 506 bp).
Lane 11: pSOC-Ol digested with Sal I (6,750; 5,520; 1,860 bp)
Lane 12: pAAMY-01 digested with Sal I (6,750; 5,880; 1,500 bp)
Lane 13: pSOC-02 digested with Sal I (6,750; 5,520; 1,860 bp)
Lane 14: pAAMY-02 digested with Sal I (6,750; 5,880; 1,500 bp)
Lane 15: pSOC-Ol digested with BamH I (10,230; 3,450; 450 bp)
Lane 16: pAAMY-01 digested with BamH I (10,230; 2,350; 1,550 bp)
Lane 17: pSOC-02 digested with BamH I (10,230; 3,900 bp)
*-5090
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Lane 18: I kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072:
3,054; 2,036; 1,636; 1,018; 506 bp).
L ane 19: pA A M Y -02 digested with Bam H  I (10,230; 3,900 bp)
The Kpn I restriction data clearly demonstrates the antisense and sense 
orientation o f the a-amylase gene, with the expected fragment sizes of 6.77, 4.86 
and 2.5 kb (lane 8, Figure 4.52) and 7.49, 4.14 and 2.5 kb (lane 9, Figure 4.52) 
respectively. The successful removal o f the internal BamH I site from the oc- 
amylase gene was demonstrated by restriction digestion of pSC)C-02 and 
pAAMY-02 with BamH I, which gave the expected band sizes o f 10.23 and 3.9 
kb respectively (lanes 17 and 19, Figure 4.52). In contrast, the plasmids pSOC-Ol 
and pAAMY-01 which contain the internal BamH I site gave fragment sizes of 
10.23, 3.45 and 0.45 kb (lane 15, Figure 4.52) andl0.23, 2.35 and 1.55 kb (lane 
16, Figure 4.52) respectively.
Finally, verification of the cloning of the 3.9 kb ^¿////promoter - 
antisense a-amylase gene - AdHI terminator into the multiple integrating vector 
pMIRY was also achieved by restriction enzyme analysis (Figure 4.53).
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Figure 4.53 Restriction analysis of pMISOC (and pMIAMY, which does contain 
a BamW I site in the a-amylase gene insert).
The approximate sizes o f each of the restriction fragments is shown in 
base pairs (bp) in brackets below. The relevant sizes o f the 1 kb ladder are as 
indicated.
L an e  1: 1 kb ladder (12,216; 11,198; 10,180; 9 ,162; 8,144; 7,126; 6,108; 5,090; 4,072;
3,054; 2,036; 1,636; 1,018; 506 bp).
L an e  2 : pM ISOC undigested
L an e  3 : pM IAM Y undigested
L an e  4: pM ISOC digested w ith  H ind  IE (5,350; 3,950; 2,900; 1,900 bp)
L an e  5: pM IAM Y  digested w ith H ind  m  (6,450; 2,900; 2,850; 1,900 bp)
L an e  6: pM ISOC digested w ith  Pst I (11,200; 2 ,900 bp)
L an e  7 : pM IAM Y  digested w ith  P sl I (10,100; 4,000 bp)
L an e  8: pM ISOC digested w ith  BamW  I (10,200; 3,900 bp)
L an e  9: pM IAM Y  digested w ith  BamW  I (10,200; 2,350; 1,550 bp)
L an e  10: pM ISOC digested w ith  Kpn  I (8,800; 5 ,300 bp)
L an e  11: pM IAM Y  digested w ith K pn  I (7,700; 6,400 bp)
L an e  12: pM ISOC digested w ith Sal I (14,100 bp)
L an e  13: pM IAM Y  digested w ith Sa l I (14,100 bp)
L an e  14: pM ISOC digested w ith Sma  I (14,100 bp)
L an e  15: pM IAM Y  digested w ith  Sm a  I (14,100 bp)
L an e  16: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072;
3,054; 2,036; 1,636; 1,018; 506 bp).
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The band of 3.9 kb visualised on the ethidium bromide stained agarose gel 
following restriction digestion o f pMISOC with BamH I (lane 8, Figure 4.53) 
constitutes proof o f the cloning of the AdHI promoter - antisense a-amylase - 
AdHI terminator into pMIRY. Linearisation o f the plasmid with Sal I (lane 12, 
Figure 4.53) or Sma I (lane 14, Figure 4.53) also gave the predicted band size of
14.1 kb. Orientation o f the antisense a-amylase gene cloned between the AdHI 
promoter - terminator cassette in the plasmid pMISOC was demonstrated by 
restriction with either Hind ID (lane 4, Figure 4.53), Pst I (lane 6, Figure 4.53) or 
Kpn I (lane 10, Figure 4.53). For comparison purposes the plasmid pMIAMY 
which contains the sense a-amylase gene cloned between the AdHI promoter - 
terminator cassette was restricted with the same enzymes as the plasmid 
pMISOC.
4.2.3 INTEGRATION OF THE ANTISENSE a-AMYLASE GENE INTO 
THE RIBOSOMAL DNA OF SACCHAROMYCES CEREVISIAE TO 
PRODUCE THE STRAIN ML
Plasmid pMISOC was transformed into S. cerevisiae DBY746 cells after 
linearisation of this plasmid at the unique Sma I site (Figure 4.54) which cuts 
within the rDNA sequences on the vector and serves to direct integration into the 
rDNA loci. After integrative transformation the cells were plated on selective 
media minus leucine. The plates were also supplemented with 2% Lintners starch 
and the plates were analysed for a lack o f amylolytic activity. As expected the 
transformants displayed no haloes when subjected to iodine vapour.
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Figure 4.54 Schematic representation of most likely integration event.
4.2 J . l  Characterisation of the integration event
4.2.3.1.1 Growth on selective plates
Only the transformants which received the LEU2d genes from the 
plasmid pMISOC which complements the LEU2 mutations o f the host cell would 
be capable o f growth on leucine minus minimal media. As the plasmid pMISOC 
lacks an origin of replication, in addition to possessing a leucine deficient 
marker, growth o f transformants on media lacking leucine would strongly 
suggest the presence o f the integrated plasmid. As DBY746 is auxotrophic for 
both uracil and leucine, growth on minimal media containing only uracil 
constitutes proof o f the presence o f the integrated plasmid.
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Yeast transformants were grown initially in minimal medium, then they 
were transferred to YEPD media where they were kept growing for over 100 
generations by repeatedly transferring them into fresh YEPD medium (see 
methods section 2.9). The percentage o f cells with the LEU + marker was then 
determined by plating single colonies on YEPD and checking for the loss of the 
plasmid associated marker by replica plating onto selective medium. The 
episomal plasmid pAAMY-01 was used as a control. The number of URA + cells 
harbouring the YEp-type plasmid pAAMY-01 which contains the a-amylase 
gene, showed a decrease over the first few generations and dropped to 
approximately 10.0% after 50 generations. In contrast, no decrease in the number 
of L E l f  cells was observed among the rDNA integrants after 100 generations. 
These results indicated that the rDNA integrated sequences were maintained very 
stably during mitotic growth in rich medium. The high stability o f the L E lf  
phenotype was also another indication that integration into the yeast genome had 
occurred.
120
^  100
2  80
$Kl*0 60
I 40E^
 20c
0
0 25 50  75 100
Number o f  generations
4.2.3.1.2 Stability o f  the Integrated strain
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-■— pAAMY-01
Figure 4.55 Graph depicting the mitotic stability of the integrated strain, MI.
4.2.4 ANALYSIS OF THE EFFECT OF THE ANTISENSE a-AMYLASE 
RNA TRANSCRIBED FROM THE INTEGRATED STRAIN, MI, ON THE 
SENSE a-AMYLASE RNA TRANSCRIBED FROM pFL38-AMY
After transformation o f pFL38-AMY into MI, the cells were plated onto 
leucine and uracil minus minimal media (leu and urd  , leucine being provided
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by the plasmid pMISOC and uracil from the pFL38-AMY plasmid) 
supplemented with 2% starch. From the initial visualisation of the plates it 
appeared that the a-amylase gene was still active as clear haloes were seen 
surrounding the transformants after exposure to iodine vapour (Figure 4.56). 
Three transformants were taken for further analysis and a DNS assay was 
performed on the supernatants after 36 hours growth in minimal media at 30°C, 
to assess if any down regulation o f the enzymes’ activity had occurred. The 
positive control used was DBY746 transformed with pFL38-AMY 
(DBY746::pFL38-AMY) alone and the negative control was DBY746.
pMISOC
Mi::PFL38-AMY
PFL38-AM Y
Figure 4.56 a-amylase plate activity assays for several DBY746 transformants.
The three transformants were assayed in triplicate and the entire assay 
was repeated 3 times. The cumulative results o f this experiment are represented 
by the bar chart shown below (Figure 4.57). Results are reported as the % 
relative amylase activity in comparison to the control strain DBY746::pFL38- 
AMY (100% activity).
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Figure 4.57 Bar Chart depicting the effect o f the antisense plasmid pMISOC on 
the levels of a-amylase produced by the plasmid pFL38-AMY.
From the barchart (Figure 4.57) one can see that the presence of the 
integrated antisense RNA construct, pMISOC, did not downregulate to any 
significant extent, or ablate the expression of the a-amylase gene, produced from 
pFL38-AMY.
4.2.5 RNA ANALYSIS
One of the transformants was analysed using Northern hybridization, to 
determine the level o f antisense transcripts in this transformant. Total RNA was 
isolated under the conditions described in section 2.6.10. RNA was separated on 
an agarose - formaldehyde gel and bidirectionally transferred to a nitrocellulose 
membrane. The first blot was probed with a sense a-amylase riboprobe (section 
4.1.2.4) to detect all antisense transcripts (Figure 4.58) and the second blot was 
probed with an antisense a-amylase riboprobe (section 4.1.2.4) to detect all the 
sense transcripts (Figure 4.59). This second blot was also probed with a (3-actin 
riboprobe (section 4.1.2.4) to enable a comparison of the intensities of loadings 
and secondly to allow a comparison between the sense transcripts produced by SI 
and DBY746::pFL38-AMY (lane 2 and 7, Figure 4.59). Northern analysis 
revealed that no antisense RNA was being produced from the integrated strain 
MI (lane 6 and 8, Figure 4.58). However as was expected due to the visualisation
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of starch breakdown on agar plates, a 1.9 kb sense mRNA was being produced 
by the transformants DBY746::pFL38-AMY and Ml:: pFL38-AMY (lane 7 and 
8, Figure 4.59). This Northern was repeated 3 times and on each occasion the 
result was the same.
DBY746 (lane 1, Figure 4,58 and Figure 4.59) was loaded as a negative 
control in this experiment, as expected no bands were visualised in this lane 
when probed with both the sense and antisense riboprobes. SI (lane 2, Figure 
4.59) was run as a positive control for the antisense riboprobe and also so that a 
comparison o f its’ mRNA levels to the mRNA levels produced from the low 
copy number plasmid pFL38-AMY could be made. DBY746::pSC)C-01 (lane 3, 
Figure 4.58) was run as a positive control to confirm that the sense riboprobe was 
capable o f binding to antisense transcripts.
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Figure 4.58 Northern blot o f total RNAs probed with a 32P-labelled sense a- 
amylase riboprobe.
Lane 1: DBY746
Lane 2: SI
Lane 3: DBY746::pSC>C-01
Lane 4: SI::pSOC-01
Lane 5: RNA markers (6,583; 4,981; 3,638; 2,604; 1,908; 1,383; 955; 623; 281 bp)
Lane 6: MI
Lane 7: DBY746::pFL38-AMY
Lane 8: MI:: pFL38-AMY
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Figure 4.59 Northern blot of total RNAs probed with a 32P-labelled antisense a- 
amylase and P-actin riboprobe.
L ane 1: D BY 746
L an e  2 : SI
L an e  3 : DBY746::pSC>C-01
L an e  4: SI::pSC)C-01
L an e  5: R N A  markers (6,583; 4 ,981; 3,638; 2,604; 1,908; 1,383; 955; 623; 281 bp)
L an e  6: M I
L an e  7: D BY 746::pFL38-AM Y
L an e  8: M I:: pFL3 8-AM Y
The fact that a 1.3 kb discrete P-actin band was present in MI and 
MI::pFL38-AMY (lanes 6 and 8, Figure 4.59) indicates that the RNA samples 
were undegraded. Thus if antisense RNA was produced it must be selectively 
degraded. Temporal coincidence as with /raws-Experiment I (a) should have been 
ensured by the presence of the Ad H I promoter on both the integrating and 
episomal plasmids.
Hybridisation o f the antisense riboprobe to the sense transcript in the 
lanes containing DBY746::pFL38-AMY and MI::pFL38-AMY (lane 7 and 8, 
Figure 4.59) whose transcripts should have been present in lower copy numbers
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than the antisense transcripts may indicate that the antisense plasmid did not 
integrate in the high copy numbers expected. Although integration did appear to 
take place as ascertained by growth o f the strain on selective minimal media 
plates and also by the mitotic stability o f the strain.
A further point to note here was that the copy number of the episomal 
plasmid pFL38-AMY which should be similar to the copy number of the 
integrant SI (from iraw.v-Experiment I (a)) was indeed reflected in the mRNA 
levels. The ratio o f sense transcript produced from SI in comparison to pFL38- 
AMY was 1.17:1. The fact that copy number o f the sense integrated a-amylase 
gene in SI was 2 indicates that the copy number of pFL38-AMY was similar as 
reflected by its’ RNA levels and also by its activity (section 4.2.1.1).
4.2.6 COPY NUMBER ANALYSIS OF THE INTEGRANTS
Due to the fact that no antisense RNA band was visualized on the 
Northern blots, it was decided to carry out further characterisation of the 
integrant, MI. Plasmid copy number was determined using the approach o f Lopes 
et al., (1996). To perform this, total DNA was isolated from the integrant and 
digested with Bgl II. Bgl II digestion of the genomic ribosomal DNA produces 
two 4.5kb fragments, while this enzyme linearises the plasmid. The copy number 
of the plasmid according to Lopes et al., (1996) should have been able to be 
determined by electrophoresis of the digest on an 0.8% agarose gel and visual 
comparison o f the intensities o f the plasmid and rDNA bands after staining with 
ethidium bromide taking into account the relative lengths o f the various 
fragments. If the plasmid had integrated at the rDNA loci one would expect to 
see the 14.1 kb band clearly on the agarose gel and then a comparison of 
intensities could have been made with the 4.5 kb rDNA band, however no strong 
band equivalent to the plasmid was visualised after ethidium bromide staining of 
the gel. This result may suggest once again the low copy number o f the 
integrated antisense gene sequences.
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Figure 4.60 Agarose gel to allow determination of the plasmid copy number of 
integrations o f the plasmid pMISOC.
Lane 1: D BY 746 undigested
Lane 2: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072;
3,054; 2,036; 1,636; 1,018; 506 bp).
Lane 3 : M I undigested
Lane 4: D BY 746 digested w ith  B gl II
L an e  5: M I digested w ith  B gl II
Lane 7: pM ISOC digested w ith B gl II
Lane 8: pM ISOC undigested
Lane 9: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072;
3,054; 2 ,036; 1,636; 1,018; 506 bp).
Lane 10: M I::pFL38-A M Y  undigested
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Figure 4.61 Southern blot to determine plasmid copy number of integrations of 
the plasmid pMISOC.
Lane 1: D BY 746 undigested
Lane 2 : 1 kb ladder (12 ,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072;
3,054; 2,036; 1,636; 1,018; 506 bp).
Lane 3: M I undigested
Lane 4: D BY 746 digested  w ith  B g l  II
Lane 5: M I digested w ith  B g l  II
Lane 6: ------------
Lane 7: pM ISOC digested w ith  B gl n
Lane 8: pM ISOC undigested
Lane 9: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072;
3,054; 2 ,036; 1,636; 1,018; 506 bp).
Lane 10: M I::pFL38-A M Y  undigested
The above gel was also blotted and probed with a 32P-labelled a-amylase 
probe, unfortunately there was no hybridisation to the lanes containing MI (lanes 
3 and 5, Figure 4.61). This indicates either that integration o f the a-amylase gene 
was very low or that it did not occur at all. The fact that the integrant was able to 
grow in the absence o f leucine however suggests that possibly that there may
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have been integration of the leu2-d gene but loss of the remaining vector 
sequences.
The lane containing MI::pFL38-AMY undigested (lane 10, Figure 4.61) 
produced three weak bands and possibly a fourth “fuzzy” band marked by an 
asterisk. Two of these bands were of high molecular weight. One of these high 
molecular weight bands may represent the integrated plasmid pMISOC, while 
the other band may represent the linear form of the undigested plasmid pFL38- 
AMY. The remaining 2 bands may correspond to nicked and covalently closed 
circular forms of the undigested episomal plasmid pFL38-AMY. However 
because of the omission of running a sample containing undigested pFL38-AMY 
plasmid DMA this cannot be said for certainty. To overcome this shortcoming, if 
one sizes the linear, nicked and covalently closed circular forms of the plasmid 
pFL38-AMYfrom lane 3 (Figure 4.49), then make a comparison with the band 
sizes obtained in the lane containing MI::pFL38-AMY (lane 10, Figure 4.61). 
The band sizes o f the linear, nicked and covalently closed circular forms of 
pFL38-AMY, from lane 3 (Figure 4.49) are o f high molecular weight (> 12.2 
kb), 11.0 and 5.0 kb respectively. If this data is applied to the lower 3 bands in 
lane 10 (Figure 4.61) containing MI::pFL38-AMY which are of sizes 14.1 kb 
(this band is the same size as that of the band visualized in lane 7, Figure 4.61), 
10.0 and 5.0 kb respectively, on inference one could conclude that these 3 bands 
in lane 10 (Figure 4.61) do indeed represent the undigested pFL38-AMY bands. 
If the highest molecular weight band represents the integrated pMISOC plasmid 
and the remaining 3 bands the episomal pFL38-AMY, the fact that the intensities 
of the 3 bands are similar may suggest the low copy number o f integration for 
pMISOC.
Finally, from Figure 4.60, there is an intense band o f approximately 5 kb 
in lane 10 containing MI::pFL38-AMY, which was not highlighted by the probe, 
which indicates that this band does not contain any a-amylase gene sequences. It 
appears to be an anomalous band not related to either the integrating plasmid 
pMISOC (as it was not visualized in lane 3 containing MI), or the episomal 
plasmid pFL38-AMY (lane 10, MI::pFL38-AMY).
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The failure to observe any inhibition of a-amylase activity in this system 
may have simply been due to the absence of the antisense construct. However, a 
successful integration event was implied by the growth of transformants on 
minimal media plates lacking leucine as the integrating vector possesses a leu2-d 
marker. In order for amplification to occur a strong selection pressure was 
required which it was hoped was created by using this selection marker. This 
marker expresses a deficient gene involved in the production o f the nutrient 
leucine. In some systems where antisense RNA is successful in down-regulating 
or ablating the expression of a particular gene it has sometimes been the case that 
no anti-mRNA could be detected in the cell. In these cases this could be due to 
the fact that the anti-mRNA:mRNA hybrid has been recognised by nucleases 
specific for double-stranded RNAs (such as RNase H) and been degraded. This 
was not however, the situation in this experimental system as activity assays 
showed no reduction in a-amylase activity.
Although integration was targeted to the rDNA locus by linearising the 
plasmid within its’ rDNA sequence it is possible that due to the large size of the 
plasmid (14.1 kb) that this may have led to instability and hence no amplification 
o f the integrated sequences to the high copy numbers that have been reported by 
Lopes et al., (1996). Lopes et al., (1996) also reported that targeting of pMIRY to 
the LEU2 locus by linearising the plasmid within the leu2-d gene never resulted 
in HCN transformants. Instead as for the more common type of YIP vectors only 
cells carrying a small number of plasmid copies were recovered from such 
transformants. Since these cells grew normally on medium lacking leucine, the 
result also demonstrates that 2 - 5  copies of the leu2-d gene are sufficient to 
provide the cells with an adequate supply of this amino acid, (Lopes et al., 1991). 
Hence a copy number o f 2 for the integrating plasmid pMISOC would provide a 
sufficient amount o f leucine for the cells to survive.
Analysis o f the integrated plasmid copy number by a method described 
by Lopes et al., (1991 and 1996) failed to indicate a high copy number of 
integrations for the plasmid pMISOC. One theory as to why high copy number 
integration was unsuccessful may be the large size of the plasmid pMISOC. 
According to Lopes et al., (1996) plasmid length seems to influence the initial
4.2.7 DISCUSSION
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copy number of pMIRY-type vectors. The copy number of pMlRY2-D (6.7 kb) 
was about 180, some 50% higher than the copy number typically observed for 
pMIRY2 (10.2 kb) transformants. Therefore a smaller size of integrated plasmid 
may also increase PCN, (Lopes, 1991). In addition stable maintenance is only 
observed when the complete plasmid has a size no larger than that of the rDNA 
unit (Lopes et al., 1996). It seems reasonable to assume therefore that this 
inverse correlation between plasmid length and copy number reflects a limitation 
in the amount of extra DNA that can be accommodated by chromosome XII.
Lopes et al., (1991) hypothesised that the utility of this vector may be 
reduced by its’ location in the nucleolus where transcription is mainly dedicated 
to the rRNA (by RNA polymerase I) and not to protein genes. However it has 
been demonstrated that protein genes can be transcribed in the nucleolus (Lopes 
et al., 1991 got good expression of superoxide dismutase, SOD and thaumatin 
and McMahon, 1995 demonstrated the expression of the a-amylase gene cloned 
into this pMIRY vector) although the efficiency o f such transcription might be 
limited to a greater or lesser extent by sub-optimal concentrations of RNA 
polymerase II and/or transcription factors (Lopes et al., 1991).
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I Sense amylase sequences 
I Antisense amylase sequences
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Chr, Chromosomal location
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4.3 TRANS-EXPERIMENT I  (c) -  INTRODUCTION
An important consideration in the design of an antisense expression 
system, is the choice of the gene fragment which will provide the optimal effects 
for gene silencing. In such studies, antisense genes have been directed towards 
all regions of target genes, such as the 5’ untranslated region (5’ UTR), the AUG 
start codon, the coding sequence and the 3’ UTR. Furthermore, various studies 
demonstrate that different fragments o f the same gene may vary significantly in 
their ability to bring about an antisense effect. Phenotypic variation ranging from 
wild-type to a complete block o f development have been seen using different 
fragments o f the MIIHC gene for antisense expression (Scherczinger and Knecht, 
1993). A fragment overlapping the 5’ end seems to be essential for the 
inactivation of the calmodulin gene (Liu et al., 1992), whereas for the MIIHC 
gene a 3’ fragment was found to be most effective (Scherczinger and Knecht, 
1993). The influence of construct composition on the effectiveness of antisense 
inhibition has been studied for the suppression of the chalcone synthase (CHS) 
gene in Petunia (van der Krol et al., 1990), the granule bound starch synthase 
gene (GBSS) in potato (Kuipers et al., 1995) and the CAT enzyme activity in 
carrot protoplasts that transiently expressed both sense and antisense CAT genes 
introduced simultaneously by co-electroporation (Bourque and Folk, 1992). For 
petunia, inhibition o f CHS gene expression, resulting in inhibited flower 
pigmentation, has been achieved with antisense genes based on either the full- 
length CHS cDNA or 3 ’ cDNA. Antisense genes based on 5 ’ fragments of the 
CHS cDNA were shown not to affect flower pigmentation (van der Krol et al., 
1990).
Antisense inhibition o f granule bound starch synthase (GBSS), in potato, 
was achieved using full-length cDNA constructs. Complete inhibition o f GBSS 
gene expression could also be achieved with a construct based on a 0.7 kb 
internal fragment of the GBSS cDNA, and with a construct based on the 0.6 kb 
3’ end of the GBSS genomic DNA (gDNA). The latter fragment comprises 
transcribed GBSS sequences and contains the 3’ end o f the GBSS coding region 
(0.3 kb) including one intron. In carrot protoplasts, reduced CAT activity has 
been observed after co-electroporation of a sense CAT gene and an antisense 
gene based on either a 5’ fragment, a 3’ fragment, or the complete CAT gene
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(Bourque and Folk, 1992). The inhibition was found to be the greatest after 
introduction of an antisense gene based on the 3’ CAT gene fragment.
Arndt et al., (1995, section 1.5.3.6) constructed antisense genes to target 
the entire exogenous lacZ gene its’ 5’ and 3’ regions, o f the fission yeast 
Schizosaccharomyces pombe, to examine which, (if any), of these constructs was 
effective in reducing (3-galactosidase activity. Olsson et al., (1997) chose to 
target three regions o f the S. cerevisiae MIG J gene, comprising o f the coding 
region alone or in combination with parts o f the 5’ untranslated region. Coleman 
et al., (1984, section 1.3.1.1), constructed several antisense genes from the ompA 
gene of E. coli, in order to find the most effective antisense RNA. Each of the 
antisense genes exerted an effect, however some antisense gene fragments were 
more successful than others. Daugherty et al., (1989, section 1.3.1.2), also 
performed many detailed experiments which examined the effects of different 
anti-/ocZ RNAs of various lengths and representing different parts of the lacZ 
coding region. Once again their findings demonstrated that targeting certain 
regions o f the gene was more successful than others.
The preceding observations demonstrate that although there have been 
numerous successful (and unsuccessful, Olsson et al., 1997) examples, in a 
diverse range of eukaryotic organisms, of where antisense genes have been used 
to down-regulate gene expression, the susceptible subregion o f a specific target 
RNA for antisense RNA hybridisation, varies considerably between studies. This 
is due to the fact that each RNA molecule which is targeted has its’ own 
characteristic secondary structure, location and may also be bound by 
ribonucleoproteins, therefore the accessibility of an RNA will vary from gene to 
gene, cell type to cell type and organism to organism. Due to these variables each 
antisense gene that is designed is designed on an empirical basis. In trcms- 
Experiments I (a) it may have been that the intramolecular secondary structures 
of the two interacting RNAs, hindered an efficient interaction between the RNAs 
and it is possible that this problem may be overcome by using a different and/or 
shorter part o f the target gene for the antisense construct. In the context of these 
findings, /rans-Experiment I (c) was undertaken.
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This experimental system focuses on the construction (and subsequent 
analysis) of truncated a-amylase antisense genes designed to target different 
regions o f the gene. These regions included the following:
1. Antisense genes directed towards the 5 ’ UTR for example, are expected 
to change the secondary or tertiary structure of an mRNA in order to 
inhibit the initiation o f translation. The most common approach to 
inhibition of protein translation is to direct the antisense gene towards the 
AUG start codon because theoretically once antisense compounds are 
successfully hybridised in this region the ribosome will no longer be able 
to recognise the translation initiation site. Besides this region is also 
usually free of secondary structure presumably to allow the ribosome to 
bind.
2. If the coding region is targeted, it is possible that the antisense 
compounds may block the movement o f the ribosome along the mRNA 
molecule or this double-stranded structure, formed between the sense 
and antisense genes, may provide a substrate for RNaseH cleavage.
3. Finally by targeting the 3 ’ UTR this may increase the instability of the 
mRNA by removing the poly(A) tail (Mitsuhashi, 1997).
The trans configuration in this experimental system is more or less 
identical to trans I (a), in that the sense a-amylase RNA was transcribed from the 
chromosomally located a-amylase gene in SI (where the gene copy number of 
the sense a-amylase gene was 2) and the newly constructed antisense genes were 
introduced on the higher copy number yeast episomal vector, pAAH5.
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4.3.1 CONSTRUCTION OF YEp PLASMIDS PRODUCING 
ANTISENSE RNA COMPLEMENTARY TO VARIOUS REGIONS OF 
THE BACILLUSLICHENIFOXMIS a-AMYLASE GENE.
Since it is difficult to predict the most susceptible region of target mRNA 
for antisense RNA hybridisation, different regions of the a-amylase gene were 
inserted between the AdHI promoter and terminator (in the vector pAAH5) to 
produce a series o f truncated constructs. For each antisense plasmid a 
corresponding control plasmid was constructed (see Figure 4.62). The antisense 
genes were constructed to produce antisense RNAs of varying sizes, 
complementary to different regions o f  the target message.
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Figure 4.62 Schematic representation of the a-amylase target gene and antisense 
and control plasmids.
The B acillus licheniform is a-am ylase gene, under th e  control o f  the A d H I  prom oter and 
term inator is show n (top) integrated at the  ura3-52  locus in S. cerevisiae chromosome V . D NA  
fragments o f  the a-am ylase gene cloned into th e  H ind  m  site on the expression vector pAAH5 
are show n below the a-am ylase target gene. A rrow s indicate the norm al direction o f  transcription 
for a  given segm ent o f  D N A . The plasm id designations for each insert are given beside each 
specific D N A  fragment.
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4.3.1.1 Construction of pAS600 and pS600.
A YEp plasmid containing an expression cassette capable of expressing 
antisense a-amylase mRNA complementary to the 5 ’ end of the sense amylase 
mRNA was constructed (see Appendix III for the complete sequence of the a- 
amylase gene, the exact positions of the truncated inserts and relevant restriction 
sites are also shown). This plasmid, pAS600 is represented schematically in 
Figure 4.63 and the details o f construction are included in the legend to this 
figure. Plasmids pAS600 and pS600 differed only in the orientation of the 0.6 kb 
Hind HI - a-amylase DNA insert relative to the Ad H i promoter and AdHl 
terminator sequences. Transcription from m A dH I  start site within the expression 
cassette located on plasmid pAS600 was expected to produce an antisense a- 
amylase-AdHI fusion transcript composed of antisense a-amylase RNA and a 
portion of the Ad HI terminator mRNA. The antisense a-amylase RNA was 
complementary to 31 nucleotides o f the 5’ upstream region, including the 
ribosome binding site and 557 nucleotides o f the coding part of the a-amylase 
RNA. Plasmid pS600 was constructed as a control plasmid in order to examine 
non-specific effects o f high-level AdHl promoter driven transcription on the a- 
amylase levels. These plasmid constructions were confirmed using diagnostic 
restriction enzyme analysis. BamH I digestion o f pAS600 resulted in the 
production o f three bands o f sizes, 10.2 kb, 2.15 kb and 0.45 kb, while the same 
analysis o f pS600 yielded 10.2 kb, 1.55 kb and 1 kb fragment sizes (Figure 4.64).
4.3.1.2 Construction of pAS1300 and pS1300.
In an attempt to determine whether the 3’ end of the sense mRNA would 
be an effective template for antisense control, YEp plasmids were constructed in 
which the middle to 3’ end of the a-amylase gene and the 3 ’ UTR region (600 - 
1847 base pairs, Appendix IE) were cloned into the unique Hind III site of the 
vector pAAH5 (see legend to Figure 4.63 for details of cloning). Plasmid 
pAS1300 (antisense) contained the insert in the antisense orientation relative to
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the AdHI promoter and terminator, while plasmid pS1300 (sense) contained the 
insert in the sense direction. Transcription from the AdHI promoter on pAS 1300 
was expected to produce an antisense a-amylase-AdHI fusion transcript in which 
the antisense RNA sequences were complementary to the 3’ coding and non­
coding region of the B. licheniformis a-amylase mRNA.
A number of restriction digests were performed to confirm the plasmid 
constructions for pAS1300 and pS1300. Firstly a Hind III digest was carried out 
to confirm the presence of the insert which should release a 1.3 kb fragment from 
both plasmids and the vector band of 12.2 kb. Secondly, the orientation o f the 
inserts was determined using Sal 1 as the diagnostic enzyme (Figure 4.64). Sal I 
digestion o f pAS1300 resulted in three bands with molecular sizes of 6.75 kb, 
5.45 kb and 1.27 kb. The same digest o f pS1300 also produced three restriction 
fragments of the following sizes: 6.75, 5.30 and 1.4 kb.
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Figure 4.63 Construction of the YEp-antisense plasmids, pAS600 and pAS1300 
harbouring the 5’ end and the mid - 3’ end respectively of the B. lichen iformis a- 
amylase gene.
S tep  I: The plasmid pSL52(4.6 kb, M cM ahon, 1995) w hich contains the sense a-am ylase gene 
cloned in as a 1.9 kb H ind  III fragment into the vector pUC8 (2 .7  kb, A ppendix V) w as digested 
w ith the restriction enzyme Kpn  I. This site was present approximately 557 base pairs into the 5 ’ 
coding region o f  th e  a-am ylase gene, (the pUC8 vector contains no K pn  I site). A fter digestion 
w ith Kpn  I the 5 ’ overhang w as blunt-ended using the K lenow  enzymes 3 ’ - 5 ’ exonuclease 
activity and an 8 mer ( 5 ’CAAGCTTG 3 ’) H ind  III linker w as ligated onto the molecule, the 
plasmid was recircularised using T4 DNA ligase and the ligation m ix was transform ed into D H 5a 
E. coli cells. A fter the K lenow reaction and H ind  III linker addition the K pn  I site was destroyed, 
and this also abolished a-am ylase activity. The transform ants w ere screened for the presence o f  
an additional H ind  ID site, th e  plasm id now possessing H ind  HI fragm ents o f 2 .7  kb, 1.3 kb and 
0.6 kb respectively. This plasmid w as named pKSL52 and the 0.6 kb [s tep  II] and 1.3 kb [step 
III] H ind  IE fragments w ere then gene cleaned from a 0 .7%  TAE agarose gel.
S tep  IV : The yeast shuttle vector pAAH5 w hich possesses a  unique H ind  III site for cloning 
situated between th e  A d H I  prom oter and term inator was linearised w ith  this restriction enzyme to 
produce a 12.2 kb band w hich  was colum n cleaned (section 2 .6 .11.8) to  remove any restriction 
enzyme buffer. It w as then  dephosphorylated w ith CIP (section 2 .6 .11.3) and this linearised 
vector fragment w as ligated in the presence o f  the gene-cleaned 0.6 kb and 1.3 kb H ind  in  
fragment o f  pKSL52to produce the following plasmids pA S600, w hich has the 5’ end o f  the a -  
amylase gene cloned in reverse orientation relative to the A d H l  prom oter and terminator; pS600, 
the sense version o f  th is plasm id, contains the 5’ end o f  th e  a-am ylase gene cloned in sense 
orientation relative to  th e  ,4 rf///p rom oter and term inator; pA S1300, spanning the m id - 3 ’ region 
o f  the a-am ylase grate and pS1300, differing only in the orientation o f  th e  a-am ylase D N A  insert 
relative to  the A d H I  prom oter and terminator.
4.3.1.3 Construction of pM03.
The plasmid pM03 was constructed by Olsen, (1995, Appendix IV, for 
reasons which will become clear in chapter 6). This plasmid contains a truncation 
of the a-amylase gene from Bacillus licheniformis inserted in antisense 
orientation relative to the AdHI promoter and terminator. The truncation involved 
the removal of a number of base pairs from the 3’ flanking region of the a- 
amylase gene including the transcription termination signal. This truncated 
version o f the a-amylase gene was 1.6 kb and its’ transcripts would target the 
5’UTR and 5’ to 3’ coding region of the sense a-amylase gene.
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4.3.1.4 Confirmation of the constructions of pAS600, pS600, pAS1300, 
pS1300 and pM03.
Plasmid DNA was extracted from E. coli DH5a cells to confirm the 
construction of each of the above plasmids. The diagnostic restriction enzymes 
chosen were Hind III (to confirm the correct size o f the a-amylase gene inserts), 
BamH I was used to confirm the orientation of the inserts in pS600 and pAS600, 
finally Sal I was used to orientate the inserts in the plasmids pS1300, pAS1300 
and pM03 respectively.
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2Figure 4.64 Restriction Analysis o f pAS600, pS600, pAS1300, pS1300 and 
pM03.
The approximate sizes o f each of the restriction fragments are shown in kilobases 
in brackets below. The relevant sizes o f the 1 kb ladder are as indicated.
Lane 1: 1 kb ladder (12.216; 11.198; 10.180; 9.162; 8.144; 7.126; 6.108; 5.090; 4.072; 
3.054; 2 .036; 1.636; 1.018; 0.506 kb)
Lane 2: pS600 undigested
Lane 3: pA S600 undigested
Lane 4: pS1300 undigested
Lane 5: pA S1300 undigested
Lane 6: p M 0 3  undigested
Lane 7: pS600 digested w ith  H ind  III (12.23 kb; 0.6 kb)
Lane 8: pA S600 digested w ith  H ind  III (12.23 kb: 0.6 kb)
Lane 9: pS1300 digested w ith  H ind  IE (12.23 kb; 1.3 kb)
Lane 10: pA S1300 digested w ith H ind  HI (12.23 kb; 1.3 kb)
Lane 11: p M 0 3  digested w ith  H ind  III (12.23 kb; 1.6 kb)
Lane 12: pS600 digested w ith  B am l 11 (10.23 kb; 1.55 kb; 1.05 kb)
Lane 13: pA S600 digested w ith BamW  I (10.23 kb; 2.15 kb; 0.45 kb)
Lane 14: pS1300 digested w ith  Sal I (6.75 kb; 5.29 kb; 1.45 kb)
Lane 15: pA S1300 digested w ith Sa l I (6.75 kb; 5.45 kb; 1.27 kb)
Lane 16: p M 0 3  digested w ith  Sal I (6.75 kb; 5.22 kb; 1.86 kb)
Lane 17: 1 kb ladder (12.216; 11.198; 10.180; 9.162; 8.144; 7.126; 6.108; 5.090; 4.072; 
3 .054; 2 .036; 1.636; 1.018; 0.506kb)
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The restriction data obtained confirms the construction of each of the 
above mentioned plasmids. The Hind III digests confirmed a 0.6 kb insert for the 
plasmids pS600 and pAS600 (lanes 7 and 8, Figure 4.64), an insert of 1.3 kb for 
each of the plasmids pS1300 and pAS1300 (lanes 9 and 10, Figure 4.64) and an 
insert o f 1.6 kb for the plasmid pM03. Finally, the enzymes chosen to prove 
orientation gave the expected band sizes for each plasmid. Each of the plasmids 
constructed were transformed into DBY746 and plated on minimal media 
supplemented with 0.25 % uracil and 2% Lintners starch to demonstrate that 
none of these constructs expressed an active a-amylase gene (Figure 4.65).
DBY746
MOSOC
Figure 4.65 Strains DBY746::pSC>C-01, DBY746::pAS600, DBY746::pS600, 
DBY746::pAS1300, DBY746::pS1300 and DBY746::pM03 all patched onto 
minimal media supplemented with 0.25% uracil and 2% starch.
2 4 3
4.3.1.5.1 Growth on selective media
After transformation o f SI with the antisense and sense plasmids 
confirmation of their presence in the integrated strain SI was established by their 
ability to grow on minimal media plates lacking uracil and leucine. This is 
because the integrating plasmid (pFAMY) has converted DBY746 to uracil 
prototrophy while the YEp-antisense and sense plasmids bear a LEU2 marker. 
Hence a successful transformation event into the yeast strain SI exhibited 
colonies growing on minimal media minus uracil and leucine (data not shown).
4.3.1.5.2 Southern Blot Analysis.
Genomic DNA was extracted from DBY746, SI, SI::pAS600, pS600, 
pAS1300, pS1300 and pM03. All were electrophoresed undigested on a 0.7% 
agarose gel (Figure 4.66), then blotted and probed with a non-radioactively 
labelled DIGoxygenin a-amylase probe (Figure 4.67). The presence of the 
plasmid was confirmed by the appearance o f multiple bands o f the various forms 
o f undigested DNA on the blot. It was also evident from the blot, as expected, 
that the plasmids transformed into this yeast strain were o f different sizes as 
demonstrated by the covalently closed circular bands (Figure 4.67).
4.3.1.5 C onfirm ation  o f  the presence o f  the various antisense and sense
plasm ids in SI.
244
2 4
■
6  8  10
^  _ _
Figure 4.66 Agarose gel o f undigested genomic DNA extracted from various 
yeast strains.
Lane 1: X DNA Hind lUJEcoR I digested (21,226; 5,148; 4,973; 4,277; 2,027; 1904;
1,584; 1,330; 983; 831; 564 bp)
Lane 2: DBY746
Lane 3: DBY746::pSOC-01
Lane 4: SI
Lane 5: SI::pAS600
Lane 6: SI::pS600
Lane 7: SI::pAS1300
Lane 8: SI::pS1300
Lane 9: SI::pM03
LanelO: SI-pSOC-Ol
Lane 11: 1 kb ladder (12.216; 11.198; 10.180; 9.162; 8.144; 7.126; 6.108; 5.090;
4.072; 3.054; 2.036; 1.636; 1.018; 0.506 kb)
2 4 5
10 8 6 4 2
Figure 4.67 Southern blot to confirm the presence of the various sense and 
antisense plasmids in the integrated strain SI, probed with a non-radioactively 
labelled DIGoxygenin a-amylase probe.
Lane 1: X DNA Hind W EcoR  I digested (21,226; 5,148; 4,973; 4,277; 2,027; 1904; 
1,584; 1,330; 983; 831; 564 bp)
Lane 2: DBY746
Lane 3; DB Y746::pSOC-01
Lane 4: SI
LaneS: SI::pAS600
Lane 6: SI::pS600
Lane 7: SI::pAS1300
Lane 8: SI::pS1300
Lane 9: SI::pM03
LanelO: SI::pSOC-01
Lane 11: 1 kb ladder (12.216; 11.198; 10.180; 9.162; 8.144; 7.126; 6.108; 5.090; 
4.072; 3.054; 2.036; 1.636; 1.018; 0.506 kb)
A single high molecular weight band was clearly visible in lane 
containing SI (lane 4, Figure 4.67). This band should also have been visible in 
each of the lanes 5 to 10, Figure 4.67. The reason for the lack o f visualisation of
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this band poss ib ly  was because the genomic DNA for SI was extracted from  a 
culture which was grown up in rich media (YEPD) hence a higher OD o f  growth 
than the other strains, S I::pA S 600 , p S 6 0 0 ,  p A S 1 3 0 0 ,  p S 1 3 0 0  and p M 0 3 ,  which 
were all grown in minimal media. The OD of growth was lower hence not as 
high a concentration of genomic DNA was extracted from these strains. Also 
from plasmid copy number analysis o f the strain SI there are only 2 copies of the 
amylase gene present per cell whereas the episomal plasmids are in higher copy 
numbers hence visualisation of these bands but not of the SI a-amylase.
4.3.1.6 Analysis of the in vivo activity of the trans-acting antisense 
transcripts from the plasmids pAS600, pAS1300 and pM 03 on the 
expression of a-amylase from SI.
The inhibitory effect o f antisense RNA on the target gene was assessed 
initially by plating transformants on media containing 2% starch and searching 
for colonies with either no haloes or reduced halo size. These colonies were then 
chosen for further analysis by the DNS assay. This approach could be used to 
identify those transformants in which antisense RNA was functional in 
downregulating the level of target enzyme. The integrated strain SI transformed 
with the antisense plasmids pSOC-Ol, pAS600, pAS1300 and pM03 were grown 
up in minimal media until cell growth had reached mid-log phase. The cultures 
were then spun down at 5,000 rpm for 5 minutes at 4°C and the supernatants 
were analysed for a change in a-amylase activity in comparison to the control 
strain SI. All samples were assayed in triplicate and the entire assay was repeated 
3 times. The cumulative results o f this experiment are represented by the bar 
chart shown below (Figure 4.68). Results are reported as 
the % relative amylase activity in comparison to the control strain SI (100% 
activity). The corresponding sense plasmids of pS600 and pS1300 were also 
transformed into the integrated strain SI as controls, and were demonstrated to 
have no significant effect on the levels o f a-amylase produced.
247
■  SI
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■  SI::pM 03
Figure 4.68 Effect o f the presence of the various antisense plasmids on a- 
amylase activity.
From the barchart shown in Figure 4.68 one can see that the presence of 
the antisense RNA constructs (pAS600, pAS1300 and pM03) did not 
significantly downregulate or ablate the level of a-amylase activity being 
produced as compared the control strain SI. These findings, taken together with 
that observed for SI::pSC>C-01 (/r<mv-Experiment I (a)) clearly show that 
regardless of which part of the gene that is used, either whole or truncated, no 
antisense effect is observed. In order to confirm that antisense was being 
produced in these strains, Northern analysis was undertaken.
4.3.1.7 Northern analysis
Northern blot analysis was undertaken to show firstly, that antisense 
RNA was being made by the cell, secondly, that the antisense transcripts 
produced from the constructs SI::pAS600, SI::pAS1300 and SI::pM03, were of 
different sizes. Thirdly, to obtain a ratio for the level of antisense to sense 
transcripts and finally fourthly, to prove the existence of temporal coincidence of 
both transcripts, in each of these strains. Total RNA was isolated from 
SI::pAS600, SI::pASl300 and SI::pM03 (in addition to various controls) under 
the conditions described in section 2.6.10, from cells grown to mid-log phase 
(ODO.8- 1.0).
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\Figure 4.69 Northern blot hybridized with [a] a 32P-labelled sense a-amylase 
riboprobe, [b] and [c] with a digoxygenin labelled a-amylase probe.
[a]
Lane 1: RNA Markers' 
Lane 2: SI 
Lane 3: SI::pM03 
Lane 4: SI::pAS1300
Lane 5: SI::pAS600
[b]
Lane 1: RNA Markers 
Lane 2: DBY746 
Lane 3: SI::pS600 
Lane 4: SI::pAS600
Lane 5: SI::pAS1300
Lane 6: SI::pS1300
Lane 7: SI::pM03
[C]
Lane 1: SI::pS600 
Lane 2: SI::pAS600 
Lane 3: DBY746
RNA Markers: (6,583; 4,981; 3,638; 2,604; 1,908; 1,383; 955; 623; 281 bp)
For the blot shown in figure 4.69 [a], the RNA was separated on an 
agarose - formaldehyde gel and bidirectionally transferred to a nitrocellulose 
membrane. The blot shown here was hybridised with a 32P-labelled sense a- 
amylase riboprobe (for the detection o f all antisense transcripts). Analysis of this 
blot, demonstrates the presence o f antisense RNA in SI::pM03, SI::pAS1300 and 
SI::pAS600 (lanes 3, 4 and 5, Figure 4.69 [a]), with transcript sizes o f 1.7, 1.3 
and 0.65 kb respectively. These were approximately the expected sizes 
considering how the antisense expression cassettes were constructed.
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Confirmation of the temporal coincidence of both antisense and sense 
transcripts in the strains SI::pAS600 and SI::pAS 1300 is demonstrated in the 
blots shown in Figure 4.69 [b] and [c]. These blots were probed with a non­
radioactive digoxygenin labeled a-amylase probe, which is capable of 
hybridizing to both sense and antisense transcripts. The presence of both 
transcripts is clearly visible for SI::pAS600 (lane 4, Figure 4.69 [b] and lane 2, 
Figure 4.69 [c]) and SI::pAS1300 (lanes 5, Figure 4.69 [b]). Although, only the 
antisense transcript was visible in the lane containing SI::pM03 (lane 7, Figure 
4.69 [b], possibly due to poor loading of the sample, and the fact that the 
antisense transcript is expected to be present in a higher copy number than the 
sense transcript), temporal coincidence has been confirmed in another Northern 
blot analysis. In fact, the blot shown in Figure 4.69 [a] was taken from a gel that 
was bi-directionally blotted, the second blot (data not shown) was hybridized 
with an antisense a-amylase riboprobe, together with a p-actin riboprobe. This 
blot demonstrated the presence of the sense a-amylase transcript and also 
allowed for calculation of the antisense:sense transcript ratio. All ratios were 
obtained by measuring the band intensities o f the sense and antisense transcripts 
on a Pharmacia-Biotech (ImageMaster ID) Imaging densitometer (taking into 
account the backgrounds). The ratio of sense to antisense RNA being produced 
from the above transformants is tabulated in Table 4-6.
Table 4-6 Ratio o f antisense to sense RNA transcripts.
ANTISENSE mRNA SENSE mRNA
SI::pM03 3.5 1
SI::pAS1300 3.5 1
SI::pAS600 4.0 1
As a negative control for blots [a], [b] and [c] (data not shown for [a]) 
total RNA was extracted from DBY746 (lane 2, Figure 4.69 [b] and lane 3, 
Figure 4.69 [c]). As expected, this strain generated no signal on the 
autoradiograph when probed with either the sense a-amylase riboprobe or a- 
amylase probe.
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Finally, these blots demonstrate the presense and stability of antisense 
transcripts of the expected sizes, the existence o f temporal coincidence and also 
that there was an excess of antisense to sense RNA being produced.
4.3.2 DISCUSSION
When the full-length antisense a-amylase transcript from pSOC-Ol in 
/'ra«i-Experiment I (a) failed to produce downregulation o f a-amylase gene 
expression (even though there was temporal coincidence and stability of the two 
RNAs, and an excess of antisense to sense mRNA) it was decided then to target 
specific regions within the a-amylase gene, as many papers have cited the 
importance of targeting the antisense sequences to particular areas within the 
gene (Coleman et al., 1984; Daugherty et al., 1989; Liu et al, 1992; Scherczinger 
and Knecht, 1993; Kuipers et al., 1995). In addition to the effectiveness of an 
antisense RNA being dependent on the region of the gene to which it is targeted, 
the length o f an antisense gene may also be contributing factor to either the 
success or failure o f an antisense experiment. However, there is conflicting 
evidence, regarding the optimum length, as there is with the region o f the gene 
targeted. For example Knecht, (1989) reasons that the larger the antisense 
molecule, the faster and more stable the duplex formed. However this author also 
states that, results regarding the length o f an antisense molecule have been so 
variable that no absolute size limit can be stated. Olsson et al., (1997) reasoned 
that the failure o f their antisense experiments was possibly due to the fact that the 
antisense constructs were designed to produce large RNAs which may have in 
turn lead to the opportunity for secondary structure formation. Therefore, these 
antisense RNAs may not bind to the sense mRNA with a high enough efficiency 
to prevent translation. Furthermore, Rittner et al., (1993) hypothesises that small 
changes in the length of an antisense RNA may significantly alter secondary 
structure and thus lead to dramatic changes in the gene silencing capacity.
In this study, antisense a-amylase RNA was expressed against the 5’ 
upstream, RBS and 5’ coding sequences of the a-amylase gene (pAS600); in 
addition to the mid - 3’ coding and untranslated regions o f the a-amylase gene 
(pAS1300) and to the entire gene minus its 3’ non-coding regions (pM03). As 
well as targeting different subregions of the target mRNA, various lengths of
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complementarity between the antisense a-amylase transcripts and the target 
mRNA were also used in the present study. The antisense a-amylase RNA 
expressed from the plasmid pAS600 complementary to only the 5’ upstream 
region, RBS and base pairs of the coding region was predicted to cover only 585 
nucleotides of the target mRNA. In the case of the antisense RNA 
complementary to the mid to 3 ’ and terminal coding sequences o f the target 
mRNA, the length o f complementarity was 1,247 base pairs (pAS1300) and 
1,613 base pairs in the case o f pM03 complementary to the entire coding 
sequence. There was however no significant reduction in the level of a-amylase 
produced from transformants expressing any of the truncated antisense 
transcripts, regardless o f size or region targeted.
Once again, as was the case with pSOC-Ol, the antisense transcripts 
derived from pAS600, pAS1300 and pM03 all exhibited stability and temporal 
coincidence with respect to both sense and antisense RNAs, in addition to an 
excess of antisense to sense mRNA (4.0:1, 3.5:1 and 3.5:1 respectively). 
However, all of these constructs failed to reduce or abolish a-amylase gene 
activity. It may be important to note here that, each o f the antisense a-amylase 
RNAs was expressed as a chimeric transcript, which included non­
comp \smen\ary AdHI sequences. It is always possible that the AdHI portion of 
these antisense RNAs interfered with successful hybridisation between the 
antisense a-amylase sequences o f the chimeric transcript and the target mRNA.
Furthermore, although temporal coincidence was ensured in trans- 
Experiment I (c), it is possible that failure to achieve antisense inhibition in this 
experimental system could be due to the fact that the two RNAs are not present 
in the same physical space in the cell. If this is so, they would not be able to 
interact with one another. In order to try and address this potential problem trans- 
Experiment II (described in chapter 5) was undertaken. In summary, the main 
focus here was to improve the spatial coincidence of the two RNAs and, if 
possible, increase the amount of antisense relative to sense RNA.
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CHAPTER 5
Tra/fs-Experiment II
Sense amylase sequences 
I Antisense amylase sequences
P; Plasmid
Chr; Chromosomal location
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5. TRANS -EXPERIMENT II  - INTRODUCTION
I f  one  focuses on  the potentia l interactions b e tw een  tw o  com plem en ta ry
RNA molecules in vivo, many factors must be considered, such as the relative 
stabilities of the two RNA molecules. The stability of RNA molecules is in part 
dependent on their individual secondary structures. But two aspects that are of 
critical importance are the spatial and temporal coincidence of the two 
interacting RNA molecules. This means that the two potential interacting 
molecules must be present within the same part or organelle o f the cell, at the 
same time. From Northern analysis temporal coincidence is assumed by the 
coincident hybridisation signal for both RNAs. Spatial coincidence, however, is 
more difficult to predetermine or prove.
In a publication by Atkins et al., (1994), it appears that investigators have 
found a higher degree of subcellular localisation exists in addition to the simple 
nuclear\cytoplasmic division. The nucleus itself possesses a defined architecture 
and studies have revealed that mRNA molecules within the nuclear structure are 
assigned to discrete tracks. These tracks are formed following transcription and 
they extend from the gene toward the nuclear membrane. In the model system 
^«¿'-Experiment I the antisense and sense RNAs were transcribed from different 
locations within the nucleus, i.e. from either an episomal or chromosomal 
location. An interesting question to ask is, does the transcription o f genes 
encoded on episomes result in RNA transcripts that occupy tracks distinct from 
those occupied by chromosomally-encoded gene mRNA? If this were the case, 
there would be no contact between the two RNAs.
To investigate this hypothesis further it was decided to introduce both the 
sense and antisense a-amylase sequences into the yeast cell, episomally. The 
sense a-amylase gene was introduced into the cell on the plasmid pAAMY-01, 
which places the a-amylase gene under the control of the constitutively 
expressed AdHI promoter. The antisense a-amylase gene was introduced on 
another plasmid, pYES2-SOC, which placed the gene under the control o f the 
powerful GAL1 promoter. By using this promoter it was also hoped to increase 
the amount of antimessage being produced. Both o f these plasmids carry 
different selection markers, LEU2 and URA3, on the plasmids pAAMY-01 and 
PYES2-SOC respectively.
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For proper induction of the inducible GAL1 promoter the host cell must 
be genotypically GAL*. In /ra«s-Experiment 1 (a), (b) and (c) the S. cerevisiae 
strain DBY746 was used as the host strain for integrative transformation and for 
the introduction of various sense and antisense plasmids. However for trans- 
Experiment II a different strain o f yeast had to be used as DBY746 does not 
possess the necessary genes required to metabolise galactose. The S. cerevisiae 
strain MT235 was chosen for /ran.y-Experiment II as it does possess the required 
genes to metabolise galactose.
In yeast, the regulation o f the galactose genes has been extensively 
studied. Briefly, there are two regulatory proteins GAL4 and GAL80, which 
calibrate transcription o f several structural genes; GAL2, a permease; GAL1 a 
kinase; GAL7, a transferase; GAL10, an epimerase and MEL I a galactosidase. 
When there is an inducer present in the media, the GAL4 protein binds to sites 
within the upstream activating sequence, UAS (UAS is a generic term for 
sequences located upstream of yeast genes that provide for activation of 
transcription, presumably by binding transcriptional regulatory proteins) and 
activates transcription. When no inducer (galactose) is present or in the presence 
o f glucose, GAL80 binds to the carboxyl terminus o f the GAL4 protein, thus 
masking the activation domain. The GAL80 protein therefore acts as a negative 
regulator, GAL4 being a positive regulator o f gene transcription (Martin and 
Scheinbach, 1989, Figure 5.1).
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Figure 5.1 Galactose regulation in yeast.
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The tight regulation of expression by carbon source makes the UAS of 
the GAL I and GAL10 genes highly suitable for manipulating the expression of 
cloned genes. In addition, the extremely strong induction o f transcription in the 
presence o f galactose is useful for expressing high levels of a protein. For 
example expression of galactokinase (GAL1) is induced 1,000-fold in galactose 
from barely detectable levels in glucose (Martin and Scheinbach, 1989).
The first third of this chapter describes the cloning o f the B. licheniformis 
a-amylase gene in both the sense and antisense orientations under the control of 
the GAL1 promoter into the high-copy episomal yeast expression vector pYES2. 
This is followed by a characterisation of the growth of the yeast strain MT235 on 
different carbon sources. The next section goes on to deal with the investigation 
of the optimal induction conditions for the GAL1 promoter. Following this 
MT235::pAAMY-01s’ a-amylase expression levels are investigated when grown 
on raffinose and galactose to ensure that this plasmid produces a level of a- 
amylase activity that can be easily monitored. Finally as with iram-Experiment I 
the important results come in the latter part of this chapter with the analysis of 
the effect o f the antisense a-amylase transcripts from pYES2-SOC on the levels
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of a-amylase activity produced by the plasmid pAAMY-OI. This chapter will 
conclude with a discussion on the results obtained.
5.1 PLASMIDS CONTAINING THE a-AMYLASE SENSE AND 
ANTISENSE GENES UNDER THE CONTROL OF THE INDUCIBLE GAL1 
PROMOTER
Because o f the high levels o f gene expression that the GAL gene 
promoters can direct, they are attractive for use in vectors designed for high level 
regulated gene expression in S. cerevisiae. Two distinct advantages associated 
with using the GAL promoters to direct gene expression are firstly, the ability to 
grow the cells under conditions that almost completely repress these promoters 
which would allow one to express genes whose product(s) may be toxic to yeast 
cells. Secondly, these promoters are among the strongest in S. cerevisiae and 
even higher levels o f gene expression can be obtained if these promoters are 
present on high copy number yeast vectors. In this study the yeast shuttle vector 
PYES2 (Appendix IX) was used to construct YEp plasmids carrying expression 
cassettes capable o f producing either antisense or sense a-amylase RNA upon 
galactose induction in yeast cells. The pYES2 plasmid contains a 2\i origin of 
replication (which permits this plasmid to exist in high copy number in [cir4] 
yeast cells), a URA3 selectable marker and an expression cassette composed o f 
the GAL1 promoter and CYC1 transcription terminator. Any transcripts produced 
from this expression cassette would be expected to contain both a 5’ cap and a 3’ 
poly(A) tail.
The sense a-amylase gene was cloned under the control of the GAL1 
promoter and CYC1 terminator, in order to assess the optimal induction 
conditions for this promoter. These conditions were then implemented for the 
induction of the antisense a-amylase gene.
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5.1.1 CONSTRUCTION OF PLASMIDS W HICH CONTAIN THE a- 
AMYLASE ANTISENSE (pYES2-SOC) AND SENSE (pYES2-AMY) 
GENES UNDER THE CONTROL OF THE INDUCIBLE GAL1 
PROMOTER
The plasmid constructions pYES2-AMY and pYES2-SOC are represented 
schematically in Figure 5.2. These constructs were confirmed using diagnostic 
restriction enzyme analysis. The 1.9 kb Hind III a-amylase gene contains an 
asymmetric Kpn I site located 0.6 kb from its 5’ end. Kpn I digestion o f pYES2- 
SOC resulted in the production of two bands of sizes 7.2 and 0.6 kb, while the 
same analysis o f pYES2-AMY yielded 6.5 and 1.3 kb fragments. (Data shown 
for pYES2-SOC only). Plasmids pYES2-AMY (sense orientation) and pYES2- 
SOC (antisense orientation) differ only in the orientation of the 1.9 kb Hind in  
a-amylase DNA insert relative to the GAL1 and CYC1 terminator sequences. 
Transcription from the GALJ start site within the expression cassette located on 
plasmid pYES2-SOC was expected to produce an antisense a-amylase - CYC1 
fusion transcript composed of the antisense a-amylase RNA and a portion of the 
CYC1 mRNA.
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Figure 5.2 Schematic illustrating the cloning of a sense and antisense a-amylase 
gene into pYES2.
The 1.9 kb Hind HI a-amylase gene was cut from the plasmid pAAMY-01, this fragment was 
then gene cleaned from a 0.7% agarose gel and cloned into the unique Hind III site o f a CIP 
(section 2.6.11.3) treated pYE£>2 vector. The ligation mix was transformed into DH5a and the 
colonies were screened on LB amp plates containing 2% Lintners starch. Once again, as in the 
case o f pSOC-Ol the amylase gene was expressed in both orientations in E. coli.
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The appropriate sizes o f each of the restriction fragments is shown in base 
pairs in brackets below. The relevant sizes o f the 1 kb ladder are as indicated.
Lane 1: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072; 3,054;
2,036; 1,636; 1,018; 506 bp).
Lane 2: pYES2-SOC undigested
Lane 3: pYES2-SOC digested with Hind III (5,900; 1,900)
Lane 4: pYES2-SOC digested with Kpn I (7,210; 600)
Lane 5: 1 kb ladder (12,216; 11,198; 10,180; 9,162; 8,144; 7,126; 6,108; 5,090; 4,072; 3,054;
Figure 5.3 Restriction Analysis of pYES2-SOC.
EXPRESSION CONDITIONS BEFORE CO-TRANS FORMA TION OF THE
5.2 OPTIMISA TION O F THE GROWTH. INDUCTION AND
ANTISENSE (pYESy-SOC) AND SENSE (nAAMY-01) PLASMIDS INTO 
MT235
5.2.1 ANALYSIS OF GROWTH OF THE MT235 YEAST STRAIN 
WHEN GROWN IN  THE PRESENCE OF DIFFERENT CARBON 
SOURCES
MT235 was grown on minimal media supplemented with adenine, 
leucine and uracil and either in the presence o f 2% raffinose, 2% galactose or 2% 
glucose to examine the effect of these sugars on the growth of MT235 over a 
time period o f 72 hours at 30°C. The reasons for choosing raffinose as a carbon 
source was because this is a neutral, non-inducing sugar and it is also said to 
have a more rapid induction o f the GAL1 promoter on addition o f galactose in 
comparison to glucose. This is because raffinose, unlike glucose, has no 
repression effects.
On glucose medium there is repression in addition to the absence of 
inducer. These repressors act between the UAS and TATA box. Galactose uptake 
and inducer synthesis are also inhibited. For this reason, if glucose is used as a 
non-inducible carbon source, induction o f expression will take longer than with 
other carbon sources. However growth o f this strain was also tested on 2% 
glucose.
The results indicated that MT235 growth was slower on the plates 
containing 2% glucose in comparison to growth of this strain on 2% raffinose or 
2% galactose (Table 5-1). Also this yeast strain contains a mutation of the A DEI 
gene (ade2-l). The ADE1 gene encodes an enzyme involved in de novo purine 
biosynthesis. A mutation in this gene results in the production of a red colour 
phenotype. Hence when MT235 was grown in either liquid or on solid media this 
characteristic red/pink colour was observed.
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Table 5-1 Analysis of the growth of the yeast strain MT235 on different carbon 
sources.
CARBON SOURCES
STRAIN 2 %  RAFFINOSE 2 %  GLUCOSE 2 %  GA L
MT235 ### ## ###
### good growth
## slow  growth
5.2.2 DETERMINATION OF THE OPTIMAL CONDITIONS FOR THE 
INDUCTION OF THE GAL1 PROMOTER IN MT235
As the antisense transcripts from pYES2-SOC do not express a functional 
product in S. cerevisiae this makes analysis o f the optimal induction conditions 
of the GAL1 promoter from this plasmid difficult to assess. However the plasmid 
PYES2-AMY, which does express the functional a-amylase gene and whose 
expression can be easily monitored by the growth of the strain on starch 
containing media plates or by DNS assay was therefore used for the 
determination o f the optimal induction conditions o f the GAL1 promoter. The 
optimal induction conditions could then be applied to the induction of the GAL1 
promoter on the plasmid pYES2-SOC.
Preliminaiy analysis o f  the effect o f different carbon sources on this 
promoter were analysed by plating MT235::pYES2-AMY and PYES2-SOC on 
minimal media containing 2% starch supplemented with different carbon sources 
(section 5.2.2.1). These studies were followed by growth o f this strain in liquid 
minimal media containing a non-inducing carbon source with subsequent 
analysis of the levels o f a-amylase activity being produced by DNS assay after 
the GAL1 promoter has been induced by the addition o f galactose to the growth 
media (section 5.2.2.2).
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5.2.2.1 Analysis of the effect of different carbon sources on the
GAL1 promoter monitored by either the expression or non-expression of the 
sense a-amylase gene from pYESi-AMY
The yeast strains MT235:: pYES2-AMY and MT235:: pYES2-SOC were 
grown on minimal media plates supplemented with the necessary amino acids,
2% Lintners starch (BDH #30260) and either 2% raffinose, 2% glucose, 2% 
galactose or a combination of 0.5% raffinose/2% galactose for a period of 72 
hours at 30°C. The plates were then flooded with iodine vapour. Analysis of the 
plates in Figure 5.4 showing MT235:: pYES2-SOC and MT235:: pYES2-AMY, 
demonstrates that as expected there was no induction o f the GAL1 promoter 
when the strain MT235:: pYES2-AMY was grown on media containing 2% 
raffinose or 2% glucose. These results were confirmed using the DNS assay. This 
is because raffinose is a neutral non-inducing sugar whereas in the presence of 
glucose the GAL1 promoter was repressed.
When performing experiments with the GAL1 promoter it is usual to 
initially grow the strain in a non-inducing or repressing carbon source. The 
reason for this is because the GAL1 promoter is so powerful if it is being 
continually induced by the presence o f galactose in the media its’ products may 
affect the viability o f the cells. To examine this hypothesis the strain 
MT235::pYES2-AMY was grown on galactose alone and on a combination of 
raffinose and galactose.
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Figure 5.4 Starch containing minimal media plates inoculated with 
MT235::pYES2-SOC and MT235::pYES2-SOC. [1] Strains grown on 2% 
raffinose, [2] 2% glucose, [3] 2% galactose and [4] 0.5% raffinose/2 % galactose.
From analysis of the plates (Figure 5.4) it appears that growing the 
MT235::pYES2-AMY and MT235 ::pYES2-SOC on 2% galactose alone had no 
adverse effect on the viability of the cells. Expression o f the a-amylase gene 
from MT235:: pYES2-AMY on 2% galactose appears to be the greatest, followed 
by growth on 0.5% raffmose/2% galactose (Table 5-2). A further point to note 
from this experiment was that as expected MT235::pYES2-SOC showed no a- 
amylase activity (i.e. no haloes around the patches o f growth) and secondly these
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strains grew least well on 2% glucose (these plates were left at 30°C for 24 hours 
longer). The latter finding is unimportant for the purposes of the experiments to 
be carried out as raffmose instead of glucose can be used as the non-inducing 
carbon source. The only concern is that the sense a-amylase gene (pAAMY-01) 
under the control of the AdHI promoter will be capable of expression when 
transformed into MT235 and grown on raffinose and/or galactose (section 5.2.3).
Table 5-2 Analysis o f the expression o f the a-amylase gene under the control of 
the GAL1 promoter when grown on different carbon sources.
CARBON SOURCES
STRAIN 2%  Raffinose 2%  Glucose 2%  Galactose 0.5% Raffinose/2% 
Galactose
MT235 m #  - m  - ### - ### -
MT235 ::pYES2-AMY -ffffff m  - ### + # m  +
MT235::pYES2-SOC mm - m  - ### - ### -
### good growth
## slow growth
+ a-amylase expression
no a-amylase expression
5.2.2.2 Determination of the optimal induction conditions by DNS
assay
MT235::pYES2-AMY was grown up in liquid minimal media 
supplemented with 2% raffmose at 30°C and grown until the culture reached an 
O D 6oo o f 0.7 - 1 .0. Following this the cells were pelleted by centrifugation at 
5,000 rpm for 1 minute and the supernatant was discarded. The cells were then 
resuspended in minimal media containing 2% galactose, pelleted again and the 
supernatant discarded. The cells were then resuspended in minimal media 
containing 2% galactose and grown for a further 18 hours. The following source 
was used: Sigma G-0750, as recommended.
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Samples were taken at 0, 2, 4, 6 and 8 hours after the addition of 
galactose to the minimal media and analysed by DNS assay to find a time point 
at which there is good expression (induction) o f the a-amylase gene. The 
assumption being made here is that the levels of a-amylase activity should 
reflect the RNA levels. All samples were assayed in triplicate and the entire 
assay was repeated 3 times. The cumulative results o f this experiment are 
documented in Figure 5.5. The time at which the level o f a-amylase gene 
expression was the greatest (4 hours after induction) was then taken as the time 
point for the analysis o f the effect o f the antisense a-amylase transcripts from 
PYES2-SOC on the sense transcripts from pAAMY-01 (section 5.3.1).
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Figure 5.5 Measurement of a-amylase activity from the plasmid pYES2-AMY 
at different time points after induction of the GAL1 promoter with galactose.
5.2.3 EFFECT OF (i) HOST STRAIN, (ii) CARBON SOURCE, AND (iii) 
PRMOTER CHOICE ON THE LEVELS OF a-AMYLASE GENE 
EXPRESSION
In /ram-Experiment I (a), the plasmid pAAMY-01 was transformed into 
the yeast strain DBY746 and grown on 2% glucose where there was effective 
expression o f the a-amylase gene under the control of the constitutively 
expressed^¿¿///promoter. For /ram-Experiment II pAAMY-01 was the plasmid 
of choice for the introduction of the sense a-amylase gene into MT235. However
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it has been documented (Ammerer, 1983; Cantwell et al., 1986) that identical 
plasmids give variable expression of a foreign gene in different yeast strains. 
Hence it was essential to investigate the effect, if any, on expression of this gene 
under the control of the AdHI promoter when grown [1] in MT235 and [2] on the 
sugars, raffinose and galactose.
Furthermore a comparison was made between the levels of a-amylase 
activity produced when this gene was under the control of the AdHI promoter 
(DBY746::pAAMY-01 and MT235::pAAMY-01) and the inducible GAL1 
promoter (MT235::pYES2-AMY). The reason for carrying out this analysis is 
that one of the aims of this particular experimental system was to produce a 
favourable antisense:sense transcript ratio. In the earlier experimental systems, 
frvmy-Experiment I (a) and (b), the approaches adopted to obtain a favourable 
transcript ratio included the choice o f plasmid or chromosomal integration. In 
this experimental system, trans II, different promoters were chosen to achieve a 
favourable antisense:sense transcript ratio. In choosing the GAL1 promoter, after 
reading the literature, it is expected that this promoter should result in a 
significantly higher number of transcripts than the constitutively expressed AdHI 
promoter. By analysing the levels o f a-amylase activity produced by the plasmid 
PYES2-AMY (where the gene is under the control o f the GAL1 promoter), it is 
hoped that the activity levels will reflect the RNA levels, and consequently that 
this will reflect the amount o f RNA transcripts produced from the plasmid 
PYES2-SOC, where the antisense a-amylase gene is under the control of the 
GAL1 promoter. Additionally this analysis should also provide a comparison of 
the relative amounts o f a-amylase activity produced, when the gene is under the 
control o f the 2 different promoters. Once again it is hoped that the levels of 
activity will be reflected in the amount o f RNA transcripts produced and this 
should provide an estimation of the antisense:sense transcript ratios.
All samples were grown up in minimal media supplemented with either 
2% raffinose, glucose or galactose to an OD6oo o f 0.7 - 1.0. The cultures were 
then spun down at 5,000 rpm for 5 minutes at 4°C, dialysed and the supernatants 
were analysed by DNS assay. All samples were assayed in triplicate and the 
entire assay was repeated 3 times. The cumulative results of this experiment are 
documented in Table 5-3.
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Table 5-3 Effect of [1] host strain, [2] carbon source and [3] promoter choice on 
the level o f a-amylase gene expression.
Strain Carbon Source 2% Raffinose 
(Units/cell)
2% Glucose 
(Units/cell)
2% Galactose 
(Units/cell)
MT235::pAAMY-01 2.25 x 10'5 2.06 x 10 s 2.25 x 10*
DBY746::pAAMY-01 3.04 x 10 5 2.82 x I O'5 —
MT235::pYESrAMY XXX XXX 9.26 x 10 s
XXX no expression of the a-amylase gene 
—  no growth of strain
The important points to be noted from the results shown in Table 5-3 are
as follows;
1. The tram II experiments were designed to use raffinose as the preferred 
non-inducing carbon source. A comparison of the strains 
MT235::pAAMY-01 and DBY746::pAAMY-01 when grown on 2% 
raffinose demonstrates that there is a significant reduction (approximately 
26%) in the levels of a-amylase produced, in moving from the DBY746 
strain to MT235. However the important point to note is that the levels of 
a-amylase produced in MT235 when grown on 2% raffinose are still 
present at a level easy for measuring increases or reductions upon the 
introduction o f an antisense gene sequence.
2. Very importantly, upon changing the carbon source from 2% raffinose to 
2% galactose there was no change in the constitutive expression of the 
Ad HI promoter as demonstrated by the levels of a-amylase produced 
from MT235::pAAMY-01.
3. As expected expression of the a-amylase gene under the control o f the 
GAL1 promoter (pYES2-AMY) is far greater than the expression of this 
gene under the control o f  the AdHl promoter (pAAMY-01). 
MT235::pYES2-AMY produces 3 times as much a-amylase activity as 
DBY746::pAAMY-01 and 4 times as much as MT235::pAAMY-01. It is
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hoped from this finding that when the induction levels are high, that this 
will be reflected in the number o f antisense RNA transcripts produced.
4. Finally, similar to point [1] above, when the strains MT235::pAAMY-01 
and DBY746::pAAMY-01 a-amylase activities’ were compared, when 
grown on 2% glucose, there was a significant decrease (approximately 
27%) in the levels of a-amylase activity in moving from DBY746 to 
MT235.
5.3 CO-TRANSFORMATION OF dYESt-SOC AND dAAMY-01 INTO
MT235
Initially when designing this experimental system a point to consider was 
the fact that the two plasmids chosen to express the sense (pAAMY-01) and 
antisense (pYES2-SOC) a-amylase gene may be incompatible. Compatibility 
studies by Warren (1983) who examined the mitotic segregation o f three 2ji - 
pBR322 chimaeric plasmids in S. cerevisiae found that each plasmid individually 
displayed a characteristic rate o f loss. However these loss rates were not 
significantly increased when two chimaeric plasmids were coresident, nor was 
the endogenous 2fi plasmid itself displaced. Co-transformation of MT235 with 
the sense a-amylase gene (pAAMY-01) and the antisense a-amylase gene 
(pYES2-SOC) bearing a LEU2 and URA3 selection marker respectively 
demonstrated the ability o f the strain to grow on minimal media lacking each o f 
the amino acids provided by the two plasmids thus indicating a successful co­
transformation event.
Transformants resulting from the co-transformation were plated on 
minimal media supplemented with 0.25% adenine, 2% Lintners starch and 2% 
galactose. Initial visualisation o f the plates after incubation at 30°C for 72 hours 
revealed individual haloes surrounding each colony indicating a-amylase 
activity. Ideally one might have hoped for colonies with little or no a-amylase 
activity. However it appeared that the haloes were o f varying sizes. 
Approximately 100 transformants were purified and then patched out on minimal 
media starch plates containing 2% galactose. A certain amount o f variation in a-
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amylase activity was noted for these transformants. Two transformants were then 
chosen for further analysis, MT235::pYES2-SOC + pAAMY-Ol [1] and [2].
5.3.1 ANALYSIS OF THE EFFECT OF THE ANTISENSE a-AM YLASE  
TRANSCRIPTS PRODUCED FROM  THE PLASM ID pYES2-SOC  
UNDER THE CONTROL OF THE INDUCIBLE G A L 1  PROM OTER ON 
THE LEVELS OF a-AM YLASE ACTIVITY PRODUCED FROM  THE 
PLASMID pAAM Y-01.
Samples for determining a-amylase levels were prepared in the following 
way. MT235::pYES2-SOC + pAAMY-01 [1] and [2] were grown in minimal 
medium containing 2% raffinose to mid-log phase o f growth, the cells were 
washed, and then placed in 2% galactose and incubated for a further 4 hours. 
Samples were taken before the addition of the inducing sugar in order to quantify 
the levels of a-amylase enzyme activity before induction of the GAL1 promoter. 
Triplicate cell samples were harvested and DNS assays were completed. The 
complete assay procedure was carried out 3 times. Table 5-4 shows the 
cumulative results for the in vivo analysis o f the efficacy of the antisense RNA 
transcripts produced from pYES2-SOC in reducing a-amylase gene expression.
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Table 5-4 The cumulative results (including controls) of the in vivo assay of the 
effects of the /ram -acting antisense transcripts from pYES2-SOC on a-amylase 
gene expression from pAAMY-01.
MT235::pYES2- 
SOC + pAAMY- 
01 [1]
MT235::pYES2- 
SOC + pAAMY- 
01 [2]
MT235::pAAMY
-01
(Control #1)
MT235::pYES2- 
AMY 
(Control #2)
Levels o f a- 
amylase activity 
before induction
2.26 x 10 5 2.05 x 10 s 2.14 x 10 ^ XXX
Levels o f a- 
amylase activity 
after induction
1.96 x 1 0 s 1.84 x 10'5 2.2 x 10 5 8.76 x 1 0 5
% reduction in a -  
amylase activity
13 10 No reduction Not applicable
XXX no expression o f  the a-amylase gene
The antisense RNA plasmid pYES2-SOC reduced a-amylase activity by 13% in 
the transformant MT235::pYES2-SOC + pAAMY-01 [1] and by 10% in 
MT235::pYES2-SOC + pAAMY-01 [2] only following galactose induction of the 
GAL1 promoter. This suggests that the decrease in a-amylase activity observed 
was due to the presence of the a-amylase antisense RNA and was not due to non­
specific interference with gene expression. Two controls were carried out in 
conjunction with the analysis of the two co-transformants to reinforce the results 
obtained.
The first control involved the growth of MT235::pAAMY-01 under the 
same conditions as the two co-transformants examined. The result obtained for 
this control demonstrated that there was no reduction (in fact there was a slight 
increase, 0.06 x 10'5 units/cell) in a-amylase activity, on shifting the cells from 
growth on 2% raffinose to 2% galactose. This implies that there was little or no 
effect on the constitutively expressed AdHI promoter upon changing carbon 
source. This further substantiates the finding that the decrease in a-amylase
271
activity is due to an antisense effect and not to a reduction caused by less 
efficient transcription of the AdHI promoter upon changing the carbon source.
For the second control, MT235::pYES2-AMY was also grown under the 
same conditions as the co-transformants. This was a control to monitor induction. 
The result indicates that there was a dramatic increase in the level of a-amylase 
gene expression, upon induction o f the GAL1 promoter, achieved by changing 
the carbon source from the non-inducing sugar, raffmose to the inducing sugar, 
galactose. Hopefully, one can infer from this that the antisense plasmid pYES2- 
SOC would behave in the same way with respect to the amount of transcript 
produced.
Because there was a reduction in a-amylase gene expression noted for 
both co-transformants, one would expect that there was [1] induction o f the 
GAL1 promoter leading to high expression of the antisense a-amylase gene and 
[2] that there was excess antisense:sense RNA being produced. These issues will 
be addressed in the following section where RNA analysis was carried out. 
Another important point to note here, is that the observed reduction in a-amylase 
activity may not be because there is an excess o f antisensersense RNA, but due to 
the fact that both transcripts are more spatially accessible, due to transcription of 
the sense and antisense a-amylase genes from episomes.
5.4 RNA ANALYSIS
The reduction in a-amylase activity levels upon induction o f the GAL1 
promoter observed in the previous section (5.3.1), would suggest that antisense 
transcripts were being made. By carrying out Northern blot analysis, it should be 
possible to be able to quantify the transcripts directly and from there to calculate 
the relative abundancies o f the messages.
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The yeast strains MT235::pYES2-AMY and MT235::pYES2-SOC were 
cultured first in 2% raffinose containing media, to mid-log phase. A sample was 
taken and total RNA was extracted. This yielded the samples MT235::pYES2- 
AMY (uninduced) and MT235::pYES2-SOC (uninduced). The remainder of the 
cells were harvested by centrifugation, washed and recultured in 2% galactose 
containing media, (for induction) for a further 4 hours, at which time point total 
RNA was extracted to provide the samples MT235::pYES2-AMY (induced) and 
MT235::pYES2-SOC (induced). Total RNA was extracted from the 
cotransformants MT235::pYES2-SOC + pAAMY-01 [1] and [2] after induction 
of the GAL1 promoter, as described in section 2.6.10. The RNA was separated on 
an agarose-formaldehyde gel and bi-directionally transferred to a nitrocellulose 
membrane. As with /rara-Experiment I (a) and (b), the sense and antisense a- 
amylase transcripts are expected to be of the same size, therefore the, Promega 
Riboprobe system was used (see section 4.1.2.4). The first blot (Figure 5.6) was 
probed with an antisense probe which should detect all sense a-amylase 
transcripts and conversely the second blot (Figure 5.7) was probed with a sense 
probe to detect all the a-amylase antisense gene sequences. One of the blots was 
then stripped o f it’s probe and reprobed with a (3-actin probe (Figure 5.8) in order 
to standardise the loadings and to allow a comparison between the two blots.
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Lane 1: R.NA markers (6,583; 4,981; 3,638; 2,604;
1,908; 1,383; 955; 623; 281 bp)
pYES2-AMY uninduced
pYES2-AMY induced
pYES2-SOC uninduced
pYES2-SOC induced
pYES2-SOC + pAAMY-01 [1] induced
pYESj-SOC + pAAMY-01 [2] induced
Lane 2: MT235
Lane 3 MT235:
Lane 4: MT235:
Lane 5: MT235:
Lane 6: MT235:
Lane 7: MT235:
Lane 8: MT235:
Figure 5.6 Northern blot o f total RNAs probed with a 32P-labelled antisense a- 
amylase riboprobe.
6 7 8
Lane 1: RNA markers (6,583; 4,981; 3,638; 2,604;
1,908; 1,383; 955; 623; 281 bp)
Lane 2: MT235
Lane 3 MT235::pYES2-AMYuninduced
Lane 4: MT235::pYES2-AMY induced
Lane 5: MT235::pYES2-SOC uninduced
Lane 6: MT235;;pYES2-SOC induced
Lane 7: MT235::pYES2-SOC + pAAMY-01 [1] induced 
Lane 8: MT235::pYES2-SOC + pAAMY-01 [2] induced
Figure 5.7 Northern blot o f total RNAs probed with a 32P-labelled sense a- 
amylase riboprobe.
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Lane 1: RNA markers (6,583; 4,981; 3,638; 2,604;
1,908; 1,383; 955; 623; 281 bp)
Lane 2: MT235
Lane 3 MT235::pYES2-AMYuninduced
Lane 4: MT235::pYES2-AMY induced
I^n c  5: MT235::pYES2-.SOC uninduced
Lane 6: MT235::pYES2-SOC induced
Lane 7: MT235:;pYES2-SOC + pAAMY-01 [1] induced
Ijine  8: MT235::pYES2-SOC + pAAMY-01 [2] induced
Figure 5.8 Northern blot o f total RNAs, which was initially probed with the 
sense a-amylase probe, stripped and reprobed with a 32P -labelled (3-actin 
riboprobe.
The first point to mention from analysis of the blots are the specificity of the 
riboprobes. The blot shown in Figure 5.6, very specifically picks up all the sense 
a-amylase transcripts using the antisense riboprobe, conversely, Figure 5.7 
probed with the sense riboprobe specifically picks up all of the antisense a- 
amylase gene transcripts. Secondly from both blots, it can be clearly seen, that 
the transcripts under the control the GAL1 promoter are present only in induced 
cultures (compare MT235::pYES2-AMY uninduced and induced, lanes 3 and 4, 
Figure 5.6 and MT235::pYES2-SOC uninduced and induced, lanes 5 and 6, 
Figure 5.7). The 1.9 kb transcripts produced from both MT235::pYES2-AMY 
and MT235::pYES2-SOC are of a length consistent with that expected if 
transcription was initiated close to the GAL1 promoter and terminated at the 
CYC1 transcript terminator. Also the presence of these bands indicates little or no 
degradation o f the RNA, which would imply stability of the RNAs.
pAAMY-01 [1] (co-transformant [1], lane 7, Figure 5.6 and Figure 5.7) it 
appears to possess a greater abundance of antisense transcripts (Figure 5.7) 
relative to sense. To ascertain the relative ratios of antisense to sense RNA both 
blots were analysed by measuring the band intensities o f the sense, antisense and
On analysis of the co-transformant MT235::pYES2-SOC +
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p-actin transcripts produced from MT235::pYES2-SOC + pAAMY-01 [I] and 
[2], The intensities were measured on a Pharmacia-Biotech (ImageMaster I D) 
Imaging Densitometer. An antisense:sense transcript ratio o f 7.5:1 was recorded 
for co-transformant [1]. Obviously temporal coincidence was ensured in this 
experimental system, as both sense and antisense transcripts of 1.9 kb were 
visualised, (lanes 7 and 8, Figure 5.6 and Figure 5.7). However, MT235::pYES2- 
SOC + pAAMY-01 [2] (co-transformant [2]) produced a much lower 
antisense:sense transcript ratio of 2:1. This latter result is interesting in light of 
the fact that in earlier experiments (trans I (a) and (c)) where there was a slightly 
higher ratio o f antisense:sense transcript recorded and yet no downregulation of 
the a-amylase activity levels were recorded. The difference in this particular 
experimental system, however, is that both sense and antisense transcripts are 
being transcribed from episomes in the nucleus and possibly therefore both 
transcripts are more spatially coincident, than in the previous experimental 
systems mentioned, hence the 10% decrease in a-amylase activity levels noted.
To confirm the latter results, these two co-transformants were re-analysed 
by the same method detailed above and the ratios produced reflected those 
observed above (see Figure 5.9).
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, Lane 1: MT235::pYES2-SOC + pAAMY-01
[1];
Lane 2: MT235::pYES2-SOC + pAAMY-01
[2]
Upper: Agarose-formaldehyde gel.
Middle: Hybridisation with the antisense a- 
amylase riboprobe.
Lower: Hybridisation with the sense a- 
amylase riboprobe.
Figure 5.9 Northern analysis o f the sense and antisense a-amylase transcripts 
produced from the co-transformants, MT235::pYES2-SOC + pAAMY-01 [1] and 
[2].
Another issue raised when analysing these blots, was that there was more 
antisense transcripts present in MT235::pYES2-SOC (induced, lane 6, Figure 5.7) 
than in lane 8 containing MT235::pYES2-SOC + pAAMY-01 [2]. Possibly, one 
explanation for this is that there was competition between the 2 plasmids present 
in the cell, which lead to a decrease in the copy number o f pYES2-SOC, hence 
there would be less antisense transcripts being produced.
Finally, MT235 (lane 2, Figure 5.6 and Figure 5.7) was loaded as a 
negative control in this experiment, as expected no bands were visualised when 
this sample was probed with both the sense and antisense riboprobes.
5 .5  DISCUSSION
Studies involving the use o f cloned antisense RNA to regulate specific 
gene expression usually result in partial down-regulation (Erickson and Izant, 
1992). The experiments described here in /ram-Experiment II agree with this
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finding with the demonstration o f the ability of an artificial antisense RNA to 
only partially downregulate the expression of the heterologous B. licheniformis 
a-amylase gene, by 13% and 10% in MT235::pYES2-SOC + pAAMY-01 [1] and
[2] respectively. An attractive hypothesis to account for the inability of antisense 
RNA to inhibit target gene expression completely is compartmentalisation of the 
two RNAs, with a fraction of the target mRNA unavailable for hybridisation with 
excess antisense RNA. In the present Experimental system care was taken to 
ensure temporal coincidence of target and inactivating genes. In addition, the 
strain was constructed to achieve an excess of antisense to sense RNA. Although 
both RNAs were transcribed from episomal locations in an attempt to ensure 
spatial coincidence the fact that the two RNAs were under the control of two 
different promoters may have resulted in the discrete localisation of the RNAs in 
separate “tracks” of the nucleus. This would rule out any antisense 
downregulation o f gene expression in the nucleus thus restricting the usefulness 
of an antisense molecule to the cytoplasm where it is more likely to be degraded.
Alternatively, partial inhibition may result if a target gene is 
downregulated in a subset o f cells rather than in the entire cell population. In 
some cases transgenic animals and plants containing antisense gene constructs 
have shown a mosaic phenotype in response to antisense RNA expression 
(Katsuki et al., 1988; van der Krol et al., 1988b). Within the yeast cell population 
it is not known whether 100% o f the antisense RNA-expressing cells from 
MT235::pYES2-SOC + pAAMY-01 [1] and [2] are inhibiting target gene 
expression by 13% and 10% respectively, or whether subsets o f the cell 
population show differing levels o f antisense RNA-mediated inhibition.
In this Experimental system similar to many other systems the antisense 
gene was constructed in such a way that the antisense RNA was as long as the 
sense mRNA molecule. The formation o f intramolecular secondary structures 
may have possibly prevented the formation of an antisense RNA/sense mRNA 
hybrid. On the other hand studies o f the kinetics of RNA-RNA interactions 
among the naturally occurring antisense RNAs found in bacteria have 
demonstrated that RNA hybrid formation involves an initial contact between 
short regions of complementarity, or nucleation sites, located in the loop regions 
of stem-loop structures followed by full-length hybridisation. One might predict
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therefore that longer antisense RNAs, such as the antisense RNA used in this 
system, may have a larger number of nucleation sites and thus greater potential 
for RNA-RNA annealing.
Although a more favourable antisense:sense RNA ratio was achieved in 
this system, when compared to the trans I systems, one might have expected an 
even more favourable ratio by choosing the GAL system. The antisense 
transcript level obtained (7.5:1) may have been due to certain limiting factors 
such as the GAL4 protein. This yeast protein is a transcription factor that is 
required for the induction o f the GAL1 promoter. The GAL4 protein normally is 
present at such low levels that it is rate limiting for the maximal induction of the 
GAL1 promoter. According to Schultz et al., (1994) the limitation is especially 
apparent in cells containing multicopy expression vectors with GAL promoters 
and pYES2-SOC had a 2\x origin of replication to allow this plasmid to exist in 
high copy number in yeast cells.
In this Experimental system, the physical location (or spatial coincidence) 
of the sense and antisense transcripts in the cell was considered. This parameter 
was the reason for introducing both the sense and antisense a-amylase genes into 
the cell on episomes. Experiments carried out by Sullenger and Cech (1993), 
where they utilised murine retroviral vectors to deliver both target and ribozyme 
RNAs have indicated that co-localising RNAs in murine cells may increase 
ribozyme mediated suppression o f the target RNA. Also the finding that the co­
transformant MT235::pYES2-SOC + pAAMY-01 [2] produced an 
antisense:sense transcript ratio o f 2:1, with a concomitant 10% reduction in a- 
amylase activity levels, possibly suggests that there was co-localisation of the 
transcripts. Furthermore, not all experimental systems, in which antisense 
transcripts have been examined require an excess o f antisense:sense RNA. The 
occurrence of antisense inhibition with comparable amounts o f antisense RNA 
and target mRNA has been demonstrated in several studies (van der Krol et al., 
1990). For naturally occurring antisense RNAs in plants, which are thought to be 
involved in gene regulation, the steady-state levels o f antisense RNA and mRNA 
do not differ greatly (Rogers, 1988). This might indicate that, in contrast to what 
has often been hypothesised, the formation of an excess o f antisense RNA
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relative to  sense m R N A  may not be  a p re requ is i te  for successfu l inhibition 
(K u ip e rs  et al., 1995).
Although both the sense and antisense ot-amylase genes were expressed 
from episomes, the fact that both genes had different promoter and terminator (or 
5’ and 3’) sequences this may have conferred a particular nuclear export and 
cytoplasmic distribution, for the different terminal sequences (Gottlieb, 1992). If 
this situation holds true for this experimental system, then that implies that 
spatial coincidence has not been ensured. This thought led to the design of the 
final Experimental system, the cw-Experimental system. Spatial coincidence will 
be ensured in this system by the insertion o f cw-acting antisense sequences 
within the 3’ untranslated region o f the a-amylase gene. Such an arrangement 
should provide an optimal situation for RNA-RNA interaction by linking both 
temporal and spatial distribution o f the antisense and target RNA transcripts.
5.6 FUTURE WORK
After analysing the data and results from /ram-Experiment II, there are a 
number of further issues which could be addressed. Firstly, due to the fact that 
there was such a variation between the two co-transformants examined, more co­
transformants should have been taken for analysis. Also, for co-transformants [1] 
and [2], the plasmid copy numbers o f both pAAMY-01 and pYES2-SOC should 
be determined and also their relative stabilities over time should be examined.
Also it was assumed, that the activity levels which produced the greatest 
amount o f a-amylase activity, after induction o f the GAL1 promoter (which was 
determined to be 4 hours after galactose addition to the media) would reflect the 
time at which there would be the highest number o f transcripts being produced. 
However, although 4 hours was optimal for protein production, this may not be 
the optimal time point for transcript production. To address this, total RNA 
should be extracted at different time points and the transcript levels assessed.
It would also be interesting to investigate, if an arrangement where the 
antisense a-amylase gene was introduced into the cell under the control o f a 
constitutively expressed promoter, to allow the establishment o f the antisense 
transcripts in the cell, before induction of the sense a-amylase gene, (under the
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contro l o f  an inducible  p rom ote r) ,  w ould  be m ore  effective at reducing a -  
am ylase activity.
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CHAPTER 6
C/s-Experiment (a) and (b)
I S en se am ylase sequences 
I A ntisense am ylase sequences
P; Plasmid
Chr; Chromosomal location
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6. CIS -  EXPERIMENT (a) AND (b)- INTRODUCTION
Within the yeast S. cerevisiae, it appears that the failure of antisense 
sequences tested in a trans configuration, is not an uncommon situation, (Arndt, 
1993; Arndt et al., 1994; Atkins and Gerlach, 1994; Olsson et al., 1997). The first 
report of a successful antisense mediated inhibition o f gene expression in a trans 
configuration, in this organism, (Xiao and Rank, 1988) was actually retracted 
(Arndt et al., 1994). In fact, the earliest demonstration o f a successful 
downregulation o f an RNA sequence in S. cerevisiae was not from a iram-acting 
antisense RNA, but from a cw-acting antisense RNA (Atkins and Gerlach, 1994). 
In a cis configuration, the transcription of the sense and antisense genes are 
linked, thus guaranteeing spatial and indeed, temporal coincidence.
In /nms-Experiment II, the concept o f spatial coincidence was 
introduced, in conjunction with attempting to increase the copy number of 
antisense RNA transcripts in the cell, relative to the sense messenger RNA. The 
latter objective was achieved (7.5:1) and this resulted in a small, but significant 
downregulation o f a-amylase gene expression. But whether this downregulation 
was as a result of a more favourable ratio o f antisense:sense RNA, than what was 
achieved in iram'-Experimental systems I (a) (4:1) and I (c) (3.5:1; 3.5:1; 4:1), or 
due to a more favourable spatial coincidence remains to be evaluated. From a 
spatial aspect, in trans II both interacting RNAs were transcribed from episomes, 
in contrast to trans I, where the sense and antisense transcripts were transcribed 
from different locations within the nucleus, i.e. either episomally or 
chromosomally. In the context o f the above findings, it was decided to test the 
effect o f  an antisense sequence, designed to work in cis, on a-amylase gene 
expression
The cis experiments involved linking the transcription o f the sense and 
antisense genes, (both genes being transcribed by the same promoter as part of 
the same transcriptional unit) thus ensuring temporal and spatial coincidence. It 
was hoped that this configuration o f sense and antisense genes should provide an 
optimal situation for RNA-RNA interaction. The anticipated outcome of such an 
arrangement would be that the antisense RNA would fold-back and bind to its’ 
complementary 5’ sense RNA and thus, either down-regulate or totally inhibit 
translation o f the gene, due to either sequesterisation o f the ribosome binding
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site, by  c leavage o f  the d o u b le  stranded  s tructure ,  o r  by destabilisation  o f  the 
m essage.
Another reason for undertaking the investigation of cw-acting antisense 
sequences comes from the analysis of the distribution of natural RNA transcripts 
within eukaryotic cells. Experimental work carried out by Lawrence and Singer 
(1986), suggests that a higher order o f subcellular localisation exists, in addition 
to the simple nuclear\cytoplasmic division. Analysis o f the intracellular 
distribution o f mRNAs for cytoskeletal proteins, demonstrated that actin mRNA 
concentrations were highest at cell extremities, vimentin mRNA was distributed 
near the nucleus and tubulin mRNA appeared to be concentrated in the peripheral 
cytoplasm. Such results demonstrate that cytoplasmic mRNAs are localised in 
specific non-random cellular patterns, and that localised concentrations of 
specific proteins, may result from corresponding localisation of their respective 
mRNAs (Lawrence and Singer, 1986). Another striking example of localised 
messages can be found among the maternal mRNAs o f frogs and flies where 
localisation has been implicated in the establishment of axial polarity (Gottlieb, 
1992).
Other laboratories seeking to define the basic physical structure o f the 
nucleus have provided evidence for a non-chromatin nuclear matrix composed of 
a network o f predominantly proteinaceous fibrils. These laboratories postulate 
that RNAs are unlikely to diffuse freely through the highly viscous nucleus, but 
are more likely to be actively transported from their site o f synthesis to the 
nuclear pores across a “solid-phase” nuclear architecture (Lawrence et al., 1989). 
Spector (1990) also agrees that the nucleus has a defined architecture, and that 
the components o f the machinery, responsible for each step of gene expression 
are located at defined positions within the nucleus, rather than in a diffuse 
pattern. Lawrence et al., (1989) and Xing et al., (1993) have gone further to show 
that mRNA molecules within the nuclear structure are restricted to discrete 
“tracks”. These “tracks” form immediately after transcription and extend from 
the gene toward the nuclear membrane. Hence, the spatial fate of the mRNA can 
be correlated with gene location. This is potentially important for antisense 
activity, as the position o f the specific genes may predetermine that the tracks 
occupied by the complementary RNAs do not coincide with the target RNA. This 
would rule out any antisense down-regulation o f gene expression in the nucleus
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thus restricting the usefu lness  o f  an antisense R N A  m olecu le  to the cy top lasm  
w here  it is m ore  likely to  be degraded .
This chapter is divided into c/.v-Experiment (a), where the construction, 
characterisation and effect, of an episomal cis construct on a-amylase gene 
expression is described. This is followed by c/.v-Experiment (b), where the 
construction, characterisation and effect o f an integrated cis plasmid are reported. 
This chimeric sense-antisense gene sequence was cloned into the two different 
types of expression vector, (i.e. episomal (cw-(a)) and integrative (cw-(b)) to 
examine whether the location o f the transcriptional unit would alter the outcome. 
RNA analysis for both cw-Experimental systems is then documented, followed 
by a discussion and future work, which could be undertaken.
285
Cw-Experiment (a)
Sense amylase sequences P; Plasmid
Antisense amylase sequences
Cw-Experiment (a) described here involves the cloning into a single 
expression unit, part of the a-amylase gene - in antisense orientation - fused to 
the 3' end of the complete gene. This transcriptional unit, under the control of the 
AdHI promoter and terminator was cloned into a yeast expression vector, to 
create what will be known as a “cw-acting” plasmid. This episome was 
transformed into the yeast strain DBY746 and the transformants were examined 
for any change in a-amylase activity levels in comparison to a control construct.
6.1 ANEPISOMAL PLASMID CONTAINING THE CIS-ACTING
ANTISENSE a-AMYLASE GENE SEQUENCE
An antisense a-amylase gene sequence (complementary to the 5 ’ end of 
the sense a-amylase gene) was ligated to the 3 ’ end of a sense a-amylase gene 
and cloned into the yeast episomal vector pAAH5 to produce the cw-acting 
plasmid, pMAS-H5. An important point to note about this plasmid construction 
is that the sense a-amylase gene sequence is missing its’ transcriptional stop site. 
The a-amylase sense gene sequence used to construct the cw-acting plasmid, 
pMAS-H5 came from the plasmid pM 02 (see materials section 2.2). 
Approximately, 243 base pairs o f the parental B. licheniformis a-amylase gene 
were deleted, from the 3 ’ end. This deletion disrupted the putative palindromic 
transcriptional termination site, but left the entire a-amylase gene and its’ 
translational stop site intact (Appendix IQ). I f  the a-amylase genes’ 
transcriptional stop site was present this would mean that transcription would 
terminate before the RNA polymerase would have had a chance to read through 
to the antisense sequence tagged onto the end of the sense a-amylase gene 
(Figure 6.1).
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Figure 6.1 Schematic representation o f the arrangement of the c/s-acting sense- 
antisense gene sequence.
6.1.1 CONSTRUCTION OF THE EPISOM AL C IS -ACTING PLASMID, 
pMAS-H5
The cloning of the sense-antisense a-amylase gene sequences as a single 
transcriptional unit can be divided into two steps. Firstly, the sense and antisense 
a-amylase gene sequences were fused together by directional ligation (see Figure 
6.1). Secondly, this sense-antisense gene sequence was subcloned into a yeast 
episomal vector, so that the entire sense-antisense a-amylase gene sequences 
were under the control of the same promoter.
To construct the m-acting plasmid, pMAS-H5, a functional sense a- 
amylase gene without its’ transcriptional stop site was required, in addition to an 
a-amylase sequence complementary to the 5’ region of the sense a-amylase 
gene. The functional sense a-amylase gene was removed from the plasmid 
pM 02 (Olsen, 1 9 9 5 )asa l.6 k b  BamR I - Hind ID restriction fragment 
(Appendix III). A 0.6 kb antisense a-amylase gene sequence was also removed 
as a BamR I - Hind III restriction fragment, from the plasmid pAS600. These 
fragments were ligated together in the presence of BamR I restricted pUC-19, to 
produce the plasmid pMAS. pUC-19 was chosen as the initial cloning vehicle for 
the sense-antisense a-amylase gene sequence as it possesses a unique BamR I 
site for cloning and the lacZ phenotype could be exploited for rapid screening of 
the transformants (a more detailed description of the construction of pMAS is 
given in the legend to Figure 6.2).
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Figure 6.2 Schematic representation o f the construction of the plasmid, pMAS.
Plasmid pM 02 (see section 2.2) which contains a truncated version o f the a-amylase gene (it 
lacks the transcriptional stop site, Appendix HI) was double-digested with BamH I and Hind in
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to yield a 1.6 kb fragment. Simultaneously the plasmid pAS600 was double-digested with the 
same restriction enzymes that resulted in the release of a 0.6 kb 5’ a-amylase gene fragment. 
Both fragments (1.6 and 0.6 kb) were gene cleaned (section 2.6.11.9) from a 0.7% agarose gel 
and ligated together in the presence of BamH I digested and CIP (section 2.6.11.3) treated pUC- 
19. The ligation mix was transformed into E. coli DH5a cells. Selection o f the transformants 
involved plating onto LB amp starch (2% Lintners) plates containing X-gal and IPTG, which 
allows exploitation o f the lacZ phenotype (colonies with inserts are white, while no insert results 
in the production o f a blue colony). White colonies were then screened for the presence o f  a 2.2 
kb BamU I fragment containing the pM 02 sense a-amylase gene ligated to the 0.6 kb antisense 
a-amylase fragment. This plasmid was named pMAS and is 4.9 kb in size.
To confirm the successful cloning of the sense-antisense a-amylase gene 
sequence into pUC-19 to produce the plasmid pMAS, plasmid DNA was 
extracted from white colonies and analysed by restriction enzyme analysis 
(Figure 6.3). The diagnostic restriction enzymes chosen were BamU I and Hind 
III. BamU I was chosen to confirm that the insert was the correct size (2.2 kb, 
lane 2, Figure 6.3) and Hind III was chosen to verify that the cloned BamH I 
fragment contained the desired 1.6 and 0.6 kb fragments. Depending on the 
overall orientation o f the fused BamH VHind in  fragments, a Hind ID digest 
could yield either restriction fragments of 1.6 and 3.3kb or 0.6 and 4.3 kb. The 
former arrangement was observed in this clone (lane 1, Figure 6.3).
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The appropriate sizes o f each of the restriction fragments are shown in 
kilobases, in brackets below. The relevant sizes o f the 1 kb ladder are as 
indicated.
Lane 1: pMAS digested with Hind HI (3.3; 1.6 kb)
Lane 2: pMAS digested with BamH I (2.7; 2.2 kb)
Lane 3: 1 kb ladder (12.216; 11.198; 10.180; 9.162; 8.144; 7.126; 6.108; 5.090; 4.072;
3.054; 2.036; 1.636; 1.018; 0.506 kb).
The second step in the construction of pMAS-H5 involved restricting the 
plasmid pMAS with BamH I to release the 2.2 kb fragment containing the sense- 
antisense a-amylase gene fragment. This fragment was then subcloned into the 
yeast episomal vector, pAAH5. This vector contains one unique site for cloning, 
a Hind III site, situated between theAdHI promoter and terminator. However, 
this restriction site was unsuitable for the cloning of the sense-antisense a- 
amylase gene, which was cloned into pUC-19 as a BamH I fragment. To 
overcome this problem, the plasmid pMAS was restricted with BamH I, the 2.2 
kb BamH I fragment was gene cleaned from an agarose gel, and the sticky ends 
produced after BamH I restriction digestion were filled-in using the Klenow 
enzyme. Meanwhile the vector pAAH5 was restricted with Hind ID and the ends 
produced were once again filled-in using the Klenow enzyme. Both the vector 
and the fragment were then ligated in a blunt-ended ligation and transformed into 
DH5a cells (a more detailed description of the construction of pMAS-H5 is 
given in the legend to Figure 6.4).
Figure 6.3 Restriction analysis of pMAS.
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292
F ig u r e  6 .4  S ch em atic  representation  o f  the con stru ction  o f  the p lasm id , p M A S -  
H5.
pAAH5 was restricted with Hind III and gene cleaned (section 2.6.11.9) to remove the restriction 
buffer. In the meantime the 2.2 kb BamH I fragment from pMAS was gene cleaned from a 0.7% 
agarose gel. Both the Hind III digested pAAH5 vector and the 2.2 kb BamH I pMAS fragment 
were placed in the same microfuge tube and the overhangs produced following restriction 
digestion were filled-in using the Klenow enzyme (section 2.6.11.2) in the presence o f 0.5mM 
dNTPs for 30 minutes at room temperature. Following this the reaction mix was phenol extracted 
twice, chloroform extracted once and then ethanol precipitated (section 2.6.11.7). The blunt ends 
were then ligated with T4DNA ligase at 4°C overnight. The ligation mix was then transformed 
into DH5a cells. Transformants were plated on LB amp starch (2% Lintners) plates. Colonies 
were then screened for the presence o f the 0.6 kb 5 ’ antisense a-amylase fragment tagged onto 
the 3 ’ UTR o f the pM 02 sense a-amylase gene. The correct insert orientation being determined 
by either a Kpn I or a Hind WVXba I digest. This plasmid was named pMAS-H5 and is 14.43 kb 
in size.
Plasmid DNA was extracted from colonies after transformation of the ligation 
mixture into DH5a cells. This plasmids’ construction was then confirmed using 
diagnostic restriction enzyme analysis (Figure 6.5). The enzymes chosen for the 
determination o f the desired orientation o f the sense-antisense a-amylase gene 
sequence insert in pAAH5 were either Kpn I or Hind WVXba I (see Appendix 
VIII for details). A Kpn I digest o f pMAS-H5 with the fragment in the desired 
sense-antisense orientation relative to the Ad HI promoter and terminator should 
give restriction fragments o f 7.78,4.14 and 2.5 kb respectively. If the fragment 
ligated to pAAH5 in the antisense-sense orientation relative to the AdHI 
promoter and terminator, a Kpn I restriction digest should produce fragments o f 
6.77, 5.15 and 2.5 kb. In the desired sense-antisense orientation a Hind WMXba I 
restriction digest should produce fragments o f 10.67 and 3.75 kb whereas in the 
antisense-sense orientation fragments of 11.68 and 2.74 kb would be visualised.
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Figure 6.5 Restriction analysis o f pMAS-H5.
The appropriate sizes of each of the restriction fragments are shown in 
kilobases, in brackets below. The relevant sizes of the 1 kb ladder are as 
indicated.
Lane 1: 1 kb ladder (12.216; 11.198; 10.180; 9.162; 8.144; 7.126; 6.108; 5.090; 4.072;
3.054; 2.036; 1.636; 1.018; 0.506 kb).
Lane 2: pAAH5 undigested
Lane 3: pMAS-H5 undigested
Lane 4: pAAH5 digested with Hind HI (12.23 kb)
Lane 5: pMAS-H5 digested with Hind HI (14.43 kb)
Lane 6: pAAH5 digested with Xba I (12.23 kb)
Lane 7: pMAS-H5 digested with Xba I (14.43 kb)
Lane 8: pAAH5 digested with Hind HI \Xba I (10.08; 2.15 kb)
Lane 9: pMAS-H5 digested with Hind III \Xba I (10.67; 3.75 kb)
Lane 10: pAAH5 digested with BamH I (10.23; 2.0 kb)
Lane 11: pMAS-H5 digested with BamH I (10.23; 4.2 kb)
Lane 12: pAAH5 digested with Kpn I (9.73; 2.5 kb)
Lane 13: pMAS-H5 digested with Kpn I (7.78; 4.14; 2.5 kb)
Lane 14: 1 kb ladder (12.216; 11.198; 10.180; 9.162; 8.144; 7.126; 6.108; 5.090; 4.072;
3.054; 2.036; 1.636; 1.018; 0.506 kb).
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Figure 6.5 confirms the construction o f pMAS-H5 from the Hind WMXba I (lane 
9) and Kpn 1 (lane 13) restriction digests. Both these lanes producing the 
expected band sizes of 10.67 and 3.75 kb in the case of the Hind III /Xba I 
restriction, and fragment sizes o f 7.78, 4.14 and 2.5 kb when restricted with Kpn 
I. Also the Hind III digest of pMAS-H5 (lane 5, Figure 6.5) produced a single 
high molecular weight band (expected to be 14.43 kb). This band is greater than 
the 12.23 kb band produced after restriction digestion o f pAAH5 with Hind III, 
(lane 4, Figure 6.5), which indicates a successful cloning event. Because, 
although the unique Hind III site for cloning had been removed from pAAH5, 
there was an internal Hind III restriction enzyme site within the cloned sense- 
antisense a-amylase gene fragment, which when digested with this enzyme, 
should yield this band of 14.43 kb (lane 5, Figure 6.5). For a detailed restriction 
map of pMAS-H5 see Figure 6.6.
Figure 6.6 Plasmid map of pMAS-H5, (pAAH5 vector with a-amylase e f­
fusion sequences).
BHI represents the restriction enzyme BamH I.
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6.2 TRANSFORMA T1 ON AN D  CONFIRMA TION O F THE PRESENCE
OF THE PLASMID PMAS-H5 INDBY746
The plasmid pMAS-H5 was transformed into DBY746. Confirmation of 
the presence o f this plasmid in DBY746 was demonstrated initially by its’ ability 
to grow on selective media. The transformation mixture was plated onto minimal 
media supplemented with uracil only, as the plasmid pMAS-H5 (a derivative of 
pAAH5, appendix VIII) carries a LEU2 marker thus a successful transformation 
event will convert the DBY746 strain to leucine prototrophy. Leu+ transformants 
were isolated.
Southern blot analysis was carried out to (i) prove the presence o f the 
plasmid in DBY746 and (ii) to establish the integrity of the plasmid i.e. that no 
rearrangements or loss/deletions had occurred within the plasmid. Genomic DNA 
was extracted from DBY746::pMAS-H5 and electrophoresed both undigested 
and digested with various restriction enzymes on a 0.8% agarose gel, then blotted 
and probed with a 32P-labelled sense a-amylase riboprobe (section 4.1.2.4). The 
restriction enzymes chosen were Hind III (which linearises the plasmid to give a 
band o f 14.43 kb, the presence of a band this size on the blot would indicate no 
deletions from the plasmid) and BamH I (which should cut out the 4.2 kb AdHI 
promoter-sense-antisense a-amylase gene sequence-^ /// terminator fragment).
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Figure 6.7 Southern blot, probed with a 32P-labelled sense a-amylase riboprobe,
to confirm the presence o f the plasmid pMAS-H5 in DBY746.
Lane 1: lkb ladder (12.216; 11.198; 10.180; 9.162; 8.144; 7.126; 6.108; 5.090; 4.072; 
3.054; 2.036; 1.636; 1.018; 0.506 kb).
Lane 2: pMAS-H5 undigested
Lane 3: pMAS-H5 digested with Hind HI (14.43 kb)
Lane 4: pMAS-H5 digested with Kpn I (7.78; 4.14 kb)
Lane 5: pMAS-H5 digested with BamH I (4.2 kb)
Lane 6: DBY746:: pMAS-H5 undigested
Lane 7: DBY746::pMAS-H5 with digested with Hind III
Lane 8: DBY746::pMAS-H5 with digested with BamH I
The Hind m  digest o f DBY746::pMAS-H5 (lane 7, Figure 6.7) 
highlighted 2 bands on the autoradiograph, one of these bands corresponds to 
undigested DNA, and the second band was equivalent to linearised pMAS-H5. 
The BamH I digest o f DBY746::pMAS-H5 (lane 8, Figure 6.7) digest revealed a
4.2 kb band equivalent to the AdHI promoter-sense-antisense a-amylase gene 
sequence-^ /// terminator fragment. From the Hind HI and BamH I digests one
can co n c lude  the presence  o f  p M A S -H 5  in D B Y 7 4 6 ,  also that the p lasm id  w as o f  
the correc t  size, with the correc t  insert s ize o f  4 .2  kb.
6.3 EFFECT OF THE CIS-ACTING ANTISENSE SEQUENCE ON a-
AMYLASE GENE EXPRESSION IN  THE YEAST STRAIN DBY746 FROM 
THE EPISOMAL PLASMID dMAS-H5
When the plasmid pMAS-H5 was transformed into DBY746, the 
transformation mixture was plated onto minimal media containing 2% Lintners 
starch. All o f the transformants, from visualisation of the plates were unable to 
degrade the starch, thus demonstrating the ablation of a-amylase activity by the 
cw-acting antisense sequences.
An important point to note here in relation to the chimeric sense-antisense 
transcript is that there was expression o f the a-amylase gene when the plasmid 
pMAS-H5 was transformed into DH5a and plated on LB amp plates containing 
2% Lintners’ starch. This indicates that the a-amylase gene is functional and that 
the fusion to the antisense sequence and subsequent cloning into the yeast shuttle 
vector pAAH5 has not knocked-out expression of the gene. Therefore the lack of 
a-amylase activity observed when transformed into DBY746, is most likely due 
to the cw-acting antisense sequence and not to an anomaly of the cloning. The 
fact that the sense-antisense construct exhibits a-amylase activity in DH5a might 
be explained because transcription and translation are coupled processes in 
prokaryotes. When a gene is being transcribed ribosomes latch onto nascent 
transcripts and begin to translate before transcription is complete. Hence the 
sense sequence would be in the process o f being translated before the antisense 
sequence has even been transcribed. Since most bacterial mRNAs are translated 
as soon as transcription has created a molecule long enough to be recognised by 
ribosomes, the degree of inhibition achieved by the antisense RNAs will depend 
on its rate o f interaction with the target. In turn, the rate will depend on the 
concentration of both RNA species and their reactivity towards one another, 
assuming that they are in present in the cell.
Approximately 50 colonies, produced after transformation of pMAS-H5 
into DBY746, were patched onto minimal media plates containing 2% Lintners 
starch. No a-amylase activity was observed for any of the transformants (see
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Figure 6.8, where one transformant is shown). A DNS assay was performed to 
confirm this result. The assay was repeated 3 times. The cumulative results of 
this experiment are represented by the bar chart shown below (Figure 6.9). 
Results are reported as the % amylase activity relative to the control strain 
DBY746::pM02 (100%).
1 2
Figure 6.8 Minimal media plate containing 2% Lintners’ starch, supplemented 
with the appropriate amino acid. Section [1] contains the amylolytic strain 
DBY746::pM02 and section [2] strain DBY746::pMAS-H5.
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Figure 6.9 Effect o f the c/.v-acting antisense sequence on a-amylase gene 
expression from the yeast episomal plasmid, pMAS-H5.
As can be seen from the barchart (Figure 6.9), the result obtained confirms what 
was observed after the transformants had been plated onto minimal media starch 
plates, which was, a complete inhibition o f a-amylase activity.
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301
In cis-Experiment (b), the same sense-antisense a-amylase sequence used 
in cis (a) was subcloned into a yeast-integrating vector. Integration was targeted 
to the ura3-52 locus o f DBY746. This was carried out to determine whether the 
location of the gene was significant.
6.3.1 CONSTRUCTION AND INTEGRATION OF THE “CZS-ACT1NG” 
INTEGRATING VECTOR, pFL34-MAS
The AdifI promoter-sense-antisense a-amylase gene sequence-AdHI 
terminator fragment from pMAS-H5 was cloned into the integration vector 
pFL34 (section 4.1.1, Appendix I) to produce pFL34-MAS. The plasmid pFL34- 
MAS is represented schematically in Figure 6.10 and a detailed description of 
its’ construction are included in the legend to this figure.
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Figure 6.10 Schematic representation of the construction o f the integrating cis- 
acting plasmid, pFL34-MAS.
The 4.2 kb BamH I fragment from pMAS-H5 which contains the sense-antisense a-amylase 
fragment between the AdHl promoter and terminator was gene cleaned (section 2.6.11.9) from a 
0.7% agarose gel and cloned into the unique BamH I site o f  the integrating vector pFL34. DH5a 
cells were transformed with this ligation mix and screened on LB amp starch (2% Lintners) plates 
containing X-gal and IPTG, which allows exploitation o f the lacZ phenotype. With this clone 
orientation does not matter as the insert is in the correct orientation with respect to the AdHl 
promoter and terminator. This plasmid was named pFL34-MAS and is 8.0 kb in size.
To confirm the successful construction of the plasmid pFL34-MAS, 
restriction enzyme analysis was performed (Figure 6.11). Plasmid DNA was
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extracted from white colonies after transformation of the ligation mix into DH5a 
E. coli cells. The restriction enzyme BamH I was chosen to prove that the insert 
was of the correct size (i.e. 4.2 kb). pFL34-MAS was also restricted with Hind III 
and Pst I to determine in which orientation was the cassette ligated into pFL34.
As mentioned already, orientation does not matter in this case, as the sense- 
antisense a-amylase gene sequence is in the correct orientation, relative to the 
Ad HI promoter and terminator. Also, the restriction fragments obtained after 
digestion with Hind III and Pst I are of the expected sizes and are a further proof 
of the construction of the plasmid pFL34-MAS.
2 4  6  8
4072
Figure 6.11 Restriction analysis ofpFL34-MAS.
The appropriate sizes o f each of the restriction fragments are shown in 
kilobases in brackets below. The relevant sizes of the 1 kb ladder are as 
indicated.
Lane 1: 1 kb ladder (12.216; 11.198; 10.180; 9.162; 8.144; 7.126; 6.108; 5.090; 4.072;
3.054; 2.036; 1.636; 1.018; 0.506 kb).
Lane 2: pFL34 undigested
Lane 3: pFL34-MAS undigested
Lane 4: pFL34 digested with BamH I (3.799 kb)
Lane 5: pFL34-MAS digested with BamH I (4.2; 3.799 kb)
Lane 6: pFL34 digested with Hind in (3.799 kb)
Lane 7: pFL34-MAS digested with Hind 111(6.95; 1.05 kb)
Lane 8: pFL34 digested with Pst I (3.799 kb)
Lane 9: pFL34-MAS digested with Pst I (5.459; 1.97; 0.56 kb)
304
Lane 10: 1 kb ladder (12.216; 11.198; 10.180; 9.162; 8.144; 7.126; 6.108; 5.090; 4.072;
3.054; 2.036; 1.636; 1.018; 0.506 kb).
From Figure 6.11, the BamH I digest confirms an insert of 4.2 kb into the 
3.8 kb vector, pFL34. Also both the Hind III and Pst I restriction digests which 
gave fragment sizes o f 6.95 and 1.05 kb in the case o f the former and 5.459, 1.97 
and 0.56 kb in the case o f the latter, demonstrate that the cassette ligated in the 
orientation shown in Figure 6.10.
6.4 INTEGRA TIONAND CONFIRMA TION OF INTEGRA TION OF
THE PLASMID vFL34-MAS INTO DBY746 TO PRODUCE THE 
INTEGRANT. SA.
Integration o f the plasmid pFL3 4-MAS was directed towards the ura3-52 
locus of the yeast strain DBY746 by linearisation of this plasmid at the unique 
Stu I site within the URA3 marker. Integration leads to a duplication of the URA3 
gene and conversion of the strain to uracil prototrophy (Figure 6.12).
Chromosome V
URA3-e2 AdHIT  M -------------- AdHIp AmpK TJRA3
Figure 6.12 Schematic representation of the probable integration event o f the 
plasmid pFL34-MAS into the ura3-52 locus of DBY746 to produce the integrant, 
SA.
To show that integration had occurred the transformants were (i) grown on 
selective media, (ii) the stability of one of the transformants was analysed and 
(iii) Southern blot analysis was carried out. Only the transformants which
305
received the URA3 gene from the plasmid pFL34-MAS were capable of growth 
on uracil minus minimal media. As the plasmid, pFL34-MAS does not contain an 
origin of replication, growth of transformants on media lacking uracil would 
strongly suggest the presence of the integrated plasmid. As DBY746 is 
auxotrophic for both uracil and leucine, the transformants were plated on 
minimal media containing only leucine. According to the predicted mechanism 
of integration, if  the ura gene is integrated, one would expect the sense-antisense 
a-amylase gene also to be inserted into the chromosome.
To examine the mitotic stability of the ura3-52 integrated exogenous 
DNA sequences the yeast transformants were analysed as described in section 
4.1.1.1.2. The results (Figure 6.13) indicated that the ura3-52 integrated 
sequences were stably maintained during mitotic growth in rich medium. This 
high stability of the ura+ phenotype constitutes additional proof that integration 
into the yeast genome had occurred.
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Figure 6.13 Mitotic stability of the um3-52 sense-antisense a-amylase integrant, 
SA.
To prove integration by Southern blot analysis genomic DNA extracted 
from SA was digested with a restriction endonuclease which cuts outside the 
plasmid DNA. The enzyme chosen was Xho I. This should yield a single band of 
high molecular weight on the gel when Southern blotted and probed with a 32P-
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labelled a -am y la se  probe , i f  integration had been successful.  Integration was 
dem onstra ted  by the p resence  o f  a single high m olecu la r  w eight band (data  not 
shown).
6.5 EFFECT OF THE CIS-ACTING ANTISENSE SEQUENCE ON a- 
AMYLASE GENE EXPRESSION IN THE INTEGRATED STRAIN SA. 
FROM THE VECTOR pFL34- MAS.
An inhibitory effect (if any) on the expression of the target gene was 
analysed initially by plating the transformants o f SA onto minimal media plates 
containing 2% Lintners’ starch. After growth at 30°C for 72 hours, the plates 
were either flooded with iodine vapour or incubated for 12 hours at 4°C, in order 
to allow the starch to precipitate. The transformants were then checked for 
haloes. Interestingly, visualisation of these plates, displayed the same result 
which was found with the DBY746::pMAS-H5 transformants. There were no 
haloes surrounding any of the colonies thus indicating a complete down- 
regulation o f a-amylase gene activity. A number o f colonies from the integrative 
transformation event were patched onto fresh minimal media plates with an 
amylolytic strain as a positive control. The same result was obtained, no 
amylolytic activity was observed (Figure 6.14).
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Figure 6.14 Minimal media plate containing 2% Lintners’ starch, with each 
section o f the plate supplemented with the appropriate amino acid. Section [1] 
contains the amylo lytic strain DBY746::pM02, section [2] strain 
DBY746::pMAS-H5 and [3] SA, the integrant.
A number o f the transformants were further analysed by DNS assay to 
substantiate the findings obtained from observation o f the minimal media starch 
plates. The transformants were grown up in liquid minimal media until the cell 
growth had reached mid-log phase. The cultures were then spun down at 5,000 
rpm for 5 minutes at 4°C and the supernatants were analysed for a change in cx- 
amylase activity in comparison to the control strain SI. The strain DBY746 was 
used as a negative control in this experiment. All samples were assayed in 
triplicate and the entire assay was repeated 3 times.
Figure 6.15 Effect of the cm-acting antisense sequence on a-amylase gene 
expression from the integrated yeast strain, SA.
The results o f these assays (Figure 6.15) did indeed substantiate what was 
found when the transformants were grown on minimal media starch plates, that 
being there was no a-amylase activity detected.
6.6 RNA ANALYSIS
In an attempt to determine the mechanism of suppression of the activity 
o f the a-amylase gene, Northern blot analysis was performed. This analysis 
involved the extraction of total RNA, under the conditions described in section 
2.6.10. The RNA was then separated on a denaturing agarose-formaldehyde gel 
and bi-directionally transferred to a nitrocellulose membrane. One blot was 
probed with a 32P-labelled antisense a-amylase riboprobe and the second with a 
32P-labelled P-actin riboprobe. The purpose of probing with the latter probe was 
to demonstrate [1] that the RNA was not degraded and [2] to allow quantification 
o f the levels of RNA produced. The Northern analysis was completed on two
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independently prepared RNA samples from a representative transformant for 
DBY746::pMAS-H5 and SA (data shown for one RNA sample only). DBY746 
total RNA was run on the gel as a negative control and DBY746::pM02 (a 
plasmid which contains the sense a-amylase gene, minus its’ transcription stop 
site) was run as a positive control.
2 4
u
I f H
Figure 6.16 [a] Formaldehyde agarose gel o f total RNAs. Bi-directional 
Northern blot of total RNAs probed with 6.16 [b] a 32P-labelled antisense a- 
amylase riboprobe and with 6.16 [c] a 32P-labelled P-actin riboprobe.
Lane 1: RNA markers (6,583; 4,981; 3,638; 2,604; 1,908; 1,383; 955; 623; 281 bp)
Lane 2: DBY746
Lane 3: DBY746::pM02
Lane 4: DBY746::pMAS-H5
Lane 5: SA
Surprisingly, when lanes 4 and 5 (Figure 6.16 [b]) containing the ex­
acting episomal plasmid, DBY746::pMAS-H5 and the strain SA containing the 
cis-acting integrated plasmid pFL34-MAS respectively, were probed with the 
antisense a-amylase riboprobe a 1.4 kb transcript was visualised. A larger 
transcript of approximately 2.3 kb was expected if transcription of this chimeric 
sense-antisense transcript was initiated close to the AdHI promoter and 
terminated at the AdHI transcript terminator. Hybridisation of the P-actin 
riboprobe produced a strong discrete band o f the expected size o f 1.3 kb in the 
lanes containing DBY746::pMAS-H5 and SA (lanes 4 and 5, Figure 6.16 [c]) 
which indicates that there was ho degradation of the RNA samples loaded.
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Studies carried out by Melton (1985) observed a somewhat similar result 
to what was found here. Melton found that an antisense RNA of 625 base pairs 
formed an antisense RNA:sense RNA duplex in injected oocytes of ~ 220 base 
pairs, the same size as the protected antisense:sense RNA duplex observed after 
hybridisation in vitro. The reason why a much shorter duplex was protected is 
unknown, but the author speculated that this might have been due to the 
formation of strong intramolecular hairpins. This may be one possible 
explanation for the existence of the 1.4 kb transcript visualised, as opposed to the 
expected 2.3 kb transcript. If this is the correct interpretation of the data, this 
finding possibly indicates a post-transcriptional mechanism of a-amylase gene 
expression. Intramolecular RNA duplex formation favourable in the cis 
conformation, would stabilise the mRNA by the protection of the molecule from 
single-stranded nucleases, but still interfere at the translational level by 
prevention o f polysome assembly, thus eliminating a-amylase gene expression.
As previously mentioned antisense transcripts can be rather unstable and 
are not always easy to detect. Although a random primed probe or a nick 
translated fragment should detect both sense and antisense RNA, Nellen and 
Lichtenstein (1997) strongly recommend the use of strand-specific in vitro 
transcripts as hybridization probes. This is because these probes do not only 
unambiguously allow for distinguishing between the two types o f RNA, but they 
are also more sensitive. They also state that the sense or antisense transcripts may 
not always correspond in size to the wild-type mRNA or to the length expected 
from the vector construct respectively; sometimes specific degradation products 
are observed. The RNA samples in this experiment were probed with an 
antisense a-amylase riboprobe, which should bind to the sense sequences within 
the sense-antisense transcript. However, after observing the unexpected size (1.4 
kb) o f the actual sense-antisense transcript, upon reflection it would have been 
more informative if the samples were also hybridized with a sense a-amylase 
riboprobe, as this would detect any specific antisense a-amylase degradation 
products also.
As expected the negative control strain used in this experiment, DBY746 
generated no signal on the autoradiograph when probed with the antisense a- 
amylase riboprobe (lane 2, Figure 6.16 [b]). However a stong, discrete band of
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1.3 kb was visualised when DBY746 was probed with the (3-actin riboprobe (lane 
2, Figure 6.16 [c]). The positive control, D B Y 746::pM 02, expressed its’ full- 
length transcript of 1.7 kb when probed with the antisense a-amylase riboprobe 
(lane 3, Figure 6.16 [b]). Also a strong, discrete band of 1.3 kb was visualised 
when this sample was probed with the P-actin riboprobe (lane 3, Figure 6.16 [c]).
The intensities of the bands from both blots were analysed on a 
Pharmacia-Biotech (ImageMaster ID) Imaging Densitometer. Analysis o f the 
blot probed with the p-actin riboprobe showed a weak hybridisation signal for 
the lane containing the DBY746::pMAS-H5 RNA due to a lower loading when 
compared to DBY746::pFL34-MAS or DBY746. However a greater amount of 
message was being produced by DBY746::pMAS-H5 in contrast to 
DBY746::pFL34-MAS (2.0:1, respectively) whose p-actin hybridisation signal 
was strong but when probed with the antisense a-amylase riboprobe the message 
was weaker. This result was expected as the episomal pMAS-H5 should be 
present in higher copy number than the integrating plasmid pFL34-MAS and this 
indeed was what was reflected in the levels o f message being produced.
6.7 DISCUSSION
The aims of this experiment were to [1] position the antisense a-amylase gene 
sequence in the vicinity of the target gene (“location or spatial effect”) and [2] to 
determine if this antisense RNA, synthesized in the same physical space in the cell 
as the sense RNA, improved upon antisense RNA control. The experiments 
documented in this chapter succeeded in achieving both of these goals. A chimeric 
sense-antisense a-amylase gene was cloned into both a ysast episomal vector and a 
yeast integrating vector, with the result that a-amylase gene expression was 
inhibited when expressed from either its’ episomal or chromosomal position within 
the cell.
Although the results obtained demonstrated a total inhibition o f a- 
amylase gene activity, (from the chimeric cw-acting transcript, regardless of its’ 
episomal or chromosomal location), the precise mechanism of the cw-effect was 
not determined. Atkins and Gerlach, (1994) who reported a 90% reduction in
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CAT expression, when both target and antisense genes were transcribed in cis, 
found that the steady-state levels o f the antisense RNA construct were two to 
three times higher than that of the CAT RNA. Although, the authors did not 
determine precisely the mechanism of inhibition by the c/.s-acting RNA, they 
postulated that in view o f the higher steady-state levels o f the antisense RNA that 
this result indicated a post-transcriptional mechanism of CAT inactivation, that is 
not dependent on antisense-mediated degradation o f the mRNA. They propose 
that an intramolecular duplex formation, favourable in the cis conformation, 
would stabilise the mRNA by the protection of the molecule from single­
stranded nucleases, but still interfere at the translational level by preventing 
polysome assembly, thus reducing CAT expression (Atkins and Gerlach, 1994). 
A similar translational-level interference has been reported for as-acting 
antisense RNA regulation of the human a  globin cDNA chimeric mRNAs in in 
vitro translation systems (Liebhaber et al., 1992).
Although the results obtained in this chapter, demonstrated a total 
inhibition of a-amylase gene activity, (from the chimeric c/5-acting transcript, 
regardless o f its’ episomal or chromosomal location), the precise mechanism 
(similar to Atkins and Gerlach, 1994), o f  the cis-e ffect was not determined. The 
RNA analysis carried out in this chapter showed that a 1.4 kb transcript was 
being made from both the pMAS-H5 (episomal) and pFL34-MAS 
(chromosomal) plasmids, even though a 2.3 kb chimeric transcript was expected. 
One possible explanation for the presence o f this 1.4 kb transcript may be that 
the antisense sequence folded-back on the sense and was cleaved in such a way 
as to produce this 1.4 kb discrete transcript.
Another hypothesis to explain suppression o f a-amylase gene expression, 
may be that the formation o f an intramolecular duplex in the nucleus may have 
prevented nucleo-cytoplasmic transport (Kim and Wold, 1985), hence no 
translation of the a-amylase gene. Also the fact that the antisense sequence 
tagged onto the sense a-amylase gene was targeted to the 5’ RBS and coding 
region, may mean that if this transcript did reach the cytoplasm, the fact that the 
RBS was complexed with the antisense RNA sequence would mean that 
translation could not proceed. One method to test this particular hypothesis 
would be the examination o f polysome association of the mRNA of interest; if it
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is associated with large polysomes (as found in wild-type cells) then there is 
obviously no effect from the antisense transcripts. If, however, the RNA is found 
in the monosome peak or with smaller polysomes, it is most likely that there is an 
antisense-mediated inhibition of translation (Melton, 1985).
Further investigations to determine the precise mechanism of action could 
include determining what part of the transcript was cleaved (by performing RNA 
fingerprint analysis). Also, presuming that a specific cleavage occurred, which 
finally resulted in the 1.4 kb transcript, it would be interesting to determine if the 
chimeric transcript was degraded from either the 5’, 3 ’ or both ends of the 
transcript. Both 5’—> 3’ and 3’ —» 5’ exoribonucleases have been detected in 
yeast. This could be achieved by probing with a probe specific for the CAP 
binding site or with a poly(T) probe to detect the presence of a poly(A) tail. Also, 
analysis of the a-amylase gene sequence shows that any transcript of 1.4 kb 
would not contain the necessary translational start, coding and translational stop 
sequences, to allow expression of this gene.
It is known that at least 5 factors affect or strongly influence the stability 
o f yeast mRNA; [1] the 5’ cap, [2] the 3’ poly(A) tail, [3] mRNA length, [4] 
mRNA stability determinants (sequences within both prokaryotic and eukaryotic 
mRNAs that strongly influence their half-lives) and [5] the presence or absence 
o f various nucleases in the yeast cell (Brown et al., 1988). Due to the fact that the
1.4 kb transcript appears to be stable one would presume that either the 5’ cap or 
3 ’ poly-A tail must be present. A recent study carried out by Donahue and Fedor 
(1997) on the kinetics o f hairpin ribozyme cleavage in yeast stated that the 
impact o f cleavage on mRNA abundance is shown to depend directly on intrinsic 
mRNA stability and surprisingly, the cleavage products were no more labile than 
uncleaved mRNAs despite the loss of terminal cap structures or poly(A). Hence 
it is possible that the 1.4 kb transcript visualized could lack either of these 
structures and still remain relatively stable.
The a-amylase sense gene sequence used to construct the c«-acting 
plasmid contained a deletion which disrupted the putative palindromic 
transcriptional termination site, but left the entire a-amylase gene and its’ 
translational stop site intact. When designing this experiment it was important to 
demonstrate that this truncated a-amylase gene from pM02 was capable (which
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it was) ofa-amylase activity. In fact, McMahon (1995) and Olsen (1995) both 
designed experiments to analyse what effect, if any, the disruption of this 
palindromic sequence would have on the levels of a-amylase produced from 
both E. coli and S. cerevisiae. Essentially this palindromic sequence is 
characteristic o f classical prokaryotic terminators, centred some 1 2 -2 4  bases 
upstream of the termination site (12 bases in this case), immediately followed by 
a run o f 8Ts (7 Ts in the case o f this a-amylase gene sequence). There are no 
obvious terminator signals for RNA polymerase II known in eukaryotes except, 
in yeast where the 8 base pair consensus TTTTTATA has been implicated as a 
necessary determinant and is provided by the AdHI terminator in the pAAH5 
vector. Both McMahon (1995) and Olsen (1995) noted that this truncated a- 
amylase gene gave higher expression than the full gene fragment in both E. coli 
and S. cerevisiae.
6.8 FUTURE WORK
From other studies in mammalian systems (Liebhaber et al., 1992) it 
appears that translation can be blocked if antisense sequences form stable 
duplexes in the 5’ UTR, or in close proximity to the initiation AUG site within 
the 80S assembly region. It has also been observed that once the 80S ribosome is 
assembled, and has initiated elongation, it has the ability to displace extensive 
duplexes and translate substrate mRNA. An interesting experiment in light o f  the 
result obtained for the c/'s-acting episomal (pMAS-H5) and integrating (pFL34- 
MAS) plasmids would be to construct another cis plasmid, by inserting an 
antisense sequence within the 3 ’UTR of the sense a-amylase gene which, when 
and if, the antisense sequence folded back on the sense sequence that it would 
not be complementary to the 5’ UTR or RBS, in order to determine if the 
ribosomes would have the ability to displace the duplex, and thus lead to 
expression o f the gene.
The design o f this new cis plasmid, pRBS-AS, involved taking a sense a- 
amylase gene (lacking its’ transcriptional terminator) and fusing to its’ 3 ’ end an 
antisense gene sequence complementary to the coding region o f the gene, but 
lacking complementarity to the RBS. The sense a-amylase gene was obtained
315
from the plasmid pM02. The antisense gene sequence, lacking complementarity 
to the RBS was obtained by removing the first 110 base pairs from the sense a- 
amylase gene. The remaining 1.8 kb Hind III a-amylase fragment (minus the 5’ 
UTR and RBS) was gene cleaned and ligated in the presence o f the 1.6 kb Hind . 
Ill pM02 a-amylase fragment and the Hind III restricted yeast-shuttle vector, 
pAAH5. The ligation mix was transformed into DH5a E. coli cells and screened. 
The clones that were screened did not contain the sense and antisense fragments 
in the desired orientation (see Figure 6.17) in pAAH5. For a more detailed 
explanation o f how this cloning experiment was designed see the legend to 
Figure 6.18
Hind ffl — -S E N S E -------- > Hind III <—ANTISENSE------- Hind in
Figure 6.17 Desired orientation of the a-amylase sense and antisense gene 
fragment, when cloned into pAAH5.
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Figure 6.18 Schematic representation of how to construct the cis-acting plasmid, 
pRBS-AS.
Step I: The plasmid pSL52(4.6 kb, McMahon, 1995) which contains the sense a-amylase gene 
cloned in as a 1.9 kb Hind III fragment into the vector pUC8 (2.7 kb, Appendix V) was digested 
with the restriction enzyme Pst I. This site was present approximately 110 base pairs into the 5’ 
coding region of the a-amylase gene, (the pUC8 vector contains no Pst I site). After digestion 
with Pst I the 5’ overhang was blunt-ended using the Klenow enzymes 3’ - 5’ exonuclease 
activity and an 8 mer ( 5’CAAGCTTG 3’) Hind ID linker was ligated onto the molecule, the 
plasmid was recircularised using T4 DNA ligase and the ligation mix was transformed into DH5a 
E. coli cells. After the Klenow reaction and Hind III linker addition the Pst I site was destroyed, 
and this also abolished a-amylase activity. The transformants were screened for the presence of
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an additional Hind [II site, the plasmid now possessing Hind III fragments of 2.7 kb, 1.8 kb and
0.1 kb respectively. This plasmid was named pPSL52 Step II: The plasmids pM02 and pPSL5; 
were digested with Hind 111 and the 1.6 and 1.8 kb a-amylase gene fragments respectively, were 
gene cleaned from a 0.7% TAE agarose gel. Step III: The yeast shuttle vector pAAH5 which 
possesses a unique Hind III site for cloning situated between the AdHl promoter and terminator 
was linearised with this restriction enzyme to produce a 12.2 kb band which was column cleaned 
(section 2.6.11.8) to remove any restriction enzyme buffer. It was then dephosphorylated with 
CIP (section 2.6.11.3). Step IV: The linearised pAAH5 was ligated in the presence of the gene- 
cleaned 1.6 kb and 1.8 kb Hind III fragment of pM02 and pPSL52. The ligation mix was 
transformed into DH5a E. coli cells and the transformants were screened.
One of the clones obtained had the correct inserts but in the wrong orientation. 
Future work could involve redigesting this clone with Hind III, religating, 
transforming DH5a and screening for the desired insert. The construct would 
then be transformed into DBY746 and analysed to determine if there was any 
effect on a-amylase activity.
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CHAPTER 7
Discussion
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7. DISCUSSION
In contrast to the situation in plants and animals, there have been few 
published examples o f the use of antisense RNA to regulate gene expression in 
yeast. This is probably due to the fact that, firstly, homologous recombination is 
efficient in S. cerevisiae and can be used to rapidly and routinely replace, disrupt, 
or alter the sequence o f any gene, thereby facilitating analysis (Rothstein, 1991). 
With such an effective approach available in yeast for analyzing genes, there was 
less need to develop alternative strategies, such as antisense. Secondly, the 
widespread development and successful application of antisense RNA as a gene 
therapy strategy in mammalian cells (Ho and Parkinson, 1997; Putnam, 1996) 
and as a way of altering traits in plants (Mol et al., 1990; Kuipers et al., 1995; 
Bendahmane and Gronenbom, 1997) had lessened the need to examine the 
parameters governing antisense function in simple organisms such as yeast, when 
the desired outcome can be successfully achieved in the organism of interest. 
Thirdly, when genetic modifications o f yeast strains are required for commercial 
purposes such as in the brewing or baking industries, strain modification is 
usually accomplished using traditional techniques. Yeast strains produced by 
conventional techniques prevent potential concerns regarding the release of 
strains containing recombinant DNA (Atkins et al., 1994).
Nevertheless, it is now apparent that some antisense strategies work 
effectively, while others fail completely or result in only partial suppression. The 
precise reason(s) for this variability in effectiveness are not well understood, thus 
reliable application o f antisense RNA mediated gene suppression is not always 
possible. These observations therefore, created the need for rapid and simple in 
vivo model systems to evaluate the parameters governing antisense function. 
Lower eukaryotes, and in particular fungi, are good candidates for such systems 
based on a number o f features (Arndt and Atkins, 1996).
Although antisense RNA technology has many advantages, a major 
drawback is that success is rather unpredictable as gene silencing can vary 
depending on the fragments used to generate antisense transcripts. Additionally, 
there can be variability among different clones and some genes have completely
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resisted antisense-mediated gene silencing (Nellen and Sczakiel, 1996). Also the 
stability or instability of the RNA targeted may influence the outcome of an 
antisense experiment (Inouye, 1988). According to Bricca (1995) most 
successful attempts to inhibit mRNA translation have been directed towards 
transiently expressed genes, with the target mRNA being at a low level when the 
antisense molecule is introduced. It was hoped that by using Saccharomyces 
cerevisiae as a model system that more could be learned about the design, the use 
and the critical parameters of artificial antisense RNA technology.
After completing experimental work on 4 different /raw-Experimental 
systems in Saccharomyces cerevisiae, it appears however, that this organism is 
somewhat refractory to antisense RNA regulation, in particular when the two 
components of the system reside episomally and chromosomally. This 
conclusion has been confirmed by many other studies in S. cerevisiae where 
sense and antisense genes have been tested in a trans configuration, (Arndt,
1993; Arndt et al., 1994; Atkins and Gerlach, 1994; Olsson et al., 1997). A 
question that arises is whether the yeast S. cerevisiae differs in some specific way 
from other eukaryotic cells, to occasion an intracellular environment 
incompatible with antisense RNA regulation. If this is the case, the reasons for 
failure o f the majority o f trans-acting RNAs, may be a reflection of certain 
unique features inherent in the biology o f this yeast.
The success o f cw-Experimental systems in S. cerevisiae, where the 
transcription o f the sense and antisense genes were linked to maximize RNA- 
RNA interaction suggests that it is the spatial coincidence o f the interacting 
genes that is critical to the success o f the experiments. Although, this is an 
obvious statement it may be more crucial in this organism that spatial 
coincidence is optimized due to the fact that the majority o f genes in S. 
cerevisiae lack introns (GofFeau et al., 1996), as does the reporter gene used in 
this study. This lack o f introns suggests that most mRNAs in this organism are 
less dependent on splicing as a means o f post-transcriptional regulation. The lack 
o f a splicing step may permit more rapid nuclear transport, than for typical 
spliced RNAs.
Also, the third stage in mRNA trafficking (after movement of the 
message from its’ site o f transcription to the nuclear pore and translocation of the 
mRNA through the pore) where the mRNA is distributed in the cytoplasm in the
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appropriate context for translation appears to be done in a specific non-random 
manner (Amberg et al., 1992). Therefore if the interacting RNAs are not 
coincident in the nucleus, it is far less likely that they will be coincident in the 
much larger area o f the cytoplasm. Additionally, this rapid nuclear export would 
mean that any potential points o f regulation in the nucleus, such as transcription 
and RNA processing, would be bypassed (Murray and Crockett, 1992).
Another factor to support the fact that the failure of antisense RNAs in 
trans may be due to S. cerevisiaes ’ cell biology is the identification of a yeast 
splicing protein (Lin and Rossi, 1996). This protein interacted in vivo with a cis- 
ribozyme by specifically recognising the ribozyme structure. The binding of this 
protein to the ribozyme can account for the inability o f ribozymes to efficiently 
cleave in yeast. More recently, Castanotto et al., (1998) found that when yeast 
extracts were added to in vitro trans cleavage reactions, the cleavage ability of 
the ribozyme was hampered, whereas the addition of mammalian extracts yielded 
an enhancement o f the reactions. These results confirm the presence of factor(s) 
that can block this type of antisense function in the yeast intracellular 
environment.
An alternative or additional possibility for the failure o f antisense systems 
to interfere with gene expression in trans, is that S. cerevisiae may lack a 
factor(s) required for antisense RNA function. Antisense RNA is predicted to 
function by forming a specific RNA duplex with target mRNA (Erickson and 
Izant, 1992). The effectiveness o f this form of regulation, as we know is thus 
dependent on efficient RNA-RNA interaction and the fate o f the resulting RNA 
duplex. It has been suggested that both of these features are influenced by 
cellular factors (Nellen and Lichtenstein, 1993). One candidate enzyme is the 
heterogeneous nuclear ribonucleoprotein (hnRNP) Al which has RNA annealing 
activity. Other host-encoded activities that have been implicated in the 
modification o f RNA duplexes include double-stranded RNA adenosine 
deaminase (dsRAD), double-stranded RNases and RNA helicases. S. cerevisiae 
has been shown to lack an hnRNP A 1-like renaturation activity, however 
sequencing of a 43.5 kb segment of chromosome XTV has revealed the presence 
o f a putative adenosine deaminase gene, which should lead to an enhancement of 
antisense activity. This sequence presents significant similarity to adenosine 
deaminase from different organisms, such as E. coli, mouse and human (Mallet
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et al., (1995). The enzyme which catalyses the deamination of adenosine to 
inosine, was purified and characterized by Marmocchi et al., (1987) in S. 
cerevisiae.
This enzyme requires a double-stranded RNA substrate and it acts to 
convert adenosine (A) residues within its substrate to inosine (I) residues. Due to 
the fact that IU base pairs are less stable than AU base pairs, the double-stranded 
RNA substrate becomes increasingly single-stranded during the reaction. Also, 
as inosines are read as guanosines during translation, this modification would be 
expected to change the coding capacity o f the DNA drastically, this in turn 
should lead to the production of a non-functional protein, with a concomitant 
enhancement of an antisense RNA effect (Bass, 1992). However, although this 
enzyme is present in S. cerevisiae, there are obviously other factors needed for 
the successful application of antisense in a trans configuration.
When this work began, the /ra«s-Experimental systems studied in this thesis 
were designed so as to investigate many o f the parameters deemed to be 
important for the successful application o f antisense RNA technology. Some of 
these parameters are shown in Table 7-1, (Arndt and Atkins, 1996).
Table 7-1 Parameters with the potential to influence antisense RNA mediated 
suppression of gene expression in vivo.
1. Relative position of the antisense gene and the target gene in the host genome
2. Differential timing of expression of the target gene and the antisense gene
3. Rate of turnover of target mRNA and antisense RNA
4. Intracellular location and stability of the target mRNA .antisense RNA duplex
5. Secondary and tertiary structure of the target mRNA and antisense RNA
6. Are there cellular enzymes either present or absent in the system under investigation, which 
could enhance or repress antisense RNA inhibition?
7. By what mechanism will the anti sense RNA inhibit target gene expression?
8. What is the optimum ratio of antisense:target RNA?
Upon reading the literature and in light o f the findings presented in this thesis, 
there does not seem to be a single defined set o f parameters governing antisense 
regulation.
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Jhms-Experiment I (a) and (c) were designed in a way, which have been 
shown to be successful in mammalian and plant systems, where the gene to be 
silenced is present on a chromosome and the antisense sequence is introduced 
either episomally or as an oligonucleotide. The overall picture from the most 
recent literature on antisense data suggests that antisense oligonucleotides are 
more effective inhibitors of gene expression than artificial antisense genes. 
However antisense genes were chosen for this study in preference to 
oligonucleotides, as once an antisense gene is proved to be effective, gene 
inhibition would become a stable property o f the transformed cells or organisms 
and it would not be necessary to provide a continuous supply of antisense 
molecules. The reasons for oligonucleotides being more successful than antisense 
genes may include; [1] the relatively low number o f antisense transcripts that can 
be synthesised by the transformed cell with respect to the much greater number 
of antisense oligonucleotides able to penetrate the cell and [2] antisense genes are 
generally constructed in such a way that the antisense RNA is as long as the 
mRNA molecule. The formation of the antisense RNA/mRNA hybrids could 
then be easily prevented by the formation of intramolecular secondary 
structure^). One future possibility to bridge oligonucleotide and antisense gene 
technology would be to construct antisense genes by shuffling only those 
sequence domains that are effective targets in the inhibition by antisense 
oligonucleotide sequences.
7>(mv-Experiment I (a) and fra/w-Experiment II utilized the full-length a- 
amylase gene for the construction of the antisense molecule on the basis that full- 
length sequences had proven successful in other systems (Knecht, 1989; Pear et 
al., 1993; Kuipers et al., 1995). Also studies of the kinetics o f RNA-RNA 
interactions among the naturally occurring antisense RNAs found in bacteria, 
have led to the hypothesis where longer antisense RNAs, such as the antisense 
RNA used in this system, may have a larger number of nucleation sites and thus 
greater potential for RNA-RNA annealing. Knecht (1989) states that in relation 
to the size o f an antisense transcript that the larger the antisense molecule, the 
faster and more stable the duplex formed. However, Knecht also states that 
results have been so variable that no absolute size limit can be stated, but it 
seems reasonable that the larger fragments will work better. On the other hand, in
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contrast to these hypotheses, other authors (Olsson et al., 1997) have suggested 
that large mRNAs may provide more opportunity for secondary structure 
formation and therefore they may not bind with enough efficiency to their sense 
RNAs to prevent translation.
The success o f an interaction between a sense and antisense RNA will be 
dependent on the accessibility o f the target RNA. The number o f accessible sites 
on an RNA molecule is determined by a combination of the inherent structure of 
the RNA and its collection o f bound proteins at any one moment (Branch, 1998). 
Computer-aided secondary structure predictions which could help to approach 
part o f this problem are according to Nellen and Lichtenstein (1993)
‘surprisingly unpredictable’. They cite the example o f the 3’ UTR o f the 
transferrin receptor mRNA which can fold into two very different structures of 
similar free energy. While one o f them reflects the regulatory iron responsive 
elements, the other one is most likely not formed in vivo.
Another study fairly recently carried out (Milner et al., 1997) 
emphasized the extent to which the native RNA structure can restrict the binding 
of an antisense molecule. Milner et al., (1997) examined the ability of 1,938 
oligonucleotides (ranging in size from monomers to 17-mers) to bind to a 122 
nucleotide RNA representing the 5’ end o f p-globin mRNA. They found that 
very few oligonucleotides bound stably to the mRNA and concluded that binding 
is probably restricted to those regions in the RNA which provide accessible 
substructure. Similarly Chen and co-workers (1997) demonstrated that cellular 
proteins and ribonucleoprotein complexes, such as ribosomes could prevent 
ribozyme-mediated cleavage. They showed that a reporter gene was ribozyme- 
insensitive in wild-type E. coli but was ribozyme-sensitive in a ‘slow-ribosome’ 
mutant. As can be seen from these examples it is very difficult to predict what 
regions o f an RNA molecule will be accessible in vivo hence effective antisense 
molecules must be found empirically by screening large numbers o f candidates.
Two of the potential secondary structures that could be formed by the 
full-length antisense a-amylase gene were obtained using the Mfold prediction 
algorithm (Appendix X). Unfortunately, as demonstrated by the examples given 
by Nellen and Lichtenstein (1993) and Milner et al., (1997) one cannot trust the 
output o f  these programs to even approximately represent the true in vivo
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structure. Reasons for this are firstly, an RNA molecule can start to fold in a 5’-> 
3’ direction as it is being synthesized, therefore there may be a decisive kinetic 
element that in part determines which complementary regions will in fact pair 
and which will not. Secondly, the initial folded structure may change its 
conformation by local rearrangements of the base pairs, thus relaxing toward 
lower energy states. Thirdly, tertiary interactions between unpaired base pairs in 
loops or at the ends of a molecule may alter the structure. Finally, most RNAs 
are strongly bound to other RNAs or to proteins when in their functional state. 
The secondary structure prediction methods currently in use are far from 
capturing all the essentials of this complex folding process.
Once again, as with the length of an antisense molecule, depending on 
what gene is being targeted and in what organism, antisense genes targeting the 
5’, 3 ’ untranslated and coding regions have been shown to be effective. Trans- 
Experiment I (c) involved targeting different regions of the Bacillus licheniformis 
a-amylase gene, such as the 5’ and 3’ untranslated and coding regions. However 
none of the antisense genes were successful, this result in light o f the outcomes 
of trans II and the cis, suggests that spatial coincidence was not ensured.
The ratio of antisense RNA to sense RNA is one of the parameters 
governing antisense RNA function. However as with the length and regions 
which the antisense RNA targets, the optimum appears to be different for 
different genes and cell types. For example an antisense RNA directed against 
the creatine-kinase B gene was capable of inhibiting translation at a ratio of 1 to 
2 copies o f antisense RNA per copy o f native RNA (Cirullo et al., 1992). 
Expression o f the mhc A protein was dramatically inhibited with a ratio of 
antisense over sense transcripts o f 10:1 (Knecht, 1989). Whereas a 100 -  200 
fold excess of antisense to sense RNA was necessary to reduce the expression of 
the thymidine kinase gene by 4 -  5 fold.
The majority of successful applications of antisense technology in S. 
cerevisiae have been achieved through a cis configuration (Atkins and Gerlach, 
1994; Ferbeyre et al., 1995). Ferbeyre et a l, (1995) state that hammerhead 
ribozymes can be catalytically active in yeast and can reduce gene expression 
only when the target is in cis and very close as evidenced by the comparisons of 
the effects o f 5’ cis (close to the target site), 3’ cis (far from the target site) and
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irons ribozymes. Following on from this finding Ferbeyre et al., (1996) treated 
yeast cells expressing hammerhead ribozyme RNA with the a-factor mating 
pheromone, with the result that the levels of the targeted mRNA, ADE1 was 
reduced by 50%. The rationale for this study was to evaluate the hypothesis that 
yeast metabolism is simply too rapid to allow for a ribozyme-based cleavage 
activity and that the success o f /nmv-activity in mammalian cells may owe its 
feasibility to a markedly slower cell cycle and corresponding slower RNA 
metabolism.
The c/s-Experiments described in this thesis produced the desired 
inhibitory effect on the gene of interest and further reinforces the importance of 
spatial coincidence, especially in the light of the findings of Ferbeyre et al., 
(1996). Traws-Experiment II also produced a partial suppression o f a-amylase 
gene expression, even though the ratio o f antisense to sense RNA was lower in 
one co-transformant (2:1) than what was achieved in iram-Experiment I (a) and 
(c), 4, 3.5 and 3.5:1 respectively. The major difference between these 
experimental systems was the fact that in trans-Experiment II both sense and 
antisense genes were transcribed episomally and possibly were more spatially 
coincident than the trans configurations in I (a) and (c). The majority of papers 
that have shown the failure o f antisense to inhibit gene expression in irons in S. 
cerevisiae (Atkins and Gerlach, 1994; Olsson et al., 1997) have designed their 
fraHs-Experimental systems similar to iram-Experiment I, where the sense and 
antisense genes were expressed from different locations within the cell, i.e. either 
chromosomally or episomally. In retrospect, the fact that the antisense and sense 
genes which were both expressed from episomes in trans-Experiment II, lead to 
a 12% reduction in a-amylase activity suggests that the spatial coincidence was 
more favourable in this experimental system, than trans I and possibly, this 
particular type of trans configuration is worthy of further investigation.
Although S. cerevisiae has not been successfully utilized as a host for the 
analysis of antisense-mediated gene regulation, it has raised a number of basic 
questions about gene expression, in particular with respect to RNA metabolism. 
Central to this discussion is to be able to understand more fully what key features 
influence RNA diffusion, RNA transport and RNA compartmentalisation in 
vivo? An insight into these aspects o f RNA metabolism may provide a better
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framework within which to re-examine and further assess the theory o f location 
effect/spatial coincidence.
Particular factors/proteins (for example hnRNP A l) have been identified 
which influence gene control by an antisense mechanism. May be such factors 
also play a role in yeast cells, but have yet to be identified. Possible future work, 
which could be undertaken for the development of S. cerevisiae as an 
experimental host for studying antisense function, could include mutagenesis of 
the yeast strain, which may result in a modified strain in which antisense function 
is enhanced. An alternative, but complementary approach would be to introduce 
into yeast cells some of the genes which have been shown to influence antisense 
activity in other systems, and test whether they enhance antisense activity. A 
further approach could involve the introduction o f a gene library from another 
eukaryote and then selecting for genes which complement antisense RNA 
function.
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Appendices
Appendix I - Plasmid map of pFL34.
C?r10 ! 2892
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Appendix II - Schematic representation of the plasmid pRBI49 (Canavan, 1994).
URA3 
1.1 kb
EcoRI restriction
EcoRI EcoRI f$-actin
3 8 kb
URA3 
1.1 kb
EcoRI
Appendix III - a-amylase gene sequence.
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G CT AACG A CTG CG ACAAT AAACG CGAGTAGAAGAACG ACGG AGT AA'GKCGTCGT CGC CG CCGTTTAGAAT
ATGGGACGCTGATGCAGTATTTTGAATGGTACATGCCCAATGACGGCCAACATTGGAAGCGCTTGCAAAA 2 1 0  
TACCCTGCGACTACGTCATAAAACTTACCATGTACGGGTTACTGCCGGTTGTAACCTTCGCGAACGTTTT
CGACTCGGCATATTTGGCTGAACACGGTATTACTGCCGTCTGGATTCCCCCGGCATATAAGGGAACGAGC 2 8 0  
GCTGAGCCGTATAAACCGACTTGTGCCATAATGACGGCAGACCTAAGGGGGCCGTATATTCCCTTGCTCG
CAAGCGGATGTGGGCTACGGTGCTTACGACCTTTATGATTTAGGGGAGTTTCATCAAAAAGGGACGGTTC 3 5 0  
GTTCGCCTACACCCGATGCCACGAATGCTGGAAATACTAAATCCCCTCAAAGTAGTTTTTCCCTGCCAAG
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CCGTTGATACTAATAAACTACATACGGCTGTAGCTAATACTGGTAGGACTACAGCGTCGTCTTTAATTCT
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‘TGTGTAATT
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GGCCCCGTTAGCGAACTCAGCTGACAGGTTTGTACCAAATTCGGCGAACGAATGCGAAAATAAGAGTGTT
V V V V V V V
GGGAATCTGGATACCCTCAGGTTTTCTACGGGGATATGTACGGGACGAAAGGAGACTCCCAGCGCGAAAT 1 2  6 0  
CCCTTAGACCTATGGGAGTCCAAAAGATGCCCCTATACATGCCCTGCTTTCCTCTGAGGGTCGCGCTTTA
V V V V V V V
TCCTGCCTTGAAACACAAAATTGAACCGATCTTAAAAGCGAGAAAACAGTATGCGTACGGAGCACAGCAT 13  3 0 
AGGACGGAACTTTGTGTTTTAACTTGGCTAGAATTTTCGCTCTTTTGTCATACGCATGCCTCGTGTCGTA
t i  xr \r \r \t V
1 4 0 0
'TAAGTCCAA
V V V V V  V Jt 1 V
TGGCGGCATTAATAACAGACGGACCCGGTGGGGCAAAGCGAATGTATGTCGGCCGGCAAAACGCCG'JBBB 1 4 7 0  
ACCGCCGTAATTATTGTCTGCCTGGGCCACCCCGTTTCGCTTACATACAGCCGGCCGTTTTGCGGCflBQP
1 5 4 0TTACCGGAAACCGTTCGGAGCCGGTTGTCATCAATTCGGAAGGCTGGGGAGAGTTT 
AATGGCCTTTGGCAAGCCTCGGCCAACAGTAGTTAAGCCTTCCGACCCCTCTCAAArC/i'^ LAtioM ìtop wre
CACGTAAACGGCGGGTCGGTTTCAATTTATGTTCAAAGAàriiCvXAGAGCAGAGAGGÀCGGATTTCC^ÌÀG 1 6 1 0  
GTGCATTTGCCGCCCAGCCAAAGTTAAATACAAGTTTCTATCTTCTCGTCTCTCCTGCCTAAAGGACTTC
1 V V V V V V V
Ga S S t CCSTTTTTTTATTTTGCCCGTCTTATAAATTTCTTTGATTACATTTTATAATTAATTTTAACAAA 1 6 8 0  
CTTTAGGCAAAAAAATAAAACGGGCAGAATATTTAAAGAAAGTAATGTAAAATATTAATTAAAATTGTTT
V V V V V V 1 V
GTGTCATCAGCCCTCAGGAAGGACTTGCTGACAGTTTGAATCGCATAGGTAAGGCGGGGATGAAWTGGCA 1 7 5 0  
CACAGTAGTCGGGAGTCCTTCCTGAACGACTGTCAAACTTAGCGTATCCATTCCGCCCCTACTTTACCGT
ACGTTATCTGATGTAGCAAAGAAAGCAAATGTGTCGAAAATGACGGTATCGCGGGTGATCAkTCATCCTG 1 8 2  0 
TGCAATAGACTACATCGTTTCTTTCGTTTACACAGCTTTTACTGCCATAGCGCCCACTAGTTAGTAGGAC
V V 
AGACTGTGACGGATGAATTGAAAAGCT 1 8 4 7  
TCTGACACTGCCTACTTAACTTTTCGA. p A S\^ jOO
'?C%  ? R lM t£ S  ¡¡¡j '^xi-STZlCXIOKl -VH^/JSLA T/Dij S T o f
SD -  ?ossifltó 'RBS S(TE^  — *■ 4—  fAtSotOHlC ieQu6iJ£ÈS
Appendix IV -  The a-amylase gene sequence (minus its transcription stop site) 
cloned into pAAH5 in antisense orientation to produce, pM 03.
 *  J S  b o o  I 3 0  x, J ti-u
HtuoTJLj 6W IÜ J 1 *  V ■ V  — ___________V V  V  V
-------------------- ^CbmTGTTTCACATTGAAAGGGGAGGAGAATCATGAAACAACAAAAACGGCTTTACGCC 7  0
3GCATACAAAGTGTAACTTTCCCCTCCTCTTAGTACTTTGTTGTTTTTGCCGAAATGCGGfit I
V  V  V V  I V  I V  V
CGATCGCTGACGCTGTTATTTGCGCTCATCTTCTTGCTGCCTCATTCTGCAGCAGCGGCGGCAAATCTTA 1 4 0  
GCTAACGACTGCGACAATAAACGCGAGTAGAAGAACGACGGAGTAAGACGTCGTCGCCGCCGTTTAGAAT
V  V  V  V  V  V  V
ATGGGACGCTGATGCAGTATTTTGAATGGTACATGCCCAATGACGGCCAACATTGGAAGCGCTTGCAAAA 2 1 0  
TACCCTGCGACTACGTCATAAAACTTACCATGTACGGGTTACTGCCGGTTGTAACCTTCGCGAACGTTTT
V  V  V  V  V  V  V
CGACTCGGCATATTTGGCTGAACACGGTATTACTGCCGTCTGGATTCCCCCGGCATATAAGGGAACGAGC 2 8 0  
GCTGAGCCGTATAAACCGACTTGTGCCATAATGACGGCAGACCTAAGGGGGCCGTATATTCCCTTGCTCG
V  V  V  V  V  V  V
CAAGCGGATGTGGGCTACGGTGCTTACGACCTTTATGATTTAGGGGAGTTTCATCAAAAAGGGACGGTTC 3 5 0
GTTCGCCTACACCCGATGCCACGAATGCTGGAAATACTAAATCCCCTCAAAGTAGTTTTTCCCTGCCAAG
GGACAAAGTACGGCACAAAAGGAGAGCTGCAATCTGCGATCAAAAGTCTTCATTCCCGCGACATTAACGT 4 2 0
CCTGTTTCATGCCGTGTTTTCCTCTCGACGTTAGACGCTAGTTTTCAGAAGTAAGGGCGCTGTAATTGCA
TTACGGGGATGTGGTCATCAACCACAAAGGCGGCGCTGATGCGACCGAAGATGTAACCGCGGTTGAAGTC 4 9 0  
AATG CCCCTACACCAGTAGT------------------------------------------------------------------------------------------------------------------------
GATCCCGCTGACCGCAACCGCGTAATTTCAGGAGAACACCGAATTAAAGCCTGGACACATTTTCATTTTC
CTAGGGCGACTGGCGTTGGCGCATTAAAGTCCTCTTGTGGCTTAATTTCGGACCTGTGTAAAAGTAAAAG«------------ >■ asiaco
V  V  V IV  _L V
5 6 0  
6 3 0
V  V  V V V  V  v
GTCCCGAAAGCTGAACCGCATCTATAAGTTTCAAGG AAAGGCTTGGGATTGGGAAGTTTCCAATGAAAAC 7 0  0
CAGGGCTTTCGACTTGGCGTAGATATTCAAAGTTCCTTTCCGAACCCTAACCCTTCAAAGGTTACTTTTG
V  V  V V V V  v
GGCAACTATGATTATTTGATGTATGCCGACATCGATTATGACCATCCTGATGTCGCAGCAGAAATTAAGA 7 7  0
CCGTTGATACTAATAAACTACATACGGCTGTAGCTAATACTGGTAGGACTACAGCGTCGTCTTTAATTCT
V V  V V V  V V
GATGGGGCACTTGGTATGCCAATGAACTGCAATTGGACGGTTTCCGTCTTGATGCTGTCAAACACATTAA 8 4  0 
CTACCCCGTGAACCATACGGTTACTTGACGTTAACCTGCCAAAGGCAGAACTACGACAGTTTGTGTAATT
ATTTTCTTTTTTGCGGGATTGGGTTAATCATGTCAGGGAAAAAACGGGGAAGGAAATGTTTACGGTAGCT 9 1 0  
TAAAAGAAAAAACGCCCTAACCCAATTAGTACAGTCCCTTTTTTGCCCCTTCCTTTACAAATGCCATCGA
V  V  V  V  V  V  v
GAATATTGGCAGAATGACTTGGGCGCGCTGGAAAACTATTTGAACAAAACAAATTTTAATCATTCAGTGT 9 8 0  
CTTATAACCGTCTTACTGAACCCGCGCGACCTTTTGATAAACTTGTTTTGTTTAAAATTAGTAAGTCACA
TTGACGTGCCGCTTCATTATCAGTTCCATGCTGCATCGACACAGGGAGGCGGCTATGAt Xt GAGGAAATT 1 0 5 0  
AACTGCACGGCGAAGTAATAGTCAAGGTACGACGTAGCTGTGTCCCTCCGCCGATACTATACTCCTTTAA
V V V V V  V V
GCTGAAC AGT ACGGTCGTTTCC aACC ATCCGTTGAAAGCGGTTACATTTGTCGATAACCATGATACACAG 1 1 2  0 
CGACTTGTCATGCCAGCAAAGGTTCGTAGGCAACTTTCGCCAATGTAAACAGCTATTGGTACTATGTGTC  
Alt
CCGGGGCAATCGCTTGa 'iVTCG.-VX’GTCCAAACATGGTTTAAGCCGCTTGCTTACGCTTTTATTCTCACAA 1 1 9  0 
GGCCCCGTTAGCGAACTCAGCTGACAGGTTTGTACCAAATTCGGCGAACGAATGCGAAAATAAGAGTGTT
V V V V V v v
GGGAATCTGGATACCCTCAGGTTTTCTACGGGGATATGTACGGGACGAAAGGAGACTCCCAGCGCGAAAT 12  6 0
c c c t t a g a c c t a t g g g a g t c c a a a a g a t g c c c c t a t a c a t g c c c t g c t t t c c t c t g a g g g t c g c g c t t t a
V V V V V V  V
TCCTGCCTTGAAACACAAAATTGAACCGATCTTAAAAGCGAGAAAACAGTATGCGTACGGAGCACAGCAT 13  3 0 
AGGACGGAACTTTGTGTTTTAACTTGGCTAGAATTTTCGCTCTTTTGTCATACGCATGCCTCGTGTCGTA
V V V V V V V
GATTATTTCGACCACCATGACATTGTCGGCTGGACAAGGGAAGGCGACAGCTGGGTTGCAAATTCAGGTT 1 4  0 0 
CTAATAAAGCTGGTGGTACTGTAACAGCCGACCTGTTCCCTTCCGCTGTCGAGCCAACGTTTAAGTCCAA
V V V V V V f  1 v
TGGCGGCATTAATAACAGACGGACCCGGTGGGGCAAAGCGAATGTATGTCGGCCGGCAAAACGCCGGTGA 1 4 7  0 
ACCGCCGTAATTATTGTCTGCCTGGGCCACCCCGTTTCGCTTACATACAGCCGGCCGTTTTGCGGCCACT
v f v  v  V v  V v
GACATGGCATGACATTACCGGAAACCGTTCGGAGCCGGTTGTCATCAATTCGGAAGGCTGGGGAGAGTTT 15 4 0 
CTGTACCGTACTGTAATGGCCTTTGGCAAGCCTCGGCCAACAGTAGTTAAGCCTTCCGACCCCTCTCAAA-ltftuSLiAnow Mop SITE
v  v  V V«  v  - ,-------- « -------------- *  4 —v
C ACGTAAACGGCGGGTCGGTTTCAATTTATGTTCAAAGAirAGAAGAGCAGAGAGGACGGATTTCCTGAAG 1 6 1 0  
G TG C A TTTG C C GC C C AG C C A AA G TTAA ATA CA A GTTTC TA TC TTCTC GTC TC TC C TG C C TA AA G G A C TTC
P MC;i  v  v  v  v  V v  v
-X * V’J t . ■ .
C TTT ■
- . í^ r  »'I'1
Appendix V -  Plasmid map of pUC8.
EcoRI 
Bam  HI
A c c i, Hind'S, Sal I 
Pst I
4ccl,W/ndII,Sa/I 
B am H l 
''— Eco RI
Replicon : pMB 12
Size : 2.7 kb
Selectable phenotype: AmpR
Genetic markers : lacZa +
Cloning sites for : (Accl), (BamHI), (EcoRI), (Hindll), Pstl, (SalI)
gene-inactivation 
Other cloning sites : not given
Amplifiable : yes 
Self-transmissible : no 
Mobilisation genes: no 
Mob site : yes
Plasm id pUC7 can be used for cloning DNA sequences in the lacZa  region providing a detection of transfor­
m ants containing recombinant plasmids on the basis of their L ac” phenotype. Bacteria harboring plasmids 
without inserts make blue colonies on indicator plates (plates with X-gal) whilst those harboring recombinant 
plasmids make white colonies (ref. 18). Plasmid pUC7 contains several unique restriction sites in the lacZa 
region, downstream o f the /acZ-initiation codon; the sequence with the cloning sites in the lacZa  region is 
the same as in M13mp7 (I-A-v-1). The terminal sequence of any DNA cloned in the plasmid can be 
characterized using the universal M13 primers.
Plasmid pUC7 consists oJLthe £coRI-.PvwII fragment o f nBR322 fl-A-iv-l) containing_thca m p s^n z  and 
a 391 bp H aeII fragment containing tnzE . coli-lacZa sequence cioneu inio a ¿-¡aelI sue. The 391 b p  fragment 
contains the lac prom oter-operator region and 59 codons o f the beginning of the lacZ gene. This part is suffi­
cient to complement the M15 deletion of the lacZ gene (ref. 70). The A cc l, H indi] and PsiT restriction sites 
in the pBR322 part o f the plasmid were removed by mutation.
Plasmids pU C8^2.7 kb; ref. 67) and pUC9 (2.7 kb; ref. 67) have the same properties as pUC7 but contain 
other sequences in the lacZa region useful for cloning DNA sequences in different reading frames with 
respect to the initiation codon. Plasmid's pUC8 and pUC9 contain the same cloning sites in the lacZa  region 
as M13mp8 (I-A-v-1) and M13mp9 (I-A-v-1), respectively. Plasmids pUC8 and pUC9 allow one to clone 
double-digested restriction fragments separately in both orientation with respect to the lac promoter.
Appendix VI -  Plasmid map of pMIRY.
pBR322 5S ETS
»  Lcu2d 1-v—   v z v z m v m  -?,TS1 -i  Nfr 2 - i
Pvu 2
Xliol Hind3 Kpn! Pstl (!,,#£ înki HmdJ H J  t Sma 1
bedh— i— i------------------- 1---------------------- f f e S i  j c : 3 ' -----------1-.» <'”■««
1,64 SäS 1223 3142 5419 7870 | 9870
8680
Clal-122/1163
EcoRl-573/1643/2390/6857/7224/7815/10120 
Ilhal-86
Hinc2-1908/2846/5479/5770/6380 
Hpa2-228/403/511/7895/8520/9245/9870 
Pvul-818 
Stul-5883/7568
Appendix VII - Plasmid map o f pFL38
632 Bgl II
Nsil
Clr101 3703
1071 Stul 
1131 Apal 
1149 Bsm I
1241 BstB I 
1300 Nco I 
1319 EcoRV 
1352 PpuMI 
1375 Xcm I
. Cla I 2665
1728 Bgl II* 
1854 ClaI *
2140 Pmll 
2256 Nrul
Appendix VIII- Plasmid Map of pAAH5.
EcoRI
Note: BHI, BamK I.
Appendix IX -  pYESj.
pYES2
5.9  k b
Appendix X -  Mfold structure (1) o f the antisense a-amylase gene sequence.
Structure 1
Appendix X -  Mfold structure (2) o f the antisense a-amylase gene sequence.
